Top

Jean-Nicolas Vauthey, MD 09

Department of Surgical Oncology, Division of Surgery

About Dr. Jean-Nicolas Vauthey

Jean-Nicolas Vauthey, MD, FACS, is Professor of Surgery and the Dallas/Fort Worth Living Legend Chair of Cancer Research in the Department of Surgical Oncology at The University of Texas MD Anderson Cancer Center in Houston.

Dr. Vauthey’s clinical research focuses on methods to measure and improve outcome after hepatic resection for hepatobiliary malignancies. He developed a standardized method for calculating the volume of the anticipated liver remnant prior to major liver resection. He created the International Cooperative Study Group for Hepatocellular Carcinoma. Based on his work, the American Joint Committee on Cancer and the International Union Against Cancer adopted a new simplified staging system for hepatocellular carcinoma. He is the Chair of The American Joint Committee on Cancer Hepatobiliary and Pancreas Task Force for the 8^th Edition of the Manual for Staging Cancer. He has evaluated the use of preoperative chemotherapy in the multidisciplinary treatment of colorectal liver metastases. He is the author of a treatment algorithm for hepatic colorectal liver metastases. His most recent research focuses on the evaluation of the biology of colorectal liver metastases. Dr. Vauthey and his research team have shown that 6 mutated genes in 5 cancer pathways predict the outcome and prognosis of Stage IV resectable and unresectable colorectal cancer. Recently, he developed a fast track treatment for multiple colorectal liver metastases combining radiological and surgical procedures in a single hybrid room with state of the art surgical and imaging technology.

Dr. Vauthey is Past President of the Americas Hepato-Pancreato-Biliary Association and current Chairman of the Board of the Society for Surgery of the Alimentary Tract. He co-authored more than 700 publications in peer-reviewed journals (citations 58607 and h-index, 119) and more than 85 reviews and book chapters in major textbooks. He is editor or co-editor of multiple textbooks devoted to hepatobiliary and pancreatic cancers. He organized and chaired Consensus Conferences on Colorectal Liver Metastases, Hepatocellular Carcinoma, Resectable and Borderline Resectable Pancreas Cancer. He is honorary member of the Portuguese Surgical Association, the Brazilian Society of Surgical Oncology, the Association de Chirurgie Hépatobiliaire et de Transplantation, as well as the European Surgical Association. He is member of the Swiss Academy of Medical Sciences and the French Academy of Surgery. He is on the editorial board of major journals including the Journal of the American College of Surgeons and Annals of Surgery. He is the recipient of multiple awards including the prestigious 2011 Faculty Achievement Award in Patient Care for his commitment to the mission of The University of Texas MD Anderson Cancer Center.

Primary Appointment

Endowed Professor Dallas/Fort Worth Living Legend Chair for Cancer Research, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

Professor, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Chair, Weekly Liver Tumor Conference, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Dallas/Fort Worth Living Legend Chair for Cancer Research, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Professor, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1983	Lausanne University Medical School, Lausanne, CH, MD
1979	Lausanne University Medical School, Lausanne, CH, MD
1973	Gymnase of Vevey, Vevey, CH, Physics and Biology, BA

Postgraduate Training

2007-2011	Advanced Cardiac Life Support, American Heart Association, Certified, American Heart Association, n/a
1993-1997	Techniques in Molecular Biology Hands–on course, University of Florida, Gainesville
1991-1993	Fellowship in Surgical Oncology, Memorial Sloan–Kettering Cancer Center, New York, New York
1989-1991	Fellow, Department of Gastrointestinal and Transplantation Surgery, University of Bern Inselspital, Bern
1984-1989	Surgery Resident and Chief Resident, Alton Ochsner Medical Foundation, New Orleans, Louisiana
1983-1984	Department of Surgery, Lausanne University Medical School Switzerland, Lausanne
1982-1983	Internal Medicine, Hospital of La Chaux De Fonds, Lausanne
1981-1982	Morbid Anatomy and Surgical Pathology, Lausanne University Medical School, Lausanne
1980-1981	Internal Medicine and Surgery, Elim Hospital, Transvaal

Licenses & Certifications

2021	Florida Telehealth
1998	Texas State Board of Medical Examiners
1991	Swiss Board of Surgery - FMH
1990	American Board of Surgery
1985	Louisiana State Medical License
1983	Federation of State Medical Board Licensing Examination (FLEX)
1981	VQE
1979	ECFMG

Experience & Service

Faculty Academic Appointments

Bessie McGoldrick Professor in Clinical Cancer Research, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2018

Associate Professor, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 1998 - 2002

Associate Professor, Department of Surgery, University of Florida Shands Hospital, Gainesville, FL, 1997 - 1998

Assistant Professor, Department of Surgery, University of Florida Shands Hospital, Gainesville, FL, 1993 - 1997

Administrative Appointments/Responsibilities

Chief, Hepato-Pancreato-Biliary Section, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - Present

Chair, Weekly Liver Tumor Conference, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 1999 - Present

Other Professional Positions

Chairman of the Board of Trustees, The Society for Surgery of the Alimentary Tract, 2022 - 2023

President, The Society for Surgery of the Alimentary Tract, 2021 - 2023

Chair, Hepatobiliary Expert Panel, AJCC Cancer Staging Manual 8th Edition, Chicago, IL, 2013 - Present

Program Director, Hepato-Pancreato-Biliary Association Fellowship, Houston, TX, 2011 - Present

President, Americas Hepato-Pancreato-Biliary Association, Kansas City, MO, 2011 - 2012

Chair, Advisory Board, Sanofi-Aventis, New York, NY, 2008

Review Panel, Gastrointestinal Tumors Cancer Protocol, College of American Pathologists, 2008 - Present

Consultant, Advisory Board, Genentech, Los Angeles, CA, 2008

Chair, Hepatobiliary Task Force Committee, American Joint Commission on Cancer, 2007 - Present

Advisory Board, Scientific Publications, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006 - Present

Chair, Department of Surgical Oncology Grand Rounds, Surgery of Hepatic Colorectal Metastases, The University of Texas MD Anderson Cancer Center, Houston, TX, 2005

Consultant, Advisory Board, Sanofi-Synthelabo Oncology, Inc, Cape Cod, MA, 2004

Chair, Liver/Pancreas Symposium, The University of Texas MD Anderson Cancer Center, Houston, TX, 2004

Chair, Liver/Pancreas Symposium, The University of Texas MD Anderson Cancer Center, Houston, TX, 2003

Chair, Institutional Grand Rounds, Hepatocellular Carcinoma, The University of Texas MD Anderson Cancer Center, Houston, TX, 2003

Representative, Hepatobiliary and Neuroendocrine Cancers, National Comprehensive Cancer Network, Unknown, 2002 - Present

Member, Hepatobiliary Task Force Committee, American Joint Commission on Cancer, Chicago, IL, 2001 - 2006

Extramural Institutional Committee Activities

Co-Chair, Cholangiocarcinoma Institutional Working Group, The University of Texas MD Anderson Cancer Center, 2013 - 2015

Advisor, CME Advisory Committee, The University of Texas MD Anderson Cancer Center, 2011 - 2013

Co-Director, HPB Fellowship Program, The University of Texas MD Anderson Cancer Center, 2011 - 2020

Member, Finance Committee, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2009 - 2012

Member, Perioperative Enterprise Vendor Access, The University of Texas MD Anderson Cancer Center, 2008 - 2010

Chair, Steering Committee, The Institute Gustave Roussy and The University of Texas M. D. Anderson Cancer Center – Sister Institution Conference, The University of Texas MD Anderson Cancer Center, 2006 - 2008

Member, Steering Committee, Extramural Programs, The University of Texas MD Anderson Cancer Center, 2004 - 2008

Alternate Member, Surgical Oncology, CME Advisory Committee, The University of Texas MD Anderson Cancer Center, 2001 - 2023

Editorial Activities

Associate Editor, Liver Cancer, 2022 - Present

Editorial Board, Global Health & Medicine, 2019 - Present

Associate Editor, Digestive Surgery, 2018 - 2022

Editorial Board, Journal of Gastrointestinal Surgery, 2012 - Present

Editorial Board, Liver Cancer, 2012 - 2021

Editorial Board, Updates in Surgery, 2010 - Present

Editorial Board, World Journal of Clinical Oncology, 2010 - 2014

Editorial Board, Annals of Surgical Oncology, 2010 - 2012

Hepatobiliary Staging Chapters, The 7th Edition of the AJCC Cancer Staging Manual, 2009 - Present

Editorial Board, Surgery, 2009 - 2021

Editorial Board, Annals of Surgery, 2009 - Present

Editorial Board, World Journal of Hepatology, 2009 - Present

Editorial Board, Journal of the American College of Surgeons, 2003 - Present

Editorial Board, Annals of Surgical Oncology, 2002 - 2008

Honors & Awards

2024	Legacy in Hepato-Pancreato-Biliary Surgery, Moffitt Cancer Center HPB Group
2024	Honorary Member, International Hepato-Pancreato-Biliary Association
2023	Honorary Member, Mexican Association of Digestive System Surgery, AC
2022	President, The Society for Surgery of the Alimentary Tract
2022	Honorary Membership, German Surgical Society (Deutsche Gesellschaft tor Chirurgie)
2022	Professor Bismuth Compagnon Hépatobiliaire, IHPBA
2021 - 2023	Jean-Nicolas Vauthey, M.D. Endowed Lectureship for Liver-Directed Therapy, Board of Regents of The University of Texas System
2021 - 2022	Outstanding Contribution Award, Hepatobiliary Surgery and Nutrition(HBSN)
2018	Best Doctors in America
2017	Swiss Academy of Medical Sciences, Corresponding Member
2017	Brazilian Society of Surgical Oncology, Honorary Member
2017	European Surgical Association, Honorary Member
2017	Portuguese Surgical Society, Honorary Member, Congresso Nacional De Cirurgia
2017	Thomas E. Weiss Outstanding Alumnus, Ochsner Medical Center
2016	Recognized Reviewer, Surgical Oncology
2016	Outstanding Reviewer, European Journal of Surgical Oncology
2016	Outstanding Reviewer, Journal of Hepatology
2014	The European Society of Surgical Oncology Medal, ESSO -BASO 2014 Congress, October 29-31
2012	Cancer Fighters' Eagle Award, Cancer Fighters of Houston, Inc
2012	Highly Commended Certificate for Venous Embolization of the Liver: Radiologic and Surgical Practice book in the Radiology category, British Medical Association
2011	Apple Award, MD Anderson Patient Education Office and the Health Education Week 2011 Committee
2011	Faculty Achievement Award in Patient Care, The University of Texas MD Anderson Cancer Center
2007	French Academy of Surgery (Academie Francaise de Chirurgie), Associate Membership
2006	Center for Biomedical Engineering Summer Internship Program Excellence in Teaching Award, The University of Texas MD Anderson Cancer Center
2005 - 2024	America's Top Doctors, Castle Connolly Medical Ltd
2004	Honorary Member, Association de Chirurgie Hepatobiliaire et de Transplantation
2002	Outstanding Teacher Award, MD Anderson Cancer Center
2001	Merit Award, National Health Information Award, MD Anderson Cancer Center
1996	Lester R. Dragstedt Physician–Scientist Award, University of Florida
1995	Research Development Award, University of Florida
1987 - 1988	Clinical Paper Award, Alton Ochsner Medical Foundation
1987	Case Report Award, Alton Ochsner Medical Foundation
1987	President's Award Best Scientific Paper, Southern Thoracic Surgical Association
1984	Poster Award, Swiss Surgical Society

Professional Memberships

College of American Pathologists

2014

European Journal of Surgical Oncology

2013 - Present

Americas Hepato-Pancreato-Biliary Foundation (AHPBF)

2013 - 2014

International Hepato-Pancreato-Biliary Association

2012 - Present

American Surgical Association

2010

The Society of Surgical Oncology

2005 - 2007

Journal of Gastrointestinal Surgery

2005 - 2006

Americas Hepato-Pancreato-Biliary Association (AHPBA)

2003 - 2012

The Society for Surgery of the Alimentary Tract

2002 - Present

Harris County Medical Society

1998 - Present

American Pancreatic Association

1995 - 2005

European Society of Surgical Oncology

1991 - 2008

The Society of American Gastrointestinal and Endoscopic Surgeons

1989 - 2009

Selected Presentations & Talks

Local Presentations

2024. Colorectal Liver Metastasis: Pro-Resection. Houston, Texas, US.
2022. Transplantation of colorectal METS: are we there?. Conference. Transplantation of colorectal METS: are we there?. Houston, TX, US.
2021. Advances in the Treatment of Colorectal Liver Metastases. Conference. Advances in the Treatment of Colorectal Liver Metastases. Houston, TX, US.
2018. Criteria for resectability of colorectal liver metastases. Conference. Criteria for resectability of colorectal liver metastases. Houston, TX, US.
2017. Applied Liver Anatomy. Conference. Applied Liver Anatomy. Houston, TX, US.
2017. Optimal Exposure for Advanced Liver Surgery. Conference. Optimal Exposure for Advanced Liver Surgery. Houston, TX, US.
2017. Introduction: Hepatobiliary and pancreas surgery improvements, outcomes and minimally invasive procedures. Conference. Introduction: Hepatobiliary and pancreas surgery improvements, outcomes and minimally invasive procedures. Houston, TX, US.
2017. Cholangio Surgical Overview. Conference. Cholangio Surgical Overview. Houston, TX, US.
2016. Resection for cholangiocarcinoma. Conference. Resection for cholangiocarcinoma. Houston, TX, US.
2016. Hepatic surgery-patient selection, surgical anatomy, surgical techniques, postsurgical follow-up. Conference. Hepatic surgery-patient selection, surgical anatomy, surgical techniques, postsurgical follow-up. Houston, TX, US.
2016. Is stage IV cancer curable? Treatment paradigms for stage IV metastatic colorectal cancer in the liver. Conference. Is stage IV cancer curable? Treatment paradigms for stage IV metastatic colorectal cancer in the liver. Houston, TX, US.
2014. Evaluation and Prognosis of Patients Undergoing Resection of Colorectal Liver Metastases: The Emerging Role of RAS Mutations. Conference. Evaluation and Prognosis of Patients Undergoing Resection of Colorectal Liver Metastases: The Emerging Role of RAS Mutations. Houston, TX, US.
2014. Management of Neuroendocrine Liver Metastases: A Surgical Perspective. Conference. Management of Neuroendocrine Liver Metastases: A Surgical Perspective. Houston, TX, US.
2013. Hot Topics Debate: Resection or transplantation for hepatocellular carcinoma. Conference. Hot Topics Debate: Resection or transplantation for hepatocellular carcinoma. Houston, TX, US.
2013. Liver resection for neuroendocrine cancer. Conference. Liver resection for neuroendocrine cancer. Houston, TX, US.
2013. Liver Volumetry. Conference. Liver Volumetry. Houston, TX, US.
2011. MD Anderson Cancer Center Clinical Guidelines Update Videoconference. Conference. MD Anderson Cancer Center Clinical Guidelines Update Videoconference. Houston, TX, US.
2010. Hepatocellular Carcinoma Setting The Stage. Conference. Hepatocellular Carcinoma Setting The Stage. Houston, TX, US.
2010. New Approaches to Diseases of the Liver. Conference. New Approaches to Diseases of the Liver. Houston, TX, US.
2010. Methods to Improve Resectability. Conference. Methods to Improve Resectability. Houston, TX, US.
2009. Treatment of Liver Metastases from Colorectal Cancer: The Field has Changed. Conference. Treatment of Liver Metastases from Colorectal Cancer: The Field has Changed. Houston, TX, US.
2009. Techniques: Liver Resection. Conference. Techniques: Liver Resection. Houston, TX, US.
2009. Therapies for Hepatocellular Carcinoma. Conference. Therapies for Hepatocellular Carcinoma. Houston, TX, US.
2008. Surgical Treatment of Colorectal Cancer Liver Metastases. Conference. Surgical Treatment of Colorectal Cancer Liver Metastases. Houston, TX, US.
2008. Evaluation of the Future Liver Remnant Prior to Liver Resection. Conference. Evaluation of the Future Liver Remnant Prior to Liver Resection. Houston, TX, US.
2007. Hilar Cholangiocarcinoma. Conference. Hilar Cholangiocarcinoma. Houston, TX, US.
2006. Is extended hepatectomy for hilar cholangiocarcinoma justified?. Conference. Is extended hepatectomy for hilar cholangiocarcinoma justified?. Houston, TX, US.
2003. Role of Portal Vein Embolization Prior to Major Liver Resection. Conference. Role of Portal Vein Embolization Prior to Major Liver Resection. Houston, TX, US.
2003. Resection and Staging of Hepatocellular Carcinoma. Conference. Resection and Staging of Hepatocellular Carcinoma. Houston, TX, US.
2002. Hepatocellular Carcinoma. Conference. Hepatocellular Carcinoma. Houston, TX, US.
2002. Techniques to Improve Outcome After Hepatic Resection. Conference. Techniques to Improve Outcome After Hepatic Resection. Houston, TX, US.
2002. Bile Duct Strictures. Conference. Bile Duct Strictures. Houston, TX, US.
2001. Liver Anatomy. Conference. Liver Anatomy. Houston, TX, US.
2001. Techniques to improve outcome after hepatic resection. Conference. Techniques to improve outcome after hepatic resection. Houston, TX, US.
2001. Hepatocellular Carcinoma: an update and techniques to improve outcome after liver resection. Conference. Hepatocellular Carcinoma: an update and techniques to improve outcome after liver resection. Houston, TX, US.
2000. Special Liver Cancer Seminar. Conference. Special Liver Cancer Seminar. Houston, TX, US.
1999. Surgical Approaches to Liver Metastases. Conference. Surgical Approaches to Liver Metastases. Houston, TX, US.
1999. New Algorithms in Hepatocellular Carcinoma. Conference. New Algorithms in Hepatocellular Carcinoma. Houston, TX, US.
1999. New Algorithms in Hepatocellular Carcinoma. Conference. New Algorithms in Hepatocellular Carcinoma. Houston, TX, US.

Regional Presentations

2022. Biology of Hepatocellular Carcinoma versus Colorectal Cancer Metastasis for Transplantation Considerations. Conference. Biology of Hepatocellular Carcinoma versus Colorectal Cancer Metastasis for Transplantation Considerations. San Antonio, TX, US.
2017. Biology Predicts Outcomes in Patients Undergoing Local Therapy for Colorectal Liver Metastases. Conference. Biology Predicts Outcomes in Patients Undergoing Local Therapy for Colorectal Liver Metastases. Houston, US.
2013. From multidiscliplinary to personalized treatment of colorectal liver metastases. Conference. From multidiscliplinary to personalized treatment of colorectal liver metastases. Dallas, TX, US.
2008. Therapies for Hepatocellular Carcinoma. Conference. Therapies for Hepatocellular Carcinoma. San Antonio, TX, US.
2008. Surgical Approach to Hepatic Metastases. Conference. Surgical Approach to Hepatic Metastases. San Antonio, TX, US.
2005. Is extended hepatectomy for hepatobiliary malignance justified?. Conference. Is extended hepatectomy for hepatobiliary malignance justified?. Torino, IT.
2004. Anatomy and Embolization of the Portal Venous System. Conference. Anatomy and Embolization of the Portal Venous System. The Woodlands, TX, US.
2002. Multidisciplinary Management of Gastrointestinal Malignancies; Management of Cholangiocarcinoma. Conference. Multidisciplinary Management of Gastrointestinal Malignancies; Management of Cholangiocarcinoma. Maui, HI, US.
1999. Recent Advances in the Treatment and Outcome of Rectal Cancer and Hepatic Colorectal Metastases. Conference. Recent Advances in the Treatment and Outcome of Rectal Cancer and Hepatic Colorectal Metastases. Brownsville, TX, US.
1998. Hepatocellular Carcinoma with or without Preoperative Chemoembolization. Conference. Hepatocellular Carcinoma with or without Preoperative Chemoembolization. Orlando, FL, US.
1998. Recent Improvements in the Treatment and Outcome of Locally Advanced Rectal Cancer. Conference. Recent Improvements in the Treatment and Outcome of Locally Advanced Rectal Cancer. Gainesville, FL, US.
1998. Hepatobiliary Cancer. Conference. Hepatobiliary Cancer. Orlando, FL, US.
1998. Laparoscopic Adrenalectomy. Conference. Laparoscopic Adrenalectomy. Orlando, FL, US.
1998. Pheochromocytoma. Conference. Pheochromocytoma. Gainesville, FL, US.
1998. New Surgical Approaches to Locally Advanced Rectal Cancer. Conference. New Surgical Approaches to Locally Advanced Rectal Cancer. Gainesville, FL, US.
1998. Benign liver Masses. Conference. Benign liver Masses. Gainesville, FL, US.
1998. Benign Biliary Stricture. Conference. Benign Biliary Stricture. Gainesville, FL, US.
1997. Primary and Metastatic Liver Cancer. Conference. Primary and Metastatic Liver Cancer. Gainesville, FL, US.
1997. Benign Bile Duct Strictures. Conference. Benign Bile Duct Strictures. Gainesville, FL, US.
1997. Surgical Therapy of Colorectal Metastases. Conference. Surgical Therapy of Colorectal Metastases. Orlando, FL, US.
1996. Hydatid Infection and Liver Cysts. Conference. Hydatid Infection and Liver Cysts. Gainesville, FL, US.
1996. Management of Persistent or Recurrent Secondary Hyperparathyroidism. Conference. Management of Persistent or Recurrent Secondary Hyperparathyroidism. Gainesville, FL, US.
1996. Peutz–Jeghers Syndrome and Cancer. Conference. Peutz–Jeghers Syndrome and Cancer. Gainesville, FL, US.
1996. Management of Liver Malignancy. Conference. Management of Liver Malignancy. Titusville, FL, US.
1996. Panelist: Second Annual Oncology Symposium of the University of Florida. Conference. Panelist: Second Annual Oncology Symposium of the University of Florida. Orlando, FL, US.
1996. Management of Hepatic Injury. Conference. Management of Hepatic Injury. Gainesville, FL, US.
1996. Management of Hepatic Malignancy. Conference. Management of Hepatic Malignancy. Gainesville, FL, US.
1995. Management of Primary and Secondary Liver Tumors. Conference. Management of Primary and Secondary Liver Tumors. Jacksonville, FL, US.
1995. Role of Biological Markers in Colorectal Cancer. Conference. Role of Biological Markers in Colorectal Cancer. Orlando, FL, US.
1994. Hepatic Resection for Liver Neoplasms. Conference. Hepatic Resection for Liver Neoplasms. Gainesville, FL, US.
1994. Management of Cholangiocarcinomas. Conference. Management of Cholangiocarcinomas. Gainesville, FL, US.
1993. Transthoracic versus Transhiatal Esophagectomy for Esophageal Carcinoma. Conference. Transthoracic versus Transhiatal Esophagectomy for Esophageal Carcinoma. New York, NY, US.
1993. Hepatocarcinoma: a Comparison of Outcome between Caucasians and Orientals after Hepatic Resection at Memorial Sloan–Kettering Cancer Center (1970–1992). Conference. Hepatocarcinoma: a Comparison of Outcome between Caucasians and Orientals after Hepatic Resection at Memorial Sloan–Kettering Cancer Center (1970–1992). New York, NY, US.
1993. Transhiatal Esophagectomy for Gastroesophageal Junction Carcinoma. Conference. Transhiatal Esophagectomy for Gastroesophageal Junction Carcinoma. New York, NY, US.
1992. Palliation of Unresectable Pancreatic Cancer: Vicissitudes of Gastro-Jejunostomy. Conference. Palliation of Unresectable Pancreatic Cancer: Vicissitudes of Gastro-Jejunostomy. New York, NY, US.
1992. Surgical Resection of Pulmonary Metastasis from Head and Neck Cancer. Conference. Surgical Resection of Pulmonary Metastasis from Head and Neck Cancer. New York, NY, US.
1992. Radiation Therapy For Extremity Sarcomas: Yes or No. Conference. Radiation Therapy For Extremity Sarcomas: Yes or No. New York, NY, US.
1991. Proximal Bile Duct Tumors. Conference. Proximal Bile Duct Tumors. New York, NY, US.
1987. Distal Splenorenal Shunt for Definitive Treatment of Bleeding Esophageal Varices: A Fourteen Year Experience. Conference. Distal Splenorenal Shunt for Definitive Treatment of Bleeding Esophageal Varices: A Fourteen Year Experience. New Orleans, LA, US.
1986. Distal Splenorenal Shunt for Definitive Treatment of Bleeding Esophageal Varices: A Fourteen Year Experience. Conference. Distal Splenorenal Shunt for Definitive Treatment of Bleeding Esophageal Varices: A Fourteen Year Experience. New Orleans, LA, US.

National Presentations

2025. Personalized Treatment of Colorectal Liver Metastases. Visiting. Visiting Professor Grand Rounds Lecture. Irvine, California, US.
2024. Personalized Treatment of Colorectal Liver Metastases. Mount Sinai School of Medicine. New York, NY, US.
2024. Transplantation versus resection for colorectal liver metastases. Invited. 2024 ILTS Annual Congress. Houston, Texas, US.
2023. Tumor board complex and controversial cases. Conference. Tumor board complex and controversial cases. ZOOM, US.
2023. Advances in tumor biology of colorectal liver metastases. Conference. Advances in tumor biology of colorectal liver metastases. Webinar #2, US.
2023. Meet the Experts - HPB Malignancies. Conference. Meet the Experts - HPB Malignancies. Boston, MA, US.
2023. Standard of Care and Next Frontiers in the United States: Surgical Oncology. Conference. Standard of Care and Next Frontiers in the United States: Surgical Oncology. via ZOOM, US.
2023. Management of Catastrophic Complications. Conference. Management of Catastrophic Complications. Miami, FL, US.
2023. Resection and ablation for metastatic colon cancer to the liver. Conference. Resection and ablation for metastatic colon cancer to the liver. Whistler.
2023. Optimization of resection: management of synchronous metastatic from colorectal cancer. Conference. Optimization of resection: management of synchronous metastatic from colorectal cancer. Whistler.
2022. Integrating Tumor Biology Into Your Practice. Mutational Profiling and the Use of ctDNA as a Biomarker for Patients with Locoregional and Metastatic Colorectal Cancer. Conference. Integrating Tumor Biology Into Your Practice. Mutational Profiling and the Use of ctDNA as a Biomarker for Patients with Locoregional and Metastatic Colorectal Cancer. San Diego, CA, US.
2022. SSAT Presidential Address. Conference. SSAT Presidential Address. San Diego, CA, US.
2021. Advances in the treatment of colorectal liver metastases. Conference. Advances in the treatment of colorectal liver metastases. via ZOOM, US.
2021. COVID-19 and Surgery at MD Anderson Cancer Center. Conference. COVID-19 and Surgery at MD Anderson Cancer Center. via ZOOM, US.
2021. Molecular Genomics and Biomarkers in Colorectal Liver Metastases. Conference. Molecular Genomics and Biomarkers in Colorectal Liver Metastases. via ZOOM, US.
2020. Synchronous Colorectal Primary and Liver Metastasis. Conference. Synchronous Colorectal Primary and Liver Metastasis. via ZOOM, US.
2020. Should surgeons go out of the box to improve liver cancer patient’s outcomes?. Conference. Should surgeons go out of the box to improve liver cancer patient’s outcomes?. via ZOOM, US.
2020. Personalized Medicine in Metastatic Colorectal Cancer: Hype or Reality?. Conference. Personalized Medicine in Metastatic Colorectal Cancer: Hype or Reality?. Miami, FL, US.
2020. The Integration of Genetic Data into Clinical Decision-Making: Case Presentation. Conference. The Integration of Genetic Data into Clinical Decision-Making: Case Presentation. Miami, FL, US.
2020. Colorectal Liver Metastases Tumor Boards. Conference. Colorectal Liver Metastases Tumor Boards. New Orleans, LA, US.
2020. Sequencing of Surgical Interventions. Conference. Sequencing of Surgical Interventions. New Orleans, LA, US.
2020. Surgical Decision Making for Hilar Cholangiocarcinoma. Conference. Surgical Decision Making for Hilar Cholangiocarcinoma. New Orleans, LA, US.
2019. Resection for Metastatic Colorectal Cancer MD Anderson Cancer Center perspective. Conference. Resection for Metastatic Colorectal Cancer MD Anderson Cancer Center perspective. New York, NY, US.
2019. Innovation and future perspectives in HPB Oncology. Conference. Innovation and future perspectives in HPB Oncology. San Diego, CA, US.
2019. Using genetic profile to guide surgical therapy of CRLM. What are the future challenges?. Conference. Using genetic profile to guide surgical therapy of CRLM. What are the future challenges?. Miami, FL, US.
2019. Biology and Selection of Approaches in Advanced Disease. Conference. Biology and Selection of Approaches in Advanced Disease. Houston, TX, US.
2016. Role of RAS Mutations in Selection of Patients for Resection of CRC Mets. Conference. Role of RAS Mutations in Selection of Patients for Resection of CRC Mets. San Diego, CA, US.
2016. Pure Laparoscopic Hepatectomy Versus Open Hepatectomy For Hepatocellular Carcinoma In 110 Patients With Liver Cirrhosis- A Propensity Analysis In A Single Center. Conference. Pure Laparoscopic Hepatectomy Versus Open Hepatectomy For Hepatocellular Carcinoma In 110 Patients With Liver Cirrhosis- A Propensity Analysis In A Single Center. Chicago, IL, US.
2015. Preoperative cholangitis and future liver remnant volume determine the risk of liver failure in patients undergoing resection for hilar cholangiocarcinoma. Conference. Preoperative cholangitis and future liver remnant volume determine the risk of liver failure in patients undergoing resection for hilar cholangiocarcinoma. Napa Valley, CA, US.
2015. Predictors of safety and efficacy of two-stage hepatectomy for bilateral colorectal liver metastases. Conference. Predictors of safety and efficacy of two-stage hepatectomy for bilateral colorectal liver metastases. Napa Valley, CA, US.
2015. Resecting the unresectable colorectal hepatic metastasis. Conference. Resecting the unresectable colorectal hepatic metastasis. Houston, TX, US.
2014. Moderator, SSAT 2014 Residents and Fellows Research Conference. Conference. Moderator, SSAT 2014 Residents and Fellows Research Conference. Chicago, IL, US.
2014. Emerging role of RAS mutations in colorectal liver metastases. Conference. Emerging role of RAS mutations in colorectal liver metastases. Miami Beach, FL, US.
2013. Morbidity and mortality after pancreaticoduodenectomy in patients with borderline resectable Type C clinical classification. Conference. Morbidity and mortality after pancreaticoduodenectomy in patients with borderline resectable Type C clinical classification. Orlando, FL, US.
2013. Discussant, Modern chemotherapy mitigates adverse prognostic effect of regional nodal metastases in stage iv colorectal cancer. Conference. Discussant, Modern chemotherapy mitigates adverse prognostic effect of regional nodal metastases in stage iv colorectal cancer. Orlando, FL, US.
2013. Safety and efficacy of portal vein embolization before planned major or extended hepatectomy: an institutional experience of 358 patients. Conference. Safety and efficacy of portal vein embolization before planned major or extended hepatectomy: an institutional experience of 358 patients. Orlando, FL, US.
2013. Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion rates and survival. Conference. Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion rates and survival. Orlando, FL, US.
2013. RAS mutational status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases. Conference. RAS mutational status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases. Indianapolis, IN, US.
2013. Minimizing Posthepatectomy Liver Failure: Does ALPPS Represent a True Advance?. Conference. Minimizing Posthepatectomy Liver Failure: Does ALPPS Represent a True Advance?. National Harbor, MD, US.
2013. Debate: ALPPS versus two-stage hepatectomy for colorectal liver metastases. Conference. Debate: ALPPS versus two-stage hepatectomy for colorectal liver metastases. Miami, FL, US.
2013. Discussant: Discordance between conventional and detailed lymph node analysis in resected biliary carcinoma at or above the cystic duct: are we understaging patients?. Conference. Discussant: Discordance between conventional and detailed lymph node analysis in resected biliary carcinoma at or above the cystic duct: are we understaging patients?. Miami, FL, US.
2012. Staging Systems and Epidemiology. Conference. Staging Systems and Epidemiology. Chicago, IL, US.
2012. Tumor Board. Conference. Tumor Board. Chicago, IL, US.
2012. New paradigms for management of colorectal liver metastasis: ALPPS: An important advance in hepatic surgery or just European vacation. Conference. New paradigms for management of colorectal liver metastasis: ALPPS: An important advance in hepatic surgery or just European vacation. Chicago, IL, US.
2012. Primary Discussant, Right hepatectomy with caval thrombectomy after neoadjiuvant therapy-tace and sorafenib-for HCC with caval thrombosis. Conference. Primary Discussant, Right hepatectomy with caval thrombectomy after neoadjiuvant therapy-tace and sorafenib-for HCC with caval thrombosis. San Diego, CA, US.
2012. Moderator, SSAT/AHPBA Joint symposium: Evaluation and treatment of benign liver neoplasms. Conference. Moderator, SSAT/AHPBA Joint symposium: Evaluation and treatment of benign liver neoplasms. San Diego, CA, US.
2012. Moderator, SSAT/MOC/Postgraduate Course: Evidence based treatment of hepatopancreatobiliary disease. Conference. Moderator, SSAT/MOC/Postgraduate Course: Evidence based treatment of hepatopancreatobiliary disease. San Diego, CA, US.
2012. Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases. Conference. Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases. San Francisco, CA, US.
2012. The Best of 2012 AHPBA/SSO/SSAT Consensus Conference on the Multidiscliplinary Treatment of Colorectal Cancer Liver Metastases - Panelist. Conference. The Best of 2012 AHPBA/SSO/SSAT Consensus Conference on the Multidiscliplinary Treatment of Colorectal Cancer Liver Metastases - Panelist. Miami, FL, US.
2012. President's Plenary Session with Research and Traveling Fellowship Presentations - Moderator. Conference. President's Plenary Session with Research and Traveling Fellowship Presentations - Moderator. Miami, FL, US.
2012. AHPBA Presidential Address: From Couinaud to Molecular Biology: The Seven Virtues of HPB Surgery. Conference. AHPBA Presidential Address: From Couinaud to Molecular Biology: The Seven Virtues of HPB Surgery. Miami, FL, US.
2011. Hepatocellular Carcinoma: Staging Systems and Epidemiology. Conference. Hepatocellular Carcinoma: Staging Systems and Epidemiology. Chicago, IL, US.
2011. Discussant: Metastatic Pancreatic Neuroendocrine Carcinoma to the Liver: Surgical Treatment Options. Conference. Discussant: Metastatic Pancreatic Neuroendocrine Carcinoma to the Liver: Surgical Treatment Options. Tuscon, AZ, US.
2011. Bile Leak Post Resection: Controlled, Uncontrolled - Includes Bilioenteric Anastomotic Leaks. Conference. Bile Leak Post Resection: Controlled, Uncontrolled - Includes Bilioenteric Anastomotic Leaks. San Francisco, CA, US.
2011. How to succeed in academic surgery: The early years: Finding your strengths and leveraging your institutional assets. Conference. How to succeed in academic surgery: The early years: Finding your strengths and leveraging your institutional assets. Chicago, IL, US.
2011. Moderator, Pure laparoscopic hepatectomy for HCC patients with severe liver cirrhosis. Conference. Moderator, Pure laparoscopic hepatectomy for HCC patients with severe liver cirrhosis. Chicago, IL, US.
2010. Curable Metastatic Colorectal Cancer. Conference. Curable Metastatic Colorectal Cancer. Philadelphia, PA, US.
2010. Panelist, Advanced Colorectal Cancer Discussion. Conference. Panelist, Advanced Colorectal Cancer Discussion. Philadelphia, PA, US.
2010. Challenging Liver Cases Presentation and Interactive Audience Participation. Conference. Challenging Liver Cases Presentation and Interactive Audience Participation. New York, NY, US.
2010. Pre-Operative Vascular Redistribution to Enhance Hepatic Resectability. Conference. Pre-Operative Vascular Redistribution to Enhance Hepatic Resectability. New York, NY, US.
2009. Hepatocellular Carcinoma: Setting the Stage. Conference. Hepatocellular Carcinoma: Setting the Stage. Chicago, IL, US.
2009. Neo-adjuvant treatment of liver metastases from colorectal cancer: The field has changed. Conference. Neo-adjuvant treatment of liver metastases from colorectal cancer: The field has changed. Chicago, IL, US.
2009. Techniques to Increase Resectability of Liver Tumors. Conference. Meet the Professor Luncheon. Chicago, IL, US.
2009. Three Hundred and One Consecutive Extended Right Hepatectomies - Evaluation of outcome based on systematic liver volumetry. Conference. Three Hundred and One Consecutive Extended Right Hepatectomies - Evaluation of outcome based on systematic liver volumetry. Indian Wells, CA, US.
2009. Chemotherapy induced Hepatoxicity: work-up and therapeutic Strategies. Conference. Chemotherapy induced Hepatoxicity: work-up and therapeutic Strategies. Miami Beach, FL, US.
2009. HAI therapy for colorectal metastases – is there a role. Conference. Moderator; Special Debate II. Miami Beach, FL, US.
2009. How evidence-based medicine can be used to advance HPB Surgery in the Americas/High impact PRCTs in HPB Disease: Neoadjuvant Therapy for Colorectal Liver Metastases: EORTC 40983. Conference. How evidence-based medicine can be used to advance HPB Surgery in the Americas/High impact PRCTs in HPB Disease: Neoadjuvant Therapy for Colorectal Liver Metastases: EORTC 40983. Miami Beach, FL, US.
2009. Surgical Resection of Hepatocellular Carcinoma: Patient Selection, Pre-operative Considerations and Operative Technique. Conference. Surgical Resection of Hepatocellular Carcinoma: Patient Selection, Pre-operative Considerations and Operative Technique. Phoenix, AZ, US.
2008. Methods to Improve Resectability. Conference. 48th Annual Meeting of the Society for Surgery of the Alimentary Tract. San Diego, CA, US.
2008. Standard of Care for Metastatic Colorectal Cancer: Still a Shifting Paradigm. Conference. Tulane University Health Sciences Center. New Orleans, LA, US.
2008. For More Tomorrows. Conference. A Colorectal Cancer Advocacy Roundtable. Washington, DC, US.
2008. Benign Liver Tumors: Changing Management Paradigm?. Conference. American Hepato-Pancreato-Biliary Association 8th Annual Meeting. Ft. Lauderdale, FL, US.
2008. Chemotherapy Associated Hepatotoxicity: Do We Need to be Concerned?. Conference. The Society of Surgical Oncology. Chicago, IL, US.
2007. The Role of Surgery in Colorectal Cancer with Liver Metastases. Conference. Second Annual GI Cancer Symposium: Liver Cancer. Cincinnati, OH, US.
2007. Assessing and Managing the Future Liver Remnant, State of the Art Lecture,. Conference. Hepato-Pancreato-Biliary Association Annual Meeting. Las Vegas, NV, US.
2007. Case Presentations - Controversies in Hepatobiliary Surgery. Conference. Society of Surgical Oncology, 60th Annual Cancer Symposium. Washington, DC, US.
2006. Adjuvant Trials after Resection: What is the Primary End-point?. Conference. Adjuvant Trials after Resection: What is the Primary End-point?. Atlanta, GA, US.
2006. Outcome of Liver Transplantation in 490 Patients with Hepatocellular Carcinoma: Validation of a Uniform Staging after Surgical Treatment. Conference. Outcome of Liver Transplantation in 490 Patients with Hepatocellular Carcinoma: Validation of a Uniform Staging after Surgical Treatment. West Palm Beach, FL, US.
2006. Hepatic Insufficiency and Mortality in 1059 Noncirrhotic Patients Undergoing Major Hepatectomy. Conference. Hepatic Insufficiency and Mortality in 1059 Noncirrhotic Patients Undergoing Major Hepatectomy. West Palm Beach, FL, US.
2006. Multidiscliplinary Management of Gastrointestinal Malignancies. Conference. Multidiscliplinary Management of Gastrointestinal Malignancies. Chicago, IL, US.
2006. Symposia: Multidiscliplinary Management of Colorectal Metastases. Current and Emerging Trends - Multimodal Therapy Downstaging Hepatic Metastases and Improving Resectability. Conference. Symposia: Multidiscliplinary Management of Colorectal Metastases. Current and Emerging Trends - Multimodal Therapy Downstaging Hepatic Metastases and Improving Resectability. San Diego, CA, US.
2006. Neo-adjuvant chemotherapy prior to hepatic resection: helpful or harmful?. Conference. Neo-adjuvant chemotherapy prior to hepatic resection: helpful or harmful?. Miami Beach, FL, US.
2005. Evaluation of the Minimal Functional Liver Mass in Hepatic Surgery. Conference. Evaluation of the Minimal Functional Liver Mass in Hepatic Surgery. Hyannis, MA, US.
2005. Treatment Options for Hepatic Colorectal Metastases. Conference. Treatment Options for Hepatic Colorectal Metastases. Atlanta, GA, US.
2004. Effect of Surgical Margin Status on Survival and Site of Recurrence after Hepatic Resection for Colorectal Metastases. Conference. Effect of Surgical Margin Status on Survival and Site of Recurrence after Hepatic Resection for Colorectal Metastases. Palm Beach, FL, US.
2004. Neoadjuvant Chemotherapy for Colorectal Cancer Liver Metastases. Conference. Neoadjuvant Chemotherapy for Colorectal Cancer Liver Metastases. Kauai, HI, US.
2004. Preoperative Portal Vein Embolization to Improve Outcome After Resection of Hepatic Cancers. Conference. Preoperative Portal Vein Embolization to Improve Outcome After Resection of Hepatic Cancers. Kauai, HI, US.
2004. Simplified AJCC/UICC Staging for Hepatocellular Carcinoma: Implications for Resection and Transplantation. Conference. Simplified AJCC/UICC Staging for Hepatocellular Carcinoma: Implications for Resection and Transplantation. Seoul.
2004. Making Unresectable Liver Metastases Resectable. Does it work?. Conference. Making Unresectable Liver Metastases Resectable. Does it work?. Arlington, VA, US.
2003. Is Extended Hepatectomy in Hepatobiliary Malignancy Justified?. Conference. Is Extended Hepatectomy in Hepatobiliary Malignancy Justified?. Hot Springs, VA, US.
2003. Comparison of resection, ablation, and transplantation for hepatocellular carcinoma. Conference. Comparison of resection, ablation, and transplantation for hepatocellular carcinoma. Williamsburg, VA, US.
2003. A Multi-Institutional Phase II Trial of Neoadjuvant Capecitabine and Oxaliplatin for Resectable Colorectal Metastases in the Liver - NCI Protocol #6021. Conference. A Multi-Institutional Phase II Trial of Neoadjuvant Capecitabine and Oxaliplatin for Resectable Colorectal Metastases in the Liver - NCI Protocol #6021. Seattle, WA, US.
2003. Neoadjuvant Chemotherapy For Liver Metastases. Conference. Neoadjuvant Chemotherapy For Liver Metastases. Steamboat Springs, CO, US.
2002. Evaluation of Minimal Functional Mass in Liver Surgery. Conference. AHPBA Surgical Forum. Boston, MA, US.
2002. American Joint Commission on Cancer (AJCC) System. Conference. American Joint Commission on Cancer (AJCC) System. Boston, MA, US.
2002. Treatment of Hepatocellular Carcinoma. Conference. Treatment of Hepatocellular Carcinoma. Steamboat Springs, CO, US.
2002. Management of Colorectal Metastasis. Conference. Management of Colorectal Metastasis. Steamboat Springs, CO, US.
2001. Novel Approaches to Hepatocellular Carcinoma: Current Controversies in Cancer Management. Conference. Novel Approaches to Hepatocellular Carcinoma: Current Controversies in Cancer Management. New Orleans, LA, US.
2001. Biliary Tract Neoplasms. Conference. Biliary Tract Neoplasms. Atlanta, GA, US.
2001. Preoperative and Operative Techniques to Improve Outcome after Hepatic Resection. Conference. Preoperative and Operative Techniques to Improve Outcome after Hepatic Resection. San Antonio, TX, US.
2001. The TVF Score Predicts Survival After Hepatic Resection of Hepatocellular Carcinoma. Conference. The TVF Score Predicts Survival After Hepatic Resection of Hepatocellular Carcinoma. Miami Beach, FL, US.
2000. Preoperative and Operative Techniques to Improve Outcomes after Hepatic Resection. Conference. Preoperative and Operative Techniques to Improve Outcomes after Hepatic Resection. Chicago, IL, US.
2000. Simplified Staging for Hepatocellular Carcinoma. Conference. Simplified Staging for Hepatocellular Carcinoma. Boston, MA, US.
1998. Recent Advances in the Treatment and Outcome of Locally Advanced Rectal Cancer. Conference. Recent Advances in the Treatment and Outcome of Locally Advanced Rectal Cancer. West Palm Beach, FL, US.
1996. Oncological Management of Biliary Malignancies. Conference. Oncological Management of Biliary Malignancies. San Francisco, CA, US.
1995. Concept of Adjuvant Regional Chemotherapy following Complete Resection for Hepatocellular Carcinoma. Conference. Concept of Adjuvant Regional Chemotherapy following Complete Resection for Hepatocellular Carcinoma. St. Louis, MO, US.
1994. Clinicopathologic Factors of Long-term Outcome following Resection of Hepatocellular Carcinoma. Conference. Clinicopathologic Factors of Long-term Outcome following Resection of Hepatocellular Carcinoma. New Orleans, LA, US.
1994. Extremity malignant peripheral nerve sheath tumors (neurogenic sarcomas): a 10–year experience". Conference. Extremity malignant peripheral nerve sheath tumors (neurogenic sarcomas): a 10–year experience". Houston, TX, US.
1992. Bacterial Translocation in Chronic Portal Hypertension and Hypovolemic Shock. Conference. Bacterial Translocation in Chronic Portal Hypertension and Hypovolemic Shock. Chicago, IL, US.
1988. Is limb–sparing surgery applicable to extremity neurogenic sarcoma?. Conference. Is limb–sparing surgery applicable to extremity neurogenic sarcoma?. New Orleans, LA, US.
1987. Left ventricular aneurysm repair with myocardial revascularization: an analysis of 246 consecutive patients over 15 years. Conference. Left ventricular aneurysm repair with myocardial revascularization: an analysis of 246 consecutive patients over 15 years. Boca Raton, FL, US.

International Presentations

2024. The impact of Biology in Defining Resectability of Colorectal Liver Metastases. Invited. Istanbul,, TR.
2024. Optimizing Outcome of Resection for Hilar Cholangiocarcinoma. Invited. Istanbul, TR.
2024. Hilar Cholangiocarcinoma: Optimizing Outcomes of Surgical Resection. Coimbra, US.
2024. The Impact of Biology in Defining Resectability. Conference. The Impact of Biology in Defining Resectability. Cape Town, ZA.
2023. Hepatectomy for colorectal liver metastases. Conference. Hepatectomy for colorectal liver metastases. Cartagena, CO.
2023. Biology colorectal liver metastases. Conference. Biology colorectal liver metastases. Cartagena, CO.
2023. Les Compagnons Hepato-Biliaries International Symposium of HPB Surgery. Conference. Les Compagnons Hepato-Biliaries International Symposium of HPB Surgery. Milan, IT.
2023. Strategies for Parenchyma Sparing Liver Surgery for CRCLM. Conference. Strategies for Parenchyma Sparing Liver Surgery for CRCLM. Lyon, FR.
2023. Precision Surgery for Colorectal Liver Metastases. Conference. Precision Surgery for Colorectal Liver Metastases. Mexico City, MX.
2023. Hepatectomy for Colorectal Liver Metastases. Conference. Hepatectomy for Colorectal Liver Metastases. Mexico City, MX.
2023. Liver Anatomy: Friend or Foe. Conference. Liver Anatomy: Friend or Foe. Mexico City, MX.
2022. Colorectal Metastsis, Where are the limits?. Conference. Colorectal Metastsis, Where are the limits?. Cancun, MX.
2022. Non Anatomical Liver Resection Parenquima Preservation. Conference. Non Anatomical Liver Resection Parenquima Preservation. Cancun, MX.
2022. Tumor Biology of Colorectal Liver Metastases. Conference. Tumor Biology of Colorectal Liver Metastases, US.
2022. Personalized medicine in metastatic colorectal cancer: Hype or reality?. Conference. Personalized medicine in metastatic colorectal cancer: Hype or reality?, JP.
2022. Evaluation and treatment of the benign hepatic tumors. Conference. Evaluation and treatment of the benign hepatic tumors. Mexico City, MX.
2022. Benign Liver Tumors (Virtual Presentation). Conference. Benign Liver Tumors (Virtual Presentation). Puerto Vallarta, MX.
2022. lmpact of Molecular Profiling in Surgery for Colorectal Liver Metastasis. Conference. lmpact of Molecular Profiling in Surgery for Colorectal Liver Metastasis. Leipzig, DE.
2021. Personalized Treatment of Colorectal Liver Metastases: Fact or Fiction. Conference. Personalized Treatment of Colorectal Liver Metastases: Fact or Fiction. via ZOOM, PH.
2021. Cholangiocarcinoma: Optimizing Outcome of Surgical Resection. Conference. Cholangiocarcinoma: Optimizing Outcome of Surgical Resection. via ZOOM, Buenos Aires, AR.
2021. Personalized Treatment of Colorectal Liver Metastases: Fact or Fiction. Conference. Personalized Treatment of Colorectal Liver Metastases: Fact or Fiction. via ZOOM, Warsaw, PL.
2021. Personalized surgical treatment of colorectal liver metastases. Conference. Personalized surgical treatment of colorectal liver metastases. via ZOOM, US.
2019. Current treatment of colon cancer liver metastases. Conference. Current treatment of colon cancer liver metastases. Cancun, MX.
2019. Can biology help select patients for resection of colorectal liver metastases?. Conference. Can biology help select patients for resection of colorectal liver metastases?. Madrid, ES.
2019. Surgical strategies in liver resection. Conference. Surgical strategies in liver resection. Lima, PE.
2019. Improving the outcome of liver resection with precision surgery. Conference. Improving the outcome of liver resection with precision surgery. Lima, PE.
2019. Genetic mutations and treatment of colorectal liver metastases. Conference. Genetic mutations and treatment of colorectal liver metastases. Lima, PE.
2019. Somatic mutations and biology of colorectal liver metastases. Conference. Somatic mutations and biology of colorectal liver metastases. Santiago, CL.
2019. Personalized therapy and surgical approaches forcolorectal liver metastases. Conference. Personalized therapy and surgical approaches forcolorectal liver metastases. Santiago, CL.
2019. Clinical cases and discussion. Conference. Clinical cases and discussion. Santiago, CL.
2019. Innovation and future perspectives in HPB Oncology. Conference. Innovation and future perspectives in HPB Oncology. Strasbourg, FR.
2018. Panelist - Diagnostic Dilemmas. Conference. Panelist - Diagnostic Dilemmas. New Dehli, IN.
2018. Panel Discussion - Clinical Scenarios. Conference. Panel Discussion - Clinical Scenarios. New Dehli, IN.
2018. Staged Resection Debate - Bilobar Liver Mets - Which is the Better Approach?. Conference. Staged Resection Debate - Bilobar Liver Mets - Which is the Better Approach?. New Dehli, IN.
2018. Surgical Management of Colorectal Liver Metastases. Conference. Surgical Management of Colorectal Liver Metastases. New Dehli, IN.
2018. Anil Agarwl Lecture - "Seven Keys to Success in Academic Surgery". Conference. Anil Agarwl Lecture - "Seven Keys to Success in Academic Surgery". New Dehli, IN.
2018. Technical Aspects of Major and Extended liver Resections (Tips and Tricks). Conference. Technical Aspects of Major and Extended liver Resections (Tips and Tricks). New Dehli, IN.
2018. Extended Left Hepatectomy (Videos). Conference. Extended Left Hepatectomy (Videos). New Dehli, IN.
2018. Applied Liver Anatomy - Friend or Foe. Conference. Applied Liver Anatomy - Friend or Foe. New Dehli, IN.
2017. Klatskin tumor - standardization of surgical treatment. Conference. Klatskin tumor - standardization of surgical treatment. Rio de Janerio, BR.
2017. Pursuing cure for mCRC patients – surgeon perspective. Conference. Pursuing cure for mCRC patients – surgeon perspective. Rio de Janerio, BR.
2017. Patient selection for conversion treatment - are the results worth it?. Conference. Patient selection for conversion treatment - are the results worth it?. Rio de Janerio, BR.
2017. Biology of Colorectal Liver Metastases in the Era of Perioperative Chemotherapy and Increased Knowledge of Genotyping. Conference. Biology of Colorectal Liver Metastases in the Era of Perioperative Chemotherapy and Increased Knowledge of Genotyping. Tokyo, JP.
2017. How to Optimize Tumor Response and Minimize Hepatic Injury in Patients Receiving Chemotherapy Prior to Resection of Colorectal Liver Metastases?. Conference. How to Optimize Tumor Response and Minimize Hepatic Injury in Patients Receiving Chemotherapy Prior to Resection of Colorectal Liver Metastases?. Tokyo, JP.
2017. The Staging Systems of Hepatocellular Carcinoma. Conference. The Staging Systems of Hepatocellular Carcinoma. Tokyo, JP.
2017. Approach to CRLM: Meet the Professor Breakfast and Satellite Sympoisium. Conference. Approach to CRLM: Meet the Professor Breakfast and Satellite Sympoisium. Mainz, DE.
2017. Optimal Timing of the Second Step in Two-Stage Concepts. Conference. Optimal Timing of the Second Step in Two-Stage Concepts. Mainz, DE.
2017. Chair, Session: Technical Aspects of Major and Extended Liver Resections. Conference. Chair, Session: Technical Aspects of Major and Extended Liver Resections. Mainz, DE.
2017. CRLM: Consequences of Molecular Profiling on Surgery. Conference. CRLM: Consequences of Molecular Profiling on Surgery. Mainz, DE.
2017. Technical Aspects of Major and Parenchymal Sparing Liver Resection: Tips and Tricks. Conference. Technical Aspects of Major and Parenchymal Sparing Liver Resection: Tips and Tricks. Lisbon, PT.
2017. ALPPS vs. 2-Stage Approach For 2-Stage Approach. Conference. ALPPS vs. 2-Stage Approach For 2-Stage Approach. Lisbon, PT.
2017. Chair: Symposium on multidisciplinary therapy for intrahepatic cholangiocarcinoma. Conference. Chair: Symposium on multidisciplinary therapy for intrahepatic cholangiocarcinoma. Sendi, JP.
2017. Living Legend Lecture: Biology predicts outcomes in patients undergoing local therapy for colorectal liver metastases. Conference. Living Legend Lecture: Biology predicts outcomes in patients undergoing local therapy for colorectal liver metastases. Sendi, JP.
2016. MODERATOR: Clinical Cases of Liver. Conference. MODERATOR: Clinical Cases of Liver. Cancun, MX.
2016. Current treatment strategies for hilar and intrahepatic cholangiocarcinoma. Conference. Current treatment strategies for hilar and intrahepatic cholangiocarcinoma. Cancun, MX.
2016. Coopérativité des mutations (RAS et tp53) dans la réponse et le pronostic des métastases hépatiques des cancers colorectaux. Conference. Coopérativité des mutations (RAS et tp53) dans la réponse et le pronostic des métastases hépatiques des cancers colorectaux. Arcachon, FR.
2016. Symposium 3: HCC Staging systems around the world: UICC/AJCC, BCLC, Hong Kong and JSGLG. Conference. Symposium 3: HCC Staging systems around the world: UICC/AJCC, BCLC, Hong Kong and JSGLG. Hong Kong, JP.
2016. Evaluation and Treatment of Colorectal Liver Metastases: Emerging Role of Somatic Mutations. Conference. Evaluation and Treatment of Colorectal Liver Metastases: Emerging Role of Somatic Mutations. Rome, IT.
2016. Technical Aspects of Major and Extended Liver Resections. Conference. Technical Aspects of Major and Extended Liver Resections. Sao Paulo, BR.
2016. ALPPS vs. 2-Stage Approach for CRM. Conference. ALPPS vs. 2-Stage Approach for CRM. Sao Paulo, BR.
2016. Evaluation and treatment of colorectal liver metastases: The emerging role of RAS mutations. Conference. The Dr. Roy Preshaw Academic Lecture in General Surgery. Calgary, CA.
2015. Chair, Clinical Cases of Liver Multidisciplinary treatment of hepatobiliary malignancies. Conference. Chair, Clinical Cases of Liver Multidisciplinary treatment of hepatobiliary malignancies. Cancun, MX.
2015. Evaluation ad prognosis of patients undergoing resection of colorectal liver metastases: The emerging role of RAS mutations. Conference. Evaluation ad prognosis of patients undergoing resection of colorectal liver metastases: The emerging role of RAS mutations. Cancun, MX.
2015. Which patients should receive chemotherapy before surgery? Do we know who will not benefit from chemotherapy?. Conference. Which patients should receive chemotherapy before surgery? Do we know who will not benefit from chemotherapy?. Oslo, NO.
2015. Resection for hepatocellular carcinoma (HCC). Conference. Resection for hepatocellular carcinoma (HCC). Oslo, NO.
2015. Chirurgie hepatique et status RAS. Conference. Chirurgie hepatique et status RAS. Montpellier, FR.
2015. Resection des MH chez les patients porteurs de Metastases pulmonaires. Conference. Resection des MH chez les patients porteurs de Metastases pulmonaires. Montpellier, FR.
2015. Patients' Selection for Resection of Hepatocellular Carcinoma: What are the limits? Resection of Hepatocellular Carcinoma in Cirrhosis. Conference. Patients' Selection for Resection of Hepatocellular Carcinoma: What are the limits? Resection of Hepatocellular Carcinoma in Cirrhosis. Valdivia, CL.
2015. Synchronous Colorectal Liver Metastases: Guidelines for the Strategy. Conference. Synchronous Colorectal Liver Metastases: Guidelines for the Strategy. Valdivia, CL.
2015. Safe and Curative Resection of Hilar Cholangiocarcinoma. Conference. Safe and Curative Resection of Hilar Cholangiocarcinoma. Valdivia, CL.
2015. Moderator, Therapeutic Guidelines: Response to chemo and post-surgical prognosis. Conference. Moderator, Therapeutic Guidelines: Response to chemo and post-surgical prognosis. Milan, IT.
2015. Evaluation and prognosis of patients undergoing resection: the emerging role of RAS mutations. Conference. Evaluation and prognosis of patients undergoing resection: the emerging role of RAS mutations. Milan, IT.
2014. Selection for resection, pathologic response, morphologic response and emerging role of RAS mutations. Conference. One Day on Resection of Initially Unresectable Colorectal Liver Metastases. Amsterdam, NL.
2014. Chemotherapy injury and hepatic insufficiency: assessment of the surgical risk. Conference. One Day on Resection of Initially Unresectable Colorectal Liver Metastases. Amsterdam, NL.
2014. Chair, Abstract Session 3, Staged operation in colorectal liver metastases. Conference. Chair, Abstract Session 3, Staged operation in colorectal liver metastases. Coex, Seoul.
2014. Surgical resection for colorectal liver metastases. Conference. Surgical resection for colorectal liver metastases. Coex, Seoul.
2014. Chair, Session 2, Complications in liver surgery. Conference. Chair, Session 2, Complications in liver surgery. Coex, Seoul.
2014. What is the limit of liver resection for colorectal liver metastases?. Conference. What is the limit of liver resection for colorectal liver metastases?. Coex, Seoul.
2014. Chair, Abstract Session 1, Laparoscopic vs open hepatectomy for HCC. Conference. Chair, Abstract Session 1, Laparoscopic vs open hepatectomy for HCC. Coex, Seoul.
2013. New paradigms in the treatment of hepatic metastasis from colorectal origin. surgery radiologic response and molecular biology. Conference. New paradigms in the treatment of hepatic metastasis from colorectal origin. surgery radiologic response and molecular biology. Sao Paulo, BR.
2013. Patients’ selection for hepatocarcinoma resection: what are the limits?. Conference. Patients’ selection for hepatocarcinoma resection: what are the limits?. Sao Paulo, BR.
2013. The Surgeon Experience” - Bevacizumab: Clinical experience of the multidisciplinary team from the MD Anderson Houston. Conference. The Surgeon Experience” - Bevacizumab: Clinical experience of the multidisciplinary team from the MD Anderson Houston. Madrid, ES.
2013. From multidisciplinary to personalized treatment of colorectal liver metastases. Conference. From multidisciplinary to personalized treatment of colorectal liver metastases. Madrid, ES.
2013. From multidisciplinary to personalized treatment of colorectal liver metastases – an American perspective. Conference. From multidisciplinary to personalized treatment of colorectal liver metastases – an American perspective. Warsaw, PL.
2013. Determining resectability, from complexity to simplicity: redefining mCRC treatment. Conference. Determining resectability, from complexity to simplicity: redefining mCRC treatment. Prague, CZ.
2013. Advances in the management of neuroendocrine liver metastases?. Conference. Advances in the management of neuroendocrine liver metastases?. Mendoza, AR.
2013. Optimizing outcomes for potentially resectable patients with metastatic colorectal cancer. Conference. Optimizing outcomes for potentially resectable patients with metastatic colorectal cancer. Mendoza, AR.
2013. Effect of specialist decision-making on treatment strategies for colorectal liver metastases. Conference. Effect of specialist decision-making on treatment strategies for colorectal liver metastases. Mendoza, AR.
2013. Recent strategy for liver cancers in the era of chemotherapeutic agents. Conference. Recent strategy for liver cancers in the era of chemotherapeutic agents. Tokyo, JP.
2013. Where is the limit of extensive hepatectomy considering the hepatic volume and function?. Conference. Where is the limit of extensive hepatectomy considering the hepatic volume and function?. Tokyo, JP.
2012. How to predict complete pathological response and should it be a new end point? The opinion of the surgeon. Conference. How to predict complete pathological response and should it be a new end point? The opinion of the surgeon. Rome, IT.
2012. How to optimize resectability: Opinion of the surgeon: Special Techniques. Conference. How to optimize resectability: Opinion of the surgeon: Special Techniques. Rome, IT.
2012. Plenary Session Chair (PL03). Conference. Plenary Session Chair (PL03). Paris, FR.
2012. Portal vein embolization. Conference. Portal vein embolization. Paris, FR.
2012. Discussant: Evaluation of The 7th AJCC/TNM staging for patients with curative resection for hepatocellular carcinoma. Conference. Discussant: Evaluation of The 7th AJCC/TNM staging for patients with curative resection for hepatocellular carcinoma. Paris, FR.
2012. How to select the journal best adapted to your paper?. Conference. How to select the journal best adapted to your paper?. Paris, FR.
2012. Borderline patients: which criteria to choose the optimal treatment and for which results?. Conference. Borderline patients: which criteria to choose the optimal treatment and for which results?. Paris, FR.
2012. Combining resection with chemotherapy. Conference. Combining resection with chemotherapy. Chicago, US.
2011. Complete Clinical Response (No metastases). Conference. Complete Clinical Response (No metastases). Rome, IT.
2011. The opinion of the surgeon. Conference. The opinion of the surgeon. Rome, IT.
2011. Multidiscliplinary Treatment of Colorectal Liver Metastases. Conference. Multidiscliplinary Treatment of Colorectal Liver Metastases. Montréal, CA.
2011. Multidiscliplinary Treatment of Colorectal Liver Metastases. Conference. Multidiscliplinary Treatment of Colorectal Liver Metastases. Greenfield Park, CA.
2011. Multidiscliplinary Treatment of Colorectal Liver Metastases. Conference. Multidiscliplinary Treatment of Colorectal Liver Metastases. Montréal, CA.
2011. Multidiscliplinary Treatment of Colorectal Liver Metastases. Conference. Multidiscliplinary Treatment of Colorectal Liver Metastases. Montréal, CA.
2011. Intervention 3 (30’): borderline patients: which criteria to choose the optimal treatment and for which results? Secondary resectability/ borderline patients: which treatment for which results?. Conference. Intervention 3 (30’): borderline patients: which criteria to choose the optimal treatment and for which results? Secondary resectability/ borderline patients: which treatment for which results?. Paris, FR.
2011. Multidiscliplinary treatment of hepatic colorectal metastases. Conference. Multidiscliplinary treatment of hepatic colorectal metastases. Petach Tikva, IL.
2011. Multidiscliplinary treatment of hepatic colorectal metastases. Conference. Multidiscliplinary treatment of hepatic colorectal metastases. Jerusalem, IL.
2011. Multidiscliplinary treatment of hepatic colorectal metastases. Conference. Multidiscliplinary treatment of hepatic colorectal metastases. Tel Avi, IL.
2011. Panelist, Decision making in surgical oncology - tricky cases. Conference. Panelist, Decision making in surgical oncology - tricky cases. Lucerne, CH.
2011. New approaches in the treatment pf synchronous liver metastases of asymptomatic colorectal carcinoma in patients. Conference. New approaches in the treatment pf synchronous liver metastases of asymptomatic colorectal carcinoma in patients. Lucerne, CH.
2011. Hepatocellular Carcinoma. Conference. Hepatocellular Carcinoma. Lisbon, PT.
2011. Colorectal Liver Metastases. Conference. Colorectal Liver Metastases. Lisbon, PT.
2011. An experience in Bevacizumab. Conference. Hospital Curry Cabral. Lisboa, PT.
2011. Careful selection of HCC patients for liver resection after TACE and PVE maximizes long-term survivals in both operative and non-operative groups. Conference. Careful selection of HCC patients for liver resection after TACE and PVE maximizes long-term survivals in both operative and non-operative groups. Paris, FR.
2011. Is there room for major hepatectomy in hepatocellular carcinoma?. Conference. Is there room for major hepatectomy in hepatocellular carcinoma?. Paris, FR.
2010. Is there an optimal neoadjuvant treatment for liver metatases?. Conference. Is there an optimal neoadjuvant treatment for liver metatases?. Maderia, PT.
2010. Session 7: Case Presentations. Conference. Session 7: Case Presentations. Montpellier, FR.
2010. Liver surgery after chemotherapy. Conference. Liver surgery after chemotherapy. Montpellier, FR.
2010. Moderator, Session 3: Metastases Hepatiqus Des Cancers Colorectaux. Conference. Moderator, Session 3: Metastases Hepatiqus Des Cancers Colorectaux. Montpellier, FR.
2010. Metastatic Colorectal Cancer: Case-based Approach. Conference. Metastatic Colorectal Cancer: Case-based Approach. Lyon, FR.
2010. L’experience americaine du MD Anderson. Conference. L’experience americaine du MD Anderson. Paris, FR.
2010. Liver Surgery in Patients Treated Previously with Bevacizumab. Conference. Liver Surgery in Patients Treated Previously with Bevacizumab. Sao Paulo, BR.
2010. Hepatocellular Carcinoma: The MD Anderson Approach. Conference. Hepatocellular Carcinoma: The MD Anderson Approach. Sao Paulo, BR.
2010. Liver Metastasis Resection in mCRC. Conference. Liver Metastasis Resection in mCRC. Santiago, CL.
2010. HCC Resection Treatment: the MD Anderson Experience. Conference. HCC Resection Treatment: the MD Anderson Experience. Sao Paulo, BR.
2010. Technical Aspects in Great Liver Resections. Conference. Technical Aspects in Great Liver Resections. Sao Paulo, BR.
2010. Management of CRLM: Preoperative Chemotherapy Versus Upfront Surgery. Conference. Management of CRLM: Preoperative Chemotherapy Versus Upfront Surgery. Sao Paulo, BR.
2010. Challenging Liver Cases with Professors. Conference. Challenging Liver Cases with Professors. Buenos Aires, AR.
2010. Hilar Cholangiocarcinoma. Conference. Hilar Cholangiocarcinoma. Buenos Aires, AR.
2010. Neoadjuvant Chemotherapy for Resectable Colorectal Liver. Conference. Neoadjuvant Chemotherapy for Resectable Colorectal Liver. Buenos Aires, AR.
2010. Biologic Targeted Therapy in the Multidiscliplinary Management of Colorectal Liver Metastases. Conference. Biologic Targeted Therapy in the Multidiscliplinary Management of Colorectal Liver Metastases. Buenos Aires, AR.
2010. Downstaging Strategies for Colorectal Metastases. Conference. Downstaging Strategies for Colorectal Metastases. Buenos Aires, AR.
2010. Is Neoadjuvant Chemotherapy Really Justified?. Conference. Is Neoadjuvant Chemotherapy Really Justified?. Buenos Aires, AR.
2009. Chemotherapy induced hepatotoxicity: Strategies and Workup. Conference. Chemotherapy induced hepatotoxicity: Strategies and Workup. London, GB.
2009. Surgical Treatment of Hepatic Colorectal Liver Metastases: Novel Approaches. Conference. Alberta Canada Health Services. Alberta, CA.
2009. Multidiscliplinary Treatment of Hepatic Colorectal Liver Metastases. Conference. Frazier Valley Cancer Center. Alberta, CA.
2009. Multidiscliplinary Treatment of Hepatic Colorectal Liver Metastases. Conference. Alberta Canada Health Services. Vancover BC, CA.
2009. Multidiscliplinary Treatment of Colorectal Liver Metastases. Conference. Multidiscliplinary Treatment of Colorectal Liver Metastases. Hamilton, CA.
2009. Surgical Treatment of Colorectal Liver Metastases. Conference. Surgical Treatment of Colorectal Liver Metastases. London, CA.
2009. Multidiscliplinary Treatment of Colorectal Liver Metastases. Conference. Multidiscliplinary Treatment of Colorectal Liver Metastases. Toronto, CA.
2009. Meet the Professor - Hepatobiliary Case Studies. Conference. Meet the Professor - Hepatobiliary Case Studies. Toronto, CA.
2009. Quel volume minimun préserver après une hépatectomie? Quelles méthodes pour l'optimiser?. Conference. Quel volume minimun préserver après une hépatectomie? Quelles méthodes pour l'optimiser?. Paris, FR.
2009. Traitement optimal du petit CHC. Pour la Résection. Conference. Debate. Paris, FR.
2009. Facteurs pronostiques de CHC réséqué. Quelle classification utiliser?. Conference. Conference Speaker. Paris, FR.
2008. Treatment of HCC 5-10 cm. Conference. 6th International Meeting Hepatocellular Carcinoma: Eastern and Western Experience. Seoul.
2008. Staging of HCC: Which Should We Use?. Conference. 6th International Meeting Hepatocellular Carcinoma: Eastern and Western Experience. Seoul.
2008. Preoperative Portal Vein Embolization in Cirrhotic Livers- Western Experience. Conference. 6th International Meeting Hepatocellular Carcinoma: Eastern and Western Experience. Seoul.
2008. Surgery and Chemotherapy for Liver Tumors - what are the limits?. Conference. The Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland. Liverpool, GB.
2008. Interesting Cases in Hepatobiliary Surgery. Conference. Canadian Surgical Forum. Halifax, CA.
2008. Colorectal Liver Metastases. Conference. Canadian Surgical Forum. Halifax, CA.
2008. Resection the best option?. Conference. EASL Monothematic Conference. Prague, CZ.
2008. Assessment and Management of the Future Liver Remnant. Conference. The 53rd Annual Chilean Chapter of the American College of Surgeons. Santiago, CL.
2008. Hepatocellular Carcinoma, Still Resectable?. Conference. The 53rd Annual Chilean Chapter of the American College of Surgeons. Santiago, CL.
2008. Preoperative Chemotherapy for Colorectal Liver Metastasis. Conference. The 53rd Annual Chilean Chapter of the American College of Surgeons. Santiago, CL.
2008. Manipulation of the Liver Mass in Primary and Secondary Liver Cancer Treatment. Conference. International Perspectives on Hepatic, Pancreatic, and Biliary Surgery. New York, US.
2008. Treatment of Colorectal Cancer Liver Metastases. Conference. 11th Annual Charles William Rasco III Symposium on Colorectal Cancer. Little Rock, US.
2008. Ablation versus Resection in Small HCC. Conference. 8th World Congress of International Hepato-Pancreato-Biliary Association. Mumbai, IN.
2008. Current Status of Portal Vein Embolization. Conference. 8th World Congress of International Hepato-Pancreato-Biliary Association. Mumbai, IN.
2008. Preoperative Assessment of Liver Function. Conference. 8th World Congress of International Hepato-Pancreato-Biliary Association. Mumbai, IN.
2007. Chemotherapy prior to liver resection: Useful or harmful?. Conference. 78th Argentine Congress of Surgery. Buenos Aires, AR.
2007. Hepatocellular Carcinoma: Do we still resect?. Conference. 78th Argentine Congress of Surgery. Buenos Aires, AR.
2007. Neuroendocrine liver metastases. Conference. 78th Argentine Congress of Surgery. Buenos Aires, AR.
2007. Hilar Cholangiocarcinoma: Resection versus transplantation. Conference. 78th Argentine Congress of Surgery. Buenos Aires, AR.
2007. Assessing and managing the future liver remnant. Conference. 78th Argentine Congress of Surgery. Buenos Aires, AR.
2007. Traditional Surgical Management. Conference. Colorectal Liver Metastases Session, World Conference on Interventional Oncology. Washington, US.
2007. Hepatic Resection for Large Hepatocellular Carcinoma. Conference. 5th International Meeting – Hepatocellular Carcinoma: Eastern and Western Experiences. Houston, US.
2006. Multimodal Therapy of Hepatic Colorectal Metastases: Helpful or Harmful?. Conference. Multimodal Therapy of Hepatic Colorectal Metastases: Helpful or Harmful?. London, GB.
2006. Preoperative Chemotherapy and Liver Injuries: Clinical Outcome. Conference. Preoperative Chemotherapy and Liver Injuries: Clinical Outcome. Paris, FR.
2006. A Surgeon's Perspective on the Current Issues: Tools to Improve Outcomes in Patients with Liver Metastases from Colorectal Cancer. Conference. A Surgeon's Perspective on the Current Issues: Tools to Improve Outcomes in Patients with Liver Metastases from Colorectal Cancer. Edinburgh.
2006. Evolutions in the treatment of hepatic metastases from Colorectal Cancer. Conference. Evolutions in the treatment of hepatic metastases from Colorectal Cancer. Edinburgh.
2006. Preoperative portal vein embolization: regeneration, resectability and outcome. Conference. Preoperative portal vein embolization: regeneration, resectability and outcome. Tokyo, JP.
2005. Surgical Approach and Staging in Biliary Cancer. Conference. Surgical Approach and Staging in Biliary Cancer. Santiago, CL.
2005. Effect of Surgical Margin Status on Survival and Site of Recurrence after Hepatic Resection for Colorectal Metastases. Conference. Effect of Surgical Margin Status on Survival and Site of Recurrence after Hepatic Resection for Colorectal Metastases. Buenos Aires, AR.
2005. Evaluation of Minimal Functional Mass in Liver Surgery. Conference. Evaluation of Minimal Functional Mass in Liver Surgery. Buenos Aires, AR.
2005. Operative Considerations in Resection of Hilar Cholangiocarcinoma. Conference. Operative Considerations in Resection of Hilar Cholangiocarcinoma. Buenos Aires, AR.
2005. Hepatocellular Carcinoma. Conference. Hepatocellular Carcinoma. Buenos Aires, AR.
2005. Surgical Treatment. Conference. Surgical Treatment. Buenos Aires, AR.
2005. Radiofrequency Ablation – Long Term Results. Can We Justify a Trial in Solitary Colorectal Liver Mets?. Conference. Radiofrequency Ablation – Long Term Results. Can We Justify a Trial in Solitary Colorectal Liver Mets?. Brisbane, AU.
2005. Is extended resection of Hilar cholangiocarcinoma justified. Conference. Is extended resection of Hilar cholangiocarcinoma justified. Brisbane, AU.
2005. Downstaging – Timing Chemotherapy Before Liver Resection and Timing Resection After Chemotherapy. Conference. Downstaging – Timing Chemotherapy Before Liver Resection and Timing Resection After Chemotherapy. Brisbane, AU.
2005. Metastatic Colorectal Liver Disease. Conference. Case Presentations/Panel Discussion. Brisbane, AT.
2005. Anatomical versus Non-anatomical Resection – Is Less More?. Conference. Anatomical versus Non-anatomical Resection – Is Less More?. Brisbane, AU.
2005. Resection of HCC – Selection and Long Term Results. Conference. Resection of HCC – Selection and Long Term Results. Brisbane, AU.
2005. Treatment and Management of Hepatocellular Carcinoma. Conference. Visiting Professor. Berlin, DE.
2005. Which is the right surgical margin?. Conference. Which is the right surgical margin?. Torino, IT.
2005. Two surgeon technique for hepatic parenchymal transaction using saline-linked cautery and ultrasonic dissection. Conference. Two surgeon technique for hepatic parenchymal transaction using saline-linked cautery and ultrasonic dissection. Torino, IT.
2005. Staging Systems for Hepatocellular Carcinoma. Conference. Staging Systems for Hepatocellular Carcinoma. London, GB.
2005. Imaging of Liver Tumors (Controversies). Conference. Imaging of Liver Tumors (Controversies). London, GB.
2004. HCC Appropriate Treatment. Conference. HCC Appropriate Treatment. Yokohama, JP.
2004. Treatment Outcome of Biliary Cancer: Present and Future. Conference. Treatment Outcome of Biliary Cancer: Present and Future. Yokohama, JP.
2004. Progress in Diagnosis and Treatment for HCC. Conference. Progress in Diagnosis and Treatment for HCC. Yokohama, JP.
2004. Simplified Staging for Hepatocellular Carcinoma: Implications for Resection and Transplantation. Conference. Simplified Staging for Hepatocellular Carcinoma: Implications for Resection and Transplantation. Paris, FR.
2004. Two Surgeon Technique for Hepatic Parenchymal Transaction using Saline Linked Cautery and Ultrasonic Dissection. Conference. Two Surgeon Technique for Hepatic Parenchymal Transaction using Saline Linked Cautery and Ultrasonic Dissection. Paris, FR.
2004. Extended Right Hepatectomy following Percutaneous Transhepatic Portal Vein Embolization. Conference. Extended Right Hepatectomy following Percutaneous Transhepatic Portal Vein Embolization. Paris, FR.
2004. Liver Update: Staging of Hepatocellular. Conference. Liver Update: Staging of Hepatocellular. Washington, US.
2004. Methods to Improve Resectability. Conference. Methods to Improve Resectability. Washington, US.
2004. Evaluation de la masse hépatique minimale en chirurgie hépatique. Conference. Evaluation de la masse hépatique minimale en chirurgie hépatique. Paris, FR.
2003. Evaluation of Minimal Functional Mass in Liver Surgery. Conference. Evaluation of Minimal Functional Mass in Liver Surgery. Rio de Janeiro, BR.
2003. Hepatocellular carcinoma: Do we still resect?. Conference. Hepatocellular carcinoma: Do we still resect?. Rio de Janeiro, BR.
2003. Hepatic Metastases. Conference. Hepatic Metastases. Rio de Janeiro, BR.
2003. Liver resection for hepatocellular carcinoma. Conference. Liver resection for hepatocellular carcinoma. Rio de Janeiro, BR.
2003. Operative considerations in surgery of hilar cholangiocarcinoma. Conference. Operative considerations in surgery of hilar cholangiocarcinoma. Rio de Janeiro, BR.
2003. New paradigms in liver surgery. Conference. New paradigms in liver surgery. Rio de Janeiro, BR.
2003. A Multi-Institutional Phase II Trial of Neoadjuvant Capecitabine and Oxaliplatin for Resectable Colorectal Metastases in the Liver - NCI Protocol #6021. Conference. A Multi-Institutional Phase II Trial of Neoadjuvant Capecitabine and Oxaliplatin for Resectable Colorectal Metastases in the Liver - NCI Protocol #6021. Montreal, CA.
2003. Operative Considerations in Resection. Conference. Operative Considerations in Resection. Miami Beach, US.
2003. Adjuvant Hepatic Artery Chemotherapy following Liver Resection for Colorectal Metastases. Conference. Adjuvant Hepatic Artery Chemotherapy following Liver Resection for Colorectal Metastases. Miami Beach, US.
2003. Liver and Pancreatic Cancers Case Presentations. Conference. Liver and Pancreatic Cancers Case Presentations. Paris, FR.
2002. Surgical Treatment: Long-Term Results in USA. Conference. Surgical Treatment: Long-Term Results in USA. Lodi, IT.
2002. Focal Liver Lesion: Percutaneous Biopsy? Pro-/Contra Discussion. Conference. Focal Liver Lesion: Percutaneous Biopsy? Pro-/Contra Discussion. Zurich, CH.
2002. Evaluation of Minimal Functional Mass in Liver Surgery. Conference. Evaluation of Minimal Functional Mass in Liver Surgery. Zurich, CH.
2001. Case Presentations Multidisciplinary Conference. Conference. Case Presentations Multidisciplinary Conference. Madrid, ES.
2001. Colorectal liver metastases: surgical management and the role of intraarterial chemotherapy. Conference. Colorectal liver metastases: surgical management and the role of intraarterial chemotherapy. Madrid, ES.
2000. Extent of Resection in Hepatic Colorectal Metastases. Conference. Extent of Resection in Hepatic Colorectal Metastases. Nice, FR.
1999. New Landmarks in Surgical Oncology / Modality Therapy for Primary and Metastatic Disease of the Liver. Conference. New Landmarks in Surgical Oncology / Modality Therapy for Primary and Metastatic Disease of the Liver. Antwerp, BE.
1998. Results of Resection for Small Hepatocellular Carcinoma. Conference. Results of Resection for Small Hepatocellular Carcinoma. Lausanne, CH.
1997. Surgical and Medical Treatment of Hepatic Colorectal Metastases. Conference. Surgical and Medical Treatment of Hepatic Colorectal Metastases. Kyoto, JP.
1997. Neoadjuvant Therapy for Resectable Rectal Cancer the University of Florida Experience 1975-1997. Conference. Neoadjuvant Therapy for Resectable Rectal Cancer the University of Florida Experience 1975-1997. Philadelphia, US.
1994. Comparison of Hepatocellular Carcinoma Resected in Orientals and Caucasians. Conference. Comparison of Hepatocellular Carcinoma Resected in Orientals and Caucasians. Boston, US.
1990. Role of surgery in the treatment of portal hypertension. Conference. Role of surgery in the treatment of portal hypertension. Inselspital Bern, CH.

Formal Peers

2024. Advanced Surgical Techniques Complex HPB Surgery. Tampa, Florida, US.
2023. Personalized Treatment of Colorectal Liver Metastases. Visiting. Syracuse, NY, US.
2022. Personalized Treatment of Colorectal Liver Metastases. Visiting. Charlottesville, VA, US.
2022. Personalized Treatment of Colorectal Liver Metastases. Visiting. Chicago, IL, US.
2022. Personalized Treatment of Colorectal Liver Metastases. Visiting. Columbus, OH, US.
2017. Oncologic Liver Surgery. Visiting. Lausanne, CH.
2017. Seven keys to success in Academic Surgery. Visiting. Bucharest, RO.
2017. Surgical treatment of colorectal liver metastasis: patient selection and outcomes. Visiting. Tampa, FL, US.
2016. Treatment of colorectal liver metastases: emerging role of somatic mutations. Visiting. Wake Forest, NC, US.
2016. Current treatment strategies for hilar and intrahepatic cholangiocarcinoma. Visiting. New Orleans, LA, US.
2016. Evaluation and Treatment of Colorectal Liver Metastases: Emerging Role of Somatic Mutations. Visiting. Houston, TX, US.
2016. Evaluation and Prognosis of Colorectal Liver Metastases: The Emerging Role of Mutations. Visiting. Toronto, CA.
2016. Evaluation and treatment of colorectal liver metastases: The emerging role of RAS mutations. Visiting. New York, NY, US.
2016. Evaluation and treatment of colorectal liver metastases: the emerging role of RAS mutations. Visiting. Cleveland, OH, US.
2014. From multidisciplinary to personalized treatment of colorectal liver metastases. Visiting. Houston, TX, US.
2013. From multidiscliplinary to personalized treatment of colorectal liver metastases. Visiting. Toronto, CA.
2013. From multidiscliplinary to personalized treatment of colorectal liver metastases. Visiting. Baltimore, MD, US.
2012. Multidisciplinary Treatment of Colorectal Liver Metastases. Visiting. Gainesville, FL, US.
2010. Recent Advances in the Surgical Treatment of Hepatocellular Carcinoma. Visiting. Houston, TX, US.
2010. Multidiscliplinary Treatment of Colorectal Liver Metastases. Visiting. Milwaukee, WI, US.
2009. Métastases Hépatiques d’origine Colorectale: Amélioration du Pronostic par une Approche Séquentielle Associant Chimiothérapie et Chirurgie,. Visiting. Lausanne, CH.
2009. Improvement in Outcome with Sequenced Chemotherapy and Surgery. Visiting. Zurich, CH.
2009. How much liver should we preserve after major hepatectomy? How can it be optimized?. Visiting. Zurich, CH.
2009. Multidiscliplinary Treatment of Colorectal Liver Metastases. Visiting. Montreal, CA.
2009. Hepatocellular Carcinoma Surgical Treatment: The M. D. Anderson Approach. Visiting. Santiago, CL.
2009. Multidiscliplinary Treatment of Liver Metastasis from Colorectal Cancer. Visiting. Santiago, CL.
2009. Hepatocellular Carcinoma Surgical Treatment: The M. D. Anderson Approach. Visiting. Santiago, South America, CL.
2009. Management of Remnant Liver Before Extended Resections. Visiting. Santiago, CL.
2009. Multidiscliplinary Management of Hepatic Colorectal Metastases. Visiting. Miami, FL, US.
2009. Management of Colorectal Metastases to the Liver. Visiting. Houston, TX, US.
2008. Treatment of Hepatic Colorectal Liver Metastases. Visiting. Santiago, CL.
2007. Multimodal Therapy of Hepatic Colorectal Metastases: Helpful or Harmful?. Visiting. Houston, TX, US.
2007. Emerging Trends in the Management of Colorectal Cancer. Visiting. Oklahoma City, OK, US.
2007. Multimodal Therapy of Hepatic Colorectal Metastases: Helpful or Harmful. Visiting. New Orleans, LA, US.
2007. Emerging Trends in the Management of Colorectal Cancer. Visiting. Baton Rouge, LA, US.
2006. Multimodal Therapy of Hepatic Colorectal Metastases: Helpful or Harmful?. Visiting. Miami, FL, US.
2006. Emerging Trends in the Management of Colorectal Cancer. Visiting, AK, US.
2006. Optimizing Resectability: Downstaging and Timing. Visiting. Chicago, IL, US.
2006. Extending the Limits of Surgical Therapy: Vascular Resection and the Palliative Whipple. Visiting, AK, US.
2006. Controversies in the Management of Hilar Cholangiocarcinoma. Visiting, AK, US.
2006. Evaluation of the Functional Liver Remnant in Preparation for Liver Surgery. Visiting, AK, US.
2006. Neoadjuvant Therapy: Is It Better than Postoperative Therapy?. Visiting, AK, US.
2005. Making Unresectable Metastases Resectable: Does it Work?. Visiting. Geneva, CH.
2005. Making Unresectable Metastases Resectable: Does it Work?. Visiting. Washington, US.
2004. Large HCC with Vascular Invasion: To Treat or Not to Treat. Visiting. Hong Kong, CN.
2004. Role of Portal Vein Embolization before Hepatic Resection for HCC. Visiting. Hong Kong, CN.
2004. Hepatobiliary Malignancies. Visiting. Kauai, HI, US.
2003. New Paradigms in Liver Surgery. Visiting. Durham, NC, US.
2002. New Paradigms in Liver Surgery. Visiting. New Orleans, LA, US.

Less

Grant & Contract Support

Date:	2019 - 2024
Title:	The University of Texas MD Anderson Cancer Center SPORE in Hepatocellular Carcinoma: Project 1: Targeting the PD-1 Pathway in HCC. And Project 2: Targeting STAT3 with an Oral Small Molecule to Treat HCC
Funding Source:	NIH/NCI
Role:	Co-PI
ID:	P50CA217674 (Beretta)

Date:	2013 - 2015
Title:	Development of novel nomograms to predict short term and long-term outcome in patients undergoing liver resection for colorectal liver metastases
Funding Source:	F. Hoffmann-LaRoche Ltd
Role:	PI
ID:	00009136

Date:	2012 - 2015
Title:	Improving Irinotecan Liver Toxicity in Obesity
Funding Source:	University of Houston
Role:	Co-PI
ID:	12022028 / 00003233

Date:	2009 - 2011
Title:	Hepatobiliary Surgery Clinical Research Fellowship
Funding Source:	Roche
Role:	PI
ID:	EPBA1000720-G-A53

Date:	2009 - 2011
Title:	Hepatobiliary Surgery Clinical Research Fellowship
Funding Source:	Sanofi-aventis U. S
Role:	PI
ID:	Sanofi-aventis U.S. Grant 29619

Date:	2006
Title:	Evaluation of the Mechanism of Liver Toxicity Associated with Chemotherapy for Colorectal Cancer Metastatic to the Liver
Funding Source:	Cancer Fighters of Houston, Inc
Role:	PI

Date:	2005
Title:	Hepatobiliary Surgical Clinical Research Fellowship - Colorectal Cancer
Funding Source:	Sanofi Aventis Group
Role:	PI

Date:	2000 - 2000
Title:	Staging Laparoscopy in patients with Hepatobiliary Malignancies
Funding Source:	American College of Surgeons
Role:	PI

Date:	1996 - 1997
Title:	Active Microspheres for Treating Hepatic Tumors
Funding Source:	Pfizer Strato/Infusaid
Role:	PI

Date:	1996 - 1997
Title:	Current Practice Patterns for the Use of Stereotactic Core Needle Breast Biopsy and Needle-Localized Breast Biopsy
Funding Source:	Shands Hospital Clinical Resource Management Small Grants
Role:	PI

Date:	1995 - 1996
Title:	Mechanisms of Hepatic Injury in Obstructive Jaundice
Funding Source:	University of Florida
Role:	Co-Program Leader

Date:	1991 - 1992
Title:	Bacterial translocation in portal hypertension & hypovolemic shock
Funding Source:	Swiss National Foundation for Scientific Research
Role:	PI

Title:	A Phase II and Biomarker Study of Dual VEGF/PD-L1 Blockade in Neoadjuvant Setting in Resectable HCC Patients
Funding Source:	NATIONAL INSTITUTES OF HEALTH
Role:	Co-PI
ID:	FP00011716

Selected Publications

Peer-Reviewed Articles

De Rose AM, Panettieri E, Lendoire M, Nakao Y, Fallon EA, Mele C, Allard MA, Newhook TE, Ardito F, Adam R, Vauthey JN, Giuliante F. ASO Visual Abstract: Short- and Long-Term Outcomes After Hepatectomy in Patients Receiving Triplet Versus Doublet Preoperative Chemotherapy for Colorectal Liver Metastases. Ann Surg Oncol 33(1):648-649, 2026. e-Pub 2026. PMID: 41148469.
Eid J, Haddad A, Hassan M, Amin HM, Newhook TE, Chun YS, Tzeng CD, Vauthey JN, Tran Cao HS, Kaseb AO. Evaluating the role of preoperative serum insulin-like growth factor 1 as a predictor of survival and recurrence for patients with resectable hepatocellular carcinoma. J Gastrointest Surg 30(1):102275, 2026. e-Pub 2026. PMID: 41197829.
De B, Dogra P, Zaid M, Elganainy D, Sun K, Amer AM, Wang C, Rooney MK, Chang E, Kang HC, Wang Z, Bhosale P, Odisio BC, Newhook TE, Tzeng CD, Tran Cao HS, Chun YS, Vauthey JN, Lee SS, Kaseb A, Raghav K, Javle M, Minsky BD, Noticewala SS, Holliday EB, Smith GL, Koong AC, Das P, Cristini V, Ludmir EB, Koay EJ. Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response. NPJ Syst Biol Appl 11(1):140, 2025. e-Pub 2025. PMID: 41387975.
Folkert IW, Mehran R, Sun R, Morris VK, Overman MJ, Kee B, Antonoff MB, Tzeng CW, Dasari A, Tran Cao H, Parseghian CM, Vilar E, Willis J, Newhook TE, Hofstetter W, Kopetz SE, Vauthey JN, Chun YS. Hepatectomy Plus Chemotherapy or Chemotherapy Alone for Resectable Liver and Unresectable Lung Metastases from Colorectal Adenocarcinoma (LUNA): A Randomized Phase II Trial. Ann Surg Oncol, 2025. e-Pub 2025. PMID: 41369813.
De Rose AM, Panettieri E, Lendoire M, Nakao Y, Fallon EA, Mele C, Allard MA, Newhook TE, Ardito F, Adam R, Vauthey JN, Giuliante F. Short- and Long-Term Outcomes After Hepatectomy in Patients Receiving Triplet Versus Doublet Preoperative Chemotherapy for Colorectal Liver Metastases. Ann Surg Oncol, 2025. e-Pub 2025. PMID: 41032196.
Benson AB 3rd, D'Angelica MI, Abrams T, Ahmed A, Akce M, Anaya DA, Anders R, Are C, Aye L, Bachini M, Baker M, Binder D, Brown DB, Burgoyne A, Castellanos J, Cloyd J, Cullinan D, Franses J, Glazer ES, Harris W, Iyer R, Jennings L, Kelley RK, Khan S, Levine M, Melstrom L, Palta M, Raman S, Ronnekleiv-Kelly S, Sahai V, Stein S, Stephans K, Thanikachalam K, Turk A, Vauthey JN, Venook AP, Yano M, Yopp A, Zhao K, Schonfeld R, Hochstetler C. Biliary Tract Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. J Natl Compr Canc Netw 23(9):403-418, 2025. e-Pub 2025. PMID: 40930144.
Minamiguchi K, Maki H, Haddad A, Cortes AC, Lendoire M, Tanaka T, Hicks ME, Vauthey JN, Avritscher R. Synthetic tumor extracellular volume as a predictive biomarker for colorectal liver metastasis patients prior to curative hepatectomy. Eur Radiol 35(9):5348-5359, 2025. e-Pub 2025. PMID: 40126606.
Nieto Y, Ward JF, Hofstetter W, Rice D, Karam JA, Pisters L, Vauthey JN, Shah A, Lin JK, Johns AC, Araujo J, Tu SM, Wang J, Li J, Abudayyeh A, Thall PF, Bassett R, Barnett M, Gulbis A, Shigle TL, Ramdial J, Popat U, Qazilbash M, Jones RB, Andersson BS, Shpall EJ, Sheikh I, Pagliaro L, Campbell MT. HIGH-DOSE CHEMOTHERAPY FOR MULTIPLY OR POOR-RISK RELAPSED GERM-CELL TUMORS. Clin Cancer Res, 2025. e-Pub 2025. PMID: 40853903.
Joliat GR, Chevallier P, Wigmore S, Martin D, Labgaa I, Uldry E, Halkic N, Newhook T, Haddad A, Vauthey JN, Memeo R, Dasari BVM, Braunwarth E, Brustia R, Sommacale D, Rodda GA, Kobeiter H, Duran R, Denys A, Demartines N, Melloul E. First results from the international registry on liver venous deprivation (EuroLVD). HPB (Oxford) 27(8):1020-1027, 2025. e-Pub 2025. PMID: 40350358.
Cox V, Haddad A, Lendoire M, Yedururi S, Marcal L, Panettieri E, Kawaguchi Y, Bassett R, Vauthey JN, Kang HC. Impact of Imaging Review and Multidisciplinary Discussion During Hepatobiliary Tumor Board: A Prospective Study. Ann Surg Oncol, 2025. e-Pub 2025. PMID: 40670845.
Acidi B, Haddad A, Newhook TE, Ikoma N, Tzeng CD, Chun YS, Vauthey JN, Tran Cao HS. Advancing Robotic Liver Resection: The Sling Technique for Improved Hepatic Retraction. Ann Surg Oncol 32(7):5021, 2025. e-Pub 2025. PMID: 40126718.
Chirban AM, Rivera B, Kawahara W, Mellado S, Niakosari M, Okuno M, Panettieri E, De Bellis M, Kristjanpoller W, Merlo I, Serenari M, Donadon M, Newhook TE, de Aretxabala X, Vivanco M, Brudvik KW, Seo S, Pekolj J, Poultsides GA, De Rose AM, Torzilli G, Giuliante F, Denbo J, Anaya DA, Vinuela E, Tzeng CD, Vauthey JN, Ruzzenente A, Vega EA. Advanced gallbladder cancer (T3 and T4): insights from an international multicenter study. J Gastrointest Surg 29(7):102080, 2025. e-Pub 2025. PMID: 40449084.
Lendoire M, Maki H, Haddad A, Jain AJ, Tran Cao HS, Chun YS, Tzeng CD, Vauthey JN, Newhook TE. Parenchymal-sparing hepatectomy vs single-stage major hepatectomy for bilateral colorectal liver metastases: a higher rate of microscopically positive margins is not associated with increased local recurrence after parenchymal-sparing hepatectomy. J Gastrointest Surg 29(7):102070, 2025. e-Pub 2025. PMID: 40280465.
Haddad A, Vauthey JN. Are We Advancing Local Control of Liver Tumors with Histotripsy?. Ann Surg, 2025. e-Pub 2025. PMID: 40560672.
Zhu Y, Solis Soto LM, Pant S, Vega EA, Vinuela E, Bozorgui B, Vauthey JN, Aguayo G, Wang Z, Lu W, Chen X, Mino B, Kakarala L, Dai J, Liu S, Wani KM, Lazar AJ, Carapeto F, Lee S, Wistuba I, Korkut A, Javle M, Kwong LN. Population-Specific Immunogenomic Alterations in Gallbladder Cancer and Prognostic Significance. Mod Pathol 38(11):100824, 2025. e-Pub 2025. PMID: 40541865.
Jain AJ, Lendoire M, Haddad A, Tzeng CD, Boyev A, Maki H, Chun YS, Arvide EM, Lee S, Hu I, Pant S, Javle M, Tran Cao HS, Vauthey JN, Newhook TE. Improved Outcomes Following Resection of Perihilar Cholangiocarcinoma: A 27-Year Experience. Ann Surg Oncol 32(6):4352-4362, 2025. e-Pub 2025. PMID: 40000564.
Serenari M, Berti D, Rivera B, Newhook TE, Kristjanpoller W, Ruzzenente A, Okuno M, De Bellis M, Panettieri E, Ahmad MU, Merlo I, De Rose AM, Nishino H, Sinnamon AJ, Donadon M, Hauger MS, Guevara OM, Munoz C, Denbo J, Chun YS, Tran Cao HS, Sanchez Claria R, Tzeng CD, De Aretxabala X, Vivanco M, Brudvik KW, Seo S, Pekolj J, Poultsides GA, Anaya DA, Torzilli G, Giuliante F, Guglielmi A, Vinuela E, Vauthey JN, Cescon M, Vega EA. Optimizing Outcomes in Gallbladder Cancer: Identifying Predictors of Futile Up-Front Surgery in a Global Multi-center Study. Ann Surg Oncol 32(6):4374-4382, 2025. e-Pub 2025. PMID: 40050485.
Fields BC, Newhook TE, Lillemoe HA, Maxwell JE, Soliz JM, Popat KU, Roland CL, Vauthey JN, Katz MHG, Tzeng CD. Persistent Improvement in Opioid Perceptions and Prescribing for Cancer Surgery: 5-Year Follow-Up. Adv Cancer Educ Qual Improv 1(1), 2025. e-Pub 2025. PMID: 40453772.
Acidi B, Haddad A, Vauthey JN, Tran Cao HS. Advancing hepatic augmentation for safer hepatic surgery: insights into portal and hepatic vein embolization strategies. Br J Surg 112(6), 2025. e-Pub 2025. PMID: 40552441.
Odisio BC, Albuquerque J, Lin YM, Anderson BM, O'Connor CS, Rigaud B, Briones-Dimayuga M, Jones AK, Fellman BM, Huang SY, Kuban J, Metwalli ZA, Sheth R, Habibollahi P, Patel M, Shah KY, Cox VL, Kang HC, Morris VK, Kopetz S, Javle MM, Kaseb A, Tzeng CW, Cao HT, Newhook T, Chun YS, Vauthey JN, Gupta S, Paolucci I, Brock KK. Software-based versus visual assessment of the minimal ablative margin in patients with liver tumours undergoing percutaneous thermal ablation (COVER-ALL): a randomised phase 2 trial. Lancet Gastroenterol Hepatol 10(5):442-451, 2025. e-Pub 2025. PMID: 40090348.
Maki H, Ayabe RI, Haddad A, Nishioka Y, Newhook TE, Tran Cao HS, Chun YS, Tzeng CD, Vauthey JN. Associations of KRAS Point Mutations with Survival of Patients Who Underwent Curative-Intent Resection of Colorectal Liver Metastases. Ann Surg Oncol 32(4):2425-2434, 2025. e-Pub 2025. PMID: 39821490.
Semaan S, Connor AA, Saharia A, Kodali S, Elaileh A, Patel K, Soliman N, Basra T, Victor DW 3rd, Simon CJ, Cheah YL, Hobeika MJ, Mobley CM, Dhingra S, Schwartz MR, Maqsood A, Heyne K, Abdelrahim M, Li XC, Javle M, Vauthey JN, Gaber AO, Ghobrial RM. Transplantation for Peri-Hilar and Intrahepatic Cholangiocarcinoma With mTOR Immunosuppression. Transplant Proc 57(2):255-263, 2025. e-Pub 2025. PMID: 39939239.
Soliman N, Connor AA, Saharia A, Kodali S, Elaileh A, Patel K, Semaan S, Basra T, Victor DW 3rd, Simon CJ, Cheah YL, Hobeika MJ, Mobley CM, Divatia M, Dhingra S, Schwartz M, Maqsood A, Heyne K, Abdelrahim M, Javle M, Vauthey JN, Gaber AO, Ghobrial RM. Neoadjuvant Multiagent Systemic Therapy Approach to Liver Transplantation for Perihilar Cholangiocarcinoma. Transplant Direct 11(3):e1760, 2025. e-Pub 2025. PMID: 39936132.
Seo YD, Acidi B, Newton A, Haddad A, Chiang YJ, Coelho R, Newhook TE, Tzeng CD, Chun YS, Ludmir EB, Koay EJ, Javle M, Vauthey JN, Cao HST. Defining the Role of Adjuvant Radiotherapy for Biliary Tract Cancers: A Site-Specific Propensity-Matched Analysis. Cancers (Basel) 17(3), 2025. e-Pub 2025. PMID: 39941861.
Hassanain H, Connor AA, Brombosz EW, Patel K, Elaileh A, Basra T, Kodali S, Victor DW 3rd, Simon CJ, Cheah YL, Hobeika MJ, Mobley CM, Saharia A, Dhingra S, Schwartz M, Maqsood A, Heyne K, Kaseb AO, Vauthey JN, Gaber AO, Abdelrahim M, Ghobrial RM. Sorafenib as Adjuvant Therapy Post-Liver Transplant: A Single-center Experience. Transplant Direct 11(2):e1746, 2025. e-Pub 2025. PMID: 39866680.
Fields BC, Newhook TE, Prakash LR, Arvide EM, Li Z, Tran Cao HS, Maxwell JE, Perrier ND, Katz MH, Vauthey JN, Tzeng CD. Impact of Non-Hepatectomy Opioid Reduction Efforts on Post-Hepatectomy Opioid Prescriptions: Analysis of 2,005 Patients. J Am Coll Surg, 2025. e-Pub 2025. PMID: 39807798.
Haddad A, Khavandi MM, Lendoire M, Acidi B, Chiang YJ, Gupta S, Tam A, Odisio BC, Mahvash A, Abdelsalam ME, Lin E, Kuban J, Newhook TE, Tran Cao HS, Tzeng CD, Huang SY, Vauthey JN, Habibollahi P. Propensity Score-Matched Analysis of Liver Venous Deprivation and Portal Vein Embolization Before Planned Hepatectomy in Patients with Extensive Colorectal Liver Metastases and High-Risk Factors for Inadequate Regeneration. Ann Surg Oncol, 2024. e-Pub 2024. PMID: 39633174.
Kuhn TN, Engelhardt WD, Kahl VH, Alkukhun A, Gross M, Iseke S, Onofrey J, Covey A, Camacho Vasquez JC, Kawaguchi Y, Hasegawa K, Odisio BC, Vauthey JN, Antoch G, Chapiro J, Madoff DC. AI-driven Patient-Selection For Preoperative Portal Vein Embolization For Patients With Colorectal Cancer Liver Metastases. J Vasc Interv Radiol, 2024. e-Pub 2024. PMID: 39638087.
Haddad A, Lendoire M, Uppal A, Maki H, Folkert I, Wang Y, Ayabe RI, Newhook TE, Chun YS, Tzeng CD, Vauthey JN, Tran Cao HS. CEA Rebound After Discontinuation of Pre-Hepatectomy Chemotherapy Predicts Worse Outcomes After Resection of Colorectal Cancer Liver Metastases. Ann Surg Oncol, 2024. e-Pub 2024. PMID: 39516416.
Landry J, Jain AJ, Tzeng CW, Newhook TE, Ikoma N, Chun YS, Vauthey JN, Cheah YL, Hawksworth JS, Tran Cao HS. Robotic Hepatic Parenchymal Transection Techniques: A Choice Between Imperfect Tools. Ann Surg Oncol, 2024. e-Pub 2024. PMID: 39414702.
De B, Dogra P, Zaid M, Elganainy D, Sun K, Amer AM, Wang C, Rooney MK, Chang E, Kang HC, Wang Z, Bhosale P, Odisio BC, Newhook TE, Tzeng CD, Cao HST, Chun YS, Vauthey JN, Lee SS, Kaseb A, Raghav K, Javle M, Minsky BD, Noticewala SS, Holliday EB, Smith GL, Koong AC, Das P, Cristini V, Ludmir EB, Koay EJ. Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response. medRxiv, 2024. e-Pub 2024. PMID: 39314943.
Azimuddin AM, Hirata Y, Boyev A, Jain AJ, Ayabe R, Ajith J, Schmeisser JA, Newhook TE, Ikoma N, Tzeng CD, Chun YS, Vauthey JN, Tran Cao HS. A propensity score matched cost analysis of robotic versus open hepatectomy. HPB (Oxford), 2024. e-Pub 2024. PMID: 39198140.
Ayabe RI, Beaty K, Newhook TE, Tran Cao HS, Tzeng CD, Helmink BA, Uppal A, Vauthey JN, Fournier KF, White MG. Incomplete Cytoreduction and Need for Major Hepatectomy Predict Shorter Survival in Patients Undergoing Combined Cytoreductive Surgery and Hepatectomy for Metastatic Colorectal Cancer. Ann Surg Oncol, 2024. e-Pub 2024. PMID: 38971956.
Lendoire M, Maki H, Haddad A, Newhook TE, Tzeng CD, Vauthey JN, Tran Cao HS. Exceptional pathologic response to preoperative therapy for colorectal liver metastases. J Gastrointest Surg. e-Pub 2024. PMID: 38723997.
Chang E, Wong FCL, Chasen BA, Erwin WD, Das P, Holliday EB, Koong AC, Ludmir EB, Minsky BD, Noticewala SS, Smith GL, Taniguchi CM, Rodriguez MJ, Beddar S, Martin-Paulpeter RM, Niedzielski JS, Sawakuchi GO, Schueler E, Perles LA, Xiao L, Szklaruk J, Park PC, Dasari AN, Kaseb AO, Kee BK, Lee SS, Overman MJ, Willis JA, Wolff RA, Tzeng CD, Vauthey JN, Koay EJ. Phase I Trial of SPECT-Guided liver-directed radiotherapy for patients with low functional liver volume. JNCI Cancer Spectr. e-Pub 2024. PMID: 38730548.
Khanduri I, Maki H, Verma A, Katkhuda R, Anandappa G, Pandurengan R, Zhang S, Mejia A, Tong Z, Solis Soto LM, Jadhav A, Wistuba II, Menter D, Kopetz S, Parra ER, Vauthey JN, Maru DM. New insights into macrophage polarization and its prognostic role in patients with colorectal cancer liver metastasis. BJC Rep 2(1):37, 2024. e-Pub 2024. PMID: 39516662.
Joliat GR, de Man R, Rijckborst V, Cimino M, Torzilli G, Choi GH, Lee HS, Goh BKP, Kokudo T, Shirata C, Hasegawa K, Nishioka Y, Vauthey JN, Baimas-George M, Vrochides D, Demartines N, Halkic N, Labgaa I. Long-term outcomes of ruptured hepatocellular carcinoma: international multicentre study. Br J Surg 111(4), 2024. e-Pub 2024. PMID: 38630792.
Maki H, Haddad A, Lendoire M, Newhook TE, Peacock O, Bednarski BK, Konishi T, Vauthey JN, You YN. Evolving survival gains in patients with young-onset colorectal cancer and synchronous resectable liver metastases. Eur J Surg Oncol 50(4):108057, 2024. e-Pub 2024. PMID: 38461567.
Maki H, Nishioka Y, Haddad A, Lendoire M, Tran Cao HS, Chun YS, Tzeng CD, Vauthey JN, Newhook TE. Reproducibility and efficiency of liver volumetry using manual method and liver analysis software. HPB (Oxford). e-Pub 2024. PMID: 38632032.
Albuquerque J, Lin YM, Paolucci I, O'Connor CS, Tzeng CW, Vauthey JN, Brock KK, Odisio BC. Incidental ring-hyperenhancing liver micronodules at ct hepatic arteriography-guided percutaneous thermal ablation of colorectal liver metastases. Radiol Imaging Cancer 6(2):e230099, 2024. e-Pub 2024. PMID: 38363196.
Tran Cao HS, Witt RG, Elsayes KM, Baiomy AA, Xiao L, Palmquist S, Lee SS, Mohamed YI, Mahvash A, Tzeng CD, Chun YS, Koay EJ, Rashid A, Hassan MM, Yao JC, Vauthey JN, Kaseb AO. Development of a Novel Comprehensive Hepatocellular Carcinoma Outcome Prognostic Scoring System With Integration of Imaging Features. Oncologist. e-Pub 2023. PMID: 38159256.
Lin K, Chowdhury S, Zeineddine MA, Zeineddine FA, Hornstein NJ, Villarreal OE, Maru DM, Haymaker CL, Vauthey JN, Chang GJ, Bogatenkova E, Menter D, Kopetz S, Shen JP. Identification of colorectal cancer cell stemness from single-cell RNA sequencing. Mol Cancer Res. e-Pub 2023. PMID: 38156967.
Martin AN, Newhook TE, Arvide EM, Kim BJ, Dewhurst WL, Kawaguchi Y, Tran Cao HS, Chun YS, Katz MH, Vauthey JN, Tzeng CD. Utilizing risk-stratified pathways to personalize post-hepatectomy discharge planning: A contemporary analysis of 1,354 patients. Am J Surg. e-Pub 2023. PMID: 38129274.
Boyev A, Tzeng CD, Maki H, Arvide EM, Mrema DE, Jain AJ, Haddad A, Lendoire M, Malik N, Odisio BC, Chun YS, Tran Cao HS, Vauthey JN, Newhook TE. Local therapy improves survival for early recurrence after resection of colorectal liver metastases. Ann Surg Oncol. e-Pub 2023. PMID: 38148351.
Jain AJ, Newhook TE, Lilley E, Ikoma N, Tzeng CD, Chun YS, Vauthey JN, Tran Cao HS. A Practical Guide to Inflow Control, Retraction, and Exposure for Robotic Hepatectomy. Ann Surg Oncol. e-Pub 2023. PMID: 37989954.
Khanduri I, Maki H, Verma A, Katkhuda R, Anandappa G, Pandurengan R, Zhang S, Mejia A, Tong Z, Soto LMS, Jadhav A, Wistuba II, Kopetz S, Parra ER, Vauthey JN, Maru DM. New Insights into Macrophage Polarization and its Prognostic Role in Patients with Colorectal Cancer Liver Metastasis. Res Sq, 2023. e-Pub 2023. PMID: 37886575.
Tran CG, Goffredo P, Mott SL, Suraju MO, Kohn JF, Mishra A, Vauthey JN, Hassan I. Conditional Overall Survival After Diagnosis of Non-Metastatic Colon Cancer: Impact of Laterality, MSI, and KRAS Status. Ann Surg Oncol. e-Pub 2023. PMID: 37857983.
Swords DS, Newhook TE, Tzeng CD, Massarweh NN, Chun YS, Lee S, Kaseb AO, Ghobrial M, Vauthey JN, Tran Cao HS. Treatment disparities partially mediate socioeconomic- and race/ethnicity-based survival disparities in Stage I-II hepatocellular carcinoma. Ann Surg Oncol. e-Pub 2023. PMID: 37679537.
De B, Upadhyay R, Liao K, Kumala T, Shi C, Dodoo G, Abi Jaoude J, Corrigan KL, Manzar GS, Marqueen KE, Bernard V, Lee SS, Raghav KPS, Vauthey JN, Tzeng CD, Tran Cao HS, Lee G, Wo JY, Hong TS, Crane CH, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong AC, Das P, Javle M, Ludmir EB, Koay EJ. Definitive Liver Radiotherapy for Intrahepatic Cholangiocarcinoma with Extrahepatic Metastases. Liver Cancer 12(3):198-208, 2023. e-Pub 2023. PMID: 37593365.
Maki H, Haddad A, Ayabe RI, Lendoire M, Khanduri I, Maru DM, Vauthey JN. TP53 alteration and its effect on pathologic response are associated with survival after resection of colorectal liver metastases. J Gastrointest Surg. e-Pub 2023. PMID: 37553514.
Maki H, Kim BJ, Kawaguchi Y, Fernandez-Placencia R, Haddad A, Panettieri E, Newhook TE, Baumann DP, Santos D, Tran Cao HS, Chun YS, Tzeng CD, Vauthey JN, Vreeland TJ. Incidence of and risk factors for incisional hernia after hepatectomy for colorectal liver metastases. J Gastrointest Surg. e-Pub 2023. PMID: 37537494.
Rogers JE, Sirisaengtaksin A, Leung M, Morris VK, Xiao L, Huey R, Wolff R, Eng C, Vauthey JN, Tzeng CD, Johnson B. Hepatic Metastasectomy in Squamous Cell Carcinoma of the Anal Canal: A Case Series of a Curative Approach. Cancers (Basel) 15(15), 2023. e-Pub 2023. PMID: 37568706.
Siriwardena AK, Serrablo A, ÅA F, Wigmore SJ, Ramia-Angel JM, Malik HZ, Stättner S, Søreide K, Zmora O, Meijerink M, Kartalis N, Lesurtel M, Verhoef C, Balakrishnan A, Gruenberger T, Jonas E, Devar J, Jamdar S, Jones R, Hilal MA, Andersson B, Boudjema K, Mullamitha S, Stassen L, Dasari BVM, Frampton AE, Aldrighetti L, Pellino G, Buchwald P, Gürses B, Wasserberg N, Gruenberger B, Spiers HVM, Jarnagin W, Vauthey JN, Kokudo N, Tejpar S, Valdivieso A, Adam R, liver metastases JECOCCWS. The multi-societal European consensus on the terminology, diagnosis and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE. HPB (Oxford). e-Pub 2023. PMID: 37471055.
Benson AB, D'Angelica MI, Abrams T, Abbott DE, Ahmed A, Anaya DA, Anders R, Are C, Bachini M, Binder D, Borad M, Bowlus C, Brown D, Burgoyne A, Castellanos J, Chahal P, Cloyd J, Covey AM, Glazer ES, Hawkins WG, Iyer R, Jacob R, Jennings L, Kelley RK, Kim R, Levine M, Palta M, Park JO, Raman S, Reddy S, Ronnekleiv-Kelly S, Sahai V, Singh G, Stein S, Turk A, Vauthey JN, Venook AP, Yopp A, McMillian N, Schonfeld R, Hochstetler C. NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023. J Natl Compr Canc Netw 21(7):694-704, 2023. e-Pub 2023. PMID: 37433432.
Siriwardena AK, Serrablo A, ÅA F, Wigmore SJ, -Angel JM, Malik HZ, Stättner S, Søreide K, Zmora O, Meijerink M, Kartalis N, Lesurtel M, Verhoef K, Balakrishnan A, Gruenberger T, Jonas E, Devar J, Jamdar S, Jones R, Hilal MA, Andersson B, Boudjema K, Mullamitha S, Stassen L, Dasari BVM, Frampton AE, Aldrighetti L, Pellino G, Buchwald P, Gürses B, Wasserberg N, Gruenberger B, Spiers HVM, Jarnagin W, Vauthey JN, Kokudo N, Tejpar S, Valdivieso A, Adam R, Hepato-Pancreato-Biliary Association JE, Surgical Oncology ESO, of Coloproctology ES, of Gastrointestinal ES, Radiology A, Cardiovascular, liver metastases IRSOECOCCWS. Multisocietal European consensus on the terminology, diagnosis, and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE. Br J Surg. e-Pub 2023. PMID: 37442562.
Lin YM, Fellman BM, Taiji R, Paolucci I, Silva JAM, Koay EJ, Avritscher R, Mahvash A, Holliday EB, Lee SS, Kaseb AO, Das P, Vauthey JN, Odisio BC. Salvage locoregional therapy following progression after radiotherapy for hepatocellular carcinoma is associated with improved outcomes. J Gastrointest Surg. e-Pub 2023. PMID: 37268830.
Maki H, Ayabe RI, Nishioka Y, Konishi T, Newhook TE, Tran Cao HS, Chun YS, Tzeng CD, You YN, Vauthey JN. Hepatectomy before primary tumor resection as preferred approach for synchronous liver metastases from rectal cancer. Ann Surg Oncol. e-Pub 2023. PMID: 37285096.
Maki H, Ayabe RI, Nishioka Y, Konishi T, Newhook TE, Tran Cao HS, Chun YS, Tzeng CD, You YN, Vauthey JN. Correction: Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer. Ann Surg Oncol. e-Pub 2023. PMID: 37344750.
Vega EA, Newhook TE, Mellado S, Ruzzenente A, Okuno M, De Bellis M, Panettieri E, Ahmad MU, Merlo I, Rojas J, De Rose AM, Nishino H, Sinnamon AJ, Donadon M, Hauger MS, Guevara OA, Munoz C, Denbo JW, Chun YS, Tran Cao HS, Sanchez Claria R, Tzeng CD, De Aretxabala X, Vivanco M, Brudvik KW, Seo S, Pekolj J, Poultsides GA, Torzilli G, Giuliante F, Anaya DA, Guglielmi A, Vinuela E, Vauthey JN. Benchmarks and geographic differences in gallbladder cancer surgery: An International Multicenter Study. Ann Surg Oncol. e-Pub 2023. PMID: 37149547.
Vega EA, Mellado S, Panettieri E, Newhook T, Vauthey JN. ASO Author Reflections: Harnessing the power of data- The impact of benchmarking in healthcare. Ann Surg Oncol. e-Pub 2023. PMID: 37202572.
Kothari AN, Massarweh NN, Flitcroft MA, Newhook T, Tzeng CD, Chun YS, Kaseb AO, Vauthey JN, Tran Cao HS. Evaluating the benefit of surgical resection for hepatocellular carcinoma with multifocality or intrahepatic vascular invasion. HPB (Oxford). e-Pub 2023. PMID: 37085394.
Chun YS, Vauthey JN, Passot G. Detection and oncologic significance of colorectal liver micrometastases: In Reply to Yin and colleagues. J Am Coll Surg 236(3):534, 2023. e-Pub 2023. PMID: 36729870.
Zeineddine FA, Zeineddine MA, Yousef A, Gu Y, Chowdhury S, Dasari A, Huey RW, Johnson B, Kee B, Lee MS, Morelli MP, Morris VK, Overman MJ, Parseghian C, Raghav K, Willis J, Wolff RA, Kawaguchi Y, Vauthey JN, Sun R, Kopetz S, Shen JP. Survival improvement for patients with metastatic colorectal cancer over twenty years. NPJ Precis Oncol 7(1):16, 2023. e-Pub 2023. PMID: 36781990.
Ayabe RI, Paez-Arango N, Estrella JS, Newhook TE, Tzeng CD, Chun YS, Lee S, Javle M, Vauthey JN, Tran Cao HS. Neoadjuvant chemotherapy for high-risk intrahepatic cholangiocarcinoma - does pathologic response mean better outcomes?. HPB (Oxford). e-Pub 2023. PMID: 36781357.
Martin AN, Tzeng CD, Arvide EM, Skibber JM, Chang GJ, Nancy You YQ, Bednarski BK, Uppal A, Dewhurst WL, Cristo JV, Chun YS, Tran Cao HS, Vauthey JN, Newhook TE. Impact of cumulative operative time on postoperative complication risk in simultaneous resections of colorectal liver metastases and primary tumors. HPB (Oxford). e-Pub 2023. PMID: 36697350.
Paolucci I, Lin YM, Kawaguchi Y, Maki H, Jones AK, Calandri M, Kopetz S, Newhook TE, Brock KK, Vauthey JN, Odisio BC. Targeted exome-based predictors of patterns of progression of colorectal liver metastasis after percutaneous thermal ablation. Br J Cancer. e-Pub 2022. PMID: 36319850.
Martin AN, Concors SJ, Kim BJ, Newhook TE, Arvide EM, Dewhurst WL, Kawaguchi Y, Tran Cao HS, Katz MHG, Vauthey JN, Tzeng CD. Individual components of post-hepatectomy care pathways have differential impacts on length of stay. Am J Surg. e-Pub 2022. PMID: 36207173.
Newton AD, Newhook TE, Ikoma N, Tzeng CD, Chun YS, Vauthey JN, Tran Cao HS. Robotic extended right hepatectomy for colorectal liver metastasis. Ann Surg Oncol. e-Pub 2022. PMID: 36112251.
Panettieri E, Kim BJ, Kawaguchi Y, Ardito F, Mele C, De Rose AM, Vellone M, Chun YS, Tzeng CD, Aloia TA, Giuliante F, Vauthey JN. Survival by number and sites of resections of recurrence after first curative resection of colorectal liver metastases. J Gastrointest Surg. e-Pub 2022. PMID: 36127553.
Ikoma N, Seo YD, Newhook TE, Maxwell JE, Kim MP, Tran Cao HS, Tzeng CD, Chun YS, Lee JE, Vauthey JN, Katz MHG. Quality of superior mesenteric and hepatic artery dissection in robotic pancreatoduodenectomy for pancreatic cancer. J Hepatobiliary Pancreat Sci. e-Pub 2022. PMID: 35950790.
Lillemoe HA, Passot G, Kawaguchi Y, DeBellis M, Glehen O, Chun YS, Tzeng CD, Aloia TA, Lopez J, Vauthey JN. RAS/TP53 co-mutation is associated with worse survival after concurrent resection of colorectal liver metastases and extrahepatic disease. Ann Surg 276(2):2020 Dec 18;Publish Ahead of Print. doi: 10.1097/SLA.0000000000, 2022. e-Pub 2022. PMID: 33351476.
Mason MC, Krasnodebski M, Hester CA, Kothari AN, Barker C, Nishioka Y, Chiang YJ, Newhook TE, Tzeng CD, Chun YS, Vauthey JN, Tran Cao HS. Outcomes of mixed pathologic response in patients with multiple colorectal liver metastases treated with neoadjuvant chemotherapy and liver resection. Ann Surg Oncol 29(8):5156-5164, 2022. e-Pub 2022. PMID: 35397746.
Witt RG, Hirata Y, Prakash LR, Newhook TE, Maxwell JE, Kim MP, Tran Cao HS, Lee JE, Vauthey JN, Katz MHG, Tzeng CD, Ikoma N. Comparative analysis of opioid use between robotic and open pancreatoduodenectomy. J Hepatobiliary Pancreat Sci. e-Pub 2022. PMID: 35796581.
Newhook TE, Overman MJ, Chun YS, Dasari A, Tzeng CD, Cao HST, Raymond V, Parseghian C, Johnson B, Nishioka Y, Kawaguchi Y, Uppal A, Vreeland TJ, Jaimovich A, Arvide EM, Cristo JV, Wei SH, Raghav KP, Morris VK, Lee JE, Kopetz S, Vauthey JN. Prospective study of perioperative circulating tumor DNA dynamics in patients undergoing hepatectomy for colorectal liver metastases. Ann Surg 277(5):813-820. e-Pub 2022. PMID: 35797554.
Kim BJ, Arvide EM, Gaskill C, Martin AN, Kawaguchi Y, Chiang YJ, Dewhurst WL, Lee T, Tran Cao HS, Chun YS, Katz, MHG, Vauthey JN, Tzeng CWD, Newhook TE. Risk-stratified post-hepatectomy pathways based upon the Kawaguchi-Gayet complexity classification and impact on length of stay. Surgery Open Science 9:109-116, 2022. e-Pub 2022.
Kim BJ, Arvide EM, Gaskill C, Martin AN, Kawaguchi Y, Chiang YJ, Dewhurst WL, Phan TL, Tran Cao HS, Chun YS, Katz MHG, Vauthey JN, Tzeng CD, Newhook TE. Risk-stratified posthepatectomy pathways based upon the Kawaguchi-Gayet complexity classification and impact on length of stay. Surg Open Sci 9:109-116, 2022. e-Pub 2022. PMID: 35747509.
DiPeri TP, Newhook TE, Day RW, Chiang YJ, Dewhurst WL, Arvide EM, Bruno ML, Scally CP, Roland CL, Katz MHG, Vauthey JN, Chang GJ, Badgwell BD, Perrier ND, Grubbs EG, Lee JE, Tzeng CD, Consortium P. A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patients. Surg Open Sci 9:51-57, 2022. e-Pub 2022. PMID: 35663797.
Chun YS, Passot G, Nishioka Y, Katkhuda R, Arvide EM, Benzerdjeb N, Lopez J, Kopetz SE, Maru DM, Vauthey JN. Colorectal liver micrometastases: association with RAS/TP53 co-mutation and prognosis after surgery. J Am Coll Surg 235(1):8-16, 2022. e-Pub 2022. PMID: 35703957.
DiPeri TP, Newhook TE, Arvide EM, Dewhurst WL, Bruno ML, Chun YS, Tran Cao HS, Lee JE, Vauthey JN, Tzeng CD. Prospective implementation of standardized post-hepatectomy care pathways to reduce opioid prescription volume after inpatient surgery. J Am Coll Surg 235(1):41-48, 2022. e-Pub 2022. PMID: 35703961.
DiPeri TP, Newhook TE, Tran Cao HS, Ikoma N, Dewhurst WL, Arvide EM, Bruno ML, Katz MHG, Vauthey JN, Lee JE, Tzeng CD. Opioid discharge prescriptions after inpatient surgery: risks of rebound refills by length of stay. J Surg Res 278:111-118. e-Pub 2022. PMID: 35597025.
Kim BJ, Newhook TE, Tzeng CD, Ikoma N, Chiang YJ, Chun YS, Vauthey JN, Tran Cao HS. Lymphadenectomy and margin-negative resection for biliary tract cancer surgery in the United States-Differential technical performance by approach. J Surg Oncol. e-Pub 2022. PMID: 35578764.
De B, Tran Cao HS, Vauthey JN, Manzar GS, Corrigan KL, Raghav KPS, Lee SS, Tzeng CD, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong AC, Das P, Javle M, Ludmir EB, Koay EJ. Ablative liver radiotherapy for unresected intrahepatic cholangiocarcinoma: Patterns of care and survival in the United States. Cancer. e-Pub 2022. PMID: 35417569.
Manzar GS, De BS, Abana CO, Lee SS, Javle M, Kaseb AO, Vauthey JN, Tran Cao HS, Koong AC, Smith GL, Taniguchi CM, Holliday EB, Das P, Koay EJ, Ludmir EB. Outcomes and toxicities of modern combined modality therapy with atezolizumab plus bevacizumab and radiation therapy for hepatocellular carcinoma. Cancers (Basel) 14(8), 2022. e-Pub 2022. PMID: 35454808.
Nishioka Y, Chun YS, Overman MJ, Cao HST, Tzeng CD, Mason MC, Kopetz SW, Bauer TW, Vauthey JN, Newhook TE, Program MD. Effect of Co-mutation of RAS and TP53 on postoperative ctDNA detection and early recurrence after hepatectomy for colorectal liver metastases. J Am Coll Surg 234(4):474-483, 2022. e-Pub 2022. PMID: 35290266.
Uppal A, Kothari AN, Scally CP, Roland CL, Bednarski BK, Katz MHG, Vauthey JN, Chang GJ, Team D. Adoption of telemedicine for postoperative follow-up after inpatient cancer-related surgery. JCO Oncol Pract:OP2100819. e-Pub 2022. PMID: 35263166.
Kawaguchi Y, Kopetz S, Panettieri E, Hwang H, Wang X, Cao HST, Tzeng CD, Chun YS, Aloia TA, Vauthey JN. Improved survival over time after resection of colorectal liver metastases and clinical impact of multigene alteration testing in patients with metastatic colorectal cancer. J Gastrointest Surg 26(3):583-593, 2022. e-Pub 2022. PMID: 34506029.
Montalvo-Jave EE, Ayala-Moreno EA, Soper NJ, Ashley SW, Stain S, Pawlik TM, Pellegrini C, Cameron JL, Vauthey JN, Jones D, Sarr MG, Callery MP, Chaba SS. Mexico: the Inaugural International Chapter of the Society for Surgery of the Alimentary Tract. J Gastrointest Surg. e-Pub 2022. PMID: 35023032.
Kaseb AO, Hasanov E, Cao HST, Xiao L, Vauthey JN, Lee SS, Yavuz BG, Mohamed YI, Qayyum A, Jindal S, Duan F, Basu S, Yadav SS, Nicholas C, Sun JJ, Singh Raghav KP, Rashid A, Carter K, Chun YS, Tzeng CD, Sakamuri D, Xu L, Sun R, Cristini V, Beretta L, Yao JC, Wolff RA, Allison JP, Sharma P. Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial. Lancet Gastroenterol Hepatol 7(3):208-218. e-Pub 2022. PMID: 35065057.
Morris VK, Overman MJ, Parseghian CM, Johnson B, Dasari A, Raghav K, Kee B Huey RW, Wolff RA, Shen JP, Li J, Zorrilla I, Tzeng CWD, Tran Cao HS, Chun YS, Newhook TE, Vauthey JN, Duose DY, Luthra R, Haymaker CL, Kopetz S. Bintrafusp alfa, an anti-PD-L1:TGF-β trap fusion protein, in patients with ctDNA-positive, liver-limited metastatic colorectal cancer. Cancer Research Communications 2(9):979–986, 2022. e-Pub 2022.
Panettieri E, Maki H, Kim BJ, Kang HC, Cox V, Vega EA, Mizuno T, Pant S, Javle M, Vauthey JN, Kawaguchi Y. Arterial enhancement pattern predicts survival in patients with resectable and unresectable intrahepatic cholangiocarcinoma. Surg Oncol 40:101696. e-Pub 2021. PMID: 34995974.
McMillan RR, Javle M, Kodali S, Saharia A, Mobley C, Heyne K, Hobeika MJ, Lunsford KE, Victor DW, Shetty A, McFadden RS, Abdelrahim M, Kaseb A, Divatia M, Yu N, Nolte Fong J, Moore LW, Nguyen DT, Graviss EA, Gaber AO, Vauthey JN, Ghobrial RM. Survival following liver transplantation for locally-advanced, unresectable intrahepatic cholangiocarcinoma. Am J Transplant. e-Pub 2021. PMID: 34856069.
Tran CG, Goffredo P, Mott SL, Hart A, You YN, Vauthey JN, Weigel RJ, Hassan I. The impact of KRAS mutation, microsatellite instability, and tumor laterality on the prognosis of nonmetastatic colon cancer. Surgery. e-Pub 2021. PMID: 34865865.
De B, Abu-Gheida I, Patel A, Ng SSW, Zaid M, Thunshelle CP, Elganainy D, Corrigan KL, Rooney MK, Javle M, Raghav K, Lee SS, Vauthey JN, Tzeng CD, Tran Cao HS, Ludmir EB, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong AC, Das P, Koay EJ. Benchmarking outcomes after ablative radiotherapy for molecularly characterized intrahepatic cholangiocarcinoma. J Pers Med 11(12):11, 1270, 2021. e-Pub 2021. PMID: 34945742.
Oppliger FA, Prakash LR, Newhook TE, Chiang YJ, Ikoma N, Maxwell JE, Kim MP, Vauthey JN, Lee JE, Katz MH, Tzeng CD. AJCC 8th edition pathologic nodal staging of resected pancreatic adenocarcinoma predicts survival regardless of treatment sequencing. Surg Oncol 40:101673. e-Pub 2021. PMID: 34894620.
Newhook TE, Prakash LR, Soliz J, Hancher-Hodges S, Speer BB, Wilks JA, Bruno ML, Dewhurst WL, Arvide EM, Maxwell JE, Ikoma N, Kim MP, Lee JE, Katz MHG, Tzeng CD. Perioperative blood transfusions and survival in resected pancreatic adenocarcinoma patients given multimodality therapy. J Surg Oncol 124(8):1381-1389, 2021. e-Pub 2021. PMID: 34398988.
Kawaguchi Y, Fuks D, Vauthey JN, Kokudo N, Gayet B, Hasegawa K. A novel simple three-level liver resection classification without compromising the performance to predict surgical and postoperative outcomes. Eur J Surg Oncol. e-Pub 2021. PMID: 34862096.
Nishioka Y, Paez-Arango N, Boettcher FO, Kawaguchi Y, Newhook TE, Chun YS, Tzeng CD, Tran Cao HS, Lee JE, Vreeland TJ, Vauthey JN. Neither surgical margin status nor somatic mutation predicts local recurrence after r0-intent resection for colorectal liver metastases. J Gastrointest Surg. e-Pub 2021. PMID: 34725784.
Arango NP, Nishioka Y, Velasco J, Mahvash A, Mehran RJ, Wang LS, Taggart MW, Vauthey JN, Odisio BC. Involution of hepatocellular neoplasm after embolization of a portosystemic vascular shunt in an adult with abernethy type ii malformation. J Vasc Interv Radiol 32(9):1391-1393, 2021. e-Pub 2021. PMID: 34462084.
Nishioka Y, Odisio BC, Velasco JD, Ninan E, Huang SY, Mahvash A, Tzeng CD, Tran Cao HS, Gupta S, Vauthey JN. Fast-track two-stage hepatectomy by concurrent portal vein embolization at first-stage hepatectomy in hybrid interventional radiology / operating suite. Surg Oncol 39:101648. e-Pub 2021. PMID: 34438236.
Kawaguchi Y, Hasegawa K, Hagiwara Y, De Bellis M, Famularo S, Panettieri E, Matsuyama Y, Tateishi R, Ichikawa T, Kokudo T, Izumi N, Kubo S, Sakamoto M, Shiina S, Takayama T, Nakashima O, Murakami T, Vauthey JN, Giuliante F, De Carlis L, Romano F, Ruzzenente A, Guglielmi A, Kudo M, Kokudo N. Effect of diameter and number of hepatocellular carcinomas on survival after resection, trans-arterial chemoembolization, and ablation. Am J Gastroenterol 116(8):1698-1708, 2021. e-Pub 2021. PMID: 33900211.
Asbun HJ, Abu Hilal M, Kunzler F, Asbun D, Bonjer J, Conlon K, Demartines N, Feldman LS, Morales-Conde S, Pietrabissa A, Pryor AD, Schlachta CM, Sylla P, Targarona EM, Agra Y, Besselink MG, Callery M, Cleary SP, De La Cruz L, Eckert P, Evans C, Han HS, Jones DB, Gan TJ, Koch D, Lillemoe KD, Lomanto D, Marks J, Matthews B, Mellinger J, Melvin WS, Moreno-Paquentin E, Navarrete C, Pawlik TM, Pessaux P, Ricciardi W, Schwaitzberg S, Shah P, Szokol J, Talamini M, Torres R, Triboldi A, Udomsawaengsup S, Valsecchi F, Vauthey JN, Wallace M, Wexner SD, Zinner M, Francis N. International Delphi Expert Consensus on safe return to surgical and endoscopic practice: from the coronavirus global surgical collaborative. Ann Surg 274(1):50-56, 2021. e-Pub 2021. PMID: 33630471.
Kawaguchi Y, Kopetz S, Kwong L, Xiao L, Morris JS, Tran Cao HS, Tzeng CD, Chun YS, Lee JE, Vauthey JN. Genomic sequencing and insight into clinical heterogeneity and prognostic pathway genes in patients with metastatic colorectal cancer. J Am Coll Surg 233(2):272-284. e-Pub 2021. PMID: 34111531.
Benson AB, D'Angelica MI, Abbott DE, Anaya DA, Anders R, Are C, Bachini M, Borad M, Brown D, Burgoyne A, Chahal P, Chang DT, Cloyd J, Covey AM, Glazer ES, Goyal L, Hawkins WG, Iyer R, Jacob R, Kelley RK, Kim R, Levine M, Palta M, Park JO, Raman S, Reddy S, Sahai V, Schefter T, Singh G, Stein S, Vauthey JN, Venook AP, Yopp A, McMillian NR, Hochstetler C, Darlow SD. Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 19(5):541-565, 2021. e-Pub 2021. PMID: 34030131.
Kawaguchi Y, Kopetz S, Tran Cao HS, Panettieri E, De Bellis M, Nishioka Y, Hwang H, Wang X, Tzeng CD, Chun YS, Aloia TA, Hasegawa K, Guglielmi A, Giuliante F, Vauthey JN. Contour prognostic model for predicting survival after resection of colorectal liver metastases: development and multicentre validation study using largest diameter and number of metastases with RAS mutation status. Br J Surg. e-Pub 2021. PMID: 33829254.
Kanikarla Marie P, Haymaker C, Parra ER, Kim YU, Lazcano R, Gite S, Lorenzini D, Wistuba II, Tidwell RSS, Song X, Foo WC, Maru DM, Chun YS, Futreal PA, Kee B, Menter D, Solis LM, Tzeng CD, Parseghian CM, Raghav K, Morris VK, Chang CC, Jenq RR, Tam A, Bernatchez C, Kopetz S, Vauthey JN, Overman MJ. Pilot clinical trial of perioperative durvalumab and tremelimumab in the treatment of resectable colorectal cancer liver metastases. Clin Cancer Res. e-Pub 2021. PMID: 33811152.
Kim BJ, Newhook TE, Blumenthaler A, Chiang YJ, Aloia TA, Roland CL, Katz MHG, Vauthey JN, Lee JE, Tzeng CD. Sustained reduction in discharge opioid volumes through provider education: Results of 1168 cancer surgery patients over 2 years. J Surg Oncol. e-Pub 2021. PMID: 33751605.
Vega EA, Newhook TE, Kawaguchi Y, Qiao W, De Bellis M, Okuno M, Panettieri E, Nishino H, Duwe G, Piccino M, De Rose AM, Ruzzenente A, Uemoto S, Vivanco M, Chun YS, Cao HST, Tzeng CD, De Aretxabala X, Seo S, Giuliante F, Guglielmi A, Vinuela E, Vauthey JN. Conditional recurrence-free survival after oncologic extended resection for gallbladder cancer: an international multicenter analysis. Ann Surg Oncol. e-Pub 2021. PMID: 33666814.
Kemp Bohan PM, O'Shea AE, Lee AJ, Chick RC, Newhook TE, Tran Cao HS, Allen CJ, Nelson DW, Clifton GT, Vauthey JN, Tzeng CD, Vreeland TJ. Lymph node sampling in resectable hepatocellular carcinoma: national practice patterns and predictors of positive lymph nodes. Surg Oncol 36:138-146, 2021. e-Pub 2021. PMID: 33418464.
Mason MC, Tzeng CD, Tran Cao HS, Aloia TA, Newhook TE, Overman MJ, Kopetz SE, Vauthey JN, Chun YS. Preliminary analysis of liquid biopsy after hepatectomy for colorectal liver mtastases. J Am Coll Surg. e-Pub 2021. PMID: 33667566.
Newton AD, Newhook TE, Ikoma N, White MG, Tzeng CD, Chun YS, Aloia TA, Vauthey JN, Tran Cao HS. Robotic completion radical cholecystectomy with fluorescence guidance. Ann Surg Oncol. e-Pub 2021. PMID: 33774771.
De Bellis M, Kawaguchi Y, Duwe G, Tran Cao HS, Mehran RJ, Vauthey JN. Short- and Long-Term Outcomes of a Transdiaphragmatic Approach for Simultaneous Resection of Colorectal Liver and Lung Metastases. J Gastrointest Surg 25(3):641-649, 2021. e-Pub 2021. PMID: 33123875.
Mason MC, Massarweh NN, Tzeng CD, Chiang YJ, Chun YS, Aloia TA, Javle M, Vauthey JN, Tran Cao HS. Time to rethink upfront surgery for resectable intrahepatic cholangiocarcinoma? Implications from the neoadjuvant experience. Ann Surg Oncol. e-Pub 2021. PMID: 33586068.
Kawaguchi Y, Newhook TE, Tran Cao HS, Tzeng CD, Chun YS, Aloia TA, Dasari A, Kopetz S, Vauthey JN. Alteration of FBXW7 is associated with worse survival in patients undergoing resection of colorectal liver metastases. J Gastrointest Surg 25(1):186-194, 2021. e-Pub 2021. PMID: 33205306.
De B, Ng SP, Liu AY, Avila S, Tao R, Holliday EB, Brownlee Z, Kaseb A, Lee S, Raghav K, Vauthey JN, Minsky BD, Herman JM, Das P, Smith GL, Taniguchi CM, Krishnan S, Crane CH, Grassberger C, Hong TS, Lin SH, Koong AC, Mohan R, Koay EJ. Radiation-Associated lymphopenia and outcomes of patients with unresectable hepatocellular carcinoma treated with radiotherapy. J Hepatocell Carcinoma 8:57-69, 2021. e-Pub 2021. PMID: 33688489.
Henry JT, Coker O, Chowdhury S, Shen JP, Morris VK, Dasari A, Raghav K, Nusrat M, Kee B, Parseghian C, Pant S, Jeyakumar N, Zhu L, Nishioka Y, Fogelman D, Wolff RA, Hong D, Overman MJ, Vauthey J, Kopetz S, Johnson B. Comprehensive Clinical and Molecular Characterization of KRAS (G12C)-Mutant Colorectal Cancer. JCO Precis Oncol 5, 2021. e-Pub 2021. PMID: 34250391.
Giménez M, Gallix B, Costamagna G, Vauthey JN, Moche M, Wakabayashi G, Bale R, Swanström L, Futterer J, Geller D, Verde JM, García Vazquez A, Boškoski I, Golse N, Müller-Stich B, Dallemagne B, Falkenberg M, Jonas S, Riediger C, Diana M, Kvarnström N, Odisio BC, Serra E, Overduin C, Palermo M, Mutter D, Perretta S, Pessaux P, Soler L, Hostettler A, Collins T, Cotin S, Kostrzewa M, Alzaga A, Smith M, Marescaux J. Definitions of Computer-Assisted Surgery and Intervention, Image-Guided Surgery and Intervention, Hybrid Operating Room, and Guidance Systems: Strasbourg International Consensus Study. Ann Surg Open 1(2):e021, 2020. e-Pub 2020. PMID: 33392607.
Day RW, Newhook TE, Dewhurst WL, Arvide EM, Bruno ML, Vauthey JN, Tzeng CD. Assessing the 5×-multiplier calculation to reduce discharge opioid prescription volumes after inpatient surgery. JAMA Surg 155(12):1166-1167, 2020. e-Pub 2020. PMID: 32997105.
Jácome AA, Vreeland TJ, Johnson B, Kawaguchi Y, Wei SH, Nancy You Y, Vilar E, Vauthey JN, Eng C. The prognostic impact of RAS on overall survival following liver resection in early versus late-onset colorectal cancer patients. Br J Cancer. e-Pub 2020. PMID: 33208919.
Lee SH, Simoneau EB, Karpinets T, Futreal PA, Zhang J, Javle M, Zhang J, Vauthey JN, Lee JS, Estrella JS, Chun YS. Genomic Profiling of Multifocal Intrahepatic Cholangiocarcinoma Reveals Intraindividual Concordance of Genetic Alterations. Carcinogenesis. e-Pub 2020. PMID: 33200197.
Kawaguchi Y, Kopetz S, Lillemoe HA, Hwang H, Wang X, Tzeng CWD, Chun YS, Aloia TA, Vauthey JN. A new surveillance algorithm after resection of colorectal liver metastases based on changes in recurrence risk and RAS mutation status. JNCCN 18(11):1-10, 2020. e-Pub 2020.
Kawaguchi Y, Kopetz S, Lillemoe HA, Hwang H, Wang X, Tzeng CD, Chun YS, Aloia TA, Vauthey JN. A New Surveillance Algorithm After Resection of Colorectal Liver Metastases Based on Changes in Recurrence Risk and RAS Mutation Status. J Natl Compr Canc Netw 18(11):1500-1508, 2020. e-Pub 2020. PMID: 33152698.
Ignatavicius P, Oberkofler CE, Chapman WC, DeMatteo RP, Clary BM, D'Angelica MI, Tanabe KK, Hong JC, Aloia TA, Pawlik TM, Hernandez-Alejandro R, Shah SA, Vauthey JN, Torzilli G, Lang H, Line PD, Soubrane O, Pinto-Marques H, Robles-Campos R, Boudjema K, Lodge P, Adam R, Toso C, Serrablo A, Aldrighetti L, DeOliveira ML, Dutkowski P, Petrowsky H, Linecker M, Reiner CS, Braun J, Alikhanov R, Barauskas G, Chan ACY, Dong J, Kokudo N, Yamamoto M, Kang KJ, Fong Y, Rela M, De Aretxabala X, De Santibañes E, MÁ M, Andriani OC, Torres OJM, Pinna AD, Clavien PA. Choices of therapeutic strategies for colorectal liver metastases among expert liver surgeons a throw of the dice?. Ann Surg 272(5):715-722, 2020. e-Pub 2020. PMID: 32833764.
De Bellis M, Kawaguchi Y, Duwe G, Tran Cao HS, Mehran RJ, Vauthey JN. Short-and Long- Term outcomes of a transdiaphragmatic approach for simultaneous resection of colorectal liver and lung metastases. J Gastrointest Surg:DOI: 10.1007/s11605-020-04828-8, 2020. e-Pub 2020.
Abdel-Wahab R, Hassan MM, George B, Carmagnani Pestana R, Xiao L, Lacin S, Yalcin S, Shalaby AS, Al-Shamsi HO, Raghav K, Wolff RA, Yao JC, Girard L, Haque A, Duda DG, Dima S, Popescu I, Elghazaly HA, Vauthey JN, Aloia TA, Tzeng CW, Chun YS, Rashid A, Morris JS, Amin HM, Kaseb AO. Impact of integrating insulin-like growth factor 1 levels into model for End-Stage liver disease score for survival prediction in hepatocellular carcinoma patients. Oncology:1-11. e-Pub 2020. PMID: 33027788.
Tzeng CD, Tran Cao HS, Roland CL, Teshome M, Bednarski BK, Ikoma N, Graham PH, Keung EZ, Scally CP, Katz MHG, Gershenwald JE, Lee JE, Vauthey JN. Surgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: A multidisciplinary approach. Surg Oncol 34:182-185, 2020. e-Pub 2020. PMID: 32891326.
Kim BJ, Lillemoe HA, Newhook TE, Dewhurst WL, Arvide EM, Katz MHG, Aloia TA, Vauthey JN, Lee JE, Tzeng CD. Educating surgical oncology providers on perioperative opioid use: A departmental survey 1 year after the intervention. J Surg Oncol 122(3):547-554, 2020. e-Pub 2020. PMID: 32447769.
Okuno M, Kawaguchi Y, De Bellis M, Vega EA, Huang SY, Ahrar K, Gupta S, Vauthey JN, Odisio BC. A new sequential treatment strategy for multiple colorectal liver metastases: Planned incomplete resection and postoperative completion ablation for intentionally-untreated tumors under guidance of cross-sectional imaging. Eur J Surg Oncol. e-Pub 2020. PMID: 32873452.
White MG, Tzeng CW, Ikoma N, Chun YS, Aloia TA, Vauthey JN, Cao HST. Robotic Partial Segment VIII Resection. Ann Surg Oncol. e-Pub 2020. PMID: 32761429.
Tzeng CD, Teshome M, Katz MHG, Weinberg JS, Lai SY, Antonoff MB, Bird JE, Shafer A, Davis JW, Adelman DM, Moon B, Reece G, Prabhu SS, DeSnyder SM, Skibber JM, Mehran R, Schmeler K, Roland CL, Tran Cao HS, Aloia TA, Caudle AS, Swisher SG, Vauthey JN. Cancer Surgery Scheduling During and After the COVID-19 First Wave: The MD Anderson Cancer Center Experience. Ann Surg 272(2):e106-e111, 2020. e-Pub 2020. PMID: 32675511.
De Bellis M, Vega EA, Kawaguchi Y, Panettieri E, Velasco JD, Vreeland TJ, You YN, Holmes AA, Mehran RJ, Vauthey JN. Simultaneous sigmoid colectomy, bilobar liver resection and lung metastasectomy via a transdiaphragmatic approach for stage IV colonic adenocarcinoma. Ann Surg Oncol(28):863-864, 2020. e-Pub 2020. PMID: 32813205.
Lillemoe HA, Newhook TE, Aloia TA, Grubbs EG, Chang GJ, Katz MHG, Vauthey JN, Lee JE, Tzeng CD. Perceptions of opioid use and prescribing habits in oncologic surgery: a survey of the society of surgical oncology membership. J Surg Oncol. e-Pub 2020. PMID: 32632993.
Newhook TE, Vreeland TJ, Dewhurst WL, Wang X, Prakash L, Feng C, Bruno ML, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHG, Tzeng CD. Clinical Factors Associated With Practice Variation in Discharge Opioid Prescriptions After Pancreatectomy. Ann Surg 272(1):163-169, 2020. e-Pub 2020. PMID: 30499795.
Nishioka Y, Tzeng CD, Tran Cao HS, Vauthey JN. COVID-19 outbreak and surgeonsresponse at a Cancer Center in the United States. Glob Health Med 2(2):135-137, 2020. e-Pub 2020. PMID: 33330793.
Kim BJ, LIllemoe HA, Newhook TE, Dewhurst W, Arvide A, Katz MHG, Aloia TA, Vauthey JN, Tzeng CWD. Educating surgical oncology providers on perioperative opioid use: results of a departmental survey on perceptions of opioid needs and prescribing habit. J Surg Oncol 26(7):2011-2018, 2020. e-Pub 2020.
Tzeng CWD, Cao T, HS, Roland CL, Teshome M, Bednarski BK, Ikoma N, Graham PH, Keung EZ, Scally CP, Katz MHG, Gershenwald JE, Lee JE, Vauthey JN. Surgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: A multidisciplinary approach. Surg Oncol. e-Pub 2020.
Chun YS, Mizuno T, Cloyd JM, Ha MJ, Omichi K, Tzeng CD, Aloia TA, Ueno NT, Kuerer HM, Barcenas CH, Vauthey JN. Hepatic resection for breast cancer liver metastases: Impact of intrinsic subtypes. Eur J Surg Oncol. e-Pub 2020. PMID: 32253074.
Joechle K, Vreeland TJ, Vega EA, Okuno M, Newhook TE, Panettieri E, Chun YS, Tzeng CD, Aloia TA, Lee JE, Vauthey JN. Anatomic Resection Is Not Required for Colorectal Liver Metastases with RAS Mutation. J Gastrointest Surg. e-Pub 2020. PMID: 32162236.
Niekamp AS, Huang SY, Mahvash A, Odisio BC, Ahrar K, Tzeng CD, Vauthey JN. Hepatic vein embolization after portal vein embolization to induce additional liver hypertrophy in patients with metastatic colorectal carcinoma. Eur Radiol. e-Pub 2020. PMID: 32144462.
Newhook TE, Vega EA, Vreeland TJ, Prakash L, Dewhurst WL, Bruno ML, Kim MP, Ikoma N, Vauthey JN, Katz MH, Lee JE, Tzeng CD. Early postoperative drain fluid amylase in risk-stratified patients promotes tailored post-pancreatectomy drain management and potential for accelerated discharge. Surgery 167(2):442-447, 2020. e-Pub 2020. PMID: 31727324.
Kawaguchi Y, Hasegawa K, Tzeng CD, Mizuno T, Arita J, Sakamoto Y, Chun YS, Aloia TA, Kokudo N, Vauthey JN. Performance of a modified three-level classification in stratifying open liver resection procedures in terms of complexity and postoperative morbidity. Br J Surg 107(3):258-267, 2020. e-Pub 2020. PMID: 31603540.
Newhook TE, Vreeland TJ, Dewhurst WL, Arvide EM, Bruno ML, Robinson KA, Rajkot N, Aloia TA, Katz MHG, Vauthey JN, Lee JE, Tzeng CD. Opioid-prescribing Practices After Oncologic Surgery: Opportunities for Improvement and a Call to Action. Ann Surg 271(2):e9-e10, 2020. e-Pub 2020. PMID: 31478982.
Newhook TE, Vreeland TJ, Dewhurst WL, Arvide EM, Bruno ML, Robinson KA, Rajkot N, Aloia TA, Katz MHG, Vauthey JN, Lee JE, Tzeng CWD. Opioid prescribing practices after oncologic surgery: opportunities for improvement and a call to action. Ann Surg 1(2):e9-e10, 2020. e-Pub 2020.
Denbo JW, Kim BJ, Vauthey JN, Tzeng CW, Ma J, Huang SY, Chun YS, Katz MHG, Aloia TA. Overall body composition and sarcopenia are associated with poor liver hypertrophy following portal vein embolization. J Gastrointest Surg. e-Pub 2020. PMID: 31997073.
Tran Cao H, Tzeng CW, Chun YS, Aloia T, Vauthey JN. Surgical Management of Localized Hepatocellular Carcinoma in Times of Crisis: A Strategic Approach to Resource Utilization. J Hepatocell Carcinoma 7:155-158, 2020. e-Pub 2020. PMID: 33062624.
Vega EA, De Aretxabala X, Qiao W, Newhook TE, Okuno M, Castillo F, Sanhueza M, Diaz C, Cavada G, Jarufe N, Munoz C, Rencoret G, Vivanco M, Joechle K, Tzeng CD, Vauthey JN, Vinuela E, Conrad C. Comparison of oncological outcomes after open and laparoscopic re-resection of incidental gallbladder cancer. Br J Surg 107(3):289-300, 2019. e-Pub 2019. PMID: 31873948.
Kawaguchi Y, Chiang YJ, Velasco JD, Tzeng CD, Vauthey JN. Long-term outcomes in patients undergoing resection, ablation, and trans-arterial chemoembolization of hepatocellular carcinoma in the United States: a national cancer database analysis. Glob Health Med 1(1):55-60, 2019. e-Pub 2019. PMID: 33330755.
Kawaguchi Y, Velasco JD, Arvide EM, Wei SH, Vauthey JN. Interactions of multiple gene alterations in colorectal liver metastases. Chin Clin Oncol 8(5):50, 2019. e-Pub 2019. PMID: 31500427.
Kawaguchi Y, Chiang YJ, Velasco JD, Tzeng CWD, Vauthey JN. Long-term outcomes in patients undergoing resection, ablation, and trans-arterial chemoembolization of hepatocellular carcinoma in the United States: a national cancer database analysis. J Glob Health 11(1):55-60, 2019. e-Pub 2019.
Okuno M, Newhook TE, Joechle K, Kawaguchi Y, De Bellis M, Tzeng CD, Chun YS, Aloia TA, Shindoh J, Kaseb AO, Vauthey JN. Characteristics of atypical large well-differentiated hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma?. HPB (Oxford). e-Pub 2019. PMID: 31533893.
Kaseb AO, Vence L, Blando J, Yadav SS, Ikoma N, Pestana RC, Vauthey JN, Allison JP, Sharma P. Immunologic correlates of pathologic complete response to preoperative immunotherapy in hepatocellular carcinoma. Cancer Immunol Res 7(9):1390-1395, 2019. e-Pub 2019. PMID: 31289040.
Tran Cao HS, Marcal LP, Mason MC, Yedururi S, Joechle K, Wei SH, Vauthey JN. Benign hepatic incidentalomas. Curr Probl Surg 56(9):100642, 2019. e-Pub 2019. PMID: 31585553.
Dasari BV, Kamarajah SK, Hodson J, Pawlik TM, Vauthey JN, Ma YT, Punia P, Coldham C, Abradelo M, Roberts KJ, Marudanayagam R, Sutcliffe RP, Muiesan P, Mirza DF, Isaac J. Development and validation of a risk score to predict the overall survival following surgical resection of hepatocellular carcinoma in non-cirrhotic liver. HPB (Oxford). e-Pub 2019. PMID: 31416786.
Vreeland TJ, McAllister F, Javadi S, Prakash LR, Fogelman DR, Ho L, Varadhachary G, Aloia TA, Vauthey JN, Lee JE, Kim MP, Katz MHG, Tzeng CD. Benefit of Gemcitabine/Nab-Paclitaxel Rescue of Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma After Early Failure of FOLFIRINOX. Pancreas 48(6):837-843, 2019. e-Pub 2019. PMID: 31210666.
Snyder RA, Prakash LR, Nogueras-Gonzalez GM, Kim MP, Aloia TA, Vauthey JN, Lee JE, Fleming JB, Katz MHG, Tzeng CD. Perioperative blood transfusions for vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: Identification of clinical targets for optimization. HPB (Oxford) 21(7):841-848, 2019. e-Pub 2019. PMID: 30501986.
Lillemoe HA, Brudvik KW, Vauthey JN. Treatment options for metastatic gastrointestinal stromal tumors to the liver: A Review. Semin Liver Dis 39(3):395-402, 2019. e-Pub 2019.
Kawaguchi Y, Kopetz S, Newhook TE, De Bellis M, Chun YS, Tzeng CD, Aloia TA, Vauthey JN. Mutation status of RAS, TP53, and SMAD4 is superior to mutation status of RAS alone for predicting prognosis after resection of colorectal liver metastases. Clin Cancer Res. e-Pub 2019. PMID: 31221662.
Vega EA, Vinuela E, Sanhueza M, Mege R, Caracci M, Diaz C, Diaz A, Okuno M, Joechle K, Goumard C, Chun YS, Tzeng CWD, Lee JE, Vauthey JN, Conrad C. Positive cystic duct margin at index cholecystectomy in incidental gallbladder cancer is an important negative prognosticator. Eur J Surg Oncol 45(6):1061-1068, 2019. e-Pub 2019.
Kim BJ, Prakash L, Narula N, Davis CH, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MH, Tzeng CD. Contemporary analysis of complications associated with biliary stents during neoadjuvant therapy for pancreatic adenocarcinoma. HPB (Oxford) 21(6):662-668, 2019. e-Pub 2019. PMID: 30522947.
Vega EA, Vinuela E, Sanhueza M, Mege R, Caracci M, Diaz C, Diaz A, Okuno M, Joechle K, Goumard C, Chun YS, Tzeng CD, Lee JE, Vauthey JN, Conrad C. Positive cystic duct margin at index cholecystectomy in incidental gallbladder cancer is an important negative prognosticator. Eur J Surg Oncol 45(6):1061-1068, 2019. e-Pub 2019. PMID: 30704808.
Newhook TE, Dewhurst WL, Vreeland TJ, Wang X, Soliz J, Speer BB, Hancher-Hodges S, Feng C, Bruno ML, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHG, Tzeng CD. Inpatient opioid use after pancreatectomy: Opportunities for reducing initial opioid exposure in cancer surgery patients. Ann Surg Oncol. e-Pub 2019. PMID: 31243665.
Vreeland TJ, Beaudry Simoneau E, Dewhurst WL, Newhook TE, Westin SN, Mehran RJ, Chun YS, Aloia TA, Vauthey JN, Tzeng CD. Intraoperative air leak test to prevent bile leak after right posterior sectionectomy with en bloc diaphragm resection for metastatic teratoma. Ann Surg Oncol. e-Pub 2019. PMID: 31065963.
Kawaguchi Y, Lillemoe HA, Panettieri E, Chun YS, Tzeng CW, Aloia TA, Kopetz S, Vauthey JN. Conditional recurrence-free survival after resection of colorectal liver metastases: Persistent deleterious association with RAS and TP53 Co-mutation. J Am Coll Surg. e-Pub 2019. PMID: 31054911.
Nelson DB, Tayob N, Mitchell KG, Correa AM, Hofstetter WL, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Antonoff MB, Roth JA, Rice DC, Vauthey JN, Mehran RJ. Surgical margins and risk of local recurrence after wedge resection of colorectal pulmonary metastases. J Thorac Cardiovasc Surg 157(4):1648-1655, 2019. e-Pub 2019. PMID: 30635188.
Lillemoe HA, Newhook TE, Vreeland TJ, Arvide EM, Dewhurst WL, Grubbs EG, Aloia TA, Vauthey JN, Lee JE, Tzeng CD. Educating surgical oncology providers on perioperative opioid use: results of a departmental survey on perceptions of opioid needs and prescribing habits. Ann Surg Oncol. e-Pub 2019. PMID: 30937660.
Benson AB, D'Angelica MI, Abbott DE, Abrams TA, Alberts SR, Anaya DA, Anders R, Are C, Brown D, Chang DT, Cloyd J, Covey AM, Hawkins W, Iyer R, Jacob R, Karachristos A, Kelley RK, Kim R, Palta M, Park JO, Sahai V, Schefter T, Sicklick JK, Singh G, Sohal D, Stein S, Tian GG, Vauthey JN, Venook AP, Hammond LJ, Darlow SD. Guidelines Insights: Hepatobiliary Cancers, Version 2.2019. J Natl Compr Canc Netw 17(4):302-310, 2019. e-Pub 2019. PMID: 30959462.
Lee AJ, Simoneau E, Chiang YJ, Lee JE, Kim MP, Aloia TA, Vauthey JN, Katz MH, Tzeng CD. Is early-stage pancreatic adenocarcinoma truly early: stage migration on final pathology with surgery-first versus neoadjuvant therapy sequencing. HPB (Oxford). e-Pub 2019. PMID: 30799277.
Cloyd JM, Chen HC, Wang X, Tzeng CD, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHG. Chemotherapy versus chemoradiation as preoperative therapy for resectable pancreatic ductal adenocarcinoma: a propensity score adjusted analysis. Pancreas 48(2):216-222, 2019. e-Pub 2019. PMID: 30629022.
Simoneau E, Goumard C, Lee JE, Vauthey JN, Aloia TA, Chun YS, Kim MP, Katz MHG, Tzeng CD. Pancreaticoduodenectomy with Mesocaval Shunt for Locally Advanced Pancreatic Adenocarcinoma. Ann Surg Oncol 26(2):652, 2019. e-Pub 2019. PMID: 30539487.
Vega EA, Vinuela E, Okuno M, Joechle K, Sanhueza M, Diaz C, Jarufe N, Martinez J, Troncoso A, Diaz A, Chun YS, Tzeng CD, Lee JE, Vauthey JN, Conrad C. Incidental versus non-incidental gallbladder cancer: index cholecystectomy before oncologic re-resection negatively impacts survival in T2b tumors. HPB (Oxford). e-Pub 2019. PMID: 30711243.
Vicente D, Patino M, Marcus R, Lillmoe H, Limani P, Newhook T, Lee A, Tzeng CW, Segraves-Chun Y, Tweardy D, Gottumukkala V, Vauthey JN, Aloia T, Cata JP. Impact of epidural analgesia on the systemic biomarker response after hepatic resection. Oncotarget 10(5):584-594, 2019. e-Pub 2019. PMID: 30728909.
Varkaris A, Katsiampoura A, Davis JS, Shah N, Lam M, Frias RL, Ivan C, Shimizu M, Morris J, Menter D, Overman M, Tran H, Heymach J, Chun YS, Vauthey JN, Calin G, Kopetz S. Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer. Br J Cancer. e-Pub 2019. PMID: 30636774.
Brudvik KW, Jones RP, Giuliante F, Shindoh J, Passot G, Chung MH, Song J, Li L, Dagenborg VJ, Fretland AA, Rosok B, De Rose AM, Ardito F, Edwin B, Panettieri E, Larocca LM, Yamashita S, Conrad C, Aloia TA, Poston GJ, Bjornbeth BA, Vauthey JN. RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases. Ann Surg 269(1):120-126, 2019. e-Pub 2019. PMID: 28549012.
Ogiso S, Okuno M, Shindoh J, Sakamoto Y, Mizuno T, Araki K, Goumard C, Nomi T, Ishii T, Uemoto S, Chun YS, Tzeng CD, Lee JE, Vauthey JN, Conrad C. Conceptual framework of middle hepatic vein anatomy as a roadmap for safe right hepatectomy. HPB (Oxford) 21(1):43-50, 2019. e-Pub 2019. PMID: 30266496.
Brudvik KW, Jones RP, Giuliante F, Shindoh J, Passot G, Chung MH, Song J, Li L, Dagenborg VJ, Fretland AA, Rosok B, DeRose AM, Ardito F, Edwin B, Panettieri E Larocca LM, Yamashita S, Conrad C, Aloia TA, Bjornbeth BA, Poston GJ, Vauthey JN. RAS mutation clinical risk score to predict survival after resection of colorectal liver metastases. Ann Surg 269(1):120-126, 2019. e-Pub 2019.
Ogiso S, Okuno M, Shindoh J, Sakamoto Y, Mizuno T, Araki K, Goumard C, Nomi T, Ishii T, Uemoto S, Chun YS, Tzeng CWD, Lee JE, Vauthey JN, Conrad C. Conceptual framework of middle hepatic vein anatomy as a roadmap for safe right hepatectomy. HPB (Oxford) 21(1):43-50, 2019. e-Pub 2019.
Joechle K, Vega EA, Okuno M, Simoneau E, Ogiso S, Newhook TE, Ramirez DL, Holmes AA, Soliz JM, Chun YS, Tzeng CD, Lee JE, Vauthey JN, Conrad C. Middle hepatic vein roadmap for a safe laparoscopic right hepatectomy. Ann Surg Oncol 26(1):296, 2019. e-Pub 2019. PMID: 30465224.
Lillemoe HA, Kawaguchi Y, Passot G, Karagkounis G, Simoneau E, You YN, Mehran RJ, Chun YS, Tzeng CD, Aloia TA, Vauthey JN. Surgical resection for recurrence after two-stage hepatectomy for colorectal liver metastases is feasible, is safe, and improves survival. J Gastrointest Surg 23(1):84-92, 2019. e-Pub 2019. PMID: 30084064.
Kim BJ, Prakash L, Narula N, Davis CH, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MH, Tzeng CWD. Contemporary analysis of complications associated with biliary stents during neoadjuvant therapy for pancreatic adenocarcinoma. HPB (Oxford), 2018. e-Pub 2018.
Newhook TE, Vreeland TJ, Dewhurst WL, Wang X, Prakash L, Feng C, Bruno ML, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MHG, Tzeng CWD. Clinical factors associated with practice variation in discharge opioid prescriptions after pancreatectomy. Ann Surg. e-Pub 2018.
Snyder RA, Prakash LR, Nogueras-Gonzalez GM, Kim MP, Aloia TA, Vauthey JN, Lee JE, Fleming JB, Katz MHG, Tzeng CWD. Perioperative blood transfusions for vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: identification of clinical targets for optimization. HPB (Oxford), 2018. e-Pub 2018.
Lee AJ, Loyer EM, Kang HC, Aloia TA, Tzeng CD, Vauthey JN, Chun YS. Intrahepatic recurrence patterns predict survival after resection of colorectal liver metastases. Ann Surg Oncol. e-Pub 2018. PMID: 30362064.
Goffredo P, Utria AF, Beck AC, Chun YS, Howe JR, Weigel RJ, Vauthey JN, Hassan I. The prognostic impact of KRAS mutation in patients having curative resection of synchronous colorectal liver metastases. J Gastrointest Surg. e-Pub 2018. PMID: 30276588.
Lee AJ, Chiang YJ, Lee JE, Conrad C, Chun YS, Aloia TA, Vauthey JN, Tzeng CD. Validation of American Joint Committee on Cancer eighth staging system for gallbladder cancer and its lymphadenectomy guidelines. J Surg Res 230:148-154, 2018. e-Pub 2018. PMID: 30100032.
Cloyd JM, Mizuno T, Kawaguchi Y, Lillemoe HA, Karagkounis G, Omichi K, Chun YS, Conrad C, Tzeng CD, Odisio BC, Huang SY, Hicks M, Wei SH, Aloia TA, Vauthey JN. Comprehensive complication index validates improved outcomes over time despite increased complexity in 3707 consecutive hepatectomies. Ann Surg. e-Pub 2018. PMID: 30339628.
Cloyd JM, Prakash L, Vauthey JN, Aloia TA, Chun YS, Tzeng CW, Kim MP, Lee JE, Katz MHG. The role of preoperative therapy prior to pancreatoduodenectomy for distal cholangiocarcinoma. Am J Surg. e-Pub 2018. PMID: 30224070.
Okuno M, Goumard C, Kopetz S, Vega EA, Joechle K, Mizuno T, Tzeng CD, Chun YS, Lee JE, Vauthey JN, Aloia TA, Conrad C. Loss of muscle mass during preoperative chemotherapy as a prognosticator for poor survival in patients with colorectal liver metastases. Surgery. e-Pub 2018. PMID: 30197278.
Elganainy D, Holliday EB, Taniguchi CM, Smith GL, Shroff R, Javle M, Raghav K, Kaseb A, Aloia TA, Vauthey JN, Tzeng CD, Herman JM, Koong AC, Krishnan SX, Minsky BD, Crane CH, Das P, Koay EJ. Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma. Cancer Med. e-Pub 2018. PMID: 30152073.
Joechle K, Goumard C, Vega EA, Okuno M, Chun YS, Tzeng CD, Vauthey JN, Conrad C. Long-term survival after post-hepatectomy liver failure for colorectal liver metastases. HPB (Oxford). e-Pub 2018. PMID: 30100391.
Goumard C, Nancy You Y, Okuno M, Kutlu O, Chen HC, Simoneau E, Vega EA, Chun YS, David Tzeng C, Eng C, Vauthey JN, Conrad C. Minimally invasive management of the entire treatment sequence in patients with stage IV colorectal cancer: a propensity-score weighting analysis. HPB (Oxford). e-Pub 2018. PMID: 30005993.
Viganò L, Costa G, Cimino MM, Procopio F, Donadon M, Del Fabbro D, Belghiti J, Kokudo N, Makuuchi M, Vauthey JN, Torzilli G. R1 resection for colorectal liver metastases: a survey questioning surgeons about its incidence, clinical impact, and management. J Gastrointest Surg. e-Pub 2018. PMID: 29948554.
Snyder RA, Prakash LR, Nogueras-Gonzalez GM, Kim MP, Aloia TA, Vauthey JN, Lee JE, Fleming JB, Katz MHG, Tzeng CD. Vein resection during pancreaticoduodenectomy for pancreatic adenocarcinoma: patency rates and outcomes associated with thrombosis. J Surg Oncol. e-Pub 2018. PMID: 29723419.
Lunsford KE, Javle M, Heyne K, Shroff RT, Abdel-Wahab R, Gupta N, Mobley CM, Saharia A, Victor DW, Nguyen DT, Graviss EA, Kaseb AO, McFadden RS, Aloia TA, Conrad C, Li XC, Monsour HP, Gaber AO, Vauthey JN, Ghobrial RM, Collaborative Committee MAJC. Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series. Lancet Gastroenterol Hepatol 3(5):337-348, 2018. e-Pub 2018. PMID: 29548617.
Okuno M, Goumard C, Kopetz S, Vega EA, Joechle K, Mizuno T, Omichi K, Tzeng CD, Chun YS, Vauthey JN, Conrad C. RAS mutation is associated with unsalvageable recurrence following hepatectomy for colorectal cancer liver metastases. Ann Surg Oncol. e-Pub 2018. PMID: 29786130.
Odisio BC, Simoneau E, Holmes AA, Conrad CH, Vauthey JN. Fast-track Two-stage hepatectomy using a hybrid interventional radiology/operating suite as alternative option to associated liver partition and portal vein ligation for staged hepatectomy procedure. J Am Coll Surg. e-Pub 2018. PMID: 29729926.
Cloyd JM, Omichi K, Mizuno T, Kawaguchi Y, Tzeng CD, Conrad C, Chun YS, Aloia TA, Katz MHG, Lee JE, Halperin D, Yao J, Vauthey JN, Dasari A. Preoperative fluorouracil, doxorubicin and streptozocin for the treatment of pancreatic neuroendocrine liver metastases. Ann Surg Oncol. e-Pub 2018. PMID: 29626307.
Okuno M, Goumard C, Mizuno T, Kopetz S, Omichi K, Tzeng CD, Chun YS, Lee JE, Vauthey JN, Conrad C. Prognostic impact of perihepatic lymph node metastases in patients with resectable colorectal liver metastases. Br J Surg 105(9):1200-1209. e-Pub 2018. PMID: 29664996.
Goumard C, Ogiso S, Okuno M, Fleming JB, Kim M, Tzeng CD, Vauthey JN, Lee JE, Conrad C. Tips and tricks of splenic vessel preservation during laparoscopic distal pancreatectomy. Surg Endosc 32(4):2149-2150, 2018. e-Pub 2018. PMID: 28733741.
Mizuno T, Cloyd JM, Vicente D, Omichi K, Chun YS, Kopetz SE, Maru D, Conrad C, Tzeng CD, Wei SH, Aloia TA, Vauthey JN. SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases. Eur J Surg Oncol. e-Pub 2018. PMID: 29551247.
Mizuno T, Cloyd JM, Omichi K, Chun YS, Conrad C, Tzeng CD, Wei SH, Aloia TA, Vauthey JN. Two-stage hepatectomy vs one-stage major hepatectomy with contralateral resection or ablation for advanced bilobar colorectal liver metastases. J Am Coll Surg, 2018. e-Pub 2018. PMID: 29454099.
Omichi K, Yamashita S, Cloyd JM, Shindoh J, Mizuno T, Chun YS, Conrad C, Aloia TA, Vauthey JN, Tzeng CD. Portal vein embolization reduces postoperative hepatic insufficiency associated with post-chemotherapy hepatic atrophy. J Gastrointest Surg 22(1):60-67, 2018. e-Pub 2018. PMID: 28585106.
Kutlu OC, Lee JE, Katz MH, Tzeng CD, Wolff RA, Varadhachary GR, Vauthey JN, Fleming JB, Conrad C. Open pancreaticoduodenectomy case volume predicts outcome of laparoscopic approach: a population-based analysis. Ann Surg 267(3):552-560, 2018. e-Pub 2018. PMID: 28045744.
Patel SH, Kim BJ, Tzeng CD, Chun YS, Conrad C, Vauthey JN, Aloia TA. Reduction of cardiopulmonary/renal complications with serum bnp-guided volume status management in posthepatectomy patients. J Gastrointest Surg 22(3):467-476, 2018. e-Pub 2018. PMID: 29234998.
Yamashita S, Brudvik KW, Kopetz SE, Maru D, Clarke CN, Passot G, Conrad C, Chun YS, Aloia TA, Vauthey JN. Embryonic origin of primary colon cancer predicts pathologic response and survival in patients undergoing resection for colon cancer liver metastases. Ann Surg 267(3):514-520, 2018. e-Pub 2018. PMID: 28002060.
Calandri M, Yamashita S, Gazzera C, Fonio P, Veltri A, Bustreo S, Sheth RA, Yevich SM, Vauthey JN, Odisio BC. Ablation of colorectal liver metastasis: interaction of ablation margins and RAS mutation profiling on local tumour progression free survival. Eur Radiol. e-Pub 2018. PMID: 29417253.
Okuno M, Gourmard C, Mizuno T, Omichi K, Tzeng CD, Chun YS, Lee JE, Vauthey JN, Conrad C. Pathological diaphragmatic invasion by colorectal liver metastases is associated with RAS mutation, peritoneal recurrence and worse survival. HPB (Oxford) 20(1):57-63, 2018. e-Pub 2018. PMID: 28943395.
Overman MJ, Ferrarotto R, Raghav K, George B, Qiao W, Machado KK, Saltz LB, Mazard T, Vauthey JN, Hoff PM, Hobbs B, Loyer EM, Kopetz S. The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: Impact Upon Hepatic Sinusoidal Injury and Thrombocytopenia. J Natl Cancer Inst. e-Pub 2018. PMID: 29346573.
Rui M, Lee JE, Vauthey JN, Conrad C. Enhancing surgical performance by adopting expert musicians' practice and performance strategies. Surgery. e-Pub 2018. PMID: 29336812.
Omichi K, Shindoh J, Cloyd JM, Mizuno T, Chun YS, Conrad C, Aloia TA, Tzeng CWD, Vauthey JN. Liver resection is justified for patients with bilateral multiple colorectal liver metastases: A propensity-score-matched analysis. Eur J Surg Oncol 44(1):122-129, 2018. e-Pub 2018.
Omichi K, Shindoh J, Cloyd JM, Mizuno T, Chun YS, Conrad C, Aloia TA, Tzeng CD, Vauthey JN. Liver resection is justified for patients with bilateral multiple colorectal liver metastases: A propensity-score-matched analysis. Eur J Surg Oncol 44(1):122-129, 2018. e-Pub 2018. PMID: 29208318.
Vega EA, Vinuela E, Yamashita S, Sanhueza M, Cavada G, Diaz C, Aloia TA, Chun YS, Tzeng CD, Okuno M, Goumard C, Vauthey JN, Lee JE, Conrad C. Extended lymphadenectomy is required for incidental gallbladder cancer independent of cystic duct lymph node status. J Gastrointest Surg 22(1):43-51, 2018. e-Pub 2018. PMID: 28752405.
Odisio BC, Yamashita S, Huang SY, Kopetz SE, Ahrar K, Mizuno T, Conrad C, Aloia TA, Chun YS, Gupta S, Vauthey JN. Impact of prior hepatectomy history on local tumor progression after percutaneous ablation of colorectal liver metastases. J Vasc Interv Radiol. e-Pub 2018. PMID: 29395898.
Passot G, Kim BJ, Glehen O, Mehran RJ, Kopetz SE, Goere D, Overman MJ, Pocard M, Marchal F, Conrad C, Aloia TA, Vauthey JN, Chun YS, Group BW. Impact of RAS mutations in metastatic colorectal cancer after potentially curative resection - does site of metastases matter?. Ann Surg Oncol 25(1):179-187, 2018. e-Pub 2018. PMID: 29071660.
Sultana A, Brooke-Smith M, Ullah S, Figueras J, Rees M, Vauthey JN, Conrad C, Hugh TJ, Garden OJ, Fan ST, Crawford M, Makuuchi M, Yokoyama Y, Büchler M, Padbury R. Prospective evaluation of the International Study Group for Liver Surgery definition of post hepatectomy liver failure after liver resection: an international multicentre study. HPB (Oxford) 20(5):462-469. e-Pub 2017. PMID: 29287736.
Yamashita S, Overman MJ, Wang H, Zhao J, Okuno M, Goumard C, Tzeng CW, Kim M, Fleming JB, Vauthey JN, Katz MH, Lee JE, Conrad C. Pathologic response to preoperative therapy as a novel prognosticator for ampullary and duodenal adenocarcinoma. Ann Surg Oncol 24(13):3954-3963, 2017. e-Pub 2017. PMID: 28980211.
Yamashita S, Sheth RA, Niekamp AS, Aloia TA, Chun YS, Lee JE, Vauthey JN, Conrad C. Comprehensive Complication Index Predicts Cancer-specific Survival After Resection of Colorectal Metastases Independent of RAS Mutational Status. Ann Surg 266(6):1045-1054, 2017. e-Pub 2017. PMID: 27735824.
Cloyd JM, Chun YS, Ikoma N, Vauthey JN, Aloia TA, Cuddy A, Rodriguez-Bigas MA, Nancy You Y. Clinical and genetic implications of DNA mismatch repair deficiency in biliary tract cancers associated with Lynch Syndrome. J Gastrointest Cancer. e-Pub 2017. PMID: 29238914.
Goumard C, Marcal LP, Wang WL, Somaiah N, Okuno M, Roland CL, Tzeng CD, Chun YS, Feig BW, Vauthey JN, Conrad C. Long-term survival according to histology and radiologic response to preoperative chemotherapy in 126 patients undergoing resection of non-gist sarcoma liver metastases. Ann Surg Oncol. e-Pub 2017. PMID: 29116489.
Omichi K, Mizuno T, Okuno M, Tzeng CD, Conrad C, Chun YS, Aloia TA, Vauthey JN. Long term outcome after resection of liver metastases from squamous cell carcinoma. Eur J Surg Oncol 43(11):2129-2134, 2017. e-Pub 2017. PMID: 28958732.
Cloyd JM, Wang H, Egger ME, Tzeng CW, Prakash L, Maitra A, Varadhachary G, Shroff R, Javle M, Fogelman D, Wolff RA, Overman M, Koay E, Das P, Herman J, Kim M, Vauthey JN, Aloia TA, Fleming JB, Lee JE, Katz MGH. Association of clinical factors with a major pathologic response following preoperative therapy for pancreatic ductal adenocarcinoma. JAMA Surg 152(11):1048-1056, 2017. e-Pub 2017.
Mazard T, Boonsirikamchai P, Overman MJ, Asran MA, Choi H, Herron D, Eng C, Maru DM, Ychou M, Vauthey JN, Loyer EM, Kopetz S. Comparison of early radiological predictors of outcome in patients with colorectal cancer with unresectable hepatic metastases treated with bevacizumab. Gut. e-Pub 2017. PMID: 29084828.
Okuno M, Goumard C, Mizuno T, Omichi K, Tzeng CD, Chun YS, Aloia TA, Fleming JB, Lee JE, Vauthey JN, Conrad C. Operative and short-term oncologic outcomes of laparoscopic versus open liver resection for colorectal liver metastases located in the posterosuperior liver: a propensity score matching analysis. Surg Endosc. e-Pub 2017. PMID: 28917012.
Aloia TA, Bradford JK, Chun YS, Cata JP, Truty MJ, Shi Q, Holmes A, Soliz JM Popat KU, Rahfs TF, Lee JE, Wang XS, Morri JS, Gottumukkala VNR, Vauthey JN. A randomized controlled trial of postoperative thoracic epidural analgesia versus intravenous patient controlled analgesia after major hepatopancreatobiliary surgery. Ann Surg 266(3):545-554, 2017. e-Pub 2017.
Omichi K, Mizuno T, Okuno M, Tzeng CWD, Conrad C, Chun YS, Aloia TA, Vauthey JN. Long term outcome after resection of liver metastases from squamous cell carcinoma. Eur J Surg Oncol, 2017. e-Pub 2017.
Aloia TA, Kim BJ, Segraves-Chun YS, Cata JP, Truty MJ, Shi Q, Holmes A, Soliz JM, Popat KU, Rahlfs TF, Lee JE, Wang XS, Morris JS, Gottumukkala VNR, Vauthey JN. A Randomized Controlled Trial of Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-controlled Analgesia After Major Hepatopancreatobiliary Surgery. Ann Surg 266(3):545-554, 2017. e-Pub 2017. PMID: 28746153.
Conrad C, Vauthey JN, Masayuki O, Sheth RA, Yamashita S, Passot G, Bailey CE, Zorzi D, Kopetz S, Aloia TA, You YN. Individualized treatment sequencing selection contributes to optimized survival in patients with rectal cancer and synchronous liver metastases. Ann Surg Oncol. e-Pub 2017. PMID: 28929463.
Cata JP, Velasquez JF, Ramirez MF, Vauthey JN, Gottumukkala V, Conrad C, Kim BJ, Aloia T. Inflammation and pro-resolution inflammation after hepatobiliary surgery. World J Surg Oncol 15(1):152, 2017. e-Pub 2017. PMID: 28807031.
Chun YS, Passot G, Yamashita S, Nusrat M, Katsonis P, Loree JM, Conrad C, Tzeng CD, Xiao L, Aloia TA, Eng C, Kopetz SE, Lichtarge O, Vauthey JN. Deleterious effect of RAS and evolutionary high risk TP53 double mutation in colorectal liver metastases. Ann Surg. e-Pub 2017. PMID: 28767562.
Clarke CN, Choi H, Hou P, Davis CH, Ma J, Rashid A, Vauthey JN, Aloia TA. Using MRI to non-invasively and accurately quantify preoperative hepatic steatosis. HPB (Oxford) 19(8):706-712, 2017. e-Pub 2017. PMID: 28528267.
Yamashita S, Venkatesan AM, Mizuno T, Aloia TA, Chun YS, Lee JE, Vauthey JN, Conrad C. Remnant liver ischemia as a prognostic factor for cancer-specific survival after resection of colorectal liver metastases. JAMA Surg:e172986. e-Pub 2017. PMID: 28854316.
Clarke CN, h C, Hou P, Davis CH, Ma J, Rashid A, Vauthey JN, Aloia TA. Using MRI to non-invasively and accurately quantify preoperative hepatic steatosis. HPB (Oxford) 19(8):706-712, 2017. e-Pub 2017.
Chun YS, Pawlik TM, Vauthey JN. 8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers. Ann Surg Oncol. e-Pub 2017. PMID: 28752469.
Al-Shamsi HO, Abdel-Wahab R, Hassan MM, Shalaby AS, Dahbour I, Lacin S, Mahvash A, Odisio BC, Murthy R, Avritscher R, Abdelsalam ME, Rashid A, Vauthey JN, Aloia TA, Conrad C, Chun YS, Krishnan S, Das P, Koay EJ, Amin HM, Yao JC, Kaseb AO. Natural History of T1N0M0 Hepatocellular Carcinoma: Large-Scale Study in the United States. Oncology. e-Pub 2017. PMID: 28683459.
Omichi K, Cloyd JM, Yamashita S, Tzeng CD, Conrad C, Chun YS, Aloia TA, Vauthey JN. Neutrophil-to-lymphocyte ratio predicts prognosis after neoadjuvant chemotherapy and resection of intrahepatic cholangiocarcinoma. Surgery. e-Pub 2017. PMID: 28688518.
Cloyd JM, Wang H, Egger ME, Tzeng CD, Prakash LR, Maitra A, Varadhachary GR, Shroff R, Javle M, Fogelman D, Wolff RA, Overman MJ, Koay EJ, Das P, Herman JM, Kim MP, Vauthey JN, Aloia TA, Fleming JB, Lee JE, Katz MHG. Association of clinical factors with a major pathologic response following preoperative therapy for pancreatic ductal adenocarcinoma. JAMA Surg. e-Pub 2017. PMID: 28700784.
Yamashita S, Shindoh J, Mizuno T, Chun YS, Conrad C, Aloia TA, Vauthey JN. Hepatic atrophy following preoperative chemotherapy predicts hepatic insufficiency after resection of colorectal liver metastases. J Hepatol 67(1):56-64, 2017. e-Pub 2017. PMID: 28192187.
Vauthey JN. Seven keys to success in academic surgery. Br J Surg 104(8):962-963, 2017. e-Pub 2017. PMID: 28608955.
Holliday EB, Tao R, Brownlee Z, Das P, Krishnan S, Taniguchi C, Minsky BD, Herman JM, Kaseb A, Raghav K, Conrad C, Vauthey JN, Aloia TA, Chun YS, Crane CH, Koay EJ. Definitive radiation therapy for hepatocellular carcinoma with portal vein tumor thrombus. Clin Transl Radiat Oncol 4:39-45, 2017. e-Pub 2017. PMID: 29594206.
Yamashita S, Odisio BC, Huang SY, Kopetz SE, Ahrar K, Chun YS, Conrad C, Aloia TA, Gupta S, Harmoush S, Hicks ME, Vauthey JN. Embryonic origin of primary colon cancer predicts survival in patients undergoing ablation for colorectal liver metastases. Eur J Surg Oncol 43(6):1040-1049, 2017. e-Pub 2017. PMID: 28187878.
Odisio BC, Cox VL, Faria SC, Yamashita S, Shi X, Ensor J, Jones AK, Mahvash A, Gupta S, Tam AL, Vauthey JN, Murthy R. Prognostic value of incidental hypervascular micronodules detected on cone-beam computed tomography angiography of patients with liver metastasis. Eur Radiol. e-Pub 2017. PMID: 28484824.
Benson AB, D'Angelica MI, Abbott DE, Abrams TA, Alberts SR, Saenz DA, Are C, Brown DB, Chang DT, Covey AM, Hawkins W, Iyer R, Jacob R, Karachristos A, Kelley RK, Kim R, Palta M, Park JO, Sahai V, Schefter T, Schmidt C, Sicklick JK, Singh G, Sohal D, Stein S, Tian GG, Vauthey JN, Venook AP, Zhu AX, Hoffmann KG, Darlow S. NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017. J Natl Compr Canc Netw 15(5):563-573, 2017. e-Pub 2017. PMID: 28476736.
You YN, Shiozaki H, Lee JE, Passot G, Goumard C, Okuno M, Aloia TA, Eng C, Chang G, Vauthey JN, Conrad C. Total laparoscopic management for stage IV colorectal cancer requiring multivisceral resection. Ann Surg Oncol. e-Pub 2017. PMID: 28510798.
Vinuela E, Vega EA, Yamashita S, Sanhueza M, Mege R, Cavada G, Aloia TA, Chun YS, Lee JE, Vauthey JN, Conrad C. Incidental gallbladder cancer: residual cancer discovered at oncologic extended resection determines outcome: a report from high- and low-incidence countries. Ann Surg Oncol. e-Pub 2017. PMID: 28417239.
Yamashita S, Koay EJ, Passot G, Shroff R, Raghav KP, Conrad C, Chun YS, Aloia TA, Tao R, Kaseb A, Javle M, Crane CH, Vauthey JN. Local therapy reduces the risk of liver failure and improves survival in patients with intrahepatic cholangiocarcinoma: A comprehensive analysis of 362 consecutive patients. Cancer 123(8):1354-1362, 2017. e-Pub 2017. PMID: 27984655.
Yamashita S, Chun YS, Kopetz SE, Maru D, Conrad C, Aloia TA, Vauthey JN. APC and PIK3CA mutational cooperativity predicts pathologic response and survival in patients undergoing resection for colorectal liver metastases. Ann Surg. e-Pub 2017. PMID: 28379870.
Odisio BC, Yamashita S, Frota L, Huang SY, Kopetz SE, Ahrar K, Chun YS, Aloia TA, Hicks ME, Gupta S, Vauthey JN. Planned treatment of advanced metastatic disease with completion ablation after hepatic resection. J Gastrointest Surg 21(4):628-635, 2017. e-Pub 2017. PMID: 27882510.
Denbo JW, Slack RS, Bruno M, Cloyd JM, Prakash L, Fleming JB, Kim MP, Aloia TA, Vauthey JN, Lee JE, Katz MH. Selective perioperative administration of pasireotide is more cost-effective than routine administration for pancreatic fistula prophylaxis. J Gastrointest Surg 21(4):636-646, 2017. e-Pub 2017. PMID: 28050766.
Klar E, Buchler MW, Lang H, Lordick F, Mittler J, Mizuno T, Torzilli G, Ulrich A, Vauthey JN. Oligometastases of Gastrointestinal Cancer Origin. Visc Med 33(1):76-81, 2017. e-Pub 2017. PMID: 28612021.
Odisio BC, Yamashita S, Huang SY, Harmoush S, Kopetz SE, Ahrar K, Shin Chun Y, Conrad C, Aloia TA, Gupta S, Hicks ME, Vauthey JN. Local tumour progression after percutaneous ablation of colorectal liver metastases according to RAS mutation status. Br J Surg 104(6):760-768, 2017. e-Pub 2017. PMID: 28240361.
Vega EA, Yamashita S, Chun YS, Kim M, Fleming JB, Katz MH, Tzeng CW, Raghav KP, Vauthey JN, Lee JE, Conrad C. Effective laparoscopic management lymph node dissection for gallbladder cancer. Ann Surg Oncol. e-Pub 2017. PMID: 28168387.
Passot G, Denbo JW, Yamashita S, Kopetz SE, Chun YS, Maru D, Overman MJ, Brudvik KW, Conrad C, Aloia TA, Vauthey JN. Is hepatectomy justified for patients with RAS mutant colorectal liver metastases? An analysis of 524 patients undergoing curative liver resection. Surgery 161(2):332-340, 2017. e-Pub 2017. PMID: 27592215.
Kutlu OC, Chan JA, Aloia TA, Chun YS, Kaseb AO, Passot G, Yamashita S, Vauthey JN, Conrad C. Comparative effectiveness of first-line radiofrequency ablation versus surgical resection and transplantation for patients with early hepatocellular carcinoma. Cancer. e-Pub 2017. PMID: 28085184.
Colbert LE, Cloyd JM, Koay EJ, Crane CH, Vauthey JN. Proton beam radiation as salvage therapy for bilateral colorectal liver metastases not amenable to second-stage hepatectomy. Surgery. e-Pub 2017. PMID: 28081954.
Tran Cao HS, Phuoc V, Ismael H, Denbo JW, Passot G, Yamashita S, Conrad C, Aloia TA, Vauthey JN. Rate of organ space infection is reduced with the use of an air leak test during major hepatectomies. J Gastrointest Surg 21(1):85-93, 2017. e-Pub 2017. PMID: 27496092.
Yamashita S, Odisio B, Huang SY, Kopetz S, Ahrar K, Chun YS, Conrad C, Aloia T, Gupta S, Harmoush S, Hicks M, Vauthey JN. Embryonic origin of primary colon cancer predicts survival in patients undergoing ablation for colorectal liver metastases. Eur J Surg Oncol 43(6):1040-1049, 2017. e-Pub 2017.
Cloyd JM, Katz MHG, Prakash L, Varadhachary GR, Wolff RA, Shroff RT, Javle M, Fogelman D, Overman M, Crane CH, Koay EJ, Das P, Krishnan S, Minsky B, Lee JH, Bhutani M, Weston B, Ross W, Bhosale P, Tamm EP, Wang H, Maitra A, Kim MP, Aloia TA, Vauthey JN, Fleming JB, Abbruzzese JL, Pisters PWT, Evans DB, Lee JE. Preoperative therapy and pancreatoduodenectomy for pancreatic ductal adenocarcinoma: a 25 year single-institution experience. J Gastrointest Surg 21(1):164-174, 2017. e-Pub 2017.
Prakash L, Bhosale P, Cloyd J, Kim M, Parker N, Yao J, Dasari A, Halperin D, Aloia T, Lee JE, Vauthey JN, Fleming JB, Katz MH. Role of fluorouracil, doxorubicin, and streptozocin therapy in the preoperative treatment of localized pancreatic neuroendocrine tumors. J Gastrointest Surg 21(1):155-163, 2017. e-Pub 2017. PMID: 27634306.
Cloyd JM, Wang H, Overman M, Zhao J, Denbo J, Prakash L, Kim MP, Shroff R, Javle M, Varadhachary GR, Fogelman D, Wolff RA, Koay EJ, Das P, Maitra A, Aloia TA, Vauthey JN, Fleming JB, Lee JE, Katz MH. Influence of preoperative therapy on short- and long-term outcomes of patients with adenocarcinoma of the ampulla of vater. Ann Surg Oncol. e-Pub 2017. PMID: 28124275.
Yamashita S, Passot G, Aloia TA, Chun YS, Javle M, Lee JE, Vauthey JN, Conrad C. Prognostic value of carbohydrate antigen 19-9 in patients undergoing resection of biliary tract cancer. Br J Surg 104(3):267-677, 2017. e-Pub 2017. PMID: 28052308.
Denbo JW, Yamashita S, Passot G, Egger M, Chun YS, Kopetz SE, Maru D, Brudvik KW, Wei SH, Conrad C, Vauthey JN, Aloia TA. RAS mutation is associated with decreased survival in patients undergoing repeat hepatectomy for colorectal liver metastases. J Gastrointest Surg 21(1):68-77, 2017. e-Pub 2017. PMID: 27334313.
Cloyd JM, Katz MH, Prakash L, Varadhachary GR, Wolff RA, Shroff RT, Javle M, Fogelman D, Overman M, Crane CH, Koay EJ, Das P, Krishnan S, Minsky BD, Lee JH, Bhutani MS, Weston B, Ross W, Bhosale P, Tamm EP, Wang H, Maitra A, Kim MP, Aloia TA, Vauthey JN, Fleming JB, Abbruzzese JL, Pisters PW, Evans DB, Lee JE. Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience. J Gastrointest Surg 21(1):164-174, 2017. e-Pub 2017. PMID: 27778257.
Mizuno T, Sheth R, Yamamoto M, Kang HS, Yamashita S, Aloia TA, Chun YS, Lee JE, Vauthey JN, Conrad C. Laparoscopic Glissonean Pedicle Transection (Takasaki) for Negative Fluorescent Counterstaining of Segment 6. Ann Surg Oncol. e-Pub 2016. PMID: 27995453.
Vega EA, Yamashita S, Shin CY, Kim M, Fleming JB, Katz MH, Raghav KP, Vauthey JN, Lee JE, Conrad C. Partial splenectomy for unknown primary cancer: a stepwise approach. Ann Surg Oncol. e-Pub 2016. PMID: 27942901.
Denbo JW, Bruno ML, Cloyd JM, Prakash L, Lee JE, Kim M, Crane CH, Koay EJ, Krishnan S, Das P, Minsky BD, Varadhachary G, Shroff R, Wolff R, Javle M, Overman MJ, Fogelman D, Aloia TA, Vauthey JN, Fleming JB, Katz MH. Preoperative chemoradiation for pancreatic adenocarcinoma does not increase 90-Day postoperative morbidity or mortality. J Gastrointest Surg 20(12):1975-1985, 2016. e-Pub 2016. PMID: 27730398.
Yamashita S, Koay EJ, Passot G, Shroff RT, Raghav KP, Conrad C, Chun Y, Aloia TA, Tao R, Kaseb AO, Javle M, Crane CH, Vauthey JN. Local therapy reduces the risk of liver failure and improves survival in patients with intrahepatic cholangiocarcinoma: a comprehensive analysis of 362 consecutive patients. Cancer 123(8):1354-1362, 2016. e-Pub 2016.
Cloyd JM, Tran Cao HS, Petzel MQ, Denbo JW, Parker NH, Nogueras-González GM, Liles JS, Kim MP, Lee JE, Vauthey JN, Aloia TA, Fleming JB, Katz MH. Impact of pancreatectomy on long-term patient-reported symptoms and quality of life in recurrence-free survivors of pancreatic and periampullary neoplasms. J Surg Oncol. e-Pub 2016. PMID: 27859270.
Kim BJ, Tzeng CD, Cooper AB, Vauthey JN, Aloia TA. Borderline operability in hepatectomy patients is associated with higher rates of failure to rescue after severe complications. J Surg Oncol. e-Pub 2016. PMID: 27807846.
Yamashita S, Loyer E, Kang HC, Aloia TA, Chun YS, Mehran RJ, Eng C, Lee JE, Vauthey JN, Conrad C. Total transthoracic approach facilitates laparoscopic hepatic resection in patients with significant prior abdominal surgery. Ann Surg Oncol. e-Pub 2016. PMID: 27878479.
Amer AM, Tao R, Kang H, Chun Y, Vauthey JN, Javle MM, Kaseb AO, Crane CH, Koay EJ. Quantitative European Association for the Study of the Liver (qEASL) as an Early Biomarker of Response After Radiation Therapy for Intrahepatic Cholangiocarcinoma. Int J Radiat Oncol Biol Phys 96(2S):S202, 2016. e-Pub 2016. PMID: 27675783.
Yamashita S, Vauthey JN, Kaseb AO, Aloia TA, Conrad C, Hassan MM, Passot G, Raghav KP, Shama MA, Chun YS. Prognosis of fibrolamellar carcinoma compared to non-cirrhotic conventional hepatocellular carcinoma. J Gastrointest Surg 20(10):1725-1731, 2016. e-Pub 2016. PMID: 27456016.
Conrad C, Kutlu OC, Dasari A, Chan JA, Vauthey JN, Adams DB, Kim M, Fleming JB, Katz MH, Lee JE. Prognostic value of lymph node status and extent of lymphadenectomy in pancreatic neuroendocrine tumors confined to and extending beyond the pancreas. J Gastrointest Surg. e-Pub 2016. PMID: 27714644.
Al-Shamsi HO, Anand D, Shroff RT, Jain A, Zuo M, Conrad C, Vauthey JN, Javle MM. BRCA-associated protein 1 mutant cholangiocarcinoma: an aggressive disease subtype. J Gastrointest Oncol 7(4):556-61, 2016. e-Pub 2016. PMID: 27563445.
Odisio BC, Richter M, Aloia TA, Conrad C, Ahrar K, Gupta S, Vauthey JN, Huang SY. Use of prophylactic antibiotics to prevent abscess formation following hepatic ablation in patients with prior enterobiliary manipulation. J Gastrointest Surg 20(8):1428-34, 2016. e-Pub 2016. PMID: 26984694.
Yamashita S, Loyer E, Chun YS, Javle M, Lee JE, Vauthey JN, Conrad C. Laparoscopic Management of Gallbladder Cancer: A Stepwise Approach. Ann Surg Oncol. e-Pub 2016. PMID: 27456958.
Ribero D, Zimmitti G, Aloia TA, Shindoh J, Forchino F, Amisano M, Passot G, Ferrero A, Vauthey JN. Preoperative cholangitis and future liver remnant volume determine the risk of liver failure in patients undergoing resection for hilar cholangiocarcinoma. J Am Coll Surg 223(1):87-97, 2016. e-Pub 2016. PMID: 27049784.
Passot G, Chun YS, Kopetz SE, Zorzi D, Brudvik KW, Kim BJ, Conrad C, Aloia TA, Vauthey JN. Predictors of safety and efficacy of 2-Stage hepatectomy for bilateral colorectal liver metastases. J Am Coll Surg 223(1):99-109, 2016. e-Pub 2016. PMID: 26968325.
Mise Y, Passot G, Wang X, Chen HC, Brudvik KW, Aloia TA, Conrad C, Huang SY, Vauthey JN. A nomogram to predict hypertrophy of liver segments 2 and 3 after right portal vein embolization. J Gastrointest Surg 20(7):1317-1323, 2016. e-Pub 2016. PMID: 27073080.
Zuo M, Rashid A, Wang Y, Jain A, Li D, Behari A, Kapoor VK, Koay EJ, Chang P, Vauthey JN, Li Y, Espinoza JA, Roa JC, Javle M. RNA sequencing-based analysis of gallbladder cancer reveals the importance of the liver X receptor and lipid metabolism in gallbladder cancer. Oncotarget 7(23):35302-12, 2016. e-Pub 2016. PMID: 27167107.
Ismael HN, Denbo J, Cox S, Crane CH, Das P, Krishnan S, Schroff RT, Javle M, Conrad C, Vauthey JN, Aloia T. Biologic mesh spacer placement facilitates safe delivery of dose-intense radiation therapy: A novel treatment option for unresectable liver tumors. Eur J Surg Oncol. e-Pub 2016. PMID: 27296729.
Brudvik KW, Mise Y, Chung MH, Chun YS, Kopetz SE, Passot G, Conrad C, Maru DM, Aloia TA, Vauthey JN. RAS mutation predicts positive resection margins and narrower resection margins in patients undergoing resection of colorectal liver metastases. Ann Surg Oncol. e-Pub 2016. PMID: 27016292.
Passot G, Chun YS, Kopetz SE, Overman MJ, Conrad C, Aloia TA, Vauthey JN. Prognostic factors after resection of colorectal liver metastases following preoperative second-line chemotherapy: Impact of RAS mutations. Eur J Surg Oncol. e-Pub 2016. PMID: 27358198.
Torzilli G, Donadon M, Belghiti J, Kokudo N, Takayama T, Ferrero A, Nuzzo G, Vauthey JN, Choti MA, De Santibanes E, Makuuchi M. Predicting individual survival after hepatectomy for hepatocellular carcinoma: a novel nomogram from the "HCC East & West Study Group". J Gastrointest Surg. e-Pub 2016. PMID: 27003271.
Conrad C, Passot G, Katz MH, Fleming JB, Kim M, Chun YS, Aloia TA, Vauthey JN, Lee JE. Laparoscopic insulinoma enucleation from the retro-pancreatic neck: a stepwise approach. Ann Surg Oncol. e-Pub 2016. PMID: 26960928.
Schwarz L, Aloia TA, Eng C, Chang GJ, Vauthey JN, Conrad C. Transthoracic port placement Increases safety of total laparoscopic posterior sectionectomy. Ann Surg Oncol. e-Pub 2016. PMID: 26903047.
Passot G, Odisio BC, Zorzi D, Mahvash A, Gupta S, Wallace MJ, Kim BJ, Yamashita S, Conrad C, Aloia TA, Vauthey JN, Chun YS. Eradication of missing liver metastases after fiducial placement. J Gastrointest Surg. e-Pub 2016. PMID: 26791387.
Mise Y, Day RW, Vauthey JN, Brudvik KW, Schwarz L, Prakash L, Parker NH, Katz MH, Conrad C, Lee JE, Fleming JB, Aloia TA. After pancreatectomy, the "90 days from surgery" definition is superior to the "30 days from discharge" definition for capture of clinically relevant readmissions. J Gastrointest Surg 20(1):77-84; discussion 84, 2016. e-Pub 2016. PMID: 26493976.
Ismael HN, Loyer E, Kaur H, Conrad C, Vauthey JN, Aloia T. Evaluating the clinical applicability of the European staging system for perihilar cholangiocarcinoma. J Gastrointest Surg. e-Pub 2016. PMID: 26801328.
Conrad C, Schwarz L, Perrier N, Fleming JB, Katz MH, Aloia TA, Vauthey JN, Lee JE. Spleen and splenic vessel preserving distal pancreatectomy for bifocal PNET in a young patient with MEN1. Surg Endosc. e-Pub 2015. PMID: 26721691.
Day RW, Cleeland CS, Wang XS, Fielder S, Calhoun J, Conrad C, Vauthey JN, Gottumukkala V, Aloia TA. Patient-reported outcomes accurately measure the value of an enhanced recovery program in liver surgery. J Am Coll Surg 221(6):1023-1030.e2, 2015. e-Pub 2015. PMID: 26611799.
Mise Y, Vauthey JN, Zimmitti G, Parker NH, Conrad C, Aloia TA, Lee JE, Fleming JB, Katz MH. Ninety-day postoperative mortality is a legitimate measure of hepatopancreatobiliary surgical quality. Ann Surg 262(6):1071-1078, 2015. e-Pub 2015. PMID: 25590497.
Day RW, Brudvik KW, Vauthey JN, Conrad C, Gottumukkala V, Chun YS, Katz MH, Fleming JB, Lee JE, Aloia TA. Advances in hepatectomy technique: Toward zero transfusions in the modern era of liver surgery. Surgery. e-Pub 2015. PMID: 26584854.
Adam R, de Gramont A, Figueras J, Kokudo N, Kunstlinger F, Loyer E, Poston G, Rougier P, Rubbia-Brandt L, Sobrero A, Teh C, Tejpar S, Van Cutsem E, Vauthey JN, Påhlman L, EGOSLIM group OT. Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev 41(9):729-41, 2015. e-Pub 2015. PMID: 26417845.
Zimmitti G, Soliz J, Aloia TA, Gottumukkala V, Cata JP, Tzeng CD, Vauthey JN. Positive impact of epidural analgesia on oncologic outcomes in patients undergoing resection of colorectal liver metastases. Ann Surg Oncol. e-Pub 2015. PMID: 26511261.
Aloia TA, Geerts WH, Clary BM, Day RW, Hemming AW, D'Albuquerque LC, Vollmer CM, Vauthey JN, Toogood GJ. Venous thromboembolism prophylaxis in liver surgery. J Gastrointest Surg. e-Pub 2015. PMID: 26489742.
Schwarz L, Bruno M, Parker NH, Prakash L, Mise Y, Lee JE, Vauthey JN, Aloia TA, Conrad C, Fleming JB, Katz MH. Active surveillance for adverse events within 90 days: the standard for reporting surgical outcomes after pancreatectomy. Ann Surg Oncol 22(11):3522-9, 2015. e-Pub 2015. PMID: 25694246.
Roland CL, Katz MH, Tzeng CD, Lin H, Varadhachary GR, Shroff R, Javle M, Fogelman D, Wolff RA, Vauthey JN, Crane CH, Lee JE, Fleming JB. The addition of postoperative chemotherapy is associated with improved survival in patients with pancreatic cancer treated with preoperative therapy. Ann Surg Oncol. e-Pub 2015. PMID: 26350371.
Brudvik KW, Kopetz SE, Li L, Conrad C, Aloia TA, Vauthey JN. Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases. Br J Surg 102(10):1175-1183, 2015. e-Pub 2015. PMID: 26206254.
Day RW, Conrad C, Vauthey JN, Aloia TA. Evaluating surgeon attitudes towards the safety and efficacy of portal vein occlusion and associating liver partition and portal vein ligation: a report of the MALINSA survey. HPB (Oxford). e-Pub 2015. PMID: 26255813.
Brudvik KW, Patel SH, Roland CL, Conrad C, Torres KE, Hunt KK, Cormier JN, Feig BW, Aloia TA, Vauthey JN. Survival after resection of gastrointestinal stromal tumor and sarcoma liver metastases in 146 patients. J Gastrointest Surg 19(8):1476-1483, 2015. e-Pub 2015. PMID: 26001368.
Mansour JC, Aloia TA, Crane CH, Heimbach JK, Nagino M, Vauthey JN. Hilar Cholangiocarcinoma: expert consensus statement. HPB (Oxford) 17(8):691-699, 2015. e-Pub 2015. PMID: 26172136.
Odisio BC, Ashton A, Yan Y, Wei W, Kaseb A, Wallace MJ, Vauthey JN, Gupta S, Tam AL. Transarterial hepatic chemoembolization with 70-150µm drug eluting beads: assessment of clinical safety and liver toxicity profile. J Vasc Interv Radiol 26(7):965-971, 2015. e-Pub 2015. PMID: 25979305.
Brudvik KW, Mise Y, Conrad C, Zimmitti G, Aloia TA, Vauthey JN. Definition of readmission in 3041 patients undergoing hepatectomy. J Am Coll Surg 221(1):38-46, 2015. e-Pub 2015. PMID: 26047760.
Cooper AB, Slack R, Fogelman D, Holmes HM, Petzel M, Parker N, Balachandran A, Garg N, Ngo-Huang A, Varadhachary G, Evans DB, Lee JE, Aloia T, Conrad C, Vauthey JN, Fleming JB, Katz MH. Characterization of anthropometric changes that occur during neoadjuvant therapy for potentially resectable pancreatic cancer. Ann Surg Oncol 22(7):2416-23, 2015. e-Pub 2015. PMID: 25519927.
Hassan MM, Abdel-Wahab R, Kaseb A, Shalaby A, Phan AT, El-Serag HB, Hawk E, Morris J, Singh Raghav KP, Lee JS, Vauthey JN, Bortus G, Torres HA, Amos CI, Wolff RA, Li D. Obesity early in adulthood increases risk but does not affect outcomes of hepatocellular carcinoma. Gastroenterology 149(1):119-29, 2015. e-Pub 2015. PMID: 25836985.
Mise Y, Kopetz S, Mehran RJ, Aloia TA, Conrad C, Brudvik KW, Taggart MW, Vauthey JN. Is complete liver resection without resection of synchronous lung metastases justified?. Ann Surg Oncol 22(5):1585-1592, 2015. e-Pub 2015. PMID: 25373535.
Shindoh J, de Aretxabala X, Aloia TA, Roa JC, Roa I, Zimmitti G, Javle M, Conrad C, Maru DM, Aoki T, Vigano L, Ribero D, Kokudo N, Capussotti L, Vauthey JN. Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study. Ann Surg 261(4):733-739, 2015. e-Pub 2015. PMID: 24854451.
Roland CL, Yang AD, Katz MH, Chatterjee D, Wang H, Lin H, Vauthey JN, Pisters PW, Varadhachary GR, Wolff RA, Crane CH, Lee JE, Fleming JB. Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic cancer. Ann Surg Oncol 22(4):1168-1175, 2015. e-Pub 2015. PMID: 25352267.
Zuo M, Rashid A, Churi C, Vauthey JN, Chang P, Li Y, Hung MC, Li D, Javle M. Novel therapeutic strategy targeting the Hedgehog signalling and mTOR pathways in biliary tract cancer. Br J Cancer 112(6):1042-51, 2015. e-Pub 2015. PMID: 25742482.
Chen ZY, Raghav K, Lieu CH, Jiang ZQ, Eng C, Vauthey JN, Chang GJ, Qiao W, Morris J, Hong D, Hoff P, Tran H, Menter DG, Heymach J, Overman M, Kopetz S. Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer. Br J Cancer 112(6):1088-97, 2015. e-Pub 2015. PMID: 25688736.
Mise Y, Aloia TA, Brudvik KW, Schwarz L, Vauthey JN, Conrad C. Parenchymal-sparing hepatectomy in colorectal liver metastasis improves salvageability and survival. Ann Surg. e-Pub 2015. PMID: 25775068.
Mise Y, Zimmitti G, Shindoh J, Kopetz S, Loyer EM, Andreou A, Cooper AB, Kaur H, Aloia TA, Maru DM, Vauthey JN. RAS mutations predict radiologic and pathologic response in patients treated with chemotherapy before resection of colorectal liver metastases. Ann Surg Oncol 22(3):834-42, 2015. e-Pub 2015. PMID: 25227306.
Ramirez MF, Ai D, Bauer M, Vauthey JN, Gottumukkala V, Kee S, Shon D, Truty M, Kuerer HM, Kurz A, Hernandez M, Cata JP. Innate immune function after breast, lung, and colorectal cancer surgery. J Surg Res 194(1):185-193, 2015. e-Pub 2015. PMID: 25475022.
Pereira AA, Rego JF, Morris V, Overman MJ, Eng C, Garrett CR, Boutin AT, Ferrarotto R, Lee M, Jiang ZQ, Hoff PM, Vauthey JN, Vilar E, Maru D, Kopetz S. Association between KRAS mutation and lung metastasis in advanced colorectal cancer. Br J Cancer 112(3):424-8, 2015. e-Pub 2015. PMID: 25535726.
Brooke-Smith M, Figueras J, Ullah S, Rees M, Vauthey JN, Hugh TJ, Garden OJ, Fan ST, Crawford M, Makuuchi M, Yokoyama Y, Büchler M, Weitz J, Padbury R. Prospective evaluation of the International Study Group for Liver Surgery definition of bile leak after a liver resection and the role of routine operative drainage: an international multicentre study. HPB (Oxford) 17(1):46-51, 2015. e-Pub 2015. PMID: 25059275.
Conrad C, Nedelcu M, Ogiso S, Aloia TA, Vauthey JN, Gayet B. Techniques of intragastric laparoscopic surgery. Surg Endosc 29(1):202-6, 2015. e-Pub 2015. PMID: 25106714.
Kulke MH, Shah MH, Benson AB, Bergsland E, Berlin JD, Blaszkowsky LS, Emerson L, Engstrom PF, Fanta P, Giordano T, Goldner WS, Halfdanarson TR, Heslin MJ, Kandeel F, Kunz PL, Kuvshinoff BW, Lieu C, Moley JF, Munene G, Pillarisetty VG, Saltz L, Sosa JA, Strosberg JR, Vauthey JN, Wolfgang C, Yao JC, Burns J, Freedman-Cass D, cancer network NC. Neuroendocrine tumors, version 1.2015. J Natl Compr Canc Netw 13(1):78-108, 2015. e-Pub 2015. PMID: 25583772.
Mise Y, Aloia TA, Conrad C, Huang SY, Wallace MJ, Vauthey JN. Volume regeneration of segments 2 and 3 after right portal vein embolization in patients undergoing two-stage hepatectomy. J Gastrointest Surg 19(1):133-41; discussion 141, 2015. e-Pub 2015. PMID: 25091849.
Churi CR, Shroff R, Wang Y, Rashid A, Kang HSC, WeatherlyJM, Zuo M, Zinner RG, Hong D, Meric-Bernstam F, Crane CH, Mishra L, Vauthey JN, Wolff RA, Mills GB, Javle M. Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications. PLoS ONE 9(12):e115383, 2014. e-Pub 2014.
Eng C, Chang GJ, You YN, Das P, Rodriguez-Bigas M, Xing Y, Vauthey JN, Rogers JE, Ohinata A, Pathak P, Sethi S, Phillips JK, Crane CH, Wolff RA. The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal. Oncotarget 5(22):11133-11142, 2014. e-Pub 2014. PMID: 25373735.
Mise Y, Mehran RJ, Aloia TA, Vauthey JN. Simultaneous lung resection via a transdiaphragmatic approach in patients undergoing liver resection for synchronous liver and lung metastases. Surgery 156(5):1197-203, 2014. e-Pub 2014. PMID: 24953274.
Andreou A, Viganò L, Zimmitti G, Seehofer D, Dreyer M, Pascher A, Bahra M, Schoening W, Schmitz V, Thuss-Patience PC, Denecke T, Puhl G, Vauthey JN, Neuhaus P, Capussotti L, Pratschke J, Schmidt SC. Response to preoperative chemotherapy predicts survival in patients undergoing hepatectomy for liver metastases from gastric and esophageal cancer. J Gastrointest Surg 18(11):1974-1986, 2014. e-Pub 2014. PMID: 25159501.
Zhou JH, Rosen D, Andreou A, Brouquet A, Abbott D, Loyer E, Gonzalez-Angulo AM, Kopetz S, Meric-Bernstam F, Kuerer H, Abdalla E, Vauthey JN, Sahin AA, Maru DM. Residual tumor thickness at the tumor-normal tissue interface predicts the recurrence-free survival in patients with liver metastasis of breast cancer. Ann Diagn Pathol 18(5):266-270, 2014. e-Pub 2014. PMID: 25205085.
Conrad C, Nedelcu M, Ogiso S, Aloia TA, Vauthey JN, Gayet B. Laparoscopic intragastric surgery for early gastric cancer and gastrointestinal stromal tumors. Ann Surg Oncol 21(8):2620, 2014. e-Pub 2014. PMID: 24647675.
Benson AB, D'Angelica MI, Abrams TA, Are C, Bloomston PM, Chang DT, Clary BM, Covey AM, Ensminger WD, Iyer R, Kelley RK, Linehan D, Malafa MP, Meranze SG, Park JO, Pawlik T, Posey JA, Scaife C, Schefter T, Sigurdson ER, Tian GG, Vauthey JN, Venook AP, Yen Y, Zhu AX, Hoffmann KG, McMillian NR, Sundar H. Hepatobiliary cancers, version 2.2014. J Natl Compr Canc Netw 12(8):1152-1182, 2014. e-Pub 2014. PMID: 25099447.
Aloia TA, Zimmitti G, Conrad C, Gottumukalla V, Kopetz S, Vauthey JN. Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy. J Surg Oncol 110(2):107-114, 2014. e-Pub 2014. PMID: 24846705.
Thomas RM, Aloia TA, Truty MJ, Tseng WH, Choi EA, Curley SA, Vauthey JN, Abdalla EK. Treatment sequencing strategy for hepatic epithelioid haemangioendothelioma. HPB (Oxford) 16(7):677-85, 2014. e-Pub 2014. PMID: 24308564.
Aloia TA, Cooper A, Shi W, Vauthey JN, Lee JE. Reoperative surgery: a critical risk factor for complications inadequately captured by operative reporting and coding of lysis of adhesions. J Am Coll Surg 219(1):143-151, 2014. e-Pub 2014. PMID: 24862888.
Cooper AB, Holmes HM, des Bordes JK, Fogelman D, Parker NH, Lee JE, Aloia TA, Vauthey JN, Fleming JB, Katz MH. Role of neoadjuvant therapy in the multimodality treatment of older patients with pancreatic cancer. J Am Coll Surg 219(1):111-121, 2014. e-Pub 2014. PMID: 24856952.
Kaseb AO, Xiao L, Hassan MM, Chae YK, Lee JS, Vauthey JN, Krishnan S, Cheung S, Hassabo HM, Aloia T, Conrad C, Curley SA, Vierling JM, Jalal P, Raghav K, Wallace M, Rashid A, Abbruzzese JL, Wolff RA, Morris JS. Development and validation of insulin-like growth factor-1 score to assess hepatic reserve in hepatocellular carcinoma. J Natl Cancer Inst 106(5):pii: dju088. doi: 10.1093/jnci/dju08, 2014. e-Pub 2014. PMID: 24815863.
Yoon SS, Aloia TA, Haynes AB, Kambadakone A, Kaur H, Vauthey JN, Ferrone CR, Zhu AX, Wo JY, Crane C, Hong TS. Surgical placement of biologic mesh spacers to displace bowel away from unresectable liver tumors followed by delivery of dose-intense radiation therapy. Pract Radiat Oncol 4(3):167-173, 2014. e-Pub 2014. PMID: 24766683.
Tzeng CW, Balachandran A, Ahmad M, Lee JE, Krishnan S, Wang H, Crane CH, Wolff RA, Varadhachary GR, Pisters PW, Aloia TA, Vauthey JN, Fleming JB, Katz MH. Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer. HPB (Oxford) 16(5):430-438, 2014. e-Pub 2014. PMID: 23991810.
Tzeng CW, Cooper AB, Vauthey JN, Curley SA, Aloia TA. Predictors of morbidity and mortality after hepatectomy in elderly patients: analysis of 7621 NSQIP patients. HPB (Oxford) 16(5):459-468, 2014. e-Pub 2014. PMID: 24033514.
Javle M, Rashid A, Churi C, Kar S, Zuo M, Eterovic AK, Nogueras-Gonzalez GM, Janku F, Shroff RT, Aloia TA, Vauthey JN, Curley S, Mills G, Roa I. Molecular characterization of gallbladder cancer using somatic mutation profiling. Hum Pathol 45(4):701-8, 2014. e-Pub 2014. PMID: 24508317.
Tzeng CW, Katz MH, Lee JE, Fleming JB, Pisters PW, Vauthey JN, Aloia TA. Predicting the risks of venous thromboembolism versus post-pancreatectomy haemorrhage: analysis of 13 771 NSQIP patients. HPB (Oxford) 16(4):373-383, 2014. e-Pub 2014. PMID: 23869628.
Huang SY, Aloia TA, Shindoh J, Ensor J, Shaw CM, Loyer EM, Vauthey JN, Wallace MJ. Efficacy and safety of portal vein embolization for two-stage hepatectomy in patients with colorectal liver metastasis. J Vasc Interv Radiol 25(4):608-17, 2014. e-Pub 2014. PMID: 24315549.
Raoof M, Aloia TA, Vauthey JN, Curley SA. Morbidity and mortality in 1,174 patients undergoing hepatic parenchymal transection using a stapler device. Ann Surg Oncol 21(3):995-1001, 2014. e-Pub 2014. PMID: 24248530.
Bednarski BK, Habra MA, Phan A, Milton DR, Wood C, Vauthey JN, Evans DB, Katz MH, Ng CS, Perrier ND, Lee JE, Grubbs EG. Borderline resectable adrenal cortical carcinoma: a potential role for preoperative chemotherapy. World J Surg 38(6):1318-1327, 2014. e-Pub 2014.
Tran Cao HS, Balachandran A, Wang H, Nogueras-González GM, Bailey CE, Lee JE, Pisters PW, Evans DB, Varadhachary G, Crane CH, Aloia TA, Vauthey JN, Fleming JB, Katz MH. Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer. J Gastrointest Surg 18(2):269-78; discussion 278, 2014. e-Pub 2014. PMID: 24129826.
Tzeng CW, Katz MH, Fleming JB, Lee JE, Pisters PW, Holmes HM, Varadhachary GR, Wolff RA, Abbruzzese JL, Vauthey JN, Aloia TA. Morbidity and mortality after pancreaticoduodenectomy in patients with borderline resectable type C clinical classification. J Gastrointest Surg 18(1):146-55; discussion 155-6, 2014. e-Pub 2014. PMID: 24129825.
Tzeng CW, Tran Cao HS, Lee JE, Pisters PW, Varadhachary GR, Wolff RA, Abbruzzese JL, Crane CH, Evans DB, Wang H, Abbott DE, Vauthey JN, Aloia TA, Fleming JB, Katz MH. Treatment sequencing for resectable pancreatic cancer: influence of early metastases and surgical complications on multimodality therapy completion and survival. J Gastrointest Surg 18(1):16-24, 2014. e-Pub 2014. PMID: 24241967.
Shindoh J, Tzeng CW, Aloia TA, Curley SA, Huang SY, Mahvash A, Gupta S, Wallace MJ, Vauthey JN. Safety and efficacy of portal vein embolization before planned major or extended hepatectomy: an institutional experience of 358 patients. J Gastrointest Surg 18(1):45-51, 2014. e-Pub 2014. PMID: 24129824.
Kaseb AO, Shah NN, Hassabo HM, MorrisJS, Xiao L, Abaza YM, Soliman K, Lee JS, Vauthey JN, Wallace M, Aloia TA, Curley SA, Abbruzzese JL, HassanMM. Reassessing hepatocellular carcinoma staging in a changing patient population. Oncology 86(2):63-71, 2014. e-Pub 2014.
Kaseb AO, Shah NN, Hassabo HM, Morris JS, Xiao L, Abaza YM, Soliman K, Lee JS, Vauthey JN, Wallace M, Aloia TA, Curley S, Abbruzzese JL, Hassan MM. Reassessing hepatocellular carcinoma staging in a changing patient population. Oncology 86(2):63-71, 2014. e-Pub 2014. PMID: 24401634.
Churi CR, Shroff R, Wang Y, Rashid A, Kang HC, Weatherly J, Zuo M, Zinner R, Hong D, Meric-Bernstam F, Janku F, Crane CH, Mishra L, Vauthey JN, Wolff RA, Mills G, Javle M. Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications. PLoS One 9(12):e115383, 2014. e-Pub 2014. PMID: 25536104.
Zimmitti G, Vauthey JN, Shindoh J, Tzeng CW, Roses RE, Ribero D, Capussotti L, Giuliante F, Nuzzo G, Aloia TA. Systematic use of an intraoperative air leak test at the time of major liver resection reduces the rate of postoperative biliary complications. J Am Coll Surg 217(6):1028-1037, 2013. e-Pub 2013. PMID: 24246619.
Shindoh J, Tzeng CW, Aloia TA, Curley SA, Zimmitti G, Wei SH, Huang SY, Gupta S, Wallace MJ, Vauthey JN. Portal vein embolization improves rate of resection of extensive colorectal liver metastases without worsening survival. Br J Surg 100(13):1777-83, 2013. e-Pub 2013. PMID: 24227364.
Shindoh J, Tzeng CW, Aloia TA, Curley S, Zimmitti G, Wei S, Huang S, Gupta S, Wallace M, Vauthey JN. Portal vein embolization improves rate of resection of extensive colorectal liver metastases without worsening survival outcomes. Br J Surg 100(13):1777-1783, 2013. e-Pub 2013.
Javle M, Rashid A, Churi C, Kar S, Zuo M, Eterovic AK, Nogueras-Gonzalez GM, Janku F, Shroff R, Aloia TA, Vauthey JN, Curley S, Mills G, Roa I. Molecular characterization of gallbladder cancer using somatic mutation profiling. Hum Pathol 45(4):701-708. e-Pub 2013.
Hassan MM, Kaseb A, Etzel CJ, El-Serag H, Spitz MR, Chang P, Hale KS, Liu M, Rashid A, Shama M, Abbruzzese JL, Loyer EM, Kaur H, Hassabo HM, Vauthey JN, Wray CJ, Hassan BS, Patt YZ, Hawk E, Soliman KM, Li D. Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction. Mol Carcinog 52(Suppl 1):E139-47, 2013. e-Pub 2013. PMID: 23776098.
Das P, Abboud MT, Haque W, Javle M, Kaseb A, Curley SA, Vauthey JN, Aloia TA, Beddar AS, Delclos ME, Krishnan S, Crane CH. Gastric bleeding after radiation therapy for intrahepatic cholangiocarcinoma. Pract Radiat Oncol 3(4):344-348, 2013. e-Pub 2013. PMID: 24674408.
Tzeng CW, Curley SA, Vauthey JN, Aloia TA. Distinct predictors of pre- versus post-discharge venous thromboembolism after hepatectomy: analysis of 7621 NSQIP patients. HPB (Oxford) 15(10):773-80, 2013. e-Pub 2013. PMID: 23869577.
Vauthey JN, Zimmitti G, Kopetz SE, Shindoh J, Chen SS, Andreou A, Curley SA, Aloia TA, Maru DM. RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases. Ann Surg 258(4):619-627, 2013. e-Pub 2013. PMID: 24018645.
Peungjesada S, Aloia TA, Kaur H, Marcal L, Choi H, Vauthey JN, Loyer EM. Intrabiliary growth of colorectal liver metastasis: spectrum of imaging findings and implications for surgical management. AJR Am J Roentgenol 201(4):W582-589, 2013. e-Pub 2013. PMID: 24059396.
Kaseb AO, Shindoh J, Patt YZ, Roses RE, Zimmitti G, Lozano RD, Hassan MM, Hassabo HM, Curley SA, Aloia TA, Abbruzzese JL, Vauthey JN. Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma. Cancer 119(18):3334-42, 2013. e-Pub 2013. PMID: 23821538.
Brouquet A, Zimmitti G, Kopetz S, Stift J, Julié C, Lemaistre AI, Agarwal A, Patel V, Benoist S, Nordlinger B, Gandini A, Rivoire M, Stremitzer S, Gruenberger T, Vauthey JN, Maru DM. Multicenter validation study of pathologic response and tumor thickness at the tumor-normal liver interface as independent predictors of disease-free survival after preoperative chemotherapy and surgery for colorectal liver metastases. Cancer 119(15):2778-88, 2013. e-Pub 2013. PMID: 23868456.
Shindoh J, Tzeng CW, Aloia TA, Curley SA, Zimmitti G, Wei SH, Huang SY, Mahvash A, Gupta S, Wallace MJ, Vauthey JN. Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases. Ann Surg Oncol 20(8):2493-2500, 2013. e-Pub 2013. PMID: 23377564.
Shindoh J, Vauthey JN, Zimmitti G, Curley SA, Huang SY, Mahvash A, Gupta S, Wallace MJ, Aloia TA. Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach. J Am Coll Surg 217(1):126-33; discussion 133-4, 2013. e-Pub 2013. PMID: 23632095.
Andreou A, Aloia TA, Brouquet A, Dickson PV, Zimmitti G, Maru DM, Kopetz S, Loyer EM, Curley SA, Abdalla EK, Vauthey JN. Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy. Ann Surg 257(6):1079-1088, 2013. e-Pub 2013. PMID: 23426338.
Torzilli G, Belghiti J, Kokudo N, Takayama T, Capussotti L, Nuzzo G, Vauthey JN, Choti MA, De Santibanes E, Donadon M, Morenghi E, Makuuchi M. A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group. Ann Surg 257(5):929-37, 2013. e-Pub 2013. PMID: 23426336.
Shindoh J, Andreou A, Aloia TA, Zimmitti G, Lauwers GY, Laurent A, Nagorney DM, Belghiti J, Cherqui D, Poon RT, Kokudo N, Vauthey JN. Microvascular invasion does not predict long-term survival in hepatocellular carcinoma up to 2 cm: reappraisal of the staging system for solitary tumors. Ann Surg Oncol 20(4):1223-9, 2013. e-Pub 2013. PMID: 23179993.
Chun YS, House MG, Kaur H, Loyer EM, Paradis V, Vauthey JN. SSAT/AHPBA joint symposium on evaluation and treatment of benign liver lesions. J Gastrointest Surg 17(4):636-44, 2013. e-Pub 2013. PMID: 23377783.
Adams RB, Aloia TA, Loyer E, Pawlik TM, Taouli B, Vauthey JN, Association AH, Surgical Oncology SO, Alimentary Tract SFSOT. Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB (Oxford) 15(2):91-103, 2013. e-Pub 2013. PMID: 23297719.
Shindoh J, Truty MJ, Aloia TA, Curley SA, Zimmitti G, Huang SY, Mahvash A, Gupta S, Wallace MJ, Vauthey JN. Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant. J Am Coll Surg 216(2):201-9, 2013. e-Pub 2013. PMID: 23219349.
Tzeng CW, Aloia TA, Vauthey JN, Chang GJ, Ellis LM, Feig BW, Curley SA, Skibber JM, Abdalla EK, You YN, Rodriguez-Bigas MA. Morbidity of staged proctectomy after hepatectomy for colorectal cancer: a matched case-control analysis. Ann Surg Oncol 20(2):482-490, 2013. e-Pub 2013. PMID: 22932858.
Schwarz R, Abdalla EK, Aloia TA, Vauthey JN. AHPBA/SSO/SSAT Sponsored consensus conference on multidisciplinary treatment of colorectal cancer metastases. HPB 15(2):89-90, 2013. e-Pub 2013.
Andreou A, Vauthey JN, Cherqui D, Zimmitti G, Ribero D, Truty MJ, Wei SH, Curley SA, Laurent A, Poon RT, Belghiti J, Nagorney DM, Aloia TA, Hepatocellular Carcinoma ICSGO. Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomy. J Gastrointest Surg 17(1):66-77, 2013. e-Pub 2013. PMID: 22948836.
Zimmitti G, Roses RE, Andreou A, Shindoh J, Curley SA, Aloia TA, Vauthey JN. Greater complexity of liver surgery is not associated with an increased incidence of liver related complications except for bile leak: an experience with 2,628 consecutive resections. J Gastrointest Surg 17(1):57-64, 2013. e-Pub 2013. PMID: 22956403.
Kaseb AO, Shama M, Sahin IH, Nooka A, Hassabo HM, Vauthey JN, Aloia T, Abbruzzese JL, Subbiah IM, Janku F, Curley S, Hassan MM. Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinoma. Oncology 85(4):197-203, 2013. e-Pub 2013. PMID: 24051705.
Shindoh J, Loyer EM, Kopetz S, Boonsirikamchai P, Maru DM, Chun YS, Zimmitti G, Curley SA, Charnsangavej C, Aloia TA, Vauthey JN. Optimal morphologic response to preoperative chemotherapy an alternate outcome end point before resection of hepatic colorectal metastases. J Clin Oncol 30(36):4566-4572, 2012. e-Pub 2012. PMID: 23150701.
Katz MH, Fleming JB, Bhosale P, Varadhachary G, Lee JE, Wolff R, Wang H, Abbruzzese J, Pisters PW, Vauthey JN, Charnsangavej C, Tamm E, Crane CH, Balachandran A. Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators. Cancer 118(23):5749-56, 2012. e-Pub 2012. PMID: 22605518.
Petzel MQ, Parker NH, Valentine AD, Simard S, Nogueras-Gonzalez GM, Lee JE, Pisters PW, Vauthey JN, Fleming JB, Katz MH. Fear of cancer recurrence after curative pancreatectomy: a cross-sectional study in survivors of pancreatic and periampullary tumors. Ann Surg Oncol 19(13):4078-84, 2012. e-Pub 2012. PMID: 22875648.
Roland CL, Katz MH, Gonzalez GM, Pisters PW, Vauthey JN, Wolff RA, Crane CH, Lee JE, Fleming JB. A high positive lymph node ratio is associated with distant recurrence after surgical resection of ampullary carcinoma. J Gastrointest Surg 16(11):2056-63, 2012. e-Pub 2012. PMID: 22914983.
Roland CL, Katz MHG, Gonzalez GMN, Pisters PWT, Vauthey JN, Wolff RA, Crane CH, Lee JE, Fleming JB. A high lymph node ratio is associated with distant recurrence after surgical resection of ampullary carcinoma. J Gastrointest Surg 16(11):2056-2063, 2012. e-Pub 2012.
Andreou A, Kopetz S, Maru DM, Chen SS, Zimmitti G, Brouquet A, Shindoh J, Curley SA, Garrett C, Overman MJ, Aloia TA, Vauthey JN. Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases. Ann Surg 256(4):642-650, 2012. e-Pub 2012. PMID: 22968062.
Jones RP, Vauthey JN, Adam R, Rees M, Berry D, Jackson R, Grimes N, Fenwick SW, Poston GJ, Malik HZ. Effect of specialist decision-making on treatment strategies for colorectal liver metastases. Br J Surg 99(9):1263-9, 2012. e-Pub 2012. PMID: 22864887.
Glazer ES, Liu P, Abdalla EK, Vauthey JN, Curley SA. Neither neoadjuvant nor adjuvant therapy increases survival after biliary tract cancer resection with wide negative margins. J Gastrointest Surg 16(9):1666-1671, 2012. e-Pub 2012. PMID: 22777053.
Thomas RM, Truty MJ, Nogueras-Gonzalez GM, Fleming JB, Vauthey JN, Pisters PW, Lee JE, Rice DC, Hofstetter WL, Wolff RA, Varadhachary GR, Wang H, Katz MH. Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection. J Gastrointest Surg 16(9):1696-704, 2012. e-Pub 2012. PMID: 22644446.
Adam R, DeGramont A, Figueras J, Guthrie A, Kokudo N, Kunstlinger F, Loyer E, Poston G, Rougier P, Rubbia-Brandt L, Sobrero A, Taberno J, Teh C, VanCutsem E, Vauthey JN. The Oncosurge approach to managing liver metastases from colorectal cancer: a multidisciplinary International Consensus. Oncologist 17(10):1225-1239, 2012. e-Pub 2012.
Jones RP, Vauthey JN, Adam R, Rees M, Berry D, Jackson R, Grimes N, Fenwick SW, Poston GJ, Malik HZ. Effect of specialist decision-making on treatment strategies for colorectal liver metastases. Br J Surg 99(9):1283-1289, 2012. e-Pub 2012.
Wang J, Estrella JS, Peng L, Rashid A, Varadhachary GR, Wang H, Lee JE, Pisters PW, Vauthey JN, Katz MH, Gomez HF, Evans DB, Abbruzzese JL, Fleming JB, Wang H. Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation. Cancer 118(15):3801-11, 2012. e-Pub 2012. PMID: 22180096.
Tzeng CW, Katz MH, Fleming JB, Pisters PW, Lee JE, Abdalla EK, Curley SA, Vauthey JN, Aloia TA. Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients. HPB (Oxford) 14(8):506-13, 2012. e-Pub 2012. PMID: 22762398.
Truty MJ, Thomas RM, Katz MH, Vauthey JN, Crane C, Varadhachary GR, Wolff RA, Abbruzzese JL, Lee JE, Fleming JB. Multimodality therapy offers a chance for cure in patients with pancreatic adenocarcinoma deemed unresectable at first operative exploration. J Am Coll Surg 215(1):41-52, 2012. e-Pub 2012. PMID: 22608401.
Tzeng CW, Katz MHG, Fleming JB, Pisters PWT, Lee JE, Abdalla EK, Curley SA, Vauthey JN, Aloia TA. Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5,651 NSQIP patients. HPB 14(8):506-513, 2012. e-Pub 2012.
Chatterjee D, Katz MH, Rashid A, Varadhachary GR, Wolff RA, Wang H, Lee JE, Pisters PW, Vauthey JN, Crane C, Gomez HF, Abbruzzese JL, Fleming JB, Wang H. Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma: a predictor for patient outcome. Cancer 118(12):3182-90, 2012. e-Pub 2012. PMID: 22028089.
Kulke MH, Benson AB, Bergsland E, Berlin JD, Blaszkowsky LS, Choti MA, Clark OH, Doherty GM, Eason J, Emerson L, Engstrom PF, Goldner WS, Heslin MJ, Kandeel F, Kunz PL, Kuvshinoff BW, Moley JF, Pillarisetty VG, Saltz L, Schteingart DE, Shah MH, Shibata S, Strosberg JR, Vauthey JN, White R, Yao JC, Freedman-Cass DA, Dwyer MA, Cancer Networks NC. Neuroendocrine tumors. J Natl Compr Canc Netw 10(6):724-764, 2012. e-Pub 2012. PMID: 22679117.
Tzeng CW, Fleming JB, Lee JE, Xiao L, Pisters PW, Vauthey JN, Abdalla EK, Wolff RA, Varadhachary GR, Fogelman DR, Crane CH, Balachandran A, Katz MH. Defined clinical classifications are associated with outcome of patients with anatomically resectable pancreatic adenocarcinoma treated with neoadjuvant therapy. Ann Surg Oncol 19(6):2045-2053, 2012. e-Pub 2012. PMID: 22258816.
Tzeng CW, Fleming JB, Lee JE, Wang X, Pisters PW, Vauthey JN, Varadhachary G, Wolff RA, Katz MH. Yield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodal therapy. HPB (Oxford) 14(6):365-72, 2012. e-Pub 2012. PMID: 22568412.
Andreou A, Brouquet A, Bharathy KG, Perrier ND, Abdalla EK, Curley SA, Glanemann M, Seehofer D, Neuhaus P, Vauthey JN, Aloia TA. Liver resection for liver metastases from nondigestive endocrine cancer: extrahepatic disease burden defines outcome. Surgery 151(6):851-859, 2012. e-Pub 2012. PMID: 22306838.
Abbott DE, Brouquet A, Mittendorf EA, Andreou A, Meric-Bernstam F, Valero V, Green MC, Kuerer HM, Curley SA, Abdalla EK, Hunt KK, Vauthey JN. Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy before metastasectomy define outcome. Surgery 151(5):710-6, 2012. e-Pub 2012. PMID: 22285778.
Janne d'Othée B, Sofocleous CT, Hanna N, Lewandowski RJ, Soulen MC, Vauthey JN, Cohen SJ, Venook AP, Johnson MS, Kennedy AS, Murthy R, Geschwind JF, Kee ST. Development of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol 23(2):153-63, 2012. e-Pub 2012. PMID: 22264550.
Estrella JS, Rashid A, Fleming JB, Katz MH, Lee JE, Wolf RA, Varadhachary GR, Pisters PW, Abdalla EK, Vauthey JN, Wang H, Gomez HF, Evans DB, Abbruzzese JL, Wang H. Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation. Cancer 118(1):268-277, 2012. e-Pub 2012. PMID: 21735446.
Katz MH, Wang H, Balachandran A, Bhosale P, Crane CH, Wang X, Pisters PW, Lee JE, Vauthey JN, Abdalla EK, Wolff R, Abbruzzese J, Varadhachary G, Chopin-Laly X, Charnsangavej C, Fleming JB. Effect of neoadjuvant chemoradiation and surgical technique on recurrence of localized pancreatic cancer. J Gastrointest Surg 16(1):68-78, 2012. e-Pub 2012. PMID: 22065318.
Abbott DE, Brouquet A, Mitendorf EA, Andreou A, Meric-Bernstam F, Valero V, Green MC, Kuerer HM, Curley SA, Abdalla EK, Hunt KK, Vauthey JN. Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy prior to surgery define outcome. Surgery 151(5):710-716, 2012. e-Pub 2012.
Gaur P, Sceusi EL, Samuel S, Xia L, Fan F, Zhou Y, Lu J, Tozzi F, Lopez-Berestein G, Vivas-Mejia P, Rashid A, Fleming JB, Abdalla EK, Curley SA, Vauthey JN, Sood AK, Yao JC, Ellis LM. Identification of cancer stem cells in human gastrointestinal carcinoid and neuroendocrine tumors. Gastroenterology 141(5):1728-37, 2011. e-Pub 2011. PMID: 21806944.
Skinner HD, Sharp HJ, Kaseb AO, Javle MM, Vauthey JN, Abdalla EK, Delclos ME, Das P, Crane CH, Krishnan S. Radiation treatment outcomes for unresectable hepatocellular carcinoma. Acta Oncol 50(8):1191-8, 2011. e-Pub 2011. PMID: 21793641.
Andreou A, Brouquet A, Abdalla EK, Aloia TA, Curley SA, Vauthey JN. Repeat hepatectomy for recurrent colorectal liver metastases is associated with a high survival rate. HPB (Oxford) 13(11):774-82, 2011. e-Pub 2011. PMID: 21999590.
Kaseb AO, Morris JS, Hassan MM, Siddiqui AM, Lin E, Xiao L, Abdalla EK, Vauthey JN, Aloia TA, Krishnan S, Abbruzzese JL. Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma. J Clin Oncol 29(29):3892-9, 2011. e-Pub 2011. PMID: 21911725.
Brouquet A, Overman MJ, Kopetz S, Maru DM, Loyer EM, Andreou A, Cooper A, Curley SA, Garrett CR, Abdalla EK, Vauthey JN. Is resection of colorectal liver metastases after a second line chemotherapy regimen justified?. Cancer 117(19):4484-4492, 2011. e-Pub 2011. PMID: 21446046.
Kaseb A, Hassan M, Siddiqui A, Lin E, Xiao L, Abdalla EK, Vauthey JN, Curley S, Aloia TA, Krishnan S, Morris J, Abbruzzese J. Clinical and prognostic implications of plasma IGF-1 and VEGF in patients with hepatocellular carcinoma. J Clin Oncol 29(29):3892-3899, 2011. e-Pub 2011.
Rahbari NN, Garden OJ, Padbury R, Maddern G, Koch M, Hugh TJ, Fan ST, Nimura Y, Figueras J, Vauthey JN, Rees M, Adam R, Dematteo RP, Greig P, Usatoff V, Banting S, Nagino M, Capussotti L, Yokoyama Y, Brooke-Smith M, Crawford M, Christophi C, Makuuchi M, Büchler MW, Weitz J. Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS). HPB (Oxford) 13(8):528-535, 2011. e-Pub 2011. PMID: 21762295.
Singal AK, Vauthey JN, Grady JJ, Stroehlein JR. Intra-hepatic cholangiocarcinoma--frequency and demographic patterns: thirty-year data from the M.D. Anderson Cancer Center. J Cancer Res Clin Oncol 137(7):1071-1078, 2011. e-Pub 2011. PMID: 21207060.
Brouquet A, Vauthey JN, Contreras CM, Walsh GL, Vaporciyan AA, Swisher SG, Curley SA, Mehran RJ, Abdalla EK. Improved survival after resection of liver and lung colorectal metastases compared with liver-only metastases: a study of 112 patients with limited lung metastatic disease. J Am Coll Surg 213(1):62-9; discussion 69-71, 2011. e-Pub 2011. PMID: 21700179.
Andreou A, Aloia TA, Brouquet A, Vauthey JN. Recent advances in the curative treatment of colorectal liver metastases. Gastrointest Cancer Res 4(4 Suppl 1):S2-8, 2011. e-Pub 2011. PMID: 22368730.
Brouquet A, Vauthey JN, Badgwell BD, Loyer EM, Kaur H, Curley SA, Abdalla EK. Hepatectomy for recurrent colorectal liver metastases after radiofrequency ablation. Br J Surg 98(7):1003-9, 2011. e-Pub 2011. PMID: 21541936.
Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R, Koch M, Makuuchi M, Dematteo RP, Christophi C, Banting S, Usatoff V, Nagino M, Maddern G, Hugh TJ, Vauthey JN, Greig P, Rees M, Yokoyama Y, Fan ST, Nimura Y, Figueras J, Capussotti L, Büchler MW, Weitz J. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149(5):713-724, 2011. e-Pub 2011. PMID: 21236455.
Koch M, Garden OJ, Padbury R, Rahbari NN, Adam R, Capussotti L, Fan ST, Yokoyama Y, Crawford M, Makuuchi M, Christophi C, Banting S, Brooke-Smith M, Usatoff V, Nagino M, Maddern G, Hugh TJ, Vauthey JN, Greig P, Rees M, Nimura Y, Figueras J, DeMatteo RP, Büchler MW, Weitz J. Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery 149(5):680-688, 2011. e-Pub 2011. PMID: 21316725.
Brouquet A, Abdalla EK, Kopetz S, Garrett CR, Overman MJ, Eng C, Andreou A, Loyer EM, Madoff DC, Curley SA, Vauthey JN. High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol 28(8):1083-1090, 2011. e-Pub 2011. PMID: 21263087.
Kaseb AO, Abbruzzese JL, Vauthey JN, Aloia TA, Abdalla EK, Hassan MM, Lin E, Xiao L, El-Deeb AS, Rashid A, Morris JS. I-CLIP: Improved stratification of advanced hepatocellular carcinoma patients by integrating plasma IGF-1 into CLIP Score. Oncology 80(5-6):373-381, 2011. e-Pub 2011. PMID: 21822028.
Munene G, Vauthey JN, Dixon E. Summary of the 2010 AHPBA/SSO/SSAT Consensus Conference on HCC. Int J Hepatol 2011:Articel ID: 565060, 2011. e-Pub 2011. PMID: 21994863.
Yang ADE, Brouquet A, Vauthey JN. Extending limits of resection for metastatic colorectal cancer-risk benefit ratio. J Surg Oncol 102(8):996-1001, 2010. e-Pub 2010.
Kishi Y, Zorzi D, Contreras CM, Maru DM, Kopetz S, Ribero D, Motta M, Ravarino N, Risio M, Curley SA, Abdalla EK, Capussotti L, Vauthey JN. Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases. Ann Surg Oncol 17(11):2870-6, 2010. e-Pub 2010. PMID: 20567921.
Kishi Y, Zorzi D, Contreras CM, Maur DP, Kopetz S, Ribero D, Motta M, Ravarino N, Risio M, Curley SA, Abdalla EK, Capussotti L, Vauthey JN. Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases. Ann Surg Oncol 17(11):2870-2876, 2010. e-Pub 2010.
Maru DM, Kopetz S, Boonsirikamchai P, Agarwal A, Chun YS, Wang H, Abdalla EK, Kaur H, Charnsangavej C, Vauthey JN, Loyer EM. Tumor thickness at the tumor-normal interface: a novel pathologic indicator of chemotherapy response in hepatic colorectal metastases. Am J Surg Pathol 34(9):1287-94, 2010. e-Pub 2010. PMID: 20697255.
Glazer ES, Tseng JF, Al-Refaie W, Solorzano CC, Liu P, Willborn KA, Abdalla EK, Vauthey JN, Curley SA. Long-term survival after surgical management of neuroendocrine hepatic metastases. HPB (Oxford) 12(6):427-33, 2010. e-Pub 2010. PMID: 20662794.
Maru DM, Kopetz S, Boonsirikamchai P, Agarwal A, Chun YS, Wang H, Abdalla EK, Kaur H, Charnsangavej C, Vauthey JN, Loyer EM. Tumor thickness at the tumor-normal interface: a novel pathologic indicator of chemotherapy response in hepatic colorectal metastases. Am J Surg Pathol 34(9):1287-1294, 2010. e-Pub 2010.
Glazer ES, Tseng JF, Al-Refaie W, Solorzano C, Wilborn KA, Abdalla EK, Vauthey JN, Curley SA. Long-term survival after surgical management of neuroendocrine hepatic metastases. HPB (Oxford) 12(6):427-433, 2010. e-Pub 2010.
Katz MH, Varadhachary GR, Fleming JB, Wolff RA, Lee JE, Pisters PW, Vauthey JN, Abdalla EK, Sun CC, Wang H, Crane CH, Lee JH, Tamm EP, Abbruzzese JL, Evans DB. Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation. Ann Surg Oncol 17(7):1794-801, 2010. e-Pub 2010. PMID: 20162463.
Katz M, Varadhachary GR, Fleming JB, Wolff RA, Lee J, Pisters P, Vauthey JN, Abdalla EK, Sun CC, Wang H, Crane C, Lee JS, Tamm EP, Abbruzzese JL, Evans DB. Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation. Ann Surg Oncol 17(7):1794-1801, 2010. e-Pub 2010.
Brouquet A, Mortenson MM, VautheyJN, Rodriguez-Bigas MA, Overman MJ, Skibber JM, Change GJ, Kopetz S, Garrett C, Fogelman D, Eng C, Chun YS, Curley SA, Abdalla EK. Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy?. J Am Coll Surg 210(6):934-941, 2010. e-Pub 2010.
Brouquet A, Mortenson MM, Vauthey JN, Rodriguez-Bigas MA, Overman MJ, Chang GJ, Kopetz S, Garrett C, Curley SA, Abdalla EK. Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy?. J Am Coll Surg 210(6):934-41, 2010. e-Pub 2010. PMID: 20510802.
Vauthey JN, Dixon E, Abdalla EK, Helton WS, Pawlik TM, Taouli B, Brouquet A, Adams RB. Pretreatment assessment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford) 12(5):289-299, 2010. e-Pub 2010.
Dixon E, Abdalla E, Schwarz RE, Vauthey JN. AHPBA/SSO/SSAT sponsored consensus conference on multidisciplinary treatment of hepatocellular carcinoma. HPB (Oxford) 12(5):287-8, 2010. e-Pub 2010. PMID: 20590900.
Vauthey JN, Dixon E, Abdalla EK, Helton WS, Pawlik TM, Taouli B, Brouquet A, Adams RB. Pretreatment assessment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford) 12(5):289-99, 2010. e-Pub 2010. PMID: 20590901.
Overman MJ, Maru DM, Charnsangavej C, Loyer EM, Wang H, Pathak P, Eng C, Hoff PM, Vauthey JN, Wolff RA, Kopetz S. Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury. J Clin Oncol 28(15):2549-55, 2010. e-Pub 2010. PMID: 20406923.
Hassan MM, Curley SA, Li D, Kaseb A, Davila M, Abdalla EK, Javle M, Moghazy DM, Lozano RD, Abbruzzese JL, Vauthey JN. Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma. Cancer 116(8):1938-46, 2010. e-Pub 2010. PMID: 20166205.
Rubbia-Brandt L, Lauwers GY, Huang H, Majno PE, Tanabe K, Zhu A, Brezault C, Soubrane O, Vauthey JN, Abdalla EK, Mentha G, Terris B. Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis. Histopathology 56(4):430-439, 2010. e-Pub 2010.
Washington MK, Berlin J, Branton PA, Burgart LJ, Carter DK, Compton CC, Fitzgibbons PL, Frankel WL, Jessup JM, Kakar S, Minsky B, Nakhleh RE, Vauthey JN. Protocol for the examination of specimens from patients with carcinoma of the perihilar bile ducts. Arch Pathol Lab Med 134(4):e19-24, 2010. e-Pub 2010. PMID: 20367295.
Washington MK, Berlin J, Branton PA, Burgart LJ, Carter DK, Compton CC, Fitzgibbons PL, Frankel WL, Jessup JM, Kakar S, Minsky B, Nakhleh RE, Vauthey JN. Protocol for the examination of specimens from patients with carcinoma of the distal extrahepatic bile ducts. Arch Pathol Lab Med 134(4):e8-13, 2010. e-Pub 2010. PMID: 20367298.
Washington MK, Berlin J, Branton PA, Burgart LJ, Carter DK, Compton CC, Fitzgibbons PL, Frankel WL, Jessup JM, Kakar S, Minsky B, Nakhleh RE, Vauthey JN. Protocol for the examination of specimens from patients with carcinoma of the perihilar bile ducts. Arch Pathol Lab Med 134(4):e19-24, 2010. e-Pub 2010.
Washington MK, Berlin J, Branton PA, Burgart LJ, Carter DK, Compton CC, Fitzgibbons PL, Frankel WL, Jessup JM, Kakar S, Minsky B, Nakhleh RE, Vauthey JN. Protocol for the examination of specimens from patients with carcinoma of the distal extrahepatic bile ducts. Arch Pathol Lab Med 134(4):e8-13, 2010. e-Pub 2010.
Washington MK, Berlin J, Branton PA, Burgart LJ, Carter DK, Compton CC, Frankel WL, Jessup JM, Kakar S, Minsky B, Nakhleh RE, Vauthey JN. Protocol for the examination of specimens from patients with carcinoma of the intrahepatic bile ducts. Arch Pathol Lab Med 134(4):e14-8, 2010. e-Pub 2010. PMID: 20367294.
Glazer ES, Beaty K, Abdalla EK, Vauthey JN, Curley SA. Effectiveness of positron emission tomography for predicting chemotherapy response in colorectal cancer liver metastases. Arch Surg 145(4):340-5; discussion 345, 2010. e-Pub 2010. PMID: 20404283.
Washington MK, Berlin J, Branton PA, Burgart LJ, Carter DK, Compton CC, Frankel WL, Jessup JM, Kakar S, Minsky B, Nakhleh RE, Vauthey JN. Protocol for the examination of specimens from patients with carcinoma of the intrahepatic bile ducts. Arch Pathol Lab Med 134(4):e14-18, 2010. e-Pub 2010.
Chang SB, Palavecino M, Wray CJ, Kishi Y, Pisters PW, Vauthey JN. Modified Makuuchi incision for foregut procedures. Arch Surg 145(3):281-4, 2010. e-Pub 2010. PMID: 20231630.
Chang SB, Palavecino M, Wray CJ, Kishi Y, Pisters PWT, Vauthey JN. Modified Makuuchi incision for foregut procedures. Arch Surg 145(3):281-284, 2010. e-Pub 2010.
Rubbia-Brandt L, Lauwers GY, Wang H, Majno PE, Tanabe K, Zhu AX, Brezault C, Soubrane O, Abdalla EK, Vauthey JN, Mentha G, Terris B. Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis. Histopathology 56(4):430-9, 2010. e-Pub 2010. PMID: 20459550.
Palavecino M, Kishi Y, Chun YS, Brown DL, Gottumukkala VN, Lichtiger B, Curley SA, Abdalla EK, Vauthey JN. Two-surgeon technique of parenchymal transection contributes to reduced transfusion rate in patients undergoing major hepatectomy: analysis of 1557 consecutive liver resections. Surgery 147(1):40-48, 2010. e-Pub 2010. PMID: 19733879.
Glazer ES, Beaty K, Abdalla EK, Vauthey JN, Curley SA. Effectiveness of positron emission tomography for predicting chemotherapy response in colorectal cancer liver metastases. Arch Surg 145(4):340-345, 2010. e-Pub 2010.
Hassan MM, Curley SA, Li D, Kaseb A, Davilla M, Abdalla EK, Javle M, Moghanzy DM, Lozano RD, Abbruzzese JL, Vauthey JN. Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma. Cancer 116(8):1938-1946. e-Pub 2010.
Chun YS, Vauthey JN, Boonsirikamchai P, Maru DM, Kopetz S, Palavecino M, Curley SA, Abdalla EK, Kaur H, Charnsangavej C, Loyer EM. Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA 302(21):2338-44, 2009. e-Pub 2009. PMID: 19952320.
Buell JF, Cherqui D, Geller DA, O'Rourke N, Iannitti D, Dagher I, Koffron AJ, Thomas M, Gayet B, Han HS, Wakabayashi G, Belli G, Kaneko H, Ker CG, Scatton O, Laurent A, Abdalla EK, Chaudhury P, Dutson E, Gamblin C, D'Angelica M, Nagorney D, Testa G, Labow D, Manas D, Poon RT, Nelson H, Martin R, Clary B, Pinson WC, Martinie J, Vauthey JN, Goldstein R, Roayaie S, Barlet D, Espat J, Abecassis M, Rees M, Fong Y, McMasters KM, Broelsch C, Busuttil R, Belghiti J, Strasberg S, Chari RS, Laparoscopic Surgery WCCO. The international position on laparoscopic liver surgery: The Louisville Statement, 2008. Ann Surg 250(5):825-830, 2009. e-Pub 2009. PMID: 19916210.
Kishi Y, Abdalla EK, Chun YS, Zorzi D, Madoff DC, Wallace MJ, Curley SA, Vauthey JN. Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg 250(4):540-548, 2009. e-Pub 2009. PMID: 19730239.
Slade JH, Alattar ML, Fogelman DR, Overman MJ, Agarwal A, Maru DM, Coulson RL, Charnsangavej C, Vauthey JN, Wolff RA, Kopetz S. Portal hypertension associated with oxaliplatin administration: clinical manifestations of hepatic sinusoidal injury. Clin Colorectal Cancer 8(4):225-30, 2009. e-Pub 2009. PMID: 19822514.
Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW, Grothey A, Vauthey JN, Nagorney DM, McWilliams RR. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 27(22):3677-83, 2009. e-Pub 2009. PMID: 19470929.
Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibañes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M. The Clavien-Dindo classification of surgical complications: Five-Year experience. Ann Surg 250(2):187-196, 2009. e-Pub 2009. PMID: 19638912.
Clark OH, Ajani JA, ABrd B, Berlin JD, Blaszkowsky LS, Byrd D, Choti MA, Doherty GM, Engstrom PF, Gibbs JF, Heslin MJ, Kandeel F, Kessinger A, Kulke MH, Kunz P, Kvols L, Jr OJ, Ratliff TW, Salem R, Saltz L, Schteingart DE, Shah MH, Shibata S, Strosberg JR, Vauthey JN, Yao JC. NCCN Clinical Practice Guidelines in Oncology: Neuroendocrine Tumors. J Natl Compr Canc Netw 7(7):712-747, 2009. e-Pub 2009.
Reddy SK, Zorzi D, Lum YW, Barbas AS, Pawlik TM, Ribero D, Abdalla EK, Choti MA, Kemp C, Vauthey JN, Morse MA, White RR, Clary BM. Timing of multimodality therapy for resectable synchronous colorectal liver metastases: a retrospective multi-institutional analysis. Ann Surg Oncol 16(7):1809-19, 2009. e-Pub 2009. PMID: 18979139.
Vauthey JN, Dixon E. AHPBA/SSO/SSAT Consensus Conference on resectable and borderline resectable pancreatic cancer: rationale and overview of the conference. Ann Surg Oncol 16(17):1726-1726, 2009. e-Pub 2009. PMID: 19396495.
Zalinski S, Abdalla EK, Mahvash A, Vauthey JN. A marking technique for intraoperative localization of small liver metastases before systemic chemotherapy. Ann Surg Oncol 16(5):1208-1211, 2009. e-Pub 2009. PMID: 19214636.
Hassan MM, Kaseb A, Li D, Patt YZ, Vauthey JN, Thomas MB, Curley SA, Spitz MR, Sherman SI, Abdalla EK, Davila M, Lozano RD, Hassan DM, Chan W, Brown TD, Abbruzzese JL. Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States. Hepatology 49(5):1563-1570, 2009. e-Pub 2009. PMID: 19399911.
Palavecino M, Chun YS, Madoff DC, Zorzi D, Kishi Y, Kaseb AO, Curley SA, Abdalla EK, Vauthey JN. Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: perioperative outcome and survival. Surgery 145(4):399-405, 2009. e-Pub 2009. PMID: 19303988.
Benson AB, Abrams TA, Ben-Josef E, Bloomston PM, Botha JF, Clary BM, Covey A, Curley SA, D'Angelica MI, Davila R, Ensminger WD, Gibbs JF, Laheru D, Malafa MP, Marrero J, Meranze SG, Mulvihill SJ, Park JO, Posey JA, Sachdev J, Salem R, Sigurdson ER, Sofocleous C, Vauthey JN, Venook AP, Goff LW, Yen Y, Zhu AX. NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw 7(4):350-391, 2009. e-Pub 2009. PMID: 19406039.
Katz MH, Wang H, Fleming JB, Sun CC, Hwang RF, Wolff RA, Varadhachary G, Abbruzzese JL, Crane CH, Krishnan S, Vauthey JN, Abdalla EK, Lee JE, Pisters PW, Evans DB. Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol 16(4):836-847, 2009. e-Pub 2009. PMID: 19194760.
Kishi Y, Kopetz S, Chun YS, Palavecino M, Abdalla EK, Vauthey JN. Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. Ann Surg Oncol 16(3):614-622, 2009. e-Pub 2009. PMID: 19130139.
Hassan MM, Spitz MR, Thomas MB, Curley SA, Patt YZ, Vauthey JN, Glover KY, Kaseb A, Lozano RD, El-Deeb AS, Nguyen NT, Wei SH, Chan W, Abbruzzese JL, Li D. The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States. J Hepatol 50(2):334-341, 2009. e-Pub 2009. PMID: 19070394.
Nathan H, Aloia TA, Vauthey JN, Abdalla EK, Zhu AX, Schulick RD, Choti MA, Pawlik TM. A proposed staging system for intrahepatic cholangiocarcinoma. Ann Surg Oncol 16(1):14-22, 2009. e-Pub 2009. PMID: 18987916.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) – A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377-381, 2009. e-Pub 2009.
Blazer DG, Kishi Y, Maru DM, Kopetz S, Chun YS, Overman MJ, Fogelman D, Eng C, Chang DZ, Wang H, Zorzi D, Ribero D, Ellis LM, Glover KY, Wolff RA, Curley SA, Abdalla EK, Vauthey JN. Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol 26(33):5344-51, 2008. e-Pub 2008. PMID: 18936472.
Kesmodel SB, Ellis LM, Lin E, Chang GJ, Abdalla EK, Kopetz S, Vauthey JN, Rodriguez-Bigas MA, Curley SA, Feig BW. Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases. J Clin Oncol 26(32):5254-60, 2008. e-Pub 2008. PMID: 18854565.
Borghero Y, Crane CH, Szklaruk J, Oyarzo M, Curley S, Pisters PW, Evans D, Abdalla EK, Thomas MB, Das P, Wistuba II, Krishnan S, Vauthey JN. Extrahepatic bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone. Ann Surg Oncol 15(11):3147-3156, 2008. e-Pub 2008. PMID: 18754070.
Kishi Y, Madoff DC, Abdalla EK, Palavecino M, Ribero D, Chun YS, Vauthey JN. Is embolization of segment 4 portal veins before extended right hepatectomy justified?. Surgery 144(5):744-51, 2008. e-Pub 2008. PMID: 19081016.
Hassan MM, Spitz MR, Thomas MB, El-Deeb AS, Glover KY, Nguyen NT, Chan W, Kaseb A, Curley SA, Vauthey JN, Ellis LM, Abdalla E, Lozano RD, Patt YZ, Brown TD, Abbruzzese JL, Li D. Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study. Int J Cancer 123(18):1883-91, 2008. e-Pub 2008. PMID: 18688864.
Zorzi D, Chun YS, Madoff DC, Abdalla EK, Vauthey JN. Chemotherapy with bevacizumab does not affect liver regeneration after portal vein embolization in the treatment of colorectal liver metastases. Ann Surg Oncol 15(10):2765-2772, 2008. e-Pub 2008. PMID: 18636296.
Varadhachary GR, Wolff RA, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Abdalla E, Wang H, Staerkel GA, Lee JH, Ross WA, Tamm EP, Bhosale PR, Krishnan S, Das P, Ho L, Xiong H, Abbruzzese JL, Evans DB. Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin Oncol 26(21):3487-95, 2008. e-Pub 2008. PMID: 18640929.
Evans DB, Varadhachary GR, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Wang H, Cleary KR, Staerkel GA, Charnsangavej C, Lano EA, Ho L, Lenzi R, Abbruzzese JL, Wolff RA. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin Oncol 26(21):3496-3502, 2008. e-Pub 2008. PMID: 18640930.
Chan ATC, Kishi Y, Chan SL, Vauthey JN. Progress in 2007 in the management of hepatobiliary cancers. GCR 2(3):S25-S31, 2008. e-Pub 2008.
Morris-Stiff G, Tan YM, Vauthey JN. Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases. Eur J Surg Oncol 34(6):609-614, 2008. e-Pub 2008.
Chan AT, Kishi Y, Chan SL, Vauthey JN. Accomplishments in 2007 in the management of hepatobiliary cancers. Gastrointest Cancer Res 2(3 Suppl):S25-31, 2008. e-Pub 2008. PMID: 19352465.
Katz MH, Pisters PW, Evans DB, Sun CC, Lee JE, Fleming JB, Vauthey JN, Abdalla EK, Crane CH, Wolff RA, Varadhachary GR, Hwang RF. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg 206(5):833-846, 2008. e-Pub 2008.
Katz MH, Pisters PW, Evans DB, Sun CC, Lee JE, Fleming JB, Vauthey JN, Abdalla EK, Crane CH, Wolff RA, Varadhachary GR, Hwang RF. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg 206(5):833-46; discussion 846-8, 2008. e-Pub 2008. PMID: 18471707.
Ribero D, Curley SA, Imamura H, Madoff DC, Nagorney DM, Ng KK, Donadon M, Vilgrain V, Torzilli G, Roh M, Vauthey JN. Selection for resection of hepatocellular carcinoma and surgical strategy: indications for resection, evaluation of liver function, portal vein embolization, and resection. Ann Surg Oncol 15(4):986-992, 2008. e-Pub 2008. PMID: 18236112.
Thomas MB, Tetzlaff E, Lozano R, Samp L, Butler CE, Gannon C, Hamilton S, Vauthey JN, Abdalla E. Curing hepatocellular carcinomatosis with biologic therapy and surgery: achieving the impossible?. J Surg Oncol 97(1):82-4, 2008. e-Pub 2008. PMID: 17918216.
Chun YS, Ribero D, Abdalla EK, Madoff DC, Mortenson MM, Wei SH, Vauthey JN. Comparison of two methods of future liver remnant volume measurement. J Gastrointest Surg 12(1):123-128, 2008. e-Pub 2008. PMID: 17924174.
Thomas MB, Tetzlaff E, Lozano R, Samp L, Butler CE, Gannon C, Hamilton S, Vauthey JN, Abdalla EK. Curing hepatocellular carcinomatosis with biologic therapy and surgery: achieving the impossible?. J Surg Oncol 97(1):82-84, 2008. e-Pub 2008.
Ribero D, Wang H, Donadon M, Zorzi D, Thomas MB, Eng C, Chang DZ, Curley SA, Abdalla EK, Ellis LM, Vauthey JN. Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Cancer 110(12):2761-7, 2007. e-Pub 2007. PMID: 17960603.
Reddy SK, Pawlik TM, Zorzi D, Gleisner AL, Ribero D, Assumpcao L, Barbas AS, Abdalla EK, Choti MA, Vauthey JN, Ludwig KA, Mantyh CR, Morse MA, Clary BM. Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. Ann Surg Oncol 14(12):3481-91, 2007. e-Pub 2007. PMID: 17805933.
Ribero D, Wang H, Donadon M, Zorzi D, Thomas MB, Eng C, Chang DZ, Curley SA, Abdalla EK, Ellis LM, Vauthey JN. Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Cancer 110(12):2761-2767, 2007. e-Pub 2007.
Hassan MM, Bondy ML, Wolff RA, Abbruzzese JL, Vauthey JN, Pisters PW, Evans DB, Khan R, Chou TH, Lenzi R, Jiao L, Li D. Risk factors for pancreatic cancer: case-control study. Am J Gastroenterol 102(12):2696-707, 2007. e-Pub 2007. PMID: 17764494.
Ribero D, Abdalla EK, Madoff DC, Donadon M, Loyer EM, Vauthey JN. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 94(11):1386-94, 2007. e-Pub 2007. PMID: 17583900.
Chun YS, Vauthey JN, Ribero D, Donadon M, Mullen JT, Eng C, Madoff DC, Chang DZ, Ho L, Kopetz S, Wei SH, Curley SA, Abdalla EK. Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. J Gastrointest Surg 11(11):1498-504; discussion 1504-5, 2007. e-Pub 2007. PMID: 17849166.
Chun YS, Vauthey JN, Ribero D, Donadon M, Mullen JC, Eng C, Madoff DC, Chang DZ, Ho L, Kopetz S, Wei SH, Curley SA, Abdalla EK. Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. J Gastrointest Surg 11(11):1498-1505, 2007. e-Pub 2007.
Ribero D, Abdalla EK, Madoff DC, Donadon M, Loyer EM, Vauthey JN. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 94(11):1386-1394, 2007. e-Pub 2007.
Pawlik TM, Gleisner AL, Bauer TW, Adams RB, Reddy SK, Clary BM, Martin RC, Scoggins CR, Tanabe KK, Michaelson JS, Kooby DA, Staley CA, Schulick RD, Vauthey JN, Abdalla EK, Curley SA, Choti MA, Elias D. Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysis. Ann Surg Oncol 14(10):2807-2816, 2007. e-Pub 2007.
Pawlik TM, Gleisner AL, Bauer TW, Adams RB, Reddy SK, Clary BM, Martin RC, Scoggins CR, Tanabe KK, Michaelson JS, Kooby DA, Staley CA, Schulick RD, Vauthey JN, Abdalla EK, Curley SA, Choti MA, Elias D. Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysis. Ann Surg Oncol 14(10):2807-16, 2007. e-Pub 2007. PMID: 17551795.
Raut CP, Tseng JF, Sun CC, Wang H, Wolff RA, Crane CH, Hwang R, Vauthey JN, Abdalla EK, Lee JE, Pisters PW, Evans DB. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 246:52-60, 2007. e-Pub 2007.
Raut CP, Tseng JF, Sun CC, Wang H, Wolff RA, Crane CH, Hwang R, Vauthey JN, Abdalla EK, Lee JE, Pisters PW, Evans DB. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 246(1):52-60, 2007. e-Pub 2007. PMID: 17592291.
Hassan MM, Abbruzzese JL, Bondy ML, Wolff RA, Vauthey JN, Pisters PW, Evans DB, Khan R, Lenzi R, Jiao L, Li D. Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: a case-control study. Cancer 109(12):2547-56, 2007. e-Pub 2007. PMID: 17492688.
Hassan MM, Bondy ML, Wolff RA, Abbruzzese JL, Vauthey JN, Pisters PW, Evans DB, Khan R, Chou TH, Lenzi R, Jiao L, Li D. Risk Factors for pancreatic cancer: case-control study. Am J Gastroenterol 102(12):2696-2707, 2007. e-Pub 2007.
Aloia TA, Charnsangavej C, Faria S, Ribero D, Abdalla EK, Vauthey JN, Curley SA. High-resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma. Am J Surg 193:702-706, 2007. e-Pub 2007.
Hassan MM, Abbruzzese JL, Bondy ML, Wolff RA, Vauthey JN, Pisters PW, Evans DB, Khan R, Lenzi R, Jiao L, Li D. Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: a case-control study. Cancer 109(12):2547-2556, 2007. e-Pub 2007.
Aloia TA, Charnsangavej C, Faria S, Ribero D, Abdalla EK, Vauthey JN, Curley SA. High-resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma. Am J Surg 193(6):702-6, 2007. e-Pub 2007. PMID: 17512280.
Mullen JT, Ribero D, Reddy SK, Donadon M, Zorzi D, Gautam S, Abdalla EK, Curley SA, Capussotti L, Clary BM, Vauthey JN. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg 204(5):854-62; discussion 862-4, 2007. e-Pub 2007. PMID: 17481498.
Vauthey JN, Ribero D, Abdalla EK, Jonas S, Bharat A, Schumacher G, Lerut J, Chapman WC, Hemming AW, Neuhaus P. Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment. J Am Coll Surg 204(5):1016-27; discussion 1027-8, 2007. e-Pub 2007. PMID: 17481532.
Vauthey JN, Ribero D, Abdalla EK, Jonas S, Bharat A, Schumacher G, Lerut J, Chapman WC, Hemming AW, Neuhaus P. Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment. J Am Coll Surg 204:1016-1027, 2007. e-Pub 2007.
Kodama Y, Ng CS, Wu TT, Ayers GD, Curley SA, Abdalla EK, Vauthey JN, Charnsangavej C. Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol 188(5):1307-12, 2007. e-Pub 2007. PMID: 17449775.
Kodama Y, Ng CS, Wu TT, Ayers GD, Curley SA, Abdalla EK, Vauthey JN, Charnsangavej C. Comparison of CT methods for determining the fat content of the liver. Am J Roentgenol 188:1307-1312, 2007. e-Pub 2007.
Mullen JT, Ribero D, Reddy SK, Donadon M, Zorzi D, Gautam S, Abdalla EK, Curley SA, Capussotti L, Clary BM, Vauthey JN. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg 204:854-862, 2007. e-Pub 2007.
Zhang J, Jia Z, Li Q, Wang L, Rashid A, Zhu Z, Evans DB, Vauthey JN, Xie K, Yao JC. Elevated expression of vascular endothelial growth factor correlates with increased angiogenesis and decreased progression-free survival among patients with low-grade neuroendocrine tumors. Cancer 109(8):1478-86, 2007. e-Pub 2007. PMID: 17340592.
Zhang J, Jia Z, Li Q, Wang L, Rashid A, Zhu Z, Evans DB, Vauthey JN, Xie K, Yao JC. Elevated expression of vascular endothelial growth factor correlates with increased angiogenesis and decreased progression-free survival among patients with low-grade neuroendocrine tumors. Cancer 109:1478-1486, 2007. e-Pub 2007.
Aloia TA, Lee JE, Vauthey JN, Abdalla EK, Wolff RA, Varadhachary GR, Abbruzzese JL, Crane CH, Evans DB, Pisters PW. Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy?. J Am Coll Surg 204:347-355, 2007. e-Pub 2007.
Aloia TA, Lee JE, Vauthey JN, Abdalla EK, Wolff RA, Varadhachary GR, Abbruzzese JL, Crane CH, Evans DB, Pisters PW. Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy?. J Am Coll Surg 204(3):347-55, 2007. e-Pub 2007. PMID: 17324767.
Donadon M, Ribero D, Morris-Stiff G, Abdalla EK, Vauthey JN. New paradigm in the management of liver-only metastases from colorectal cancer. Gastrointest Cancer Res 1(1):20-7, 2007. e-Pub 2007. PMID: 19262699.
Abdalla EK, Ribero D, Pawlik TM, Zorzi D, Curley SA, Muratore A, Andres A, Mentha G, Capussotti L, Vauthey JN. Resection of hepatic colorectal metastases involving the caudate lobe: perioperative outcome and survival. J Gastrointest Surg 11:66-72, 2007. e-Pub 2007.
Abdalla EK, Ribero D, Pawlik TM, Zorzi D, Curley SA, Muratore A, Andres A, Mentha G, Capussotti L, Vauthey JN. Resection of hepatic colorectal metastases involving the caudate lobe: perioperative outcome and survival. J Gastrointest Surg 11(1):66-72, 2007. e-Pub 2007. PMID: 17390189.
Reddy S, Zorzi D, Lum YW, Barbas AS, Pawlik TM, Ribero D, Abdalla EK, Choti MA, Kemp C, Vauthey JN, Morse MA, White RR, McClary B. Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. Ann Surg Oncol 14(12):3481-3491, 2007. e-Pub 2007.
Kobayashi K, Gupta S, Trent JC, Vauthey JN, Krishnamurthy S, Ensor J, Ahrar K, Wallace MJ, Madoff DC, Murthy R, McRae SE, Hicks ME. Hepatic artery chemoembolization for 110 gastrointestinal stromal tumors: response, survival, and prognostic factors. Cancer 107:2833-41, 2006. e-Pub 2006. PMID: 17096432.
Donadon M, Vauthey JN, Loyer EM, Charnsangavej C, Abdalla EK. Portal thrombosis and steatosis after preoperative chemotherapy with FOLFIRI-bevacizumab for colorectal liver metastases. World J Gastroenterol 12:6556-8, 2006. e-Pub 2006. PMID: 17072991.
Vauthey JN, Choti MA, Helton WS. AHPBA/SSO/SSAT Consensus Conference on hepatic colorectal metastases: rationale and overview of the conference. January 25, 2006. Ann Surg Oncol 13:1259-60, 2006. e-Pub 2006. PMID: 16952025.
Abdalla EK, Adam R, Bilchik AJ, Jaeck D, Vauthey JN, Mahvi D. Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 13:1271-80, 2006. e-Pub 2006. PMID: 16955381.
Benson AB, rd, Bekaii-Saab T, Ben-Josef E, Blumgart L, Clary BM, Curley SA, Davila R, Earle CC, Ensminger WD, Gibbs JF, Laheru D, Langnas AN, Mulvihill SJ, Nemcek AA, Jr, Posey JA, Sigurdson ER, Sinanan M, Vauthey JN, Venook AP, Wagman LD, Yeatman TJ. Hepatobiliary cancers. J Natl Compr Canc Netw 4(8):728-750, 2006. e-Pub 2006. PMID: 16948952.
Abdalla EK, Vauthey JN. Extrahepatic bile duct resection: Standard treatment for advanced gallbladder cancer?. J Surg Oncol 94(4):269-70, 2006. e-Pub 2006. PMID: 16941527.
Pawlik TM, Vauthey JN, Abdalla EK, Pollock RE, Ellis LM, Curley SA. Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver. Arch Surg 141:537-43; discussion 543-4, 2006. e-Pub 2006. PMID: 16785353.
Aloia TA, Vauthey JN, Loyer EM, Ribero D, Pawlik TM, Wei SH, Curley SA, Zorzi D, Abdalla EK. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg 141:460-6; discussion 466-7, 2006. e-Pub 2006. PMID: 16702517.
Pawlik TM, Zorzi D, Abdalla EK, Clary BM, Gershenwald JE, Ross MI, Aloia TA, Curley SA, Camacho LH, Capussotti L, Elias D, Vauthey JN. Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease. Ann Surg Oncol 13:712-20, 2006. e-Pub 2006. PMID: 16538410.
Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, Xiong HQ, Eng C, Lauwers GY, Mino-Kenudson M, Risio M, Muratore A, Capussotti L, Curley SA, Abdalla EK. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24:2065-72, 2006. e-Pub 2006. PMID: 16648507.
Scaife CL, Ng CS, Ellis LM, Vauthey JN, Charnsangavej C, Curley SA. Accuracy of preoperative imaging of hepatic tumors with helical computed tomography. Ann Surg Oncol 13:542-6, 2006. e-Pub 2006. PMID: 16474907.
Raut CP, Cleary KR, Staerkel GA, Abbruzzese JL, Wolff RA, Lee JH, Vauthey JN, Lee JE, Pisters PW, Evans DB. Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival. Ann Surg Oncol 13:582-94, 2006. e-Pub 2006. PMID: 16523362.
Abdalla EK, Eng C, Madary A, Vauthey JN. Southwest Oncology Group 0408: Phase II trial of neoadjuvant capecitabine/oxaliplatin/bevacizumab for resectable colorectal metastases in the liver. Clin Colorectal Cancer 5(6):436-9, 2006. e-Pub 2006. PMID: 16635283.
Pawlik TM, Abdalla EK, Ellis LM, Vauthey JN, Curley SA. Debunking dogma: surgery for four or more colorectal liver metastases is justified. J Gastrointest Surg 10:240-8, 2006. e-Pub 2006. PMID: 16455457.
Bedrosian I, Giacco G, Pederson L, Rodriguez-Bigas MA, Feig B, Hunt KK, Ellis L, Curley SA, Vauthey JN, Delclos M, Crane CH, Janjan N, Skibber JM. Outcome after curative resection for locally recurrent rectal cancer. Dis Colon Rectum 49:175-82, 2006. e-Pub 2006. PMID: 16392024.
Zorzi D, Abdalla EK, Pawlik TM, Brown TD, Vauthey JN. Subtotal hepatectomy following neoadjuvant chemotherapy for a previously unresectable hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 13(4):347-50, 2006. e-Pub 2006. PMID: 16858548.
Das P, Wolff RA, Abbruzzese JL, Varadhachary GR, Evans DB, Vauthey JN, Baschnagel A, Delclos ME, Krishnan S, Janjan NA, Crane CH. Concurrent capecitabine and upper abdominal radiation therapy is well tolerated. Radiat Oncol 1:41, 2006. e-Pub 2006. PMID: 17062148.
Zorzi D, Mullen JT, Abdalla EK, Pawlik TM, Andres A, Muratore A, Curley SA, Mentha G, Capussotti L, Vauthey JN. Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases. J Gastrointest Surg 10(1):86-94, 2006. e-Pub 2006. PMID: 16368496.
Mullen JT, Lee JH, Gomez HF, Ross WA, Fukami N, Wolff RA, Abdalla EK, Vauthey JN, Lee JE, Pisters PW, Evans DB. Pancreaticoduodenectomy after placement of endobiliary metal stents. J Gastrointest Surg 9(8):1094-104; discussion 1104-5, 2005. e-Pub 2005. PMID: 16269380.
Gupta S, Johnson MM, Murthy R, Ahrar K, Wallace MJ, Madoff DC, McRae SE, Hicks ME, Rao S, Vauthey JN, Ajani JA, Yao JC. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival. Cancer 104(8):1590-602, 2005. e-Pub 2005. PMID: 16134179.
Pawlik TM, Delman KA, Vauthey JN, Nagorney DM, Ng IO, Ikai I, Yamaoka Y, Belghiti J, Lauwers GY, Poon RT, Abdalla EK. Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl 11(9):1086-92, 2005. e-Pub 2005. PMID: 16123959.
Raut CP, Izzo F, Marra P, Ellis LM, Vauthey JN, Cremona F, Vallone P, Mastro A, Fornage BD, Curley SA. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis. Ann Surg Oncol 12(8):616-28, 2005. e-Pub 2005. PMID: 15965731.
Aloia TA, Zorzi D, Abdalla EK, Vauthey JN. Two-surgeon technique for hepatic parenchymal transection of the noncirrhotic liver using saline-linked cautery and ultrasonic dissection. Ann Surg 242(2):172-7, 2005. e-Pub 2005. PMID: 16041206.
Pawlik TM, Abdalla EK, Barnett CC, Ahmad SA, Cleary KR, Vauthey JN, Lee JE, Evans DB, Pisters PW. Feasibility of a randomized trial of extended lymphadenectomy for pancreatic cancer. Arch Surg 140(6):584-9; discussion 589-91, 2005. e-Pub 2005. PMID: 15967906.
Domont J, Pawlik TM, Boige V, Rose M, Weber JC, Hoff PM, Brown TD, Zorzi D, Morat L, Pignon JP, Rashid A, Jaeck D, Sabatier L, Elias D, Tursz T, Soria JC, Vauthey JN. Catalytic subunit of human telomerase reverse transcriptase is an independent predictor of survival in patients undergoing curative resection of hepatic colorectal metastases: a multicenter analysis. J Clin Oncol 23(13):3086-93, 2005. e-Pub 2005. PMID: 15860868.
Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, Curley SA, Loyer EM, Muratore A, Mentha G, Capussotti L, Vauthey JN. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241(5):715-22, discussion 722-4, 2005. e-Pub 2005. PMID: 15849507.
Pawlik TM, Poon RT, Abdalla EK, Zorzi D, Ikai I, Curley SA, Nagorney DM, Belghiti J, Ng IO, Yamaoka Y, Lauwers GY, Vauthey JN. Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. Arch Surg 140(5):450-7; discussion 457-8, 2005. e-Pub 2005. PMID: 15897440.
Van Deusen MA, Abdalla EK, Vauthey JN, Roh MS. Staging classifications for hepatocellular carcinoma. Expert Rev Mol Diagn 5(3):377-83, 2005. e-Pub 2005. PMID: 15934814.
Ng KK, Vauthey JN, Pawlik TM, Lauwers GY, Regimbeau JM, Belghiti J, Ikai I, Yamaoka Y, Curley SA, Nagorney DM, Ng IO, Fan ST, Poon RT. Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol 12(5):364-73, 2005. e-Pub 2005. PMID: 15915370.
Pawlik TM, Poon RT, Abdalla EK, Ikai I, Nagorney DM, Belghiti J, Kianmanesh R, Ng IO, Curley SA, Yamaoka Y, Lauwers GY, Vauthey JN. Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery 137(4):403-10, 2005. e-Pub 2005. PMID: 15800485.
Madoff DC, Abdalla EK, Gupta S, Wu TT, Morris JS, Denys A, Wallace MJ, Morello FA, Jr, Ahrar K, Murthy R, Lunagomez S, Hicks ME, Vauthey JN. Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol 16(2 Pt 1):215-25, 2005. e-Pub 2005. PMID: 15713922.
Parikh AA, Abdalla EK, Vauthey JN. Operative considerations in resection of hilar cholangiocarcinoma. HPB (Oxford) 7(4):254-8, 2005. e-Pub 2005. PMID: 18333202.
Tseng JF, Raut CP, Lee JE, Pisters PW, Vauthey JN, Abdalla EK, Gomez HF, Sun CC, Crane CH, Wolff RA, Evans DB. Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg 8(8):935-49; discussion 949-50, 2004. e-Pub 2004. PMID: 15585381.
Pawlik TM, Poon RT, Abdalla EK, Sarmiento JM, Ikai I, Curley SA, Nagorney DM, Belghiti J, Ng IO, Yamaoka Y, Lauwers GY, Vauthey JN. Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma. J Gastrointest Surg 8(7):794-804; discussion 804-5, 2004. e-Pub 2004. PMID: 15531232.
Bonnen M, Crane C, Vauthey JN, Skibber J, Delclos ME, Rodriguez-Bigas M, Hoff PM, Lin E, Eng C, Wong A, Janjan NA, Feig BW. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. Int J Radiat Oncol Biol Phys 60(4):1098-105, 2004. e-Pub 2004. PMID: 15519780.
Mullen JT, Walsh GL, Abdalla EK, Loyer EM, Curley SA, Vauthey JN. Transdiaphragmatic radiofrequency ablation of liver tumors. J Am Coll Surg 199(5):826-9, 2004. e-Pub 2004. PMID: 15501127.
Kobayashi S, Ng CS, Kazama T, Madoff DC, Faria SC, Vauthey JN, Charnsangavej C. Hemodynamic and morphologic changes after portal vein embolization: differential effects in central and peripheral zones in the liver on multiphasic computed tomography. J Comput Assist Tomogr 28(6):804-10, 2004. e-Pub 2004. PMID: 15538155.
Vlastos G, Smith DL, Singletary SE, Mirza NQ, Tuttle TM, Popat RJ, Curley SA, Ellis LM, Roh MS, Vauthey JN. Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases. Ann Surg Oncol 11(9):869-74, 2004. e-Pub 2004. PMID: 15342348.
Vauthey JN, Pawlik TM, Lauwers GY, Nagorney DM, Roh MS, Curley SA, Poon RT, Belghiti J, Greene F, Michael Henderson J. Critical evaluation of the different staging systems for hepatocellular carcinoma. Br J Surg 91:1072, 2004. e-Pub 2004. PMID: 15286973.
Patt YZ, Hassan MM, Aguayo A, Nooka AK, Lozano RD, Curley SA, Vauthey JN, Ellis LM, Schnirer, II, Wolff RA, Charnsangavej C, Brown TD. Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma. Cancer 101(3):578-86, 2004. e-Pub 2004. PMID: 15274071.
Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, Hess K, Curley SA. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239(6):818-25; discussion 825-7, 2004. e-Pub 2004. PMID: 15166961.
Vauthey JN, Pawlik TM, Abdalla EK, Arens JF, Nemr RA, Wei SH, Kennamer DL, Ellis LM, Curley SA. Is extended hepatectomy for hepatobiliary malignancy justified?. Ann Surg 239(5):722-30; discussion 730-2, 2004. e-Pub 2004. PMID: 15082977.
Abdalla EK, Denys A, Chevalier P, Nemr RA, Vauthey JN. Total and segmental liver volume variations: implications for liver surgery. Surgery 135(4):404-10, 2004. e-Pub 2004. PMID: 15041964.
Curley SA, Marra P, Beaty K, Ellis LM, Vauthey JN, Abdalla EK, Scaife C, Raut C, Wolff R, Choi H, Loyer E, Vallone P, Fiore F, Scordino F, De Rosa V, Orlando R, Pignata S, Daniele B, Izzo F. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg 239(4):450-8, 2004. e-Pub 2004. PMID: 15024305.
Smith DL, Soria JC, Morat L, Yang Q, Sabatier L, Liu DD, Nemr RA, Rashid A, Vauthey JN. Human telomerase reverse transcriptase (hTERT) and Ki-67 are better predictors of survival than established clinical indicators in patients undergoing curative hepatic resection for colorectal metastases. Ann Surg Oncol 11(1):45-51, 2004. e-Pub 2004. PMID: 14699033.
Regimbeau JM, Abdalla EK, Vauthey JN, Lauwers GY, Durand F, Nagorney DM, Ikai I, Yamaoka Y, Belghiti J. Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study. J Surg Oncol 85(1):36-41, 2004. e-Pub 2004. PMID: 14696085.
Bedrosian I, Rodriguez-Bigas MA, Feig B, Hunt KK, Ellis L, Curley SA, Vauthey JN, Delclos M, Crane C, Janjan N, Skibber JM. Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma. J Gastrointest Surg 8(1):56-62; discussion 62-3, 2004. e-Pub 2004. PMID: 14746836.
Parikh AA, Gentner B, Wu TT, Curley SA, Ellis LM, Vauthey JN. Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy. J Gastrointest Surg 7(8):1082-8, 2003. e-Pub 2003. PMID: 14675719.
Esnaola NF, Mirza N, Lauwers GY, Ikai I, Regimbeau JM, Belghiti J, Yamaoka Y, Curley SA, Ellis LM, Nagorney DM, Vauthey JN. Comparison of clinicopathologic characteristics and outcomes after resection in patients with hepatocellular carcinoma treated in the United States, France, and Japan. Ann Surg 238(5):711-9, 2003. e-Pub 2003. PMID: 14578734.
Zheng B, Fiumara P, Li YV, Georgakis G, Snell V, Younes M, Vauthey JN, Carbone A, Younes A. MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival. Blood 102(3):1019-27, 2003. e-Pub 2003. PMID: 12689928.
Hemming AW, Reed AI, Howard RJ, Fujita S, Hochwald SN, Caridi JG, Hawkins IF, Vauthey JN. Preoperative portal vein embolization for extended hepatectomy. Ann Surg 237(5):686-91; discussion 691-3, 2003. e-Pub 2003. PMID: 12724635.
Scaife CL, Curley SA, Izzo F, Marra P, Delrio P, Daniele B, Cremona F, Gershenwald JE, Chase JL, Lozano RD, Patt YZ, Fornage BD, Vauthey JN, Woodall ML, Gonzalez KB, Ellis LM. Feasibility of adjuvant hepatic arterial infusion of chemotherapy after radiofrequency ablation with or without resection in patients with hepatic metastases from colorectal cancer. Ann Surg Oncol 10(4):348-54, 2003. e-Pub 2003. PMID: 12734081.
Varnholt H, Vauthey JN, Cin PD, Marsh Rde W, Bhathal PS, Hughes NR, Lauwers GY. Biliary adenofibroma: a rare neoplasm of bile duct origin with an indolent behavior. Am J Surg Pathol 27(5):693-8, 2003. e-Pub 2003. PMID: 12717255.
Madoff DC, Hicks ME, Abdalla EK, Morris JS, Vauthey JN. Portal vein embolization with polyvinyl alcohol particles and coils in preparation for major liver resection for hepatobiliary malignancy: safety and effectiveness--study in 26 patients. Radiology 227(1):251-60, 2003. e-Pub 2003. PMID: 12616006.
Patt YZ, Hassan MM, Lozano RD, Brown TD, Vauthey JN, Curley SA, Ellis LM. Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma. J Clin Oncol 21(3):421-7, 2003. e-Pub 2003. PMID: 12560429.
Crane CH, Skibber JM, Feig BW, Vauthey JN, Thames HD, Curley SA, Rodriguez-Bigas MA, Wolff RA, Ellis LM, Delclos ME, Lin EH, Janjan NA. Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma. Cancer 97(2):517-24, 2003. e-Pub 2003. PMID: 12518377.
Makuuchi M, Belghiti J, Belli G, Fan ST, Lau JW, Ringe B, Strasberg SM, Vauthey JN, Yamaoka Y, Yamasaki S. IHPBA concordant classification of primary liver cancer: working group report. J Hepatobiliary Pancreat Surg 10(1):26-30, 2003. e-Pub 2003. PMID: 12918454.
Raut CP, Grau AM, Staerkel GA, Kaw M, Tamm EP, Wolff RA, Vauthey JN, Lee JE, Pisters PW, Evans DB. Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer. J Gastrointest Surg 7(1):118-26; discussion 127-8, 2003. e-Pub 2003. PMID: 12559193.
Mendenhall WM, Vauthey JN, Zlotecki RA, Marsh RD, Copeland EM, rd. Preoperative chemoradiation for locally advanced rectal adenocarcinoma-the University of Florida experience. Semin Surg Oncol 21(4):261-4, 2003. e-Pub 2003. PMID: 14648784.
Esnaola N, Vauthey JN, Lauwers G. Liver fibrosis increases the risk of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma (Br J Surg 2002; 89: 57-62). Br J Surg 89(7):939-40; author reply 940, 2002. e-Pub 2002. PMID: 12081752.
Crane CH, Macdonald KO, Vauthey JN, Yehuda P, Brown T, Curley S, Wong A, Delclos M, Charnsangavej C, Janjan NA. Limitations of conventional doses of chemoradiation for unresectable biliary cancer. Int J Radiat Oncol Biol Phys 53(4):969-74, 2002. e-Pub 2002. PMID: 12095564.
Abdalla EK, Barnett CC, Doherty D, Curley SA, Vauthey JN. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg 137(6):675-80; discussion 680-1, 2002. e-Pub 2002. PMID: 12049538.
Schell SR, Zlotecki RA, Mendenhall WM, Marsh RW, Vauthey JN, Copeland EM, rd. Transanal excision of locally advanced rectal cancers downstaged using neoadjuvant chemoradiotherapy. J Am Coll Surg 194(5):584-90; discussion 590-1, 2002. e-Pub 2002. PMID: 12025835.
Pisters PW, Wolff RA, Janjan NA, Cleary KR, Charnsangavej C, Crane CN, Lenzi R, Vauthey JN, Lee JE, Abbruzzese JL, Evans DB. Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome. J Clin Oncol 20(10):2537-44, 2002. e-Pub 2002. PMID: 12011133.
Wayne JD, Lauwers GY, Ikai I, Doherty DA, Belghiti J, Yamaoka Y, Regimbeau JM, Nagorney DM, Do KA, Ellis LM, Curley SA, Pollock RE, Vauthey JN. Preoperative predictors of survival after resection of small hepatocellular carcinomas. Ann Surg 235(5):722-30; discussion 730-1, 2002. e-Pub 2002. PMID: 11981219.
Crane CH, Abbruzzese JL, Evans DB, Wolff RA, Ballo MT, Delclos M, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Vauthey JN, Wong AB, Phan T, Nguyen Q, Janjan NA. Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?. Int J Radiat Oncol Biol Phys 52(5):1293-302, 2002. e-Pub 2002. PMID: 11955742.
Esnaola NF, Lauwers GY, Mirza NQ, Nagorney DM, Doherty D, Ikai I, Yamaoka Y, Regimbeau JM, Belghiti J, Curley SA, Ellis LM, Vauthey JN. Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J Gastrointest Surg 6(2):224-32; discussion 232, 2002. e-Pub 2002. PMID: 11992808.
Vauthey JN, Lauwers GY, Esnaola NF, Do KA, Belghiti J, Mirza N, Curley SA, Ellis LM, Regimbeau JM, Rashid A, Cleary KR, Nagorney DM. Simplified staging for hepatocellular carcinoma. J Clin Oncol 20(6):1527-36, 2002. e-Pub 2002. PMID: 11896101.
Vauthey JN, Abdalla EK, Doherty DA, Gertsch P, Fenstermacher MJ, Loyer EM, Lerut J, Materne R, Wang X, Encarnacion A, Herron D, Mathey C, Ferrari G, Charnsangavej C, Do KA, Denys A. Body surface area and body weight predict total liver volume in Western adults. Liver Transpl 8(3):233-40, 2002. e-Pub 2002. PMID: 11910568.
Lauwers GY, Terris B, Balis UJ, Batts KP, Regimbeau JM, Chang Y, Graeme-Cook F, Yamabe H, Ikai I, Cleary KR, Fujita S, Flejou JF, Zukerberg LR, Nagorney DM, Belghiti J, Yamaoka Y, Vauthey JN. Prognostic histologic indicators of curatively resected hepatocellular carcinomas: a multi-institutional analysis of 425 patients with definition of a histologic prognostic index. Am J Surg Pathol 26(1):25-34, 2002. e-Pub 2002. PMID: 11756766.
Feig BW, Curley S, Lucci A, Hunt KK, Vauthey JN, Mansfield PF, Cleary K, Hamilton S, Ellis V, Brame M, Berger DH. A caution regarding lymphatic mapping in patients with colon cancer. Am J Surg 182(6):707-12, 2001. e-Pub 2001. PMID: 11839343.
Solorzano CC, Lee JE, Pisters PW, Vauthey JN, Ayers GD, Jean ME, Gagel RF, Ajani JA, Wolff RA, Evans DB. Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients. Surgery 130(6):1078-85, 2001. e-Pub 2001. PMID: 11742342.
Taylor N, Crane C, Skibber J, Feig B, Ellis L, Vauthey JN, Hamilton S, Cleary K, Dubrow R, Brown T, Wolff R, Hoff P, Sanfilippo N, Janjan N. Elective groin irradiation is not indicated for patients with adenocarcinoma of the rectum extending to the anal canal. Int J Radiat Oncol Biol Phys 51(3):741-7, 2001. e-Pub 2001. PMID: 11597817.
Patt YZ, Hassan MM, Lozano RD, Waugh KA, Hoque AM, Frome AI, Lahoti S, Ellis L, Vauthey JN, Curley SA, Schnirer, II, Raijman I. Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer. Clin Cancer Res 7(11):3375-80, 2001. e-Pub 2001. PMID: 11705850.
Abdalla EK, Vauthey JN. Biliary tract cancer. Curr Opin Gastroenterol 17(5):450-7, 2001. e-Pub 2001. PMID: 17031200.
Sanfilippo NJ, Crane CH, Skibber J, Feig B, Abbruzzese JL, Curley S, Vauthey JN, Ellis LM, Hoff P, Wolff RA, Brown TD, Cleary K, Wong A, Phan T, Janjan NA. T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatment. Int J Radiat Oncol Biol Phys 51(1):176-83, 2001. e-Pub 2001. PMID: 11516868.
Ahmad SA, Bilimoria MM, Wang X, Izzo F, Delrio P, Marra P, Baker TP, Porter GA, Ellis LM, Vauthey JN, Dhamotharan S, Curley SA. Hepatitis B or C virus serology as a prognostic factor in patients with hepatocellular carcinoma. J Gastrointest Surg 5(5):468-76, 2001. e-Pub 2001. PMID: 11985997.
Su LK, Abdalla EK, Law CH, Kohlmann W, Rashid A, Vauthey JN. Biallelic inactivation of the APC gene is associated with hepatocellular carcinoma in familial adenomatous polyposis coli. Cancer 92(2):332-9, 2001. e-Pub 2001. PMID: 11466687.
Pisters PW, Hudec WA, Hess KR, Lee JE, Vauthey JN, Lahoti S, Raijman I, Evans DB. Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive patients. Ann Surg 234(1):47-55, 2001. e-Pub 2001. PMID: 11420482.
Bilimoria MM, Lauwers GY, Doherty DA, Nagorney DM, Belghiti J, Do KA, Regimbeau JM, Ellis LM, Curley SA, Ikai I, Yamaoka Y, Vauthey JN. Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. Arch Surg 136(5):528-35, 2001. e-Pub 2001. PMID: 11343543.
Janjan NA, Crane C, Feig BW, Cleary K, Dubrow R, Curley S, Vauthey JN, Lynch P, Ellis LM, Wolff R, Lenzi R, Abbruzzese J, Pazdur R, Hoff PM, Allen P, Brown T, Skibber J. Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol 24(2):107-12, 2001. e-Pub 2001. PMID: 11319280.
Breslin TM, Hess KR, Harbison DB, Jean ME, Cleary KR, Dackiw AP, Wolff RA, Abbruzzese JL, Janjan NA, Crane CH, Vauthey JN, Lee JE, Pisters PW, Evans DB. Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration. Ann Surg Oncol 8(2):123-32, 2001. e-Pub 2001. PMID: 11258776.
Crane, Janjan NA, Abbruzzese JL, Curley S, Vauthey JN, Sawaf HB, Dubrow R, Allen P, Ellis LM, Hoff P, Wolff RA, Lenzi R, Brown TD, Lynch P, Cleary K, Rich TA, Skibber J. Effective pelvic symptom control using initial chemoradiation without colostomy in metastatic rectal cancer. Int J Radiat Oncol Biol Phys 49(1):107-116, 2001. e-Pub 2001.
Crane CH, Janjan NA, Evans DB, Wolff RA, Ballo MT, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Vauthey JN, Wong A, Phan T, Nguyen Q, Abbruzzese JL. Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer. Int J Pancreatol 29(1):9-18, 2001. e-Pub 2001. PMID: 11560155.
Cockburn M, Swafford J, Mazur W, Walsh GL, Vauthey JN. Resolution of nonbacterial endocarditis after surgical resection of a malignant liver tumor. Circulation 102(21):2671-2, 2000. e-Pub 2000. PMID: 11085973.
Cormier JN, Vauthey JN. Biliary tract cancer. Curr Opin Gastroenterol 16(5):437-43, 2000. e-Pub 2000. PMID: 17031117.
Meric F, Patt YZ, Curley SA, Chase J, Roh MS, Vauthey JN, Ellis LM. Surgery after downstaging of unresectable hepatic tumors with intra-arterial chemotherapy. Ann Surg Oncol 7(7):490-5, 2000. e-Pub 2000. PMID: 10947016.
Vauthey JN, Chaoui A, Do KA, Bilimoria MM, Fenstermacher MJ, Charnsangavej C, Hicks M, Alsfasser G, Lauwers G, Hawkins IF, Caridi J. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 127(5):512-9, 2000. e-Pub 2000. PMID: 10819059.
Curley SA, Izzo F, Ellis LM, Vauthey JN, Paolo V. Radiofrequency ablation of hepatocellular cancer in 110 cirrhotic patients. . Ann Surg 332(3):381-391, 2000. e-Pub 2000.
Jan Jan NA, Crane CN, Feig BW, Cleary K, Dubrow R, Curley SA, Ellis LM, Vauthey JN, Lenzi R, Lynch P, Wolff R, Brown T, Pazdur R, Abbruzzese J, Hoff PM, Allen P, Brown B, Skibber J. Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer. . Int J Radiat Oncol 47(3):713-718, 2000. e-Pub 2000.
Ehrenfried JA, Vauthey JN. Biliary tract cancer. Curr Opin Gastroenterol 15(5):430-5, 1999. e-Pub 1999. PMID: 17023985.
Bilimoria MM, Chaoui AS, Vauthey JN. Postoperative liver failure. J Am Coll Surg 189(3):336-8, 1999. e-Pub 1999. PMID: 10472939.
Vauthey JN, Marsh RW, Zlotecki RA, Abdalla EK, Solorzano CC, Bray EJ, Freeman ME, Lauwers GY, Kubilis PS, Mendenhall WM, Copeland EM, rd. Recent advances in the treatment and outcome of locally advanced rectal cancer. Ann Surg 229(5):745-52; discussion 752-4, 1999. e-Pub 1999. PMID: 10235534.
Solorzano CC, Minter RM, Childers TC, Kilkenny JW, rd, Vauthey JN. Prospective evaluation of the giant prosthetic reinforcement of the visceral sac for recurrent and complex bilateral inguinal hernias. Am J Surg 177(1):19-22, 1999. e-Pub 1999. PMID: 10037302.
Abdalla EK, Forsmark CE, Lauwers GY, Vauthey JN. Monolobar Caroli's Disease and cholangiocarcinoma. HPB Surg 11(4):271-6; discussion 276-7, 1999. e-Pub 1999. PMID: 10468120.
Lind DS, Minter R, Steinbach B, Abbitt P, Lanier L, Haigh L, Vauthey JN, Russin M, Hackett R, Copeland EM. Stereotactic core biopsy reduces the reexcision rate and the cost of mammographically detected cancer. J Surg Res 78(1):23-6, 1998. e-Pub 1998. PMID: 9733612.
Vauthey JN, Abdalla EK, Rout WR. Efficacy of transanal excision of rectal cancer. Curr Surg 55(6):221-225, 1998. e-Pub 1998.
Zlotecki RA, Jung LA, Vauthey JN, Vogel SB, Mendenhall WM. Carcinoma of the extrahepatic biliary tract: surgery and radiotherapy for curative and palliative intent. Radiat Oncol Investig 6(5):240-7, 1998. e-Pub 1998. PMID: 9822171.
Vauthey JN, Tomczak RJ, Helmberger T, Gertsch P, Forsmark C, Caridi J, Reed A, Langham MR, Jr, Lauwers GY, Goffette P, Lerut J. The arterioportal fistula syndrome: clinicopathologic features, diagnosis, and therapy. Gastroenterology 113(4):1390-401, 1997. e-Pub 1997. PMID: 9322535.
Mendenhall WM, Rout WR, Vauthey JN, Haigh LS, Zlotecki RA, Copeland EM, rd. Conservative treatment of rectal adenocarcinoma with endocavitary irradiation or wide local excision and postoperative irradiation. J Clin Oncol 15(10):3241-8, 1997. e-Pub 1997. PMID: 9336361.
Solorzano CC, Ksontini R, Pruitt JH, Hess PJ, Edwards PD, Kaibara A, Abouhamze A, Auffenberg T, Galardy RE, Vauthey JN, Copeland EM, rd, Edwards CK, rd, Lauwers GY, Clare-Salzler M, MacKay SL, Moldawer LL, Lazarus DD. Involvement of 26-kDa cell-associated TNF-alpha in experimental hepatitis and exacerbation of liver injury with a matrix metalloproteinase inhibitor. J Immunol 158(1):414-9, 1997. e-Pub 1997. PMID: 8977217.
Marsh RD, Chu NM, Vauthey JN, Mendenhall WM, Lauwers GY, Bewsher C, Copeland EM. Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5-fluorouracil infusion and radiation therapy. Cancer 78(2):217-25, 1996. e-Pub 1996. PMID: 8673995.
Welborn MB, rd, Van Zee K, Edwards PD, Pruitt JH, Kaibara A, Vauthey JN, Rogy M, Castleman WL, Lowry SF, Kenney JS, Stuber D, Ettlin U, Wipf B, Loetscher H, Copeland EM, rd, Lesslauer W, Moldawer LL. A human tumor necrosis factor p75 receptor agonist stimulates in vitro T cell proliferation but does not produce inflammation or shock in the baboon. J Exp Med 184(1):165-71, 1996. e-Pub 1996. PMID: 8691130.
Beierle EA, Vauthey JN, Moldawer LL, Copeland EM, rd. Hepatic tumor necrosis factor-alpha production and distant organ dysfunction in a murine model of obstructive jaundice. Am J Surg 171(1):202-6, 1996. e-Pub 1996. PMID: 8554142.
Vauthey JN, Woodruff JM, Brennan MF. Extremity malignant peripheral nerve sheath tumors (neurogenic sarcomas): a 10-year experience. Ann Surg Oncol 2(2):126-31, 1995. e-Pub 1995. PMID: 7728565.
Vauthey JN, Klimstra D, Blumgart LH. A simplified staging system for hepatocellular carcinomas. Gastroenterology 108(2):617-8, 1995. e-Pub 1995. PMID: 7835611.
Gertsch, Vauthey JN, Looser C, Triller J, Blumgart LH. Evaluation of adaptive changes by non-invasive imaging in hepatic vein outflow obstruction. HPB Surg 8:231-236, 1995. e-Pub 1995.
Vauthey JN, Klimstra D, Franceschi D, Tao Y, Fortner J, Blumgart L, Brennan M. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 169(1):28-34; discussion 34-5, 1995. e-Pub 1995. PMID: 7817995.
Gertsch P, Vauthey JN, Looser C, Triller J, Blumgart LH. Evaluation of adaptive changes by non-invasive imaging in hepatic vein outflow obstruction. HPB Surg 8(4):231-6, 1995. e-Pub 1995. PMID: 18612469.
Vauthey JN, Duda P, Wheatley AM, Gertsch P. Portal hypertension promotes bacterial translocation in rats mono- and non mono-associated with Escherichia coli C25. HPB Surg 8(2):95-100, 1994. e-Pub 1994. PMID: 7880779.
Vauthey JN, Winter MW, Blumgart LH. Solitary metastasis from cutaneous melanoma to the liver: resection by extended left hepatectomy (trisegmentectomy) with clearance of tumor from the portal vein. HPB Surg 8(1):53-6, 1994. e-Pub 1994. PMID: 7993865.
Vauthey JN, Baer HU, Guastella T, Blumgart LH. Comparison of outcome between extended and nonextended liver resections for neoplasms. Surgery 114(5):968-75, 1993. e-Pub 1993. PMID: 8236022.
Gertsch P, Vauthey JN, Lustenberger AA, Friedlander-Klar H. Long-term results of transhiatal esophagectomy for esophageal carcinoma. A multivariate analysis of prognostic factors. Cancer 72(8):2312-9, 1993. e-Pub 1993. PMID: 8402444.
Vauthey JN, Sclafani LM. Breast carcinoma presenting as chondrosternal thickening: a long-standing masquerade. Surgery 113(5):587-9, 1993. e-Pub 1993. PMID: 8387699.
Vauthey JN, Lerut J. An "open-closed" technique for the treatment of necrotizing pancreatitis. Am J Surg 165(2):277-81, 1993. e-Pub 1993. PMID: 8427412.
Gertsch, Vauthey JN, Maddern GJ. Transhiatal esophagectomy using a ringdissector. . Surg Gynecol Obstet 176:389–391, 1993. e-Pub 1993.
Vauthey JN, Lerut J, Martini M, Becker C, Gertsch P, Blumgart LH. Indications and limitations of percutaneous cholecystostomy for acute cholecystitis. Surg Gynecol Obstet 176(1):49-54, 1993. e-Pub 1993. PMID: 8427004.
Vauthey JN, Maddern GJ, Gertsch P. Cesar Roux--Swiss pioneer in surgery. Surgery 112(5):946-50, 1992. e-Pub 1992. PMID: 1440249.
Vauthey JN, Lerut J, Laube M, Donati D, Gertsch P. Blunt oesophageal perforation: treatment with surgical exclusion and percutaneous drainage under computed tomographic guidance. Eur J Surg 158(9):509-10, 1992. e-Pub 1992. PMID: 1358222.
Vauthey JN, Maddern GJ, Kolbinger P, Baer HU, Blumgart LH. Clinical experience with adult polycystic liver disease. Br J Surg 79(6):562-5, 1992. e-Pub 1992. PMID: 1611453.
Lerut, Vauthey JN, Triller J, Ph G, Schweizer W. Intrahepatic arterioportal fistula following conservative treatment of a traumatic liver rupture. . J Trauma 33:760–764, 1992. e-Pub 1992.
Vauthey JN, Maddern GJ, Gertsch P. A simplified technique of esophagojejunostomy. Surg Gynecol Obstet 173(6):499-500, 1991. e-Pub 1991. PMID: 1948612.
Gertsch P, Wheatley AM, Maibach R, Maddern GJ, Vauthey JN. Experimental evaluation of an endoscopic balloon for manometry of esophageal varices. Gastroenterology 101(6):1692-700, 1991. e-Pub 1991. PMID: 1955134.
Guastella T, Vauthey JN, Maddern GJ, Gertsch P. A rare cause of severe bleeding from the anterior duodenal wall: the cystic artery. J Clin Gastroenterol 13(5):598-9, 1991. e-Pub 1991. PMID: 1744410.
Vauthey JN, Maddern GJ, Balsiger D, Blumgart LH, Triller J. Superselective embolization of superior gluteal artery pseudoaneurysms following intramuscular injection: case report. J Trauma 31(8):1174-5, 1991. e-Pub 1991. PMID: 1875445.
Maddern GJ, Vauthey JN, Devitt P, Britten-Jones R, Hetzel DJ, Jamieson GG. Recurrent peptic ulceration after highly selective vagotomy: long-term outcome. Br J Surg 78(8):940-1, 1991. e-Pub 1991. PMID: 1913111.
Sauter ER, Vauthey JN, Bolton JS, Sardi A. Selective management of patients with neutropenic enterocolitis using peritoneal lavage. J Surg Oncol 45(1):63-7, 1990. e-Pub 1990. PMID: 2381215.
Bolton JS, Vauthey JN, Farr GH, Jr, Sauter EI, Bowen JC, rd, Kline DG. Is limb-sparing surgery applicable to neurogenic sarcomas of the extremities?. Arch Surg 124(1):118-21, 1989. e-Pub 1989. PMID: 2910239.
Berry DW, Vauthey JN, Snyder D, Mills NL, Ochsner JL. The approach to large left ventricular aneurysms. A report of three difficult cases. J Cardiovasc Surg (Torino) 29(6):658-62, 1988. e-Pub 1988. PMID: 3209608.
Vauthey JN, Matthews CC. Portal vein air embolization after blunt abdominal trauma. Am Surg 54:586-8, 1988. e-Pub 1988. PMID: 3415102.
Vauthey JN, Berry DW, Snyder DW, Gilmore JC, Sundgaard-Riise K, Mills NL, Ochsner JL. Left ventricular aneurysm repair with myocardial revascularization: an analysis of 246 consecutive patients over 15 years. Ann Thorac Surg 46(1):29-35, 1988. e-Pub 1988. PMID: 3382282.
Bowen, Vauthey JN, Vallette RC. Decamp PT. Long–term results after distal splenorenal shunt. . Dig Surg 5:201–206, 1988. e-Pub 1988.
Vauthey JN, Mosimann F, Gardiol D, Mosimann R. Correlation between atherosclerotic lesions of cystic and hepatic arteries and gallbladder disease. . Dig Surg 4:14–18, 1987. e-Pub 1987.
Vauthey JN, Mosimann F, Gardiol D, Mosimann R. Pathology of the arterial hepato-cystic network. Helv Chir Acta 52:293-4, 1985. e-Pub 1985. PMID: 4055401.
Vauthey JN, Ekoe JM, Moser CA, Humair L. [Botulism: apropos of a local epidemic]. Schweiz Med Wochenschr 114:2-6, 1984. e-Pub 1984. PMID: 6695163.
Gertsch R, Vauthey JN. Appendicitis: results of an aggressive surgical approach (in French). (Appendicite: résultats d'une attitude interventionniste.) . Méd Hyg 42:2770–2778, 1984. e-Pub 1984.

Invited Articles

Chun YS, Vauthey JN. Response to Comment on "Deleterious Effect of RAS and Evolutionary High Risk TP53 Double Mutation in Colorectal Liver Metastases". Ann Surg 271(2):e16-e17, 2020. e-Pub 2020. PMID: 31913924.
Brudvik KW, Vauthey JN. Surgery: KRAS mutations and hepatic recurrence after treatment of colorectal liver metastases. Nat Rev Gastroenterol Hepatol 14:638-639, 2017. e-Pub 2017. PMID: 28930294.
Vauthey JN. Seven Keys to Success in Academic Surgery. Br J Surg 104(8):962-963, 2017. e-Pub 2017.
Brudvik KW, Passot G, Vauthey JN. Commentary "Colorectal Liver Metastases: A Changing Treatment Landscape" on: “Surgical Management of Liver Metastases from Colorectal Cancer”. J Oncol Pract 12(1):40-41, 2016. e-Pub 2016. PMID: 26759465.
Passot G, Vauthey JN. In favor of two-stage hepatectomy (TSH). Eur J Surg Oncol 41(12):1566-1567, 2015. e-Pub 2015. PMID: 26409952.
Brudvik KW, Vauthey JN. Peeling off technique or bile duct resection of tumor thrombus in hepatocellular carcinoma. Does future liver directed treatment justify less extensive surgery?. Ann Surg 261(5):e126, 2015. e-Pub 2015. PMID: 25775077.
Vauthey JN, Pawlik TM. Invited Critique - Preoperative biopsy evaluation of chemotherapy-associated liver injuries: looking for a needle in a hay-stack?. Arch Surg 147(12):1092, 2012. e-Pub 2012.
Roses RE, Vauthey JN. Transplantation or resection for hepatocellular carcinoma: biology determines outcome. Oncology (Williston Park) 25(8):760-1, 2011. e-Pub 2011. PMID: 21874839.
Dixon E, Datta I, Sutherland FR, Vauthey JN. Blood loss in surgical oncology: neglected quality indicator?. J Surg Oncol 99(8):508-512, 2009. e-Pub 2009. PMID: 19466741.
Palavecino M, Abdalla EK, Madoff DC, Vauthey JN. Portal vein embolization in hilar cholangiocarcinoma. Surg Oncol Clin N Am 18(2):257-267, 2009. e-Pub 2009. PMID: 19306811.
Katz M, Vauthey JN. Potentially curable metastatic colorectal cancer. Curr Oncol Rep 10(3):225-231, 2008. e-Pub 2008. PMID: 18765153.
Mullen JT, Vauthey JN. Intrahepatic approaches to improve resectability. Curr Colorectal Rep 2:94-98, 2006. e-Pub 2006.
Vauthey JN. Commentary on: Breast cancer metastases in liver: Laser-induced interstitial thermotherapy--local tumor control rate and survival data [Radiology 233:400-409, 2004]. Breast Diseases: A Year Book® Quarterly 16(2):162-163, 2005. e-Pub 2005.
Parikh AA, Abdalla EK, Vauthey JN. Operative considerations in resection of hilar cholangiocarcinoma. HPB 7 (4):254-258, 2005. e-Pub 2005.
Abdalla EK, Aloia TA, Vauthey JN. Laparoscopy for diagnosis and staging hepatobiliary malignancies. Surg Pract 9:78-79, 2005. e-Pub 2005.
Vauthey JN. Evaluation de la masse hépatique fonctionnelle minimale en chirurgie hépatique. e-mémoires de l’Académie Nationale de Chirurgie 3(2):18-20, 2004. e-Pub 2004.
Vauthey JN. Prognostic factors for patients with hepatic metastases from breast cancer. Breast Diseases: A Year Book® Quarterly 15:51, 2004. e-Pub 2004.
Abdalla EK, Marsh RDW, Vauthey JN. Defining the role of hepatic arterial infusion chemotherapy in metastatic colorectal cancer. Oncology (Special Issue on Colorectal Cancer) 18(6):771-773, 2004. e-Pub 2004.
Pawlik TM, Tseng JF, Vauthey JN. Controversies in the Staging of Hepatocellular Carcinoma. Cancer Review Asia-Pacific Journal 1:179-189, 2003. e-Pub 2003.
Abdalla EK, Vauthey JN. Biliary Tract Cancer. Curr Op Gastroen 17:450-457 F.A.C.S. Page 18, 2001. e-Pub 2001.
Cormier J, Vauthey JN. Biliary Tract Cancer. Curr Op Gastroen 16:437-443, 2000. e-Pub 2000.
Ehrenfried JA, Vauthey JN. Biliary Tract Cancer. Curr Op Gastroen 15:430-435, 1999. e-Pub 1999.
Josephs MD, Vauthey JN. Biliary Tract Cancer. Curr Op Gastroen 14:402-407, 1998. e-Pub 1998.
Vauthey JN. Adjuvant therapy for adenocarcinoma of the rectum: which one andwhen – before or after? . Adv Gastroenterol Hepatol Clin Nutr 2(5):207-209, 1997. e-Pub 1997.
Espat NJ, Vauthey JN. Biliary Tract Cancer. Curr Op Gastroen 13:410–415, 1997. e-Pub 1997.
Cendan JC, Zlotecki RA, Vauthey JN. Biliary Tract Cancer. Curr Op Gastroen 12:460-465, 1996. e-Pub 1996.
Vauthey JN, Dudrick P. Biliary Tract Cancer. Curr Op Gastroen 11:445-451, 1995. e-Pub 1995.
Kawaguchi Y, Jain A, Chun YS, Jn V. ASO Perspective Editorial about issues raised in, "Using Artificial Intelligence to Find the Optimal Margin Width in Hepatectomy for Colorectal Cancer Liver Metastases. Ann Surg Oncol.

Review Articles

Haddad A, Lendoire M, Ito K, Ayabe RI, Maki H, Pietz JT, Stucky CH, Tzeng CD, Cao HST, Chun YS, Newhook TE, Hallet J, Vauthey JN. Ergonomic Considerations in Open Liver Surgery. J Gastrointest Surg:102241, 2025. e-Pub 2025. PMID: 41038338.
Kawaguchi Y, De Bellis M, Panettieri E, Duwe G, Vauthey JN. Debate: Improvements in Systemic Therapies for Liver Metastases Will Increase the Role of Locoregional Treatments. Hematol Oncol Clin North Am 39(1):207-220, 2025. e-Pub 2025. PMID: 39510674.
Panettieri E, Campisi A, De Rose AM, Mele C, Giuliante F, Vauthey JN, Ardito F. Emerging Prognostic Markers in Patients Undergoing Liver Resection for Hepatocellular Carcinoma: A Narrative Review. Cancers (Basel) 16(12), 2024. e-Pub 2024. PMID: 38927889.
Haddad A, Lendoire M, Maki H, Kang HC, Habibollahi P, Odisio BC, Huang SY, Vauthey JN. Liver volumetry and liver-regenerative interventions: history, rationale, and emerging tools. J Gastrointest Surg 28(5):766-775, 2024. e-Pub 2024. PMID: 38519362.
Barcena AJR, Owens TC, Melancon S, Workeneh I, Tran Cao HS, Vauthey JN, Huang SY. Current Perspectives and Progress in Preoperative Portal Vein Embolization with Stem Cell Augmentation (PVESA). Stem Cell Rev Rep. e-Pub 2024. PMID: 38613627.
Lendoire M, Maki H, Haddad A, Jain AJ, Vauthey JN. Liver Anatomy 2.0 Quiz: Test Your Knowledge. J Gastrointest Surg. e-Pub 2023. PMID: 37803180.
Maki H, Jain AJ, Haddad A, Lendoire M, Chun YS, Vauthey JN. Locoregional treatment for colorectal liver metastases aiming for precision medicine. Ann Gastroenterol Surg 7(4):543-552, 2023. e-Pub 2023. PMID: 37416742.
Maki H, Jain AJ, Haddad A, Lendoire M, Chun YS, Vauthey JN. Locoregional treatment for colorectal liver metastases aiming for precision medicine. Ann Gastroenterol Surg. e-Pub 2023.
Lendoire M, Maki H, Haddad A, Jain AJ, Vauthey JN. Biliary Anatomy 2.0 Quiz: Test Your Knowledge. J Gastrointest Surg. e-Pub 2023. PMID: 37081218.
Ayabe RI, Vauthey JN, Newhook TE. Optimizing the future liver remnant: Portal vein embolization, hepatic venous deprivation, and associating liver partition and portal vein ligation for staged hepatectomy. Surgery. e-Pub 2023. PMID: 37024339.
Vauthey JN. SSAT 2022 Presidential Address: 7 Things to Love About SSAT. J Gastrointest Surg:1-9. e-Pub 2023. PMID: 36604376.
Joliat GR, Kobayashi K, Hasegawa K, Thomson JE, Padbury R, Scott M, Brustia R, Scatton O, Tran Cao HS, Vauthey JN, Dincler S, Clavien PA, Wigmore SJ, Demartines N, Melloul E. Guidelines for perioperative care for liver surgery: enhanced recovery after surgery (ERAS) society recommendations 2022. World J Surg. e-Pub 2022. PMID: 36310325.
Margonis GA, Vauthey JN. Precision surgery for colorectal liver metastases: Current knowledge and future perspectives. Ann Gastroenterol Surg 6(5):606-615, 2022. e-Pub 2022. PMID: 36091304.
Newhook TE, Vauthey JN. Colorectal liver metastases: state-of-the-art management and surgical approaches. Langenbecks Arch Surg. e-Pub 2022. PMID: 35397680.
Sugawara K, Kawaguchi Y, Seto Y, Vauthey JN. Multidisciplinary treatment strategy for locally advanced gastric cancer: A systematic review. Surg Oncol 38:101599. e-Pub 2021. PMID: 33991939.
Nishioka Y, Kawaguchi Y, Kothari AN, Odisio BC, Vauthey JN. Prognostic and therapeutic implications of tumor biology, including gene aterations, in colorectal liver metastases. J Gastrointest Surg. e-Pub 2021. PMID: 33742360.
Kawaguchi Y, De Bellis M, Panettieri E, Duwe G, Vauthey JN. Debate: Improvements in systemic therapies for liver metastases will increase the role of locoregional treatments. Surg Oncol Clin N Am 30(1):205-218, 2021. e-Pub 2021. PMID: 33220806.
Kawaguchi Y, Lillemoe HA, Vauthey JN. Surgical Resection: Old Dog, Any New Tricks?. Clin Liver Dis 24(4):637-655, 2020. e-Pub 2020. PMID: 33012450.
Kishi Y, Vauthey JN. Issues to be considered to address the future liver remnant prior to major hepatectomy. Surg Today. e-Pub 2020. PMID: 32894345.
Tran Cao HS, Tzeng CW, Chun YS, Aloia TA, Vauthey JN. Surgical management of localized hepatocellular carcinoma in times of crisis: a strategic approach to resource utilization. J Hepatocell Carcinoma(7):155-158, 2020. e-Pub 2020.
Kawaguchi Y, Vauthey JN. The Landmark Series: Randomized Control Trials Examining Perioperative Chemotherapy and Postoperative Adjuvant Chemotherapy for Resectable Colorectal Liver Metastasis. Ann Surg Oncol. e-Pub 2020. PMID: 32803551.
Lillemoe HA, Vauthey JN. Surgical approach to synchronous colorectal liver metastases: staged, combined, or reverse strategy. Hepatobiliary Surg Nutr 9(1):25-34, 2020. e-Pub 2020. PMID: 32140476.
Vauthey JN, Kawaguchi Y. Innovation and future perspectives in the treatment of colorectal liver metastases. J Gastrointest Surg. e-Pub 2019. PMID: 31797258.
Kawaguchi Y, Lillemoe HA, Vauthey JN. Gene mutation and surgical technique: Suggestion or more?. Surg Oncol. e-Pub 2019. PMID: 31351766.
Lillemoe HA, Brudvik KW, Vauthey JN. Treatment Options for Metastatic Gastrointestinal Stromal Tumors to the Liver: A Review. Semin Liver Dis 39(3):395-402, 2019. e-Pub 2019. PMID: 31100757.
Kawaguchi Y, Lillemoe HA, Vauthey JN. Dealing with an insufficient future liver remnant: Portal vein embolization and two-stage hepatectomy. J Surg Oncol. e-Pub 2019. PMID: 30825223.
Kim BJ, Soliz JM, Aloia TA, Vauthey JN. What is the best pain control after major hepatopancreatobiliary surgery?. Adv Surg 52(1):235-246, 2018. e-Pub 2018. PMID: 30098615.
Yamashita S, Chun YS, Kopetz SE, Vauthey JN. Biomarkers in colorectal liver metastases. Br J Surg 105(6):618-627, 2018. e-Pub 2018. PMID: 29579319.
Cata JP, Ramirez MF, Velasquez JF, Di AI, Popat KU, Gottumukkala V, Black DM, Lewis VO, Vauthey JN. Lidocaine Stimulates the Function of Natural Killer Cells in Different Experimental Settings. Anticancer Res 37(9):4727-4732, 2017. e-Pub 2017. PMID: 28870891.
Egger ME, Gottumukkala V, Wilks JJ, Soliz J, Ilmer M, Vauthey JN, Conrad C. Anesthetic and operative considerations for laparoscopic liver resection. Surgery 161(5):1191-1202, 2017. e-Pub 2017. PMID: 27545995.
Koay EJ, Odisio BC, Javle M, Vauthey JN, Crane CH. Management of unresectable intrahepatic cholangiocarcinoma: how do we decide among the various liver-directed treatments?. Hepatobiliary Surg Nutr 6(2):105-116, 2017. e-Pub 2017. PMID: 28503558.
Torzilli G, Nagino M, Tzeng CD, Kingham TP, Alatise OI, Ayandipo OO, Yamashita S, Arrington AK, Kim J, Chun YS, Vauthey JN. SSAT State-of-the-Art Conference: New Frontiers in Liver Surgery. J Gastrointest Surg 21(1):175-185, 2017. e-Pub 2017. PMID: 27480411.
Passot G, Soubrane O, Giuliante F, Zimmitti G, Goéré D, Yamashita S, Vauthey JN. Recent advances in chemotherapy and surgery for colorectal liver metastases. Liver Cancer 6(1):72-79, 2016. e-Pub 2016. PMID: 27995091.
Melloul E, Hübner M, Scott M, Snowden C, Prentis J, Dejong CH, Garden OJ, Farges O, Kokudo N, Vauthey JN, Clavien PA, Demartines N. Perioperative care for liver surgery: enhanced recovery after surgery (ERAS) society recommendations. World J Surg. e-Pub 2016. PMID: 27549599.
Shindoh J, Chun YS, Loyer EM, Vauthey JN. Non-size-based response criteria to preoperative chemotherapy in patients with colorectal liver metastases: the morphologic response criteria. Curr Colorectal Cancer Rep 9(2):198-202, 2013. e-Pub 2013. PMID: 23710157.
Shindoh J, Kaseb A, Vauthey JN. Surgical strategy for liver cancers in the era of effective chemotherapy. Liver Cancer 2(1):47-54, 2013. e-Pub 2013. PMID: 24159596.
Brouquet A, Andreou A, Shindoh J, Vauthey JN. Methods to improve resectability of hepatocellular carcinoma. Recent Results Cancer Res 190:57-67, 2013. e-Pub 2013. PMID: 22941013.
Shindoh J, D Tzeng CW, Vauthey JN. Portal vein embolization for hepatocellular carcinoma. Liver Cancer 1(3):159-167, 2012. e-Pub 2012. PMID: 24159580.
Boonsirikamchai P, Asran MA, Maru DM, Vauthey JN, Kaur H, Kopetz S, Loyer EM. CT findings of response and recurrence, independent of change in tumor size, in colorectal liver metastasis treated with bevacizumab. AJR Am J Roentgenol 197(6):W1060-1066, 2011. e-Pub 2011. PMID: 22109320.
Brouquet A, Andreou A, Vauthey JN. The management of solitary colorectal liver metastases. Surgeon 9(5):265-272, 2011. e-Pub 2011. PMID: 21843821.
Lerut J, Mergental H, Kahn D, Albuquerque L, Marrero J, Vauthey JN, Porte RJ. Place of liver transplantation in the treatment of hepatocellular carcinoma in the normal liver. Liver Transpl 17 Suppl 2:S90-7, 2011. e-Pub 2011. PMID: 21796760.
Yang AD, Brouquet A, Vauthey JN. Extending limits of resection for metastatic colorectal cancer: risk benefit ratio. J Surg Oncol 102(8):996-1001, 2010. e-Pub 2010. PMID: 21166004.
Nordlinger B, Vauthey JN, Poston GJ, Kopetz SK, Rougier P VanCutsem EJD. The timing of chemotherapy and surgery for the treatment of colorectal liver metastases. Clin Colorectal Canc 9(4):212-218, 2010. e-Pub 2010.
Nordlinger B, Vauthey JN, Poston G, Benoist S, Rougier P, Van Cutsem E. The timing of chemotherapy and surgery for the treatment of colorectal liver metastases. Clin Colorectal Cancer 9(4):212-8, 2010. e-Pub 2010. PMID: 20920992.
Contreras CM, Vauthey JN. Staging systems: Is there a surgical staging and a medical one? A surgeon's perspective. J Hepatobiliary Pancreat Sci 17(4):438-9, 2010. e-Pub 2010. PMID: 19882373.
Truty MJ, Vauthey JN. Surgical resection of high-risk hepatocellular carcinoma: patient selection, preoperative considerations, and operative technique. Ann Surg Oncol 17(5):1219-25, 2010. e-Pub 2010. PMID: 20405326.
Truty MJ, Vauthey JN. Surgical resection of high-risk hepatocellular carcinoma: patient selection, preoperative considerations, and operative technique. Ann Surg Oncol 17(5):1219-1225, 2010. e-Pub 2010.
Truty MJ, Vauthey JN. Uses and limitations of portal vein embolization for improving perioperative outcomes in hepatocellular carcinoma. Semin Oncol 37(2):102-9, 2010. e-Pub 2010. PMID: 20494702.
Zalinski S, Bigourdan JM, Vauthey JN. [Does bevacizumab have a protective effect on hepatotoxicity induced by chemotherapy?]. J Chir (Paris) 147 Suppl 1:S18-24, 2010. e-Pub 2010. PMID: 20172201.
Chun YS, Laurent A, Maru D, Vauthey JN. Management of chemotherapy-associated hepatotoxicity in colorectal liver metastases. Lancet Oncol 10(3):278-286, 2009. e-Pub 2009. PMID: 19261256.
Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 26(18):3063-72, 2008. e-Pub 2008. PMID: 18565894.
Morris-Stiff G, Tan YM, Vauthey JN. Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases. Eur J Surg Oncol 34(6):609-14, 2008. e-Pub 2008. PMID: 17764887.
Ribero D, Chun YS, Vauthey JN. Standardized liver volumetry for portal vein embolization. Semin Intervent Radiol 25(2):104-109, 2008. e-Pub 2008. PMID: 21326551.
Chun YS, Vauthey JN. Risks of neoadjuvant chemotherapy for resectable colorectal carcinoma hepatic metastases. Current Colorectal Cancer Reports 4(2):87-92, 2008. e-Pub 2008.
Abdalla EK, Denys A, Hasegawa K, Leung TW, Makuuchi M, Murthy R, Ribero D, Zorzi D, Vauthey JN, Torzilli G. Treatment of large and advanced hepatocellular carcinoma. Ann Surg Oncol 15(4):979-985, 2008. e-Pub 2008. PMID: 18236115.
Abdalla EK, Vauthey JN. Chemotherapy prior to hepatic resection for colorectal liver metastases: helpful until harmful?. Dig Surg 25(6):421-9, 2008. e-Pub 2008. PMID: 19212114.
Chun YS, Vauthey JN. Extending the frontiers of resectability in advanced colorectal cancer. Eur J Surg Oncol 33 Suppl 2:S52-8, 2007. e-Pub 2007. PMID: 18006265.
Chun YS, Vauthey JN. Extending the frontiers of resectability in advanced colorectal cancer. Eur J Surg Oncol 33:S52-S58, 2007. e-Pub 2007.
Zorzi D, Laurent A, Pawlik TM, Lauwers GY, Vauthey JN, Abdalla EK. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastase. Br J Surg 94(3):274-286, 2007. e-Pub 2007.
Zorzi D, Laurent A, Pawlik TM, Lauwers GY, Vauthey JN, Abdalla EK. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 94(3):274-86, 2007. e-Pub 2007. PMID: 17315288.
Donadon M, Abdalla EK, Vauthey JN. Liver hanging maneuver for large or recurrent right upper quadrant tumors. J Am Coll Surg 204:329-33, 2007. e-Pub 2007. PMID: 17254939.
Donadon M, Ribero D, Morris-Stiff G, Abdalla EK, Vauthey JN. New paradigm in the management of liver only metastases from colorectal cancer. Gastrointest Ca Res 1:20-27, 2007. e-Pub 2007.
Madoff DC, Abdalla EK, Wallace MJ, Ng C, Ribero D, Vauthey JN. Portal vein embolization: A Preoperative approach to improve the safety of major hepatic resection. Current Medical Imaging Reviews 2(4):385-404, 2007. e-Pub 2007.
Ribero D, Abdalla EK, Thomas MB, Vauthey JN. Liver resection in the treatment of hepatocellular carcinoma. Expert Rev Anticancer Ther 6:567-79, 2006. e-Pub 2006. PMID: 16613544.
Vauthey JN, Zorzi D, Pawlik TM. Making unresectable hepatic colorectal metastases resectable--does it work?. Semin Oncol 32(6 Suppl 9):S118-22, 2005. e-Pub 2005. PMID: 16399448.
Madoff DC, Abdalla EK, Vauthey JN. Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care. J Vasc Interv Radiol 16(6):779-90, 2005. e-Pub 2005. PMID: 15947041.
Clavien PA, Emond J, Vauthey JN, Belghiti J, Chari RS, Strasberg SM. Protection of the liver during hepatic surgery. J Gastrointest Surg 8(3):313-27, 2004. e-Pub 2004. PMID: 15019929.
Pawlik TM, Scoggins CR, Thomas MB, Vauthey JN. Advances in the surgical management of liver malignancies. Cancer J 10(2):74-87, 2004. e-Pub 2004. PMID: 15130267.
Pawlik TM, Esnaola NF, Vauthey JN. Surgical treatment of hepatocellular carcinoma: similar long-term results despite geographic variations. Liver Transpl 10(2 Suppl 1):S74-80, 2004. e-Pub 2004. PMID: 14762844.
Curley SA, Izzo F, Abdalla E, Vauthey JN. Surgical treatment of colorectal cancer metastasis. Cancer Metastasis Rev 23(1-2):165-82, 2004. e-Pub 2004. PMID: 15000156.
Vauthey JN, Loyer E, Chokshi P, Lahoti S. Case 57: eosinophilic cholangiopathy. Radiology 227(1):107-12, 2003. e-Pub 2003. PMID: 12668742.
Singletary SE, Walsh G, Vauthey JN, Curley S, Sawaya R, Weber KL, Meric F, Hortobagyi GN. A role for curative surgery in the treatment of selected patients with metastatic breast cancer. Oncologist 8(3):241-51, 2003. e-Pub 2003. PMID: 12773746.
Denys A, Madoff DC, Doenz F, Schneider F, Gillet M, Vauthey JN, Chevallier P. Indications for and limitations of portal vein embolization before major hepatic resection for hepatobiliary malignancy. Surg Oncol Clin N Am 11(4):955-68, 2002. e-Pub 2002. PMID: 12607582.
Abdalla EK, Vauthey JN, Couinaud C. The caudate lobe of the liver: implications of embryology and anatomy for surgery. Surg Oncol Clin N Am 11(4):835-48, 2002. e-Pub 2002. PMID: 12607574.
Madoff DC, Hicks ME, Vauthey JN, Charnsangavej C, Morello FA, Jr, Ahrar K, Wallace MJ, Gupta S. Transhepatic portal vein embolization: anatomy, indications, and technical considerations. Radiographics 22(5):1063-76, 2002. e-Pub 2002. PMID: 12235336.
Vauthey JN, Rousseau DL, Jr. Liver imaging. A surgeon's perspective. Clin Liver Dis 6(1):271-95, 2002. e-Pub 2002. PMID: 11933593.
Crane CH, Wolff RA, Abbruzzese JL, Evans DB, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Lahoti S, Vauthey JN, Janjan NA. Combining gemcitabine with radiation in pancreatic cancer: understanding important variables influencing the therapeutic index. Semin Oncol 28(3 Suppl 10):25-33, 2001. e-Pub 2001. PMID: 11510031.
Pisters PW, Lee JE, Vauthey JN, Charnsangavej C, Evans DB. Laparoscopy in the staging of pancreatic cancer. Br J Surg 88(3):325-37, 2001. e-Pub 2001. PMID: 11260096.
Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: rationale, technique and future prospects. Br J Surg 88(2):165-75, 2001. e-Pub 2001. PMID: 11167863.
Freeman ME, Rose JL, Forsmark CE, Vauthey JN. Mirizzi Syndrome: A rare cause of obstructive jaundice. . Dig Dis 17(1):44-48, 1999. e-Pub 1999.
Lauwers GY, Vauthey JN. Pathological aspects of hepatocellular carcinoma: a critical review of prognostic factors. Hepatogastroenterology 45 Suppl 3:1197-202, 1998. e-Pub 1998. PMID: 9730374.
Lauwers GY, Scott GV, Vauthey JN. Adenocarcinoma of the upper esophagus arising in cervical ectopic gastric mucosa: rare evidence of malignant potential of so-called "inlet patch". Dig Dis Sci 43(4):901-7, 1998. e-Pub 1998. PMID: 9558051.
Vauthey JN. Liver imaging. A surgeon's perspective. Radiol Clin North Am 36(2):445-57, 1998. e-Pub 1998. PMID: 9520994.
Mendenhall WM, Zlotecki RA, Vauthey JN, Copeland EM, rd. Squamous cell carcinoma of the anal margin. Oncology (Williston Park) 10(12):1843-8; discussion 1848, 1853-4, 1996. e-Pub 1996. PMID: 8985968.
Vauthey JN, Marsh Rde W, Cendan JC, Chu NM, Copeland EM. Arterial therapy of hepatic colorectal metastases. Br J Surg 83(4):447-55, 1996. e-Pub 1996. PMID: 8665231.
Mendenhall WM, Zlotecki RA, Vauthey JN, Copeland EM, rd. Squamous cell carcinoma of the anal margin treated with radiotherapy. Surg Oncol 5(1):29-35, 1996. e-Pub 1996. PMID: 8837302.
Vauthey JN, Dudrick PS, Lind DS, Copeland EM, rd. Management of recurrent colorectal cancer: another look at carcinoembryonic antigen-detected recurrence. Dig Dis 14(1):5-13, 1996. e-Pub 1996. PMID: 8719729.
Vauthey JN, Blumgart LH. Recent advances in the management of cholangiocarcinomas. Semin Liver Dis 14(2):109-14, 1994. e-Pub 1994. PMID: 8047893.
Vauthey JN, Maddern GJ, Blumgart LH. Adult polycystic disease of the liver. Br J Surg 78(5):524-7, 1991. e-Pub 1991. PMID: 2059797.
Vauthey JN, Lerut J, Gertsch P. [The role of surgery in portal hypertension]. Schweiz Med Wochenschr 121(11):357-62, 1991. e-Pub 1991. PMID: 2028240.
Bolton JS, Vauthey JN, Sauter ER. Colorectal cancer: surgical management of recurrent and metastatic disease. J Natl Med Assoc 80(5):561-4, 1988. e-Pub 1988. PMID: 3047410.

Professional Educational Materials

Vauthey JN. RAS Mutations and Colorectal Cancer Liver Metastases. OncoLog, MD Anderson's Report to Physicians, 2017.
Vauthey JN. Simultaneous Resection of Liver and Lung Metastases from Colorectal Cancer Eliminates Need for Second Surgery. The University of Texas MD Anderson Cancer Center, OncoLog, 2015.
Vauthey JN. Two-Stage Resection and Improved Chemotherapy Regimens Lengthen Survival for Patients with Liver Metastases from Colorectal Cancer. The University of Texas MD Anderson Cancer Center, OncoLog, 2011.
Vauthey JN, Zorzi D. Improving Survival in Colorectal Cancer Through Optimal Management of Liver Metastases: A 63-Year-Old Woman With Colorectal Cancer and Metachronous Liver and Lung Metastasis, 2008.
Vauthey JN, Zorzi D. Liver Metastases in Colorectal Cancer: Improving survival through optimal management, 2008.
Vauthey JN. Treating Liver Metastases from Colorectal Cancer: A Multidiscliplinary Approach. Ashville Veterans Administration Medical Center, Continuing Medical Education, 2006.
Vauthey JN. Treating Liver Metastases from Colorectal Cancer: A Multidiscliplinary Approach. Los Angeles-University Southern California Medical Center, Continuing Medical Education, 2006.
Vauthey JN. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. Editor's Journal Review, Schwartz Online, 2006.
Vauthey JN. Avoiding complications from preoperative chemotherapy. The University of Texas M. D Anderson Cancer Center, OncoLog, 2006.
Vauthey JN. Online CME activity, Highlights of the AHPBA 2006 Consensus Conference on Hepatic Colorectal Metastases. Medscape, 2006.
Vauthey JN. Emerging Trends in the Management of Colorectal Cancer. Health Science Center for Continuing Medical Education, Stanford University School of Medicine, 2006.
Vauthey JN. What you need to know about liver cancer. The University of Texas M. D. Anderson Cancer Center CancerWise publication, 2003.
Vauthey JN. SSAT Patient Care Guidelines for hepatic colorectal metastases, 2003.
Vauthey JN. New AJCC Staging System for Hepatocellular Carcinoma Reflects Patient Prognosis After Surgical Resection. The University of Texas M. D Anderson Cancer Center, OncoLog, 2002.
Vauthey JN. Portal Vein Embolization Offers More Patients an Opportunity for Potentially Curative Hepatic Resection. The University of Texas M. D Anderson Cancer Center, OncoLog, 2002.
Vauthey JN. Liver Tumor Study Group. The University of Texas M. D. Anderson Cancer Center Website, 2000.
Vauthey JN, Brown TD, Patt YZ, Lozano RD. Liver Cancer Questions & Answers. The University of Texas M.D. Anderson Cancer Center, 2000.

Editorials

Acidi B, Vauthey JN, Tran Cao HS. Transplantation for colorectal liver metastases: lessons from TransMet and future challenges. Hepatobiliary Surg Nutr 14(2):271-274, 2025. PMID: 40342761.
Haddad A, Odisio BC, Vauthey JN. Should patients with colorectal liver metastases undergo ablation?. J Am Coll Surg. PMID: 38690836.
Haddad A, Vauthey JN, Newhook TE. A caution against KRAS-guided margin width during hepatectomy for colorectal liver metastases. Surgery. PMID: 38632003.
Jain AJ, Lendoire M, Boyev A, Newhook TE, Tzeng CD, Cao HST, Coronel E, Lee SS, Hu ZI, Javle M, Lee JH, Vauthey JN, Chun YS. ASO Visual Abstract: Revisiting the malignant masquerade at the liver hilum-have we made progress?. Ann Surg Oncol. PMID: 38383662.
Tran CG, Goffredo P, Mott SL, Suraju MO, Kohn JF, Mishra A, Vauthey JN, Hassan I. ASO Visual Abstract: Conditional Survival After Diagnosis of Non-metastatic Colon Cancer: Impact of Laterality, MSI, and KRAS Status. Ann Surg Oncol. PMID: 37978111.
Maki H, Ayabe RI, Nishioka Y, Konishi T, Newhook TE, Tran Cao HS, Chun YS, Tzeng CD, You YN, Vauthey JN. ASO Author Reflections: The Patient First Approach for Synchronous Liver Metastases from Rectal Cancer. Ann Surg Oncol. PMID: 37322282.
Concors S, Haddad A, Vauthey JN. Modeling the prediction of early treatment failure after hepatectomy for colorectal liver metastases. Ann Surg Oncol. PMID: 36952148.
Kawaguchi Y, Jain AJ, Chun YS, Vauthey JN. Artificial intelligence or tumor biology to predict survival after resection of colorectal liver metastases?. Ann Surg Oncol. PMID: 36809607.
Maki H, Jain AJ, Vauthey JN. Can the matrix help treat recurrent hepatocellular carcinoma?. JAMA Surg 158(2):202-203, 2023. PMID: 36576810.
Ayabe R, Vauthey JN, Tran Cao HS. High volume transplant experience is beneficial but not mandatory for the performance of complex liver resections. Hepatobiliary Surg Nutr 11(6):879-881, 2022. PMID: 36523942.
Nelson DW, Vauthey JN. Optimizing treatment strategies with preoperative assessment for microvascular invasion in hepatocellular carcinoma. Ann Surg Oncol. PMID: 36310312.
Kawaguchi Y, Newhook TE, Fuks D, Cao HST, Tzeng CD, Chun YS, Aloia TA, Gayet B, Vauthey JN. Comment on "Stratification of Major Hepatectomies According to Their Outcome Analysis of 2212 Consecutive Open Resections in Patients Without Cirrhosis". Ann Surg. PMID: 33914451.
Vega EA, Newhook TE, Vauthey JN. ASO Author Reflections: Gallbladder Cancer Research, "One for All and All for One" Strategy to Improve Research. Ann Surg Oncol. PMID: 33718976.
Kawaguchi Y, Newhook TE, Vauthey JN. Comment on "Extended Molecular Profiling Improves Stratification and Prediction of Survival After Resection of Colorectal Liver Metastases". Ann Surg. PMID: 33201092.
Allard MA, Kitano Y, Imai K, Baba H, Vauthey JN, Adam R. Comments on: "ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO" Survival Benefit of ALPPS versus TSH: a Proof of Concept or a Concept to be Proved?. Ann Surg. PMID: 33214433.
Newhook TE, Chun YS, Vauthey JN. An odyssey into the land of deleterious rare mutations in colorectal liver metastases. Ann Surg Oncol 27(9):3115-3117, 2020. PMID: 32651694.
Day RW, Newhook TE, m Dewhurst WL, Arvide EM, Bruno ML, Vauthey JN, Tzeng CWD. The 5x-Multiplier: A Simple Calculation to Reduce Discharge Opioid Prescription Volumes after Inpatient Surgery. JAMA Surg 155(12):1166-1167, 2020.
De Bellis M, Mehran RJ, Vauthey JN. ASO Author Reflections: Transdiaphragmatic Approach for Simultaneous Resection of Colorectal Liver and Lung Metastases. Ann Surg Oncol. PMID: 32712888.
Kawaguchi Y, Vauthey JN. ASO Author Reflections: The Landmark Series: Randomized control trials examining perioperative chemotherapy and postoperative adjuvant chemotherapy for resectable colorectal liver metastasis. Ann Surg Oncol. PMID: 32642998.
Vauthey JN. Commentary: Liver venous deprivation: Optimizing liver regeneration with combined inflow and outflow venous occlusion of the liver. Surgery 167(6):924-925, 2020. PMID: 32127179.
Vauthey JN. Commentary: Liver venous deprivation: Optimizing liver regeneration with combined inflow and outflow venous occlusion of the liver. Surgery 167(6):924-925, 2020.
Kawaguchi Y, Tzeng CD, Hasegawa K, Kokudo N, Vauthey JN. Author response to: Comment on: Performance of a modified three-level classification in stratifying open liver resection procedures in terms of complexity and postoperative morbidity. Br J Surg 107(4):469, 2020. PMID: 32129492.
Tran Cao HS, Vauthey JN. Repeat hepatectomy for recurrent colorectal cancer liver metastases after two-stage hepatectomy-limitations and opportunities. Hepatobiliary Surg Nutr 9(1):65-66, 2020. PMID: 32140480.
Tran Cao HS, Vauthey JN. Portal vein embolization for perihilar cholangiocarcinoma: A story worth repeating. Ann Surg Oncol. PMID: 32112210.
Tran Cao HS, Vauthey JN. ASO Author Reflections: Role of preoperative chemotherapy in the treatment of pancreatic neuroendocrine liver metastases. Ann Surg Oncol. PMID: 30334195.
Simoneau E, Vauthey JN. Progression of colorectal cancer liver metastasis after chemotherapy: a new test of time?. Ann Surg Oncol 25(6):1469-1470, 2018. PMID: 29556843.
Chun YS, Pawlik TM, Vauthey JN. Hepatobiliary information in the 8th TNM edition. Ann Surg Oncol 25(4):845-847, 2018.
Tzeng CD, Vauthey JN. Evaluation of New Classifications for Liver Surgery: Can Anatomic Granularity Predict Both Complexity and Outcomes of Hepatic Resection?. Ann Surg 267(1):24-25, 2018. PMID: 28746155.
Tzeng CD, Vauthey JN. Evaluation of new classifications for liver surgery: can anatomic granularity predict both complexity and outcomes of hepatic resection?. Ann Surg 267(1):24-25, 2018.
Chun YS, Vauthey JN. Local therapy for colorectal liver metastases: establishing today's level of evidence and defining tomorrow's roadmap. J Natl Cancer Inst 109(9):doi: 10.1093/jnci/djx018, 2017. PMID: 28376150.
Vauthey JN, Mizuno T, Overman MJ, Soubrane O. Can we navigate chemotherapy-induced hepatic injuries from pathology to bedside?. J Hepatol. PMID: 28476639.
Vauthey JN, Mizuno T. Portal vein embolization: tailoring, optimizing, and quantifying an invaluable procedure in hepatic surgery. Ann Surg Oncol. PMID: 28176025.
Vauthey JN, Yamashita S. Perfecting a challenging procedure: the Nagoya portal vein guide to left trisectionectomy. Surgery 161(2):355-356, 2017. PMID: 27592214.
Torzilli G, Vauthey JN, Belghiti J, Makuuchi M, Donadon M, Viganò L, Kokudo N. EWALT: East Meets West in a Multidisciplinary Setting to Improve the Management of Liver Tumors. Liver Cancer 6(1):13-15, 2016. PMID: 27995083.
Torres HA, Vauthey JN, Economides MP, Mahale P, Kaseb A. Hepatocellular carcinoma recurrence after treatment with direct-acting antivirals: First, do no harm by withdrawing treatment. J Hepatol 65(4):862-864, 2016.
Vauthey JN, Kopetz SE. From multidisciplinary to personalized treatment of colorectal liver metastases: 4 reasons to consider RAS. Cancer 119(23):4083-4085, 2013. PMID: 24105015.
Conrad C, Vauthey JN. When does invasion mean the war is lost?. Ann Surg Oncol 20(12):3709-11, 2013. PMID: 23838907.
Conrad C, You N, Vauthey JN. In patients with colorectal liver metastases, can we still rely on number to define treatment and outcome?. Oncology (Williston Park) 27(11):1078, 2013. PMID: 24575535.
Tzeng CW, Vauthey JN. Postoperative complications and oncologic outcomes after resection of colorectal liver metastases: the importance of staying on track. Ann Surg Oncol 20(8):2457-2459, 2013. PMID: 23579874.
Schwarz RE, Abdalla EK, Aloia TA, Vauthey JN. Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. HPB (Oxford) 26(33):5344-5351, 2013. PMID: 23297718.
Vauthey JN, Zimmitti G, Shindoh J. From Couinaud to molecular biology: the seven virtues of hepato-pancreato-biliary surgery. HPB (Oxford) 14(8):493-9, 2012. PMID: 22762396.
Vauthey JN, Zimmitti G, Shindo J. From Couinaud to Molecular Biology: The Seven Virtues of HPB Surgery. HPB(14):493-499, 2012.
Vauthey JN, Abbott DE. Commentary on "Feasibility Study of two-stage hepatectomy for bilobar liver metastases". Am J Surg 203(6):698-699, 2012. PMID: 22326822.
Aloia TA, Vauthey JN. Management of colorectal liver metastases: past, present, and future. Updates Surg 63(1):1-3, 2011. PMID: 21331669.
Vauthey JN, Nordlinger B, Kopetz S, Poston G. Sequenced chemotherapy and surgery for potentially resectable colorectal liver metastases: a debate over goals of research and an approach while the jury remains out. Ann Surg Oncol 17(8):1983-6, 2010. PMID: 20232164.
Truty MJ, Vauthey JN. Uses and limitations of portal vein embolization for improving perioperative outcomes in hepatocellular carcinoma. Sem Oncol 37(2):102-109, 2010.
Vauthey JN, Nordlinger B, Kopetz S, Poston G. Sequenced chemotherapy and surgery for potentially resectable colorectal liver metastases: a debate over goals of research and an approach while the jury remains out. Ann Surg Oncol 17(8):1983-1986, 2010.
Vauthey JN, Zorzi D. In search of the Black Sheep: Is it bevacizumab or extended chemotherapy?. Ann Surg Oncol 16(6):1463-1464, 2009. PMID: 19357926.
Vauthey JN, Zorzi D. The patient behind the code, the care behind the patient. Cancer 115(4):702-703, 2009. PMID: 19127555.
Vauthey JN, Belghiti J, Makuuchi M. Proceedings of The Fifth International Meeting, Hepatocellular Carcinoma: Eastern and Western Experiences. Overview of the Conference. Ann Surg Oncol 15(4):961, 2008. PMID: 18236116.
Kopetz S, Vauthey JN. Perioperative chemotherapy for resectable hepatic metastases. Lancet 371(9617):963-5, 2008. PMID: 18358910.
Pawlik TM, Vauthey JN. Surgical margins during hepatic surgery for colorectal liver metastases: complete resection not milimeters defines outcome. Ann Surg Oncol 15(3):677-679, 2008. PMID: 18165882.
Vauthey JN. Colorectal liver metastases: treat effectively upfront and consider the borderline resectable. J Clin Oncol 25(29):4524-4525, 2007.
Vauthey JN. Colorectal liver metastases: treat effectively up front and consider the borderline resectable. J Clin Oncol 25(29):4524-5, 2007. PMID: 17925547.
Vauthey JN. Commentary on: Is Liver Resection Justified for Patients With Hepatic Metastases from Breast Cancer?[Ann Surg 244:897-908, 2007]. Breast Diseases: A Year Book Quarterly 18(3):275-276, 2007.
Abdalla EK, Vauthey JN. Colorectal metastases: resect or ablate?. Ann Surg Oncol 13(5):602-3, 2006. PMID: 16538407.
Vauthey JN, Donadon M. Commentary on: Hepatic resection for metastatic breast cancer: Prognostic analysis of 34 patients. Breast Diseases A Year Book Quarterly 17(1):72, 2006.
Vauthey JN, Poston G, Adam R. Comments and Controversies: Downstaging or downsizing: Time for a new staging system in advanced colorectal cancer. J Clin Oncol (24)18:2702-2706, 2006.
Vauthey JN, Abdalla EK. Unresectable hepatic colorectal metastases: need for new surgical strategies. Ann Surg Oncol 13(1):5-6, 2006. PMID: 16372151.
Vauthey JN, Lauwers GY. Surgically resected hepatocellular carcinoma: protean yet predictable. Ann Surg Oncol 12(4):270-2, 2005. PMID: 15827674.
Vauthey JN, Abdalla EK. Gallbladder Carcinoma and cholangiocarcinoma: different diseases – different treatments. Commentary. Ann Surg Oncol, Am J Oncol Rev 12(4), 4(10):289-97, 642-644, 2005.
Vauthey JN, Donadon M. Commentary on: Hepatic resection for metastatic breast cancer: Prognostic analysis of 34 patients. World J Surg 29:524-527, 2005.
Vauthey JN, Abdalla EK. Focus on treatment of large hepatocellular carcinoma. Invited Editorial Ann Surg Oncol 11(12):1061-9, 1035-1036, 2004.
Abdalla EK, Vauthey JN. Focus on treatment of large hepatocellular carcinoma. Ann Surg Oncol 11(12):1035-6, 2004. PMID: 15576831.
Abdalla EK, Vauthey JN. Technique and patient selection, not the needle, determine outcome of percutaneous intervention for hepatocellular carcinoma. Ann Surg Oncol 11(3):240-1, 2004. PMID: 14993016.
Vauthey JN, Abdalla EK, Marsh RDW. Defining the role of hepatic arterial infusion chemotherapy in metastatic colorectal cancer. Oncology (Special Issue on Colorectal Cancer) 18(6):771-773, 2004.
Vauthey JN, Ajani JA. Liver transplantation and hepatocellular carcinoma biology: beginning of the end of the era of educated guesses. J Clin Oncol 21(23):4265-7, 2003. PMID: 14581443.
Yao JC, Vauthey JN. Primary and metastatic hepatic carcinoid: is there an algorithm?. Ann Surg Oncol 10(10):1133-5, 2003. PMID: 14654466.
Vauthey JN, Lauwers GY. Prognostic factors after resection of hepatocellular carcinoma: are there landmarks in the wild forest?. J Hepatol 38(2):237-9, 2003. PMID: 12547414.
Vauthey JN, Wolff RA. Resection of liver metastases: state of the art. Oncology, Commentary Oncology 16(9):1240-1256, 1258-1260, 2002.
Vauthey JN. Hepatic colorectal metastases and extrahepatic disease. J Surg Oncol 76(4):243-4, 2001. PMID: 11320514.
Vauthey JN, Marsh RW, Davis GL. Treatment of unresectable hepatocellular carcinoma. N Engl J Med 333(13):877; author reply 878, 1995. PMID: 7651489.

Abstracts

Jain AJ, Lendoire M, Boyev A, Newhook TE, Tzeng CD, Tran Cao HS, Coronel E, Lee SS, Hu ZI, Javle M, Lee JH, Vauthey JN, Chun YS. Revisiting the malignant masquerade at the Liver Hilum: Have we made progress?. Ann Surg Oncol. e-Pub 2024. PMID: 38282027.
Mason MC, Krasnodebski M, Hester CA, Kothari AN, Barker C, Nishioka Y, Chiang YJ, Newhook TE, Tzeng CD, Chun YS, Vauthey JN, Tran Cao HS. ASO visual abstract: outcomes of mixed pathologic response in patients with multiple colorectal liver metastases treated with neoadjuvant chemotherapy and liver resection. Ann Surg Oncol. e-Pub 2022. PMID: 35435560.
Vega EA, Newhook TE, Ruzzenente A, Okuno M, De Bellis M, Panettieri E, De Rose AM, Uemoto S, Chun YS, Tran Cao HS, Tzeng CWD, de Aretxabala X, Seo S, Giuliante F, Guglielmi A, Vinuela E, Vauthey JN. Benchmark analysis: multi-institutional cooperative cohort for gallbladder cancer surgery. SSAT Abstract -Plenary Session: Hepatobiliary & Pancreas II, 2022. e-Pub 2022.
DiPeri TP, Newhook TE, Tran Cao HS, Ikoma N Dewhurst WL, Arvide EM, Bruno ML, Katz MHG, Vauthey JN, Lee JE, Tzeng CWD. Quickshot Presentation: Post-hepatectomy liver failure and chronic kidney disease: time to retire the African American GFR corrector?. 17th Annual Academic Surgical Congress, 2022. e-Pub 2022.
DiPeri TP, Newhook TE, Tran Cao HS, Ikoma N Dewhurst WL, Arvide EM, Bruno ML, Katz MHG, Vauthey JN, Lee JE, Tzeng CWD. Oral Presentation:Opioid discharge prescriptions after inpatient surgery: risks of rebound refills by length of stay. 17th Annual Academic Surgical Congress:ASC20220865, 2022. e-Pub 2022.
Martin AN, Bradford BJ, Newhook TE, Arvide EM, Dewhurst WL, Kawaguchi Y, Tran Cao HS, Chun YS, Katz MHG, Vauthey JN, Tzeng CWD. Individual Components of Post-Hepatectomy Care Pathways Have Differential Impacts on Length of Stay. IHPBA 2022 – ePoster Presentation acceptance (EP01C-043), 2021. e-Pub 2021.
Day RW, Newhook TE, Dewhurst M, Arvide M, Bruno M, Kim MP, Tran Cao HS, Ikoma N, Chun YS, Aloia TA, Katz MH, Lee JE, Vauthey JN, Tzeng CW. Patient-specific opioid volume calculations reduce discharge prescriptions after hepato-pancreato-biliary surgery. AHPBA - Presidemtal Plenary Presentation - March 6, 2020, 2019. e-Pub 2019.
Newhook TE, Griffin JF, Slack RS, Tj V, Prakash L, Ikoma N, Kim MP, Vauthey JN, Lee JE, Katz MHG, Tzeng CD. Both CA19-9 response trajectory and normalization during neoadjuvant therapy are associated with post-resection prognosis in pancreatic adenocarcinoma patients. AHPBA - Mini Oral Presentation - March 6, 2020, 2019. e-Pub 2019.
Newhook T, Griffin JF, Prakash LR, Bruno M, Dewhurst WL, Ikoma N, Kim J, Vauthey JN, Lee JE, Katz JH, Tzeng CW. Neoadjuvant treatment mitigates the survival impact of major complications after resection of pancreatic adenocarcinoma. AHPBA, 2020, 2019. e-Pub 2019.
Lillemoe HA, Newhook TE, Aloia TA, Grubbs EG, Chang GJ, Katz MHG, Vauthey JN, Lee JE, Tzeng CWD. Perceptions of Opioid Use and Prescribing Habits in Oncologic Surgery: A Survey of the Society of Surgical Oncology Membership. SSO 2020, 2019. e-Pub 2019.
Kim BJ, Gaskill C, Newhook TE, Arvide E, Dewhurst WL, Tran Cao HS, Chun YS, Aloia TA, Vauthey JN, Tzeng CD. Utilization of the Kawaguchi-Gayet Complexity Classification to Stratify Hepatectomy Patients for Distinct Enhanced Recovery Pathways Based on Anticipated Length of Stay. AHPBA 2020, 2019. e-Pub 2019.
Newhook TE, Vreeland TJ, Dewhurst WL, Arvide M, Bruno ML, Robinson KA, Rajkot N, Lillemoe HA, Grubbs EG, Aloia TA, Katz MHG, Vauthey JN, Lee JE, Tzeng CWD. Opioid prescribing practices following major oncologic surgery: a single-center experience. 2019 ACS Quality and Safety Conference, 2019. e-Pub 2019.
Vreeland TJ, Simoneau E, Westin S, Mehran R, Dewhurst WH, Chun YS, Aloia TA, Vauthey JN, Tzeng CW. Right posterior sectionectomy and En Bloc diaphragm resection with intraoperative air leak test. Ann Surg Oncol (Video), 2019. e-Pub 2019.
Vega EA, Velasco J, Lin E, Gupta S, Vauthey JN, Odisio B. Fast-track two-stage hepatectomy using a hybrid IR/OR suite: a safe and effective alternative to ALPPS procedure. Abstract ID CIRSE 2019 - Barcelona, 2019. e-Pub 2019.
Simoneau E, Goumard C, Lee JE, Vauthey JN, Aloia TA, Chun YS, Conrad C, Kim MP, Katz M, Tzeng CW. Pancreaticoduodenectomy with mesocaval shunt for locally advanced pancreatic adenocarcinoma. Ann Surg Oncol (Video-Manuscript) 26(2):652, 2019. e-Pub 2019.
Lee AJ, Chiang Y, Conrad C, Chun YS, Lee J, Aloia T, Vauthey JN, Tzeng CWD. National trends and predictors of adequate nodal sampling for resectable gallbladder adenocarcinoma. J Surg Res; Abstract ASC20181128, 2017. e-Pub 2017.
Yamashita S, Omichi K, Conrad C, Chun YS, Aloia TA, Vauthey JN, Tzeng CWD. Portal vein embolization reduces postoperative hepatic insufficiency associated with hepatic atrophy caused by extensive chemotherapy. SSAT Plenary Session: HPB (I) DDW 2017 Abstract # 2684240, 2017. e-Pub 2017.
Patel S, Kim B, Tzeng CW, Chun YS, Conrad C, Vauthey JN, Aloia TA. Reduction of cardiopulmonary-renal complications with serum brain natriuretic peptide-guided volume status management in post hepatectomy patients. HPB 19((S1)):S3-S39, 2017. e-Pub 2017.
Passot G, Aloia TA, Zorzi D, Conrad C, Brudvik K, Vauthey JN. Predictors of safety and efficacy of two stage hepatectomy for bilateral colorectal liver metastases. J Am Coll Surg, 2015. e-Pub 2015.
Ribero D, Zimmitti G, Aloia TA, Shindoh J, Fabio F, Amisano M, Passot G, Ferrero A, Vauthey JN. Preoperative cholangitis and liver remnant volume determine the risk liver failure in patients undergoing resection for hilar cholangiocarcinoma, 2015. e-Pub 2015.
Vauthey JN, Zimmitti G, Shindoh J, Chen SS, Kopetz S, Andreou A, Curley SA, Aloia TA, Maru DM. RAS mutational status predicts patterns of recurrence and survival in patients undergoing hepatectomy for colorectal liver metastases, 2013. e-Pub 2013.
Aloia TA, Shindoh J, Abdalla EK, Huang S, Wallace M, Curley SA, Vauthey JN. The optimal surgical strategy for patients with extensive liver malignancy and very low future liver remnant volumne: ALPPS Vs. Percutaneous portal vein embolization and single-stage surgery. Podium Presentation -2012 Annual meeting of the WSA in Colorado Springs, Colorado, November 3-6, 2012, 2012. e-Pub 2012.
Vauthey JN, Andreou A, Maur DM, Chen S, Abdalla EK, Curley SA, Garrett C, Overman M, Aloia TA, Kopetz S. Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases. Ann Surg, 2012. e-Pub 2012.
Tzeng CD, Fleming JB, Lee JE, Wang X, Pisters PW, Vauthey JN, Varadhachard G, Wolff RA, Crane CH, Katz MH. Yield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodality therapy. HPB 14(S1):82-83, 2012. e-Pub 2012.
Tzeng CD, Katz MH, Flemnig JB, Pisters PW, Lee JE, Abdalla EK, Curley SA, Vauthey JN, Aloia TA. Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5,651 NSQIP patients. HPB 14(S1):82, 2012. e-Pub 2012.
Haque W, Das P, Javle M, Kaseb A, Curley SA, Vauthey JN, Abdalla EK, Delclos ME, Krishnan S, Crane CH. Radiation therapy for intrahepatic cholangiocardinoma. Gastrointest Cancer Res(S1):S34, 2011. e-Pub 2011.
Yang AD, Katz MH, Lin H, Chopin-Laly X, Abdalla EK, Vauthey JN, Pisters PW, Varadhachary GR, Wolff RA, Crane CH, Lee JE, Fleming JB. Preoperative therapy improves lymph node ratio in pancreatic adenocarcinoma. Ann Surg Oncol 18(S1):S74, 2011. e-Pub 2011.
Landry CS, Lin HY, Phan A, Charnangavej C, Abdalla EK, Vauthey JN, Yao JC, Fleming JB. Resection of at-risk mesenteric lymph nodes improved the outcome of patients with small bowel neuroendocrine tumors. Ann Surg Oncol 18(S1):S133, 2011. e-Pub 2011.
Abbott D, Brouquet A, Meric-Bernstam F, Valero V, Green MC, Kuerer HM, Curley SA, Abdalla EK, Hunt KK, Vauthey JN. Resection of liver metastases from breast cancer: timing of surgery and estrogen receptor status define outcome. Ann Surg Oncol 18(S1):S80, 2011. e-Pub 2011.
Aloia TA, Hill JS, Abdalla EK, Madoff DC, Curley SA, Vauthey JN. Careful selection of HCC patients for liver resection after TACE adn PVE maximizes long-term survivals in both operative and non-operative groups. 7th Annual Meeting HCC Eastern & Western Experience, 2011. e-Pub 2011.
Brouquet A, Vauthey JN, Andreou A, Curley SA, Abdalla EK. Repeat hepatectomy for recurrent colorectal liver metastases is associated with high survival rate. HPB 13(S1):7, 2011. e-Pub 2011.
Hassabo HM, Kaseb AO, Shama MA, Vauthey JN, Lozano RD, Curley SA, Li D, Hassan M. Association between prior history of cholecystectomy and hepatocellular carcinoma (HCC) development: A case-control study in the United States. J Clin Oncol 28(No 15_Suppl (May 20 Supplement)):Abstract e14643, 2010. e-Pub 2010.
Glazer ES, Ellis VG, Abdalla EK, Vauthey JN, Curley SA. Neoadjuvant and adjuvant therapy does not improve survival in resected biliary cancers. Ann Surg Oncol 17(S1):S89, 2010. e-Pub 2010.
Zalinski S, Chun YS, Abdalla EK, Curley SA, Vauthey JN. Outcomes of hepatic resection for metaboloc disorders related to hepatocellular carcinoma. HPB 11(S1):91, 2009. e-Pub 2009.
Chun YS, Abdalla EK, Zorzi D, Breaux JA, Vauthey JN. Liver hanging maneuver improves the outcomes of complex right upper quadrant resections. HPB 11(S1):76, 2009. e-Pub 2009.
Zorzi D, Kishi Y, Maru DM, Wang H, Robert D, Motta E, Ravarino N, Risio M, Curley SA, Abdalla EK, Capussotti L, Vauthey JN. Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases. Ann Surg Oncol 16(S1):20, 2009. e-Pub 2009.
Chun YS, Kopetz S, Palavecino M, Zorzi D, Curley SA, Abdalla EK, Vauthey JN. Proposed of new staging in advanced colorectal cancer. Ann Surg Oncol 16(S1):28, 2009. e-Pub 2009.
Palitano P, Pathak P, Hoff PM, Charnsangavej C, Overman MJ, Loyer E, Vauthey JN, Wallace MJ, Wolff RA, Kopetz. The use of 5-fluorouracil and oxaliplatin (FOLFOX) for colorectal cancer is associated witht he development of splenomegaly and thrombocytopenia. 2008 ASCO Annual Meeting Proceedings 26(15S):203s, 2008. e-Pub 2008.
Kishi Y, Blazer DG, Zorzi D, Mammen JM, Palavecino E, Chun YS, Curley S, Abdalla EK, Vauthey JN. Preoperative predictors of outcome after heptic resection of colorectal metastases in patients treated with preoperative chemotherapy. HPB 10(S2):47, 2008. e-Pub 2008.
Katz MH, Yao J, Anaya D, Curley S, Abdalla EK, Vauthey JN. Multi-modality therapy of heptic neuroendocrine metastases. HPB 10(S2):76, 2008. e-Pub 2008.
Palavecino M, Mammen JMV, Chun YS, Zorzi D, Kishi Y, Wei SH, Hassan MM, Thomas MB, Curley SA, Abdalla EK, Vauthey JN. Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survival. HPB 10(S2):49, 2008. e-Pub 2008.
Abdalla EK, Wilborn K, Vauthey JN, Evans DB, Ellis LM, Yao JC, Curley SA. Feasibility of synchronous resection of primary and metastatic carcinoid tumors. Ann Surg Oncol 15(S2):51, 2008. e-Pub 2008.
Nathan HJ, Aloia TA, Vauthey JN, Abdalla, EK, Zorzi D, Schulick RD, Choti MA, Pawlik TM. A simplified staging system for intrahepatic cholangiocarcioma. Ann Surg Oncol 15(S2):54, 2008. e-Pub 2008.
Katz MH, Fleming JB, Hwang RF, Sun CC, Wolff RA, Vauthey JN, Abdalla EK, Lee JE, Pisters PW. Long term survival after multidiscliplinary management of resectable pancreatic adenocarcinoma. Ann Surg Oncol 15(S2):6, 2008. e-Pub 2008.
Mortenson MM, Curley SA, VautheyJN, Beaty K, Abdalla EK. Resection of hepatic metastases before the colorectal primary: an alternate treatment strategy for synchronous disease. Ann Surg Oncol 15(S2):55, 2008. e-Pub 2008.
Zorzi D, Chun JY, Madoff DC, Abdalla EK, Vauthey JN. Chemotherapy with bevacizumab does not affect liver regeneration after portal vein embolization in the treatment of colorectal liver metastases. Ann Surg Oncol 15(S2):22, 2008. e-Pub 2008.
Chun YS, Ribero D, Abdalla EK, Madoff DC, Mortenson MM, Vauthey JN. Comparison of two methods of future liver remnant volume measurement. Presented at the American Hepato-Pancreato-Biliary Association, Las Vegas, Published in HPB 9 Suppl 1:108-9, 2007. e-Pub 2007.
Camacho LH, Madoff DC, Beringer M Bedikian AY, Valero V, Hong D, Patterson M, Vauthey JN, Moulder S, Kurzrock R. Phase I dose escalation trial of transarterial hepatic cisplatin and intravenous liposomal doxorubicin (LD) for patients with advanced solid malignancies involving the liver. Second Int’l symposium on Regional Cancer Therapies (#935), University of Pittsburgh School of Medicine, Pittsburgh, PA, 2007. e-Pub 2007.
Pawlik T M, Bauer TW, Reddy SK, Martin RC, Scoggins CR, Tanabe KK, Kooby DA, Vauthey JN, Curley SA, Choti MA. Hepatic resection for metastatic squamous cell carcinoma to the liver: a multi-center analysis. Accept for either Oral or Poster 287125. The Society of Surgical Oncology, 2007. e-Pub 2007.
Kesmodel SB, Ellis LM, Lin E, Chang G, Abdalla EK, Kopetz ES, Vauthey JN, Rodriguez-Bigas MA, Curley SA, Feig BW. Preoperative bevacizumab does not increase postoperative complications in patients undergoing hepatic surgery for colorectal cancer liver metastases. Ann Surg Oncol 14(2)A52:17-18, 2007. e-Pub 2007.
Vauthey JN, Ribero D, Abdalla EK, Jonas S, Bharat A, Schumacher G, Lerut J, Chapman WC, Hemming AW, Neuhaus P. Outcome of liver transplantation in 490 patients with Hepatocellular carcinoma: validation of a uniform staging after surgical treatment. Accepted for oral presentation at the Southern Surgical Association Annual Meeting, Palm Beach, FL, 2006. e-Pub 2006.
Mullen JT, Capussotti L, Zorzi D, Reddy S, Vauthey JN, Donadon M, Ribero D, Clary B, Abdalla EK. Hepatic insufficiency and mortality in 1059 noncirrhotic patients undergoing major hepatectomy. Abstract No. 12. Accepted for oral presentation at the Southern Surgical Annual Meeting, Palm Beach, FL, 2006. e-Pub 2006.
Mullen JT, Ribero D, Reddy S, Donadon J, Zorzi D, Abdalla EK, Capussotti L, Clary B, Vauthey JN. Hepatic insufficiency and mortality in 1,059 non-cirrhotic patients undergoing major hepatectomy (Abstract #29). Presented at the Southern Surgical Association 118th Annual Meeting, West Palm Beach, FL, 2006. e-Pub 2006.
Ribero D, Abdalla EK, Jonas S, Bharat A, Schumacher G, Lerut J, Chapman WC, Hemming AW, Neuhaus P, Vauthey JN. Outcome of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment (Abstract #12). Presented at the Southern Surgical Association 118th Annual Meeting, West Palm Beach, FL, 2006. e-Pub 2006.
Mieles L, Qu Z, Saggi B, Vauthey JN, Thomas M, Toman M, Merhav HJ. Pretransplant treatment of HCC rarely achieves complete tumor ablation. Accepted for a poster presentation at the 57th Annual Meeting of the American Association for the Study of Liver Diseases (57th AASLD), Boston, MA, 2006. e-Pub 2006.
Pawlik TM, Zorzi D, Abdalla EK, Wu TT, Ribero D, Aloia TA, Curley SA, Muratore A, Capussotti L, Vauthey JN. Preoperative chemotherapy regimen and body mass index predict hepatic injury following resection of hepatic colorectal metastasis. (GI ASCO) – J Clin Oncol, 2006. e-Pub 2006.
Madoff DC, Abdalla EK, Wallace M, Ng C, Ribero D, Vauthey JN. Portal vein embolization: a preoperative approach to imporve the safety of major hepatic resection. Current Medical Imaging Reviews 2(4):385-404, 2006. e-Pub 2006.
Madoff DC, Abdalla EK, Wallace MJ, Murthy R, Ahrar K, Gupta S, Wei SH, Hicks ME, Vauthey JN. Sequential transcatheter arterial chemoembolization and portal vein embolization before major hepatectomy for patients with hepatocellular carcinoma. Cardiovasc Interv Radiol 202, 2006. e-Pub 2006.
Aloia TA, Lee JE, Vauthey JN, Abdalla EK, Wolff RA, Crane CH, Evans DB, Pisters PW. Impact of prolonged recovery after pancreaticoduodenectomy on the delivery of adjuvant therapy to patients with pancreatic adenocarcinoma. 2005 Gastrointestinal Cancers Symposium, Hollywood, Florida, 2005. e-Pub 2005.
Poston GJ, Nordlinger B, Adam R, Alberts S, Ruers T, Primrose JN, Figueras J, Mentha G, Roh M, Curley SA, Vauthey JN, Rougier P, Alberts, Schmoll HJ, Patt Y, Kinstlinger F, Haller D. Appropriateness of treatment strategies for colorectal liver metastases (CLM): a decision model based on consensus detection within an international expert panel. European Congress Abstracts (EHPBA):9, 2005. e-Pub 2005.
Aloia TA, Vauthey JN. Novel port placement facilitates hand-assisted approach to minimally invasive right hepatectomy. HPB.

Book Chapters

Vauthey JN, Kawaguchi, Shindoh J. Hepatic Resection: General Considerations. In: Master Techniques in Surgery: Hepatobiliary and Pancreatic Surgery. Wolters Kluwer Health/Lippincott Williams & Wilkins, 2019.
Shindoh J, Mise Y, Vauthey JN. Anatomic Considerations, Operative Techniques and Perioperative Management. In: Textbook of Complex General Surgical Oncology. McGraw-Hill, 2018.
Patel S, Passot G, Vauthey JN. Malignant Liver Neoplasms. In: Maingot's Abdominal Operations. 13. McGraw-Hill, 1077-1096, 2018.
Kim BJ, Soliz JM, Aloia TA, Vauthey JN. What is the best pain control after major hepato-pancreato-biliary (HPB) surgery?. In: Advances in Surgery. Elsevier, 235-246, 2018.
Snyder RA, Vauthey JN. Hepatobiliary Cancers. In: The MD Anderson Surgical Oncology Handbook. 6th. Lippincott Williams & Wilkins, 357-397, 2018.
Mizuno T, Snyder RA, Vauthey JN. Should Patient Undergo Associated Liver Partition and Portal Vein Ligation in Staged Hepatectomy (ALPPS) or Two-Stage Liver Resection: Two-Stage Liver Resection. In: Hepato-Pancreato-Biliary and Transplant Surgery: Practical Management of Dilemmas. Beaux Books Publishing, 159-165, 2018.
Shindoh J, Brudvik KW, Vauthey JN. Primary Neoplasms of the Liver. In: Holand-Frei Cancer Medicine Book. Ninth. John Wiley & Sons, Inc, 1103-1114, 2017.
Shindoh J, Vauthey JN. Hepatic Neoplasms. Section: Hepatobiliary and Portal Venous System. In: Greenfield's Surgery: Scientific Principles & Practice. 6th. Lippincott Williams & Wilkins, 975-996, 2017.
Brudvik KW, Vauthey JN. Portal Vein Embolization. In: Extreme Hepatic Surgery and Other Strategies: Increasing Resectability in Colorectal Liver Metastases. 119-130. Springer, 2017.
Nagorney DM, Pawlik TM, Chun YS, Ebata T, Vauthey JN. Perihilar Bile Ducts. In: AJCC Cancer Staging Manual. Eighth. Springer, 311-316, 2016.
Zhu AX, Pawlik TM, Kooby DA, Schefter TE, Vauthey JN. Gallbladder. In: AJCC Cancer Staging Manual. Eighth. Springer, 303-309, 2016.
Shindoh J, Madoff DC, Aloia TA, Vauthey JN. Preoperative Portal Vein Embolization: Technique and Results. In: Blumgart's Surgery of the Liver, Biliary Tract, and Pancreas. 6th. Elsevier, 1653-1663, 2016.
Herman JM, Pawlik TM, Merchant NB, Tamm EP, Vauthey JN. Amuplla of Vater. In: AJCC Cancer Staging Manual. Eighth. Springer, 327-3354, 2016.
Kakar S, Pawlik TM, Allen PJ, Vauthey JN. Exocrine Pancreas. In: AJCC Cancer Staging Manual. Eighth. Springer, 337-347, 2016.
Abou-Alfa GK, Pawlik TM, Shindoh J, Vauthey JN. Liver. In: AJCC Cancer Staging Manual. Eighth. Springer, 287-293, 2016.
Aloia TA, Pawlik TM, Taouli B, Rubbia-Brandt R, Vauthey JN. Intrahepatic Bile Ducts. In: AJCC Cancer Staging Manual. Eighth. Springer, 295-302, 2016.
Krasinskas A, Pawlik TM, Mino-Kenudson M, Vauthey JN. Distal Bile Duct. In: AJCC Cancer Staging Maual. Eighth. Springer, 317-325, 2016.
Zalinski, S, Brouquet A, Vauthey JN. Underlying Liver Disorders in Hepatic Surgery. In: Principles of Hepatic Surgery. Benthan Science, 48-56, 2016.
Aloia TA, Vauthey JN. Hepatic metastases from colorectal cancer. In: Blumgart's Surgery of the Liver, Biliary Tract, and Pancreas. 6th. Elsevier, 1339-1354, 2016.
Abad JD, Tzeng, CWD, Vauthey JN. Extended Liver Resection Following Portal Vein Embolization. In: ACS Multimedia Atlas:Liver Volume. Cine-Med, Inc, 419-426, 2015.
Shindoh J, Vauthey JN. Postoperative Hepatic Insufficiency. In: Gastrointestinal Surgery: Management of Complex Perioperative Complications. Springer, 169-178, 2015.
Brudvik K, Vauthey JN. Present Status of the Resection Treatment of Liver Colorectal Metastasis (Patología del Hígado Vía Biliar y Páncreas: Principios y Práctica (Spanish Edition). In: Liver, Biliary Tract and Pancreas Diseases in Spanish. EdiMED, 2015.
Mise Y, Vauthey JN. Staging for Hilar Cholangiocarcinoma. In: Cholangiocarcinoma: From Diagnosis to Treatment. NOVA Publishers, 275-284, 2015.
Shindoh J, Vauthey JN. Staging of Biliary Tract and Primary Liver Tumors. In: Surg Oncol Clin N Am. 2. Elsevier, 313-322, 2014.
Shindoh J, Zimmitti G, Vauthey JN. Management of Liver Metastases from Colorectal Cancer. In: Surgical Oncology: A Practical Approach. Springer, 449-461, 2014.
Shindoh J, Zimmitti G, Vauthey JN. Surgical Techniques for Extrahepatic Management of Biliiary Tract Cancers. In: Biliary Tract and Gallbladder Cancer: A Multidiscliplinary Approach, 2nd Edition. Second Edition. Springer, 253-263, 2014.
Tzeng CWD, Vauthey JN. Liver Anatomy, Physiology, and Preoperative Evaluation for the Handbook of Pancreatic and Hepatobiliary Surgery. In: HPB Surgery Handbook. Lippincott Williams & Wilkins, 2014.
Roses RE, Vauthey JN. Hepatocellular Carcinoma: Epidemiology, Staging and Medical Management. In: Abrams' Angiography: Interventional Radiology. Third. Wolters Kluwer Health - Lippincott Williams & Wilkins, 44-50, 2013.
Ribero D, Morris-Stiff G, Vauthey JN. Hepatocellular Carcinoma: Presentation and Diagnosis. In: Textbook of Surgical Oncology. World Scientific, 205- 215, 2013.
Vauthey JN, Shindoh J. Hepatic Resection: General Considerations. In: Master Techniques in General Surgery. Wolters Kluwer Health/Lippincott Williams & Wilkins, 227-239, 2012.
Contreras CM, Brouquet A, Maru DM, Vauthey JN. Hepatic steatosis, steatohepatitis, and chemotherapy-related liver injury. In: Blumgart's Surgery of the Liver, Biliary Tract, and Pancreas. 5th. Elsevier-Saunders, 999-1005, 2012.
Cleary S, Zalinski S, Vauthey JN. Management of Cystic Disease of the Liver. In: Current Surgical Therapy. Tenth. Elsevier, 271-276, 2011.
Zorzi D, Hayashi Y, Vauthey JN. Clinical Outcomes for Liver Metastases. In: Venous Embolization of the Liver: Radiologic and Surgical Practice. Springer-Verlag London, 201-215, 2011.
Madoff DC, Vauthey JN. Indications and Contraindications for Portal Vein Embolization. In: Venous Embolization of the Liver: Radiologic and Surgical Practice. Springer-Verlag London, 123-128, 2011.
Chun YS, Vauthey JN. History of Major Liver Resections. In: Venous Embolization of the Liver: Radiologic and Surgical Practice. Springer-Verlag London, 3-8, 2011.
Zorzi D, Vauthey JN, Abdalla EK. Liver Resection for Hepatocellular Carcinoma. In: Hepatocellular Carcinoma - Targeted Therapy and Multidiscliplinary Care. Springer, 109-134, 2010.
Contreras CM, Vauthey JN, McMasters KM. Multidisciplinary Care of the Hepatocellular Carcinoma Patient. In: Hepatocellular Carcinoma - Targeted Therapy and Multidiscliplinary Care. Springer, 81-88, 2010.
McMasters KM, Vauthey JN. Follow-Up and Salvage Therapy for Recurrent Hepatocellular Carcinoma. In: Hepatocellular Carcinoma - Targeted Therapy and Multidiscliplinary Care. Springer, 383-391, 2010.
Zorzi D, Chun YS, Vauthey JN. Liver Resection of Colorectal Liver Metastases. In: Malignant Liver Tumors, Current and Emerging Therapies. Third. Wiley-Blackwell, 192-202, 2010.
Palavecino M, Zorzi D, Vauthey JN. Chemotherapy-Associated Hepatoxicity. In: Surgical Management of Hepatobiliary and Pancreatic Disorders. 2nd. Informa Healthcare, 173-179, 2010.
Donadon M, Morris-Stiff G, Vauthey JN. Metastatic Cancer of the Liver. In: General Surgery: Principles and International Practice. 2nd. Springer Verlag London Ltd, 1014-1026, 2009.
Ribero D, Chun YS, Vauthey JN. Surgery for Colorectal Metastases. In: Liver Metastases. Chapter 3. Springer-Verlag London Ltd, 25-38, 2009.
Gray KD, Ribero D, Vauthey JN. Malignant Liver Tumors. In: Current Surgical Therapy. 9th Edition. Mosby, Elsevier, 346-351, 2008.
Mullen JT, Zorzi D, Vauthey JN. Surgical Treatment of Cholangiocarcinoma. In: Advanced Therapy in Surgical Oncology. Chapter 18. BC Decker Inc, 157-164, 2008.
Mullen JT, Crane CH, Vauthey JN. Benign and Malignant Gallbladder Tumors. In: Diseases of the Gallbladder and Bile Ducts. 2nd Edition. Baillie J. Blackwell Publishing, Ltd, 252-262, 2008.
Badgwell BD, Ribero D, Vauthey JN. Surgical Management (Resection). In: Interventional Oncology: Principles and Practice. Chapter 12. Cambridge University Press, 121-134, 2008.
Vauthey JN, Pawlik TM, Abdalla EK, Aloia TA, Boudreaux CS, Chun YS, Dixon E, Fong Y, Kooby D, Lauwers GY, Mayo MS, Nagorney DM, Lombardo KR, Taouli B, Washington MK, Wittenkind C, Wu TT, Zhu A. Hepatobiliary Staging Chapters. In: AJCC Cancer Staging Manual. Seventh. Springer, 119-230, 2007.
Ribero D, Abdalla EK, Vauthey JN. Hepatocellular Carcinoma. In: Textbook of Surgical Oncology. Chapter 18. Informa Healthcare, 205-216, 2007.
Raut CP, Vauthey JN. Resection of the mid common bile duct. In: Atlas of Upper Gastrointestinal and Hepato-Pancreato-Biliary Surgery. Springer Verlag GmbH & Co, 587-590, 2007.
Aloia TA, Crane CH, Vauthey JN. Gallbladder Carcinoma. In: Textbook of Hepatology: From Basic Science to Clinical Practice. Third Edition. Blackwell, 1575-1582, 2007.
Vauthey JN, Madoff DC, Abdalla EK. Preoperative Portal Vein Embolization – A Western Perspective. In: Surgery of the Liver and Biliary Tract. Fourth Edition. Elsevier Publishers, 1461-1469, 2007.
Zorzi D, Mullen JT, Vauthey JN. Cholangiocarcinoma and Klatskin Tumor. In: Manual de Cirurgia Oncologica, 401-416, 2006.
Vauthey JN, Ajani JA, Curley SA, Janjan NA, Lynch PM. Metastatic cancer of the liver. In: Gastrointestinal Cancer New York. M. D. Anderson Cancer Care Series. Springer Science+Business Media, Inc, 165-183, 2005.
Pawlik TM, Thomas MB, Vauthey JN. Management of hepatocellular carcinoma. In: Advanced Therapy in Gastroenterology and Liver Disease. 5th Edition. Bayless TM, Diehl AM. B. C. Decker, Inc, 739-743, 2005.
Vauthey JN. Metastatic cancer of the liver. In: Anderson Associates Monograph on Gastrointestinal Cancer Care. Springer-Verlag, 202-219, 2004.
Curley SA, Izzo F, Abdalla E, Vauthey JN. Surgical treatment of colorectal cancer metastasis. Cancer and Metastasis Reviews. In: Bresalier. Kluwer Academic Publishers, 165-182, 2004.
Vauthey JN, Medgyesy D, Goffin, JR, Royce M, Ayoub JP, Hoff PM. Management options: Metastatic colorectal carcinoma. In: Gastrointestinal Oncology. Oxford University Press, 728-746, 2004.
Pawlik TM, Vauthey JN. Factors affecting morbidity and mortality of liver surgery. In: Current Surgical Therapy. 8th Edition, 348-352, 2004.
Madoff DC, Vauthey JN, Hicks ME. Preoperative portal vein embolization to increase the safety of major hepatectomies for hepatobiliary malignancies (Chapter 12). In: Society of Interventional Radiology Syllabus: Interventions in Oncology. Maryland Composition, 119-135, 2003.
Vauthey JN. Liver including intrahepatic bile ducts. In: American Joint Committee on Cancer Staging Manual (AJCC). 6th Edition, 131-144, 2002.
Saltz LB, Ahmad SA, Vauthey JN. Colorectal Cancer: Management of advanced disease. In: Principles & Practice of Gastrointestinal Oncology. Lippincott Williams & Wilkins, 825-852, 2002.
Bilimoria MM, Crane CH, Vauthey JN. Benign and malignant gallbladder tumors. In: Diseases of the Gallbladder and Bile Ducts. Blackwell Science, 197-201, 2001.
Bilimoria MM, Vauthey JN. Technique of extended hepatic resection. In: Liver Surgery – Anatomy, Operative Techniques and Avoidance of Complications. Georg Thieme Verlag, 171 178, 2001.
Wayne JD, Vauthey JN. Metastatic cancer of the liver. In: The Practice of General Surgery. Harcourt Health Sciences, 643-651, 2001.
Moshyedi AK, Vauthey JN. Cholangiocarcinoma and other tumors of the biliary tree. In: Therapy of Digestive Disorders. WB Saunders Company, 252-257, 2000.
Saldinger P, Vauthey JN. The natural history of gallstones and asymptomatic gallstones. In: Surgery of the Liver and Biliary Tract. (3rd edition). Harcourt Brace & Co., Ltd, 643 649, 2000.
Gallagher JT, Vauthey JN. Selective continuous intraarterial chemotherapy for liver tumors. In: Malignant Liver Tumors Current and Emerging Therapies. Blackwell Science Inc, 116-124, 1999.
Copeland EM III, Vauthey JN. Cáncer de mama localmente avanzado. In: Actualizacíon en Cirugía del Aparato Digestivo. Moreno González E, Hidalgo Pascual M. Jarpyo Editores SA,, 547–551, 1996.
Vauthey JN. Cholecystolithiasis: which approach? When?. In: Surgery of the Liver and Biliary Tract. (2nd edition). Blumgart LH. Churchill Livingstone, 663-665, 1994.
Vauthey JN. The natural history of gallstones and asymptomatic gallstones. In: Surgery of the liver and biliary tract. (2nd edition), 567-571, 1994.
Lerut J, Vauthey JN, Blumgart LH. Benign biliary strictures: etiology, diagnosis and therapy. In: Biliary Surgery, 1991.
Yamashita S, Vauthey JN. Surgical treatment for hepatocellular carcinoma in the era of multiple staging and algorithm. In: Complex General Surgical Oncology. Decker Intellectual Properties, Inc.
Abad J, Vauthey JN. Impact of future liver remnant volume on outcome following extended right hepatectomy. In: Advances in Surgery. Elsevier.
Shindoh J, Zimmitti G, Vauthey JN. Surgical Management of Hepatic Metastases. In: Clinical interventional oncology: Management and practice. 1st. Elsevier.
Vauthey JN, Yokoyama. Responsibilities of the Mentor. In: Mentorship and Leadership: Building for Success in Academic Surgery. Springer Science+Media, LLC.
Yao JC, Gupta S, Vauthey JN, Evans DB. Management of Nonfunctional Islet Cell Tumors of The Pancreas. In: Advanced Therapy in Surgical Oncology. B. C. Decker, Inc.
Kawaguchi Y, Vauthey JN. Improved survival after CLM resection over 20 year. In: Colorectal Liver Metastases. Springer Nature Switzerland AG.
Lillemoe H, Vauthey JN. Two-stage hepatectomy for biloblar colorectal liver metastases: experience of MD Anderson Cancer Center. In: Colorectal Liver Metastases. Springer Nature Switzerland AG.

Books (edited and written)

Vauthey JN, Kawaguchi Y, Adam R (René). Colorectal Liver Metastasis. Springer Nature Switzerland AG, 2022.
Tran Cao HS, Marcal LP, Mason MC, Yedururi S, Joechle K, Wei SH, Vauthey JN. Benign Hepatic Incidentalomas. Ed(s) 9. Mosby/Elsevier Health Sciences Division, 2019.
Vauthey JN, Brouquet A. Multidisciplinary Treatment of Hepatocellular Carcinoma. Springer-Verlag GmbH, 2013.
Madoff DC, Nagino M, Makuuchi M, Vauthey JN. Venous Embolization of the Liver: Radiologic and Surgical Practice. Springer-Verlag, 2011.
McMasters KM, Vauthey JN. Hepatocellular Carcinoma - Targeted Therapy and Multidisciplinary Care. Springer, 2010.
Vauthey JN, Hoff PM, Audisio RA, Poston GJ. Liver Metastases. Springer, 2009.
Vauthey JN, Petrelli NJ. Liver Cancer, Primary and Metastatic Liver Cancer. W. B. Saunders Company, 2003.
Vauthey JN, Petrelli NJ. Biliary Tract Cancer. W. B. Saunders Company, 2002.
Vauthey JN, Osborn AG. Evaluation and treatment of focal liver mass. Fairfield Medical Press, 1997.
Vauthey JN, Gardiol D, Mosimann R. Pathology of the arterial hepato–cystic network (in French). (Pathologie du réseau artériel hépatico-cystique. (A propos de 201 observations d’autopsie). Thesis of M.D. degree of Lausanne University Medical School,, 1983.

Letters to the Editor

Maki H, Vauthey JN, You YN. Reply to: Critical Appraisal of multidisciplinary treatment outcomes in young-onset colorectal cancer with synchronous liver metastases: A retrospective analysis and methodological Considerations. Eur J Surg Oncol: 108520, 2024.
Haddad A, Lendoire M, Paolucci I, Kang HC, Vauthey JN. Optimal imaging before local therapy of colorectal liver metastases. Lancet Oncol 25: e99, 2024.
Vega EA, Vauthey JN. Reply to: "Comment on: Benchmarks and Geographic Differences in Gallbladder Cancer Surgery: An International Multicenter Study," by Shi, Li-jun et al. Ann Surg Oncol.
Vega EA, Mellado S, Newhook TE, Vauthey JN. ASO Visual Abstract: Benchmarks and geographic differences in gallbladder cancer surgery: An international multi-center study. Ann Surg Oncol.
Kamarinos NV, Dawson LA, Saltz LB, Crane CH, Overman MJ, Vauthey JN, Odisio BC, Denys A, de Baère T, Pereira PL, Sze DY, Vogl TJ, Meijerink MR, Helmberger T, Kim HS, Solomon SB, Sofocleous CT. Trials of locoregional therapies inspired by SABR-COMET. Lancet 396: 956-957, 2020.
Nishioka Y, Tzeng CWD, Tran Cao HS, Vauthey JN. COVID-19 outbreak and surgeons’ response at a Cancer Center in the United States. Glob Health Med 2: 135-137, 2020.
Kawaguchi Y, Lillemoe HA, Vauthey JN. Comment on "Reappraising the concept of conditional survival after pancreatectomy for ductal adenocarcinoma". Ann Surg.
Odisio BC, Krampitz GW, Murthy R, Mahvash A, Javle M, Vauthey JN. Preoperative drainage for perihilar cholangiocarcinoma. Lancet Gastroenterol Hepatol 4: 10-11, 2019.
Passot G, Vauthey JN, Chun YS. ASO Author Reflections: RAS mutations in metastatic colorectal cancer. Ann Surg Oncol.
Vega EA, Simoneau E, Tzeng CD, Odisio BC, Aloia TA, Chun YS, Vauthey JN. Letter to the Editor Regarding "ALPPS Improves Resectability Compared with Conventional Two-Stage Hepatectomy in Patients with Advanced Colorectal Liver Metastasis": When Innovation is Not Enough. Ann Surg.
Cloyd JM, Mizuno T, Vauthey JN. Reply to: Dissecting the therapeutic implications of the complex SMAD4 regulatory network in metastatic colorectal cancer. Eur J Surg Oncol 44: 1285, 2018.
Lunsford KE, Javle M, Gaber AO, Vauthey JN, Ghobrial RM. Liver transplantation for locally advanced intrahepatic cholangiocarcinoma - Authors' reply. Lancet Gastroenterol Hepatol 3: 529-530, 2018.
Cloyd JM, Mizuno T, Vauthey JN. Reply To: Dissecting the therapeutic implications of the complex SMAD4 regulatory network in metastatic colorectal cancer. Eur J Surg Oncol 44: 1285, 2018.
Torres HA, Vauthey JN, Economides MP, Mahale P, Kaseb A. Hepatocellular carcinoma recurrence after treatment with direct-acting antivirals: First, do no harm by withdrawing treatment. J Hepatol 65: 862-864, 2016.
Mise Y, Vauthey JN, Kopetz S. Addition of RAS Mutation Status May Strengthen the Predictive Model for Progression of Indeterminate Pulmonary Nodules. Ann Surg 264: e7, 2016.
Brudvik KW, Vauthey JN. Re "Comparison of techniques for volumetric analysis of the future liver remnant: implications for major hepatic resections". HPB (Oxford) 18: 557, 2016.
Torzilli G, Belghiti J, Kokudo N, Takayama T, Capussotti L, Nuzzo G, Vauthey JN, Choti MA, De Santibanes E, Donadon M, Makuuchi M. Reply to Letter: A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations? An observational study of the HCC East-West Study Group": When the study setting "ignores" the patients. Ann Surg 262: e30-e31, 2015.
Mise Y, Kopetz S, Vauthey JN. Addition of RAS mutation status may strengthen the predictive model for progression of indeterminate pulmonary nodules. Ann Surg 264: e7, 2015.
Torzilli G, Belghiti J, Kokudo N, Takayama T, Capussotti L, Nuzzo G, Vauthey JN, Choti MA, De Santibanes E, Donadon M, Makuuchi M. Reply to Letter: "Dissecting EASL/AASLD recommendations with a more careful knife: A Comment on 'Surgical misinterpretation' of the BCLC staging system": real misinterpretation or lack of clarity within the BCLC?. Ann Surg 262: e18-9, 2015.
Vauthey JN, Mise Y. Commentary on "can we improve the morbidity and mortality associated with the associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) procedure in the management of colorectal liver metastases?". Surgery 157: 207-10, 2015.
Mise Y, Aloia TA, Vauthey JN. Liver volumetry in virtual hepatectomy must account for vascular territories. J Am Coll Surg 219: 1194-1195, 2014.
Aloia TA, Vauthey JN. Reply: Air leak test, two hands are better than none. J Am Coll Surg 218: 1078-1079, 2014.
Madoff DC, Vauthey JN. Re: portal vein embolization: what do we know?. Cardiovasc Intervent Radiol 36: 870-1, 2013.
Torzilli G, Belghiti J, Kokudo N, Takayama T, Capussotti L, Nuzzo G, Vauthey JN, Choti MA, De Santibanes E, Donadon M, Morenghi E, M` M. Reply to Letter to the Editor entitled "A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: Is it adherent to the EASL/AASLD recommendations? An observational study of the HCC East-West Study Group: When the study setting "Ignores" the patients. Ann Surg 257: 929-937, 2013.
Pawlik TM, Vauthey JN. Preoperative biopsy evaluation of chemotherapy-associated liver injuries: looking for a needle in a haystack? Comment on "prospective evaluation of accuracy of liver biopsy findings in the identification of chemotherapy-associated liver injury". Arch Surg 147: 1092, 2012.
Vauthey JN, Kopetz S, Aloia TA, Andreou A. KRAS mutation in colorectal cancer metastases after adjuvant FOLFOX for the primary. Br J Cancer 107: 1442-3; author reply 1444, 2012.
Vauthey JN, Kopetz S, Aloia TA, Andreou A. KRAS mutation in colorectal cancer metastases after adjuvant FOLFOX for the primary. Br J Cancer 107: 1442-1443, 2012.
Aloia TA, Vauthey JN. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): What is gained and what is lost?. Ann Surg 256: e9, 2012.
Madoff DC, Vauthey JN. Portal vein embolization: what do we know? CVIR Reply: Portal Vein Embolization: What Do We Know?. Cardiovasc Intervent Radiol, 2012.
Vauthey JN, Brouquet A, Andreou A, Kopetz S. Reply to N Personeni, et al. J Clin Oncol 29: 2734-2735, 2011.
Vauthey JN, Brouquet A, Pisters PW. Letter to the Editor in response to a Letter to the Editor by Donal B. O’Connor, MD, and Desmond C. Winter, MD, FRCSI, regarding our article published in March 2010 in Archives of Surgery entitled “Modified Makuuchi Incision for Foregut Procedures.”. Arch Surg 145: 284, 2010.
Vauthey JN, Zorzi D, Kopetz S, Abdalla EK, Kishi Y, Blazer DG, III. Reply to Colorectal hepatic metastases: adjuvant chemotherapy and survival by D. Gallagher et al. J Clin Oncol 27: e20-e21, 2009.
Palavecino M, Wittekind C, Vauthey JN. Treatment of stage IVA hepatocellular carcinoma. Arch Surg 143: 1235-1236, 2008.
Vauthey JN, Palavecino M, Curley SA, Abdalla EK. Re: Right hepatic trisectionectomy for hepatobiliary disease: results and an appraisal of its current role. Ann Surg 248: 138-9; author reply 139-40, 2008.
Abdalla EK, Vauthey JN. Letter to Editor: Steatosis at a risk factor in liver surgery. Ann Surg 246: 340-341, 2007.
Abdalla EK, Vauthey JN. Steatosis as a risk factor in liver surgery. Ann Surg 246: 340-1; author reply 341, 2007.
Abdalla EK, Vauthey JN. Improved survival after resection of colorectal liver metastases. J Clin Oncol 24: 2679; author reply 2680-1, 2006.
Poston G, Adam R, Vauthey JN. Downstaging or downsizing: time for a new staging system in advanced colorectal cancer?. J Clin Oncol 24: 2702-6, 2006.
Ribero D, Abdalla EK, Vauthey JN. In Reply: Chemotherapy-induced steatohepatitis in colorectal cancer patients. J Clin Oncol 24: 5467-5468, 2006.
Abdalla EK, Vauthey JN. Improved survival after resection of colorectal liver metastases. J Clin Oncol 24: 2679, 2006.
Pawlik TM, Abdalla EK, Thomas M, Roh MS, Lauwers GY, Ribero D, Poon RT, Belghiti J, Nagorney DM, Vauthey JN. Staging of hepatocellular carcinoma. Hepatology 42: 738-9; author reply 739-40, 2005.
Pawlik TM, Abdalla EK, Vauthey JN. Liver transplantation for hepatocellular carcinoma: need for a new patient selection strategy. Ann Surg 240: 923-4; author reply 924-5, 2004.
Vauthey JN, Pawlik TM, Lauwers GY, Nagorney DM, Roh MS, Curley SA, Poon RT, Belghiti J, Greene F, Henderson JM. Critical evaluation of the different staging systems for hepatocellular carcinoma. Br J Surg 94: 1072-1074, 2004.
Vauthey JN, Loyer E. Comment on Case 57-Diagnosis Please. Radiology 230: 595, 2004.
Pisters PW, Lee JE, Vauthey JN, Evans DB. Comment and perspective on Sewnath and colleagues' recent meta-analysis of the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice. Ann Surg 237: 594-5; author reply 595-6, 2003.
Abdalla EK, Vauthey JN. Eosinophilic cholangiopathy. Surgery 131: 237-8, 2002.
Esnaola NF, Vauthey JN, Lauwers GY. Liver fibrosis increases the risk of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. Br J Surg 89: 939-940, 2002.
Vauthey JN, Sobin LH. On the uniform use of the AJCC/UICC staging system for hepatocellular carcinoma. Surgery 128: 870, 2000.
Vauthey JN, Walsh GL, Vlastos G, Lauwers GY. Importance of field cancerisation in clinical oncology. Lancet Oncol 1: 15-6, 2000.
Vauthey JN, Walsh GL, Vlastos G, Lauwers GY. Emerging importance of field cancerization in clinical oncology. Lancet Oncology 1: 15 16, 2000.
Vauthey JN. Hepatobiliary Cancer. Cancer Control 5: 32-33, 1998.
Vauthey JN, Klimstra D, Blumgart LH. A simplified staging system for hepatocellular carcinoma. Gastroenterology 1995; 108:617–618 108: 617-618, 1995.
Vauthey JN, Lerut J. Treatment of necrotizing pancreatitits. Am J Surg 167: 458, 1994.
Vauthey JN, Matthews C. Hepatic portal venous gas identified by computed tomography in a patient with blunt abdominal trauma: a case report. J Trauma 32: 120, 1992.
Guastella T, Vauthey JN, Maddern GJ, Gertsch P. A rare cause of severe bleeding from the anterior duodenal wall: the cystic artery. J Clin Gastroenterol 13: 598-599, 1991.

Patents

Microspheres for use in the treatment of Cancer. Patent Number: No. 6,602,524.